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Abstract 
The aim of this thesis is to inform clinicians and researchers of the reliability and 
responsiveness of the most commonly used outcome measures in prosthetic 
rehabilitation in the UK.  In addition, this thesis supports the call for more studies of 
high methodological quality to provide evidence of the psychometric properties of 
outcome measures of physical function in lower limb amputees. 
 
A survey (study I) of Allied Health Professionals established that the outcome 
measures used most often during prosthetic rehabilitation in the UK were: the Timed 
Up and Go (TUG), a timed walk test, the Locomotor Capability Index (LCI) and its 
modified version (LCI-5), the Socket Comfort Score (SCS) and the Special Interest 
Group in Amputee Medicine (SIGAM) Mobility Grades. 
 
A standardised quality checklist (COSMIN) was used in a systematic review (study 
II) to measure the methodological quality and strength of evidence of the published 
literature that reported on the psychometric properties of outcome measures used to 
measure physical function during prosthetic rehabilitation.  The review found mixed 
methodological quality ratings and many studies with small sample sizes rendering 
the strength of the evidence indeterminate.  A limited number of studies commented 
on limits of agreement and measurement error when reporting on reliability.  Even 
fewer studies reported on responsiveness with only one reporting minimally clinically 
important difference (MCID) values. 
 
Values for consistency, agreement and measurement error, were calculated for the 
top five commonly used outcome measures as identified from the survey, using a 
test-retest study design with a period of 7 days between tests (study III).  Minimum 
detectable change (MDC) values were calculated for the SIGAM, LCI-5, TUG and 
2MWT. The EQ-5D-5LTM, a measure of the global health of the respondent, was 
also included as knowledge of its psychometric properties in a population of pwLLA 
is unknown. However, reliability could not be confirmed for the EQ-5D-5L or the 
SCS in this population.   
 
A longitudinal study (study IV), based during the early rehabilitation period (mean 84 
days) following provision of a primary prosthesis, gathered data to calculate indices 
of responsiveness for the same six outcome measures.  Effect sizes were presented 
for five measures: SIGAM, LCI-5, TUG, 2MWT, SCS and EQ-5D-5L.  Minimal 
clinically important difference values were also presented for the first time for all the 
outcome measures in this population.  A patient reported change questionnaire was 
used as the anchor in a Receiver Operator Characteristic (ROC) curve analysis to 
establish the MCID values. 
 
Key Words: Lower limb amputation, Prosthetic rehabilitation, Outcome 
measurement, Reliability, Measurement error, Responsiveness.  
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1 Chapter 1 Introduction 
1.1 Introduction 
A person’s life is changed forever when a limb is amputated. Whether the 
amputation is performed to save their life following a traumatic accident; or follows a 
gradual deterioration in their clinical condition, amputation surgery will alter their pre-
morbid physical and emotional state.  A variety of factors influence an amputee’s 
rehabilitation, and understanding the impact and context of these factors is essential 
to a successful outcome for the patient.   However, the focus in this thesis will be on 
the physical changes that a person with a lower limb amputation (pwLLA) 
experiences, and how these changes may be measured, in particular following 
delivery of their first artificial limb or prosthesis.   
 
It is accepted that the provision of a prosthesis following a lower limb amputation will 
change the physical performance of a pwLLA (Sansam et al. 2009, Ostler et al. 
2014).  However, arguments continue about the distinctions between different 
prosthetic components regarding their impact on this performance. In monetary 
terms the difference between two prosthetic knee joints can be thousands of 
pounds, but it is still a matter of debate whether differences in the functional abilities 
of a pwLLA due the use of two different joints can be detected.  Is one knee “better” 
than another?  What does “better” mean?  If, for example, this means, “better 
mobility” then how is mobility measured?   According to an Evidence Note produced 
in 2012 by the Scottish Government body Health Improvement Scotland (Health 
Improvement Scotland 2012), evidence suggests that “in healthy and active younger 
people, who have had a trans-femoral amputation the C-Leg® (Otto Bock, 
Duderstadt) may improve health outcomes (e.g. body image, safety, energy 
efficiency, gait and functionality) compared with mechanically controlled knees”.   
However, the strongest evidence was from crossover randomised trials, and the 
authors of the evidence note commented that these studies were “generally small” 
(range 1-41) and “methodologically weak” (non-blinded, non-randomised and not 
generalisable to the wider population of pwLLA) (Highsmith et al. 2010, Theeven et 
al. 2011).  An issue highlighted within this Highsmith review of prosthetic research 
was bias, as many studies included had also “received sponsorship from the 
manufacturers”.  
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The price for the two knees described was given as £2,000 for the mechanical knee 
and £16,000 for the C-leg, a microprocessor knee (MPCK).  The prices were correct 
at the time the evidence note was produced, though costs for new generation 
MPCKs have risen considerably since.  Health Improvement Scotland go on to 
conclude that there was little evidence relating to older people with chronic illness or 
reduced function, and there is “insufficient evidence to determine whether the 
MCPKs are cost effective compared to the mechanical knees”.  With healthcare 
costs rising it is incumbent on the clinicians prescribing these different components, 
to understand the impact of one over the other.   
 
The current condition of a patient can be captured by an outcome measure.  If an 
outcome measure is repeated then a change in their condition may then be 
determined.  Thus, data collected from outcome measures can provide the answer 
to the questions posed above, but only if the outcome measure used is fit for that 
purpose.  For example, when looking at how mobile an amputee is around their 
home and outdoors using his / her prosthesis, data from the Wheelchair Skills Test 
(Kirby et al. 2004) will only provide information on how mobile an amputee is in a 
wheelchair.  To determine how mobile an amputee is with their prosthesis, an 
outcome measure must test some weight-bearing activities: standing, walking or 
running.  Therefore, deciding which activities to measure is central to demonstrating 
the effectiveness of a prosthesis on the pwLLA’s ability to mobilise, i.e. the construct 
being measured by the outcome measure must be a construct of interest to the 
researcher or clinician.   
 
There does not appear to be a clear consensus on which outcome measure(s) to 
use, within clinical groups working in prosthetic rehabilitation; this is despite a wide 
variety of outcome measures purporting to measure aspects of physical function to 
choose from.  The choice requires an understanding, not only of the construct the 
instrument is designed to measure, but also its measurement properties i.e. its 
reliability, validity and responsiveness.  A full understanding of these measurement 
properties, also known as psychometric properties, will help clinicians and 
researchers choose the most appropriate outcome measure.  For example, when 
assessing the differences between one prosthetic component and another it is 
critical to know whether an outcome measure is able to detect changes accurately in 
the performance of a pwLLA.  The use of valid and reliable outcome measures, that 
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are responsive to change, can also objectively record the functional ability of a 
pwLLA at each stage of their rehabilitation.    
 
Previous reviews of the literature have highlighted a lack of evidence available on 
the psychometric properties of outcome measures used with pwLLAs (Condie et al 
2006, Deathe et al 2009, Hebert et al 2009).  There are also concerns that current 
prescription guidelines (e.g. Medicare K levels) may be too rigid when used in the 
standardisation of the provision of prosthetic components by not allowing lower 
functioning amputee’s access to higher functioning components.  There have been 
calls for more objective measures of ability in the prescription process (Kannenberg 
et al. 2014), where the use of more robust outcome measures in the assessment 
phase, could lead to improved performance and safety benefits for the patient.  
 
The research topic of this PhD was prompted by an interest in guiding clinicians and 
researchers on the appropriate use of outcome measures during prosthetic 
rehabilitation.  In particular, those outcome measures that measure physical 
performance of pwLLAs.  The premise being that by providing robust evidence of 
the outcome measures that are used, clinicians and researchers will be able to 
effectively measure the impact of prosthetic componentry.  In the context of rising 
healthcare costs this will assist in getting value for money for all pwLLAs. 
 
 
1.2 Topics and key terms 
1.2.1 Epidemiology and classification of lower limb amputations 
Lower limb amputees are often classified as having had a major or minor 
amputation.  This relates to the location of the surgery, and the most common major 
amputation levels of the lower limb are; trans-tibial (TT), trans-femoral (TF), through-
ankle or Symes amputation, through-knee and through-hip or hip disarticulation.  
Other amputations below the ankle, either through the mid or fore-foot or amputation 
of any or all of the toes, are classified as minor.  In many rehabilitation studies 
involving pwLLAs, these minor level amputations are usually reported together as a 
group because of the small numbers recorded.   
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Further discussion of the aetiology and care-pathway of a pwLLA from surgery to 
the provision of their prostheses, will be presented in chapter 2. 
 
1.2.2 Outcome measurement 
Outcome measures have been described in various ways as: instruments, scales, 
tools, indices etc. and have been designed to measure a huge variety of 
psychological, physiological and physical characteristics of human behaviour, 
attitudes and activities.  These characteristics can be measured in order to classify, 
predict, and motivate individuals, as well as attest to the success (or otherwise) of 
healthcare interventions.  Within the field of prosthetic rehabilitation, amputees, 
clinicians, researchers, managers and policy makers all use outcome measures for 
a diversity of reasons.   
 
The way information (data) is collected from the patient varies depending on the 
type of outcome measure.  Outcome measures that ask the individual to report on 
their own capacity or capability or how they feel about their accomplishments are 
often referred to as self-reported or patient-reported outcome measures (PROMs). 
Performance-based measures are more objective as the activities are recorded by 
an observer. These are the two main types of outcome measure that will be 
discussed in this thesis. 
 
The topic of outcome measurement will be further discussed in detail in chapter 2, 
with evidence, demonstrating which outcome measures are currently used within the 
clinical practice setting of prosthetic rehabilitation, presented in chapter 3. 
 
1.2.3 Psychometrics vs Clinimetrics  
The term psychometrics in relation to outcome measures is used to describe the 
measurement properties (i.e. internal consistency, reproducibility or reliability, 
validity and responsiveness) of the outcome measures and was developed in the 
field of psychology (Streiner 2003).  Clinimetrics is a term that is also used to 
describe measurement properties, however its base is within the clinical or health 
science fields and is employed in relation to instruments utilised in those areas.  It 
has been argued that clinimetrics widens the range of information with the inclusion 
of “soft data” (Fava et al. 2012).  When considering the role of clinical assessment in 
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the 21st Century, soft data, including judgements on impairment and well-being, are 
a necessary addition to the hard data obtained from laboratory results.   The term 
clinimetrics has only begun to be used relatively recently, whereas psychometrics 
has been in use far longer.  There has been a call to stop using the term 
clinimetrics, to clear up any confusion that may arise (Streiner 2003), as both terms 
are regularly used synonymously throughout the literature.  Galea in 2005 published 
this explanation “the purpose of clinimetrics is to alert clinicians to the psychometric 
properties of instruments that have clinical utility in current physiotherapy practice” 
(Galea 2005).   In an effort to minimise confusion, the term psychometrics will be 
used throughout this thesis.   
 
1.2.3.1 Psychometric properties  
A variety of terms can be used when describing the psychometric properties of an 
outcome measures.  A Delphi study undertaken by a group from the COSMIN 
initiative (COnsensus-based Standards for the selection of health Measurement 
INstruments) aimed to reach a consensus on a) the relevant psychometric 
(measurement) properties for health-related patient-reported outcomes (HR-PROs) 
and b) the terminology and definitions of these measurement properties (Mokkink et 
al 2010a).  The authors proposed a taxonomy of terms, with the measurement 
properties grouped within three main domains: Reliability, Validity and 
Responsiveness.  There appeared to be most debate about reliability, but the 
terminology agreed on were; internal consistency, reliability and measurement error 
all combined under the domain of reliability. The other two main domains were: 
validity, which includes the measurement properties; content validity, face validity, 
construct validity, structural validity and criterion validity and; responsiveness. 
 
While the outcome measures discussed in this thesis will also include observed 
measures of performance, and not only HR-PROs, the terminology and definitions 
published by  Mokkink et al in 2010 will be used throughout. Further discussion of 
the psychometric properties that are pertinent to this thesis will be presented in 
Chapter 2.  Study design requirements and preferred statistical methods for 
evaluating HR-PROs was an additional aim of the Delphi study undertaken by 
Mokkink et al (2010) and will also be discussed in more detail in relation to the 
systematic review in Chapter 4. 
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1.2.4 Conceptual framework  
An outcome measurement framework will be considered throughout this thesis 
together with the concept that treatments / interventions change performance.   
 
Within the International Classification of Functioning Disability and Health (ICF) 
framework if an individual has a problem executing a task or action they are 
classified as having a limitation at the person level.  If they are limited by an inability 
to perform a task to participate or be involved in personal, social or work activities 
they are deemed to have limitations at a societal level.   Prosthetic rehabilitation as 
an intervention, will impact on activity limitations for a pwLLA.  However the bio-
psychosocial model of disability, that is the basis for ICF, interlinks activity at an 
individual level with impairments at the body level and also limitations at a societal 
level (Ustun et al. 2003).   
 
Further observations of the ICF classification and its uses with regard to the pwLLA 
population will be explored more fully in Chapter 2.  Examining the outcome 
measures used in prosthetic rehabilitation and the evidence of their psychometric 
properties, will also be more fully explored and addressed in later chapters (3, 4 and 
5). 
 
 
1.3 Structure of thesis 
 
The structure of the thesis is outlined in Figure 1.1.  The thesis includes a 
background chapter followed by four chapters, each of which will present the 
methodology, results, discussion and conclusion separately for the four investigative 
and empirical studies which comprise the main body of the thesis.  The final 
discussion chapter brings together the conclusions from each study and presents 
their implications in the context of the prosthetic rehabilitation and research; as well 
as in the context of the wider debate on outcome measurement.  
 
An overview of the four studies within the context of the research aims and specific 
questions posed within this thesis will be presented at the end of chapter 2.  
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Figure 1-1   Structure of thesis 
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2 Chapter 2 Background 
2.1 Purpose of chapter 
The purpose of this chapter is to summarise the evidence on which the research 
questions of this thesis are based.  The essential features of the literature, as it 
relates to this thesis, will be presented.  Key gaps in the knowledge base identified 
will be discussed to support the rationale for the thesis. 
 
2.2 Lower limb amputee population  
This section will introduce the population of pwLLA and explore the pathway of care 
from the decision to amputate through to fitting of a prosthetic limb (limb-fitting).    
 
2.2.1 Epidemiology and aetiology 
Lower limb amputation may be undertaken for a variety of reasons, the most 
prevalent of which is peripheral arterial disease (PAD).  Atherosclerosis of the 
peripheral arterial vessels restricts the supply of blood to the extremities and, if not 
revascularised, ischaemia and necrosis of the tissues will eventually lead to 
amputation.  End-stage renal disease, poor functional status and diabetes increase 
the need for amputation in patients with PAD (Dillingham et al. 2005).  Those 
patients with diabetes, in particular, have an increased risk for amputation compared 
to those who do not have the disease (Jeffcoate et al. 2012).  In addition, not only 
are diabetics likely to experience their initial amputation at a younger age (Davie-
Smith et al. 2016) but they are also more likely to progress to higher-level 
amputations (Holman et al. 2012).  Further complications are also to be expected as 
they are likely to be more severely disabled and die at a younger age compared to 
amputees without diabetes (Dillingham et al. 2005). An epidemiological study of 
lower limb amputations in England confirmed these findings with results showing 
that 43.1% of patients undergoing an amputation had a primary diagnosis of 
cardiovascular disease, 12.3% had endocrine, nutritional or metabolic disease, 
which includes diabetes, 13.9% had injury or trauma, 2.2% neoplasm and 6.9% 
were unclassified (Moxey et al. 2011, Moxey et al. 2010).  The same study showed 
that 39.4% of patients undergoing major lower limb amputations had diabetes and 
the percentage rose to 50% in those undergoing minor amputation (below the ankle 
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joint).  Similar overall prevalence data was found in a retrospective audit of hospital 
data (Ahmad et al. 2014).  The prevalence of major lower limb amputations in men 
was seen to be twice that of women in the Ahmad study and also in a retrospective 
cohort study of non-traumatic patients undergoing amputation in Scotland (Davie-
Smith et al. 2016).   
 
The Scottish Physiotherapy Amputee Research Group (SPARG) collect data on all 
amputations carried out in Scotland.  The latest data, published in March 2016, 
giving figures for the year 2013, showed there were 848 amputations (on 809 
patients) during that year (Scott et al. 2016).  The demographic data reported, is 
broadly similar to the breakdown of the English data, with an average age at 
amputation of 67 years (median 70) and approximately two thirds (68%) male.  
However, with 85% of all amputations due to PAD and/or diabetes, this may reflect 
the higher prevalence of cardiovascular disease in the Scottish population (Morris et 
al. 2001, Leyland 2005).   The percentage of TT amputations was 56% and 40% 
were at the TF level. 
 
It is not surprising then that together, PAD and diabetes account for the majority of 
cases referred for lower limb prosthetic assessment in the UK (57%) with infections 
(10%) and trauma (9%) the next most frequent causes (United National Institute for 
Prosthetics,& Orthotics Development 2013).  The most recent report from the United 
National Institute for Prosthetics & Orthotics Development (UNIPOD) managed by 
the University of Salford showed that there were nearly 6,000 (5906) new amputee 
referrals for prosthetic treatment in 2011-2012 (UNIPOD 2013).  Lower limb 
amputations contributed to 91% of these referrals, with 53% aged 64 years or older 
and just over one quarter (27%) aged over 74.  The highest number of referrals 
were for patients with a TT amputation (56%) and 48% of the referrals were for TF 
amputations. These figures are similar to previous year’s referral data.  Although the 
average age of those referred for to the limb-fitting centres is not presented, age 
ranges show 53% of all referrals are over the age of 64 and 27% are over the age of 
74.    
 
While there has been a large amount of publicity surrounding the military personnel 
who have undergone amputations as a result of recent conflicts their numbers are 
relatively small.  Data from the UK Ministry of Defence showed a peak of 82 
11 
 
amputations in 2010 - 2011 but the annual figures are now falling, with 55 reported 
in 2011-12 and 40 in 2012-13 and no more than 10 each year since (Defence 2015).  
In contrast to the civilian population, the military amputee is much younger and with 
fewer chronic co-morbidities.  However, the demands that these younger and more 
active amputees put on their prostheses have helped to promote advances in 
prosthetic manufacturing and rehabilitation for all pwLLAs (Laferrier and Gailey 
2010).  
 
2.2.2 From surgery to limb fitting 
2.2.2.1 Pre-operative assessments and decisions on amputation level 
When an amputation is undertaken the aim is to preserve as much function as 
possible.  This is done by utilising the most viable tissue and saving as many joints 
as possible.  However, there is a fine balance to be reached on the amount of viable 
tissue with a healthy blood supply that can be retained, allowing rehabilitation 
without risking further surgery or the spread of infection in vulnerable tissue.  Which 
surgery is undertaken, and when, may have a considerable effect on the resulting 
physical capability of a pwLLA. Evidence from a recent systematic review indicated 
that skin problems affecting tissue viability appear to be linked to poor tolerability of 
the prosthesis (Butler et al. 2014).  The authors noted a lack of robust evidence on 
the long-term effects of poor tissue viability and recommended further work is 
undertaken.  Identification of clearer links between tissue viability and other key 
factors may help inform help clinical management strategies and care pathways for 
pwLLAs. 
 
An amputation at the TT level obviously preserves the knee and hip joints, while a 
TF amputation preserves only the hip joint.  The resultant energy requirements to 
propel a prosthesis are increased at the TF level (Genin et al. 2008).  With the 
majority of amputees over 60 years of age, this will therefore have an impact on 
their level of activity with a prosthesis.  Amputations that bisect a joint, cutting 
through only the soft tissues around the joint, are quicker to perform, e.g. at the 
knee joint the femoral condyles are left intact leaving a longer lever which helps 
provide more stability in sitting (Morse et al. 2008).  This type of surgery may be 
considered if the patient is an anaesthetic risk and not necessarily a candidate for 
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rehabilitation with a prosthesis as this particular level is not a popular choice with 
prosthetists as there are challenges when fitting a prosthetic knee joint. 
 
Pre-surgery consultations with the prosthetic rehabilitation multi-disciplinary team 
(MDT) can speed up the post-operative recovery period by assessing the patient 
early, and in some cases starting the rehabilitation programme before surgery.  
Establishing the physical condition of a pwLLA pre-operatively will help in this 
recovery process, as increasing age at time of amputation, a high number of co-
morbidities and poor physical function have been shown to negatively impact on the 
prosthetic outcome (Munin et al. 2001, Schoppen et al. 2003, Hamamura et al. 
2009).  Knowledge of these, and other factors, help predict whether the pwLLA will 
be a successful prosthetic limb-user; as well as the likely activity level they will 
reach, e.g. indoor / outdoor walking, or more active pursuits (Taylor et al. 2005).    
 
2.2.2.2 Early post-amputation rehabilitation 
Many factors, both physical and psychosocial will influence the outcome of the 
rehabilitation (Schaffalitzky et al. 2012, Desmond et al. 2008, Gallagher et al. 2011), 
and not all pwLLAs will benefit or be able to use a prosthetic limb.  From the SPARG 
data collected in 2013 it was seen that 322 (41%) pwLLAs progressed to prosthetic 
limb-fitting following their amputation and 22 (3%) subsequently abandoned their 
prosthesis before discharge.  Forty-six percent of pwLLAs (365) were not limb-fitted 
and the remainder either died or were lost to follow-up (Scott et al. 2016).    
 
Before a decision is made whether a prosthetic limb will be prescribed, the amputee 
is assessed by the MDT for their suitability to use a prosthesis. The use of an early 
walking aid (EWA) will help assist with this decision. There are several types of 
EWA available, but the principle is to get the LLA walking on a temporary leg, as 
soon as possible after the surgery.  This will guide the MDT, and the amputee, on 
whether they have the physical capabilities to use a prosthesis for mobilising.  
Specially designed outcome measures have been developed to assess the LLA for 
the purpose of predicting their physical potential as a successful limb-user or not, for 
example; the Trans-femoral Fitting Predictor (TFP) tool (Condie et al. 2011), and the 
Amputee Mobility Predictor (AMP) tool (Gailey et al. 2002, Raya et al. 2013).  It is 
often decided, that given the average age and range of co-morbidities of the majority 
of pwLLAs, many will have a better quality of life using a wheelchair, especially if 
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they have had a TF amputation due to the increased energy expenditure required to 
mobilise at that level (Genin et al. 2008, Goktepe et al. 2010). 
 
2.2.2.3 Limb-fitting and prosthetic rehabilitation 
If an amputee is deemed to be a suitable candidate for a prosthesis, the MDT must 
then consider which prosthetic components will suit the predicted activity levels for 
the amputee.  Whether the pwLLA is receiving their first (primary) prosthetic limb, or 
they are more established using their prosthesis and are looking for a replacement, 
or a second limb is required for other activities, e.g. swimming or running, the same 
physical considerations are taken into account.  These include; what the overall 
current clinical/medical condition of the pwLLA is, and the potential for that to 
change; how active they are and what potential improvement the prosthetic limb will 
have on their lives.  This last aspect is often the most important to the amputee but 
is the hardest to predict and measure.    
 
2.2.3 Classification of functional ability and prosthetic prescription 
It is fundamental to the prescription process that both the individual’s activity and 
capability levels are assessed when choosing the correct prosthetic component for 
that individual. The choice of prosthetic component is often guided by the level of 
the pwLLA’s functional ability and the use of a classification system assists in this 
process.  In 2001, the US Health Care Financing Administration published a 5-level 
functional classiﬁcation system using code modiﬁers (K0, K1, K2, K3, K4), known as 
the Medicare K-level classification system (see Table 2.1).  Each “K-level” relates to 
the functional abilities of the pwLLA, and the lower the activity potential of the 
amputee, the lower is his/her assigned K-level and vice versa.   
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Table 2.1   K-Level classification (adapted from AAO&P website)    
K-Level Description 
K0 This patient does not have the ability or potential to ambulate or transfer safely 
with or without assistance and a prosthesis does not enhance their quality of life 
or mobility.  
K1 This patient has the ability or potential to use a prosthesis for transfers or 
ambulation on level surfaces at fixed cadence - a typical limited or unlimited 
household ambulator.  
K2 This patient has the ability or potential for ambulation with the ability to traverse 
low-level environmental barriers such as curbs, stairs, or uneven surfaces - a 
typical community ambulator.  
K3 The patient has the ability or potential for ambulation with variable cadence - a 
typical community ambulator with the ability to traverse most environmental 
barriers and may have vocational, therapeutic, or exercise activity that demands 
prosthetic use beyond simple locomotion 
K4 The patient has the ability or potential for prosthetic ambulation that exceeds 
basic ambulation skills, exhibiting high impact, stress, or energy levels - typical 
of the prosthetic demands of the child, active adult, or athlete 
 
These levels are arrived at by questioning patients as to their current functional 
ability as well as taking into account their concurrent medical condition and trying to 
predict what level they may achieve.  There does not appear to be an agreed 
method of gathering information on activity levels nor which specific data should be 
recorded (van Twillert et al. 2013).  However, this classification system is widely 
used to guide the reimbursement of healthcare payments across the United States.  
It is also used by most prosthetic companies to classify the use of different 
prosthetic components, such as feet and knee joints.  It should be acknowledged 
that there appears to be an absence of any formal assessment of psycho-social 
factors when considering the prosthetic prescription for a pwLLA.  While this is 
worthy of further discussion, there will be no in-depth handling of that topic here, as 
the main focus of the thesis is the examination of outcome measures of physical 
function used during prosthetic rehabilitation. 
 
Regulating the choice of prosthetic components on the basis of functional ability 
represents consideration of the cost-effectiveness of prescribing such components 
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to less active users.  However, evidence is emerging that some of the newer, more 
expensive, components may be beneficial for the frailer amputee rather than the 
more active pwLLA for whom they are usually prescribed.  For example, MCPKs 
were introduced primarily for the more active amputee at the high K3 and above 
level. However, some benefits, such as “stumble control” have been observed with 
less active amputees at the K2 level (Sawers and Hafner 2013, Kannenberg et al. 
2014).    The results of both reviews however, are to be viewed with some caution 
with regard to the outcome measures used.  The evidence provided with regard to 
activity levels in the Sawers & Hafner review came from eight studies.  The authors 
recognised the use of appropriate outcome measures was essential to a good 
quality study and had therefore noted whether valid and reliable outcome measures 
were used.  However, they concluded that in only two of the eight studies, the use of 
(what they considered) a reliable outcome measure was identified (Sawers and 
Hafner 2013).   In the review by Kannenberg et al published in 2014, the authors 
identified that current classification systems have an element of subjectivity that 
calls for speculation of the amputee’s functional potential, by the assessor, and 
noted this as a limitation of the studies included.  They have called for a validated 
and “unambiguously quantifiable” classification system that could objectively assign 
functional levels and be used with performance-based tests to identify clinically 
meaningful improvements.    
  
Fortington et al (2012) also identified that a mobility outcome measure should be 
valid and reliable as well as being responsive to change when they looked at 
whether a prognosis for mobility (prosthetic or non-prosthetic) could be made in 
elderly pwLLAs.  However, their findings were inconclusive because of “incomplete 
reporting of study populations and poor reporting of the reliability of the mobility 
measures used”. They recommended further research into the mobility outcomes of 
this elderly population (Fortington et al. 2012). 
 
The use of valid and reliable outcome measures that are responsive to change and 
can objectively record the functional ability of the pwLLA at each stage of their 
rehabilitation, would help standardise the provision of prosthetic components.  This 
standardisation could play an important role in the clinical decision making process 
of prosthetic prescription. However, it would seem that there is a gap in the evidence 
provided for such outcome measures.   
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2.2.4 Outcome measures used with pwLLAs 
While the focus of this thesis is on physical function, in the context of prosthetic 
rehabilitation, many outcome measures are employed to assess different aspects of 
the individual patient’s progress as well as the effect of therapy programmes or 
changes in prosthetic components.   However, research studies investigating these 
effects will often report results only at the group level.  As a result clinicians will not 
have information on how many outcome measures may be used at the individual 
level in clinical practice.  
 
2.2.4.1 Amputee-specific outcome measures 
Despite there being a large number of general outcome measures available, many 
specific amputee outcome measures have been developed.  These outcome 
measures have been specifically designed for use with pwLLAs for a variety of 
reasons.  See table 2.2 for those that have been developed and subsequently 
described in published studies.  While others were developed with different 
populations and have been subsequently validated for use with amputees, see 
Table 2.3.    
 
Table 2.2    Outcome measures specifically developed for pwLLAs 
Outcome Measure Type Main Constructs being 
Measured 
Amputation Related Body Image Scale  PROM Body Image 
Amputee Activity Score (AAS) PROM Functional Activities 
Amputee Mobility Predictor (AMP)  Observed Functional Activities 
Functional Measure for Amputees (FMA) PROM Functional Activities 
Houghton Scale PROM Prosthetic Use 
Locomotor Capabilities Index (LCI)  or 
Modified LCI-5 
PROM Functional Mobility 
Orthotics and Prosthetics National Outcomes 
Tool (OPOT) 
Mixed Health-related Quality of Life 
(HR-QoL), Functional Mobility 
Prosthesis Evaluation Questionnaire (PEQ) PROM Prosthetic-related Quality of 
Life (PR-QoL) 
Prosthetic Profile of the Amputee (PPA) PROM PR-QoL, Functional Activities 
Prosthetic Observational Gait Score (POGS) Observed Gait 
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Russek's Code Observed Functional Ability 
Special Interest Group in Amputee Medicine 
(SIGAM) Mobility Grades 
PROM Functional Mobility 
Socket Comfort Score (SCS) PROM Pain / Discomfort 
Trinity Amputation and Prosthesis 
Experience Scales (TAPES) 
PROM HR-QoL 
 
Some of these have been developed to measure a specific feature or characteristic 
to the amputee e.g. comfort of the socket while others have been developed 
because it was felt that outcome measure that did exist, did not address particular  
issues well enough for the needs of pwLLAs. 
 
2.2.4.2 General outcome measures  
Many general outcome measures that were developed, initially for use in other 
patient populations, have subsequently been validated for use with amputees.  See 
table 2.3 for a selection of general outcome measures which have been have been 
reported in the literature as being used in pwLLA.   
 
Table 2.3   General outcome measures used with pwLLAs 
Outcome Measure Type Main Constructs being 
Measured 
Activities-specific Balance Confidence (ABC) 
Scale-UK 
PROM Balance, Functional Mobility 
Barthel Index Mixed Activities of Daily Living (ADL) 
Berg Balance Score (BBS) Observed Dynamic and static balance 
Body Image Questionnaire PROM Body Image 
Canadian Occupational Performance 
Measure (COPM) 
Mixed Functional Activities 
Frenchay Activities Index (FAI) PROM Functional Mobility, ADL, 
Occupational performance 
Functional Independence Measure (FIM) Observed Functional Activities 
Patient Generated Index PROM ADL, General Health, Motor 
Activities 
Perceived Social Stigma Scale PROM HR-QoL 
Rivermead Mobility Index (RMI) Mixed Functional Mobility, Balance 
Short Form 12 or 36 Health Survey (SF-12 or PROM HR-QoL 
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36) 
Sickness Impact Profile (SIP) PROM HR-QoL, ADL 
Timed “Up and Go” Test (TUG) Observed Mobility and Balance 
Timed Walk Test (TWT) - 2min (2MWT) or 
6min (6MWT) 
Observed Mobility Endurance 
 
An extensive number of outcome measures have been used with pwLLAs for a wide 
variety of reasons, and it has been stated on numerous occasions that there is no 
consensus about which outcome measures should be used (Rommers et al. 2001, 
Condie et al. 2006, Gremeaux et al. 2012).  There is also no consensus on any that 
may be considered gold standard measures within this population.   
 
The Core Outcome Measures in Effectiveness Trials (COMET) initiative promotes 
the importance of agreeing a standard set of outcomes that represent the minimum 
that should be reported in all clinical trials (Williamson et al. 2011, Prinsen et al. 
2014).  Reaching a consensus on which data should be collected, allows the results 
to be compared and combined, from research studies and clinical audit, as 
appropriate.   
 
All physiotherapists working in prosthetic rehabilitation in Scotland regularly collect 
outcome data on the amputees coming through their service and these data informs 
the SPARG annual report (Scott et al. 2016).  The modified Locomotor Capability 
Index (LCI-5) is collected routinely at the end of the initial period of prosthetic 
rehabilitation.  There is yet to be multi-disciplinary agreement across the care team 
on which outcomes should be collected.  However, both the Physiotherapy and 
Prosthetic Professional bodies in the UK have independently brought out a list of 
recommended outcome measures to be used in prosthetic rehabilitation, (Cole et al. 
2014, Young et al. 2015).   
 
The International Society for Prosthetic and Orthotics (ISPO), which is a multi-
disciplinary organisation, has published recommendations, for defining participants 
in prosthetics research (Lemaire 2013).  They outline measures that can be included 
such as: Manual Muscle Testing (grades 0-5), walking speed (m/s), Steps taken 
(step/min), Socket interfacial pressure (kPa) and “other” kinematic and kinetic gait 
parameters, though which are not specified. 
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The continued lack of a consensus of practice, with regard to the collection of 
outcome measure data has led to the first research question in this thesis:  
 
Research Q1  
What outcome measures are used regularly in clinical practice during prosthetic 
rehabilitation?   
 
This question will be addressed in Chapter 3. 
 
 
2.3 Outcome measurement 
Psychometric properties of outcome measures will be explored in this section of the 
chapter. Understanding what psychometric properties are will help clinicians and 
researchers interpret results obtained from outcome measures more fully.  An 
exploration of the philosophy and literature regarding aspects of measuring 
outcomes in general terms will be presented first.  Then finally, the ICF framework 
will be described, outlining its role in prosthetic rehabilitation.  
 
2.3.1 Conceptual framework and definitions of outcome measurement 
The Donabedian Theoretical Model first described in 1966 (Hoenig et al. 2010) 
provides a framework for systematic investigations in healthcare. The model is 
made up of three parts; firstly, the Structure of Care which includes the setting 
where the healthcare is being delivered, the material resources and the organization 
structure; secondly, the Process of Care i.e. what is actually being done during the 
giving and receiving of care, and; finally, the Outcomes of Care which describe the 
effect of the care on the health status of not only an individual but also the wider 
population.  Instruments that capture those effects are referred to as outcome 
measures. 
 
Outcome measures in healthcare often identify reaching certain milestones or 
achieving certain scores.  These milestones and scores may then be quoted when 
the success, or otherwise, of a service, a treatment, a programme of therapy or an 
intervention, is discussed.  During the course of an illness, clinicians, and their 
patients, often want to keep track of any changes that occur.    Implementation of 
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therapy, or any other kind of intervention, may change the condition and again 
clinicians as well as their patients will want to track the effects.  The use of outcome 
measures will help do this, if they are used in the right context for the right reason.  
They also must be “fit for purpose”.  In a review of health measurement, Cano and 
Hobart in 2011 argued that the evidence for a large number of outcome measures 
remained unclear on that point (Cano et al. 2011).  
 
During rehabilitation outcome measures may be utilised for several reasons (Stokes 
2010).  Some are used to classify the patient’s current condition, knowledge of 
which can help predict the success or failure of a procedure, treatment programme 
or intervention.  For example, lung function tests prior to an exercise programme for 
a patient with a respiratory condition, will not only categorise the level of function the 
patient has, but will also help predict their level of participation and how quickly the 
programme may need to be adjusted.  Other outcome measures are used to monitor 
progress during the rehabilitation period, e.g. balance tests undertaken by a frail 
elderly patient, before, during and after during a therapy programme, will help the 
clinician target the use of specific exercises, as well as identify if the therapy is 
helping to improve the patient’s balance.  Finally, outcome measures can also be 
used to comment on or classify the success, or otherwise, of an episode of care for 
a group of patients.    
 
It is important to understand what the purpose or target of any outcome measure is, 
so that their results may be interpreted correctly (Roach 2006).  For example, with a 
focus on outcome measures of physical function in this thesis, physical ability will 
therefore be one of the targets or constructs of interest for any outcome measure 
being studied.  
 
2.3.2 Psychometric properties 
The study of psychometrics considers the different measurement properties of 
outcome measures, how they are defined and analysed. The correct interpretation 
of any results obtained from an outcome measure, relies on that outcome measure 
being valid, reliable and responsive to changes in the performance capability of the 
population of interest, i.e. pwLLAs.  This section will outline the different 
psychometric terms used and various statistical analysis methods that are employed 
to establish the strength of each measurement property. 
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2.3.2.1 Taxonomy of terms 
Reliability and validity are arguably, the most familiar terms used to define what 
characteristics a “good” outcome measure should have.  Responsiveness, or 
sensitivity to change, are also terms that are becoming more familiar, especially 
when considering if an outcome measure is effective in detecting changes in the 
patient’s condition or their performance.  The COSMIN initiative has sought to gain 
agreement on the definitions of terms used through a Delphi study (Mokkink et al. 
2010a). The group have also proposed criteria, on the reporting of these 
measurement properties (Mokkink et al. 2010b, Mokkink et al. 2010c).  The purpose 
is to enhance the quality of the studies being published and therefore improve the 
level of the evidence for clinicians and researchers.  The quality criteria will 
discussed in more detail later in this chapter.  Table 2.4 lists the definitions proposed 
by the COSMIN group.   
 
These terms will be used throughout this thesis.  Further clarification on each of the 
major domains and the use of different statistical analysis methods to establish the 
psychometric properties of outcome measures, will be presented in more detail in 
the following sections.  Particular attention will be addressed to the topic of 
establishing reliability, measurement error and responsiveness. 
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Table 2.4   Domains and definitions of measurement properties (adapted from Mokkink et al 2010b) 
Domain Measurement 
property 
(specific aspect) 
Definition 
Reliability  The degree to which the measurement is free from measurement error : 
The extent to which scores for patients who have not changed are the same for repeated measurement under several 
conditions, e.g.  using different sets of items from the same HR-PROs 
(internal consistency), over time (test re-test) by different persons on the same occasion (inter-rater) or by the same 
persons (i.e., raters or responders) on different occasions (intra-rater) 
Reliability The proportion of the total variance in the measurements which is because of “true” differences among patients 
Internal 
Consistency 
The degree of the interrelatedness among the items. 
Measurement 
error 
The systematic and random error of a patient’s score that is not attributed to true changes in the construct to be 
measured. 
Validity  The degree to which an instrument measures the construct(s) it purports to measure. 
 Content 
(Face) 
The degree to which the content of an instrument is an adequate reflection of the construct to be measured. (degree to 
which (the items of) an instrument indeed looks as though they are an adequate reflection of the construct to be 
measured) 
 Construct 
(Structural) 
The degree to which the scores of an instrument are consistent with hypotheses (for instance with regard to internal 
relationships, relationships to scores of other instruments, or differences between relevant groups) based on the 
assumption that the instrument validly measures the construct to be measured. (degree to which the scores of an 
instrument are an adequate reflection of the dimensionality of the construct to be measured) 
 Criterion The degree to which the scores of an instrument are an adequate reflection of a ‘‘gold standard’’ 
Responsiveness  The ability of an instrument to detect change over time in the construct to be measured 
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2.3.2.2 Reliability  
The overall definition for the reliability domain is; the degree to which the 
measurement is free from measurement error and the extent to which scores for 
patients that have not changed are the same for repeated measurement under 
several conditions.  The three sub-divisions in this domain address slightly different 
aspects of reliability.  Reliability determines the extent to which scores (for patients 
who have not changed) are the same for repeated measurement under the same 
conditions. The consistency and agreement of the scores are considered in this 
measurement property. Internal consistency considers how related items are 
within the same measure.  It is used to comment on the inter-correlation of items in 
a scale or sub-scale and to what extent they are measuring the same construct or 
concept.  Internal consistency (IC) parameters have also been reported as evidence 
of the reliability of a test, however IC is based on a single occurrence and the 
variances that occur from day to day or between different raters are not taken into 
account (Tavakol and Dennick 2011).  Finally measurement error considers the 
“noise” of the instrument or outcome measure. This “noise” consists of systematic 
and random errors that are part of a patient’s score, not attributed to any true 
changes, in the construct to be measured. Reliability parameters are highly 
dependent on the variation in the population sample.  Therefore they are a 
characteristic of the outcome measure in a certain population (Weir 2005).    
 
Reliability and measurement error will now be considered in more detail given the 
focus of this thesis. 
 
2.3.2.2.1 Reliability  
This is the reproducibility of results when a test is repeated more than once on 
subjects over time (test-retest) or; implemented by different persons on the same 
occasion (inter-rater) or; by the same persons (i.e. raters or responders) on different 
occasions (intra-rater).  
 
The consistency of the results is considered the degree to which the results do not 
change when the measure is repeated, whereas agreement refers to the closeness 
of the results obtained to the “true” result and is free from measurement error.  The 
word ‘‘true’’ must be seen in the context of the Classic Test Theory (CTT), which 
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states that; any observation is composed of two components the true score and 
error associated with the observation. ‘‘True’’ is the average score that would be 
obtained if the scale were given an infinite number of times (Streiner et al. 2014).  
 
2.3.2.2.2 Considering consistency 
If a research question asks whether an outcome measure is able to distinguish 
between subjects and / or raters then reliability parameters should be investigated, 
i.e. how consistent are the results for different raters or different subjects.   Intra-
class correlations (ICC), based on analysis of variance (ANOVA) are the most 
frequently used method to report reliability of a measure in terms of its consistency.  
Correlations give an indication of the relationship between two sets of results. The 
ICC value obtained, between -1 and + 1, will demonstrate not only the strength of 
the relationship but also the direction.  Zero indicates no relationship and the nearer 
to 1 the stronger the relationship in a positive (+) or negative (-) direction.  
The precise ICC model used is very often not quoted.   Shrout and Fleiss (1979) 
outline some guidance for which model to choose (Shrout and Fleiss 1979).  They 
suggest considering the following questions before deciding which model to choose: 
Firstly, does the statistical model require one-way or two-way analysis of variance?  
Secondly, are differences between the mean scores or ratings from several raters 
relevant to the reliability being studied? Finally, is the analysis a unit of analysis an 
individual rating or the mean of several ratings?  The first two questions relate to the 
statistical model being considered.  The second two questions are related to the 
possible use of the results. 
 
With several models to choose from, e.g. 1,1, 2,1, 1,k, 2,k, where k reflects the 
number of raters or tests included in the analysis, it is important to choose the 
correct one.  If there are several raters who each rate some of the total number of 
subjects but they don’t all rate all of the subjects, then a one-way ANOVA should be 
used, i.e. models 1,1 or 1,k .  This does not take into account the variance attributed 
to the raters, because they haven’t rated all the subjects and therefore it is not 
accounted for across all the results.  However, if each of the subjects are rated by all 
raters (this may be a number of raters taken at random from a larger population of 
raters or where there is only one rater rating all the subjects) then the choice should 
be a two-way ANOVA, i.e. 2,1 or 2,k.   This will take into account the additional 
variance of multiple raters across the results.   If a one-way ANOVA is used instead 
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in this case then the resulting correlation would be an under-estimation of the 
relationship (Streiner et al. 2014).  
 
If the effect of the rater(s) is considered random and results are to be generalised to 
other raters, then models 2,1 or 2,k should be used.  If on the other hand the effects 
are not considered random then models 2,2 or 2,k should be chosen.  This implies 
that the results will only be concerned with a single rater or defined group of raters 
and the results will not be generalizable to the wider population of raters.  If model 
2,1 (the reliability unit of analysis is a single rating and not the mean of several), is 
used in preference to 2,2 then it is likely that this will result in a lower correlation 
value (Shrout and Fleiss 1979).  
 
Two other methods of analysis are sometimes used to report consistency; Pearson 
correlation and Kappa coefficient (Streiner et al. 2014).   
 
Pearson correlation is a regression analysis of pairs of results, commenting on the 
relationship between the two sets of results.  There is a suggestion that coefficient 
values obtained from this method are likely to be higher than true reliability.  As ICC 
account for the variances the ICC values will be closer to “true” reliability.  Another 
benefit to using ICC over Pearson is that the calculations can cope with multiple 
raters or observers. 
 
Kappa coefficient is the most appropriate when only two levels are expected, e.g. 
when something is either present or absent in a test result. Weighted Kappa can be 
used when a scale of results is expected, e.g. a 6 point rating scale of muscle 
strength.  This will take into account partial agreement where results differ by one or 
two points on the scale and so in this instance weighted Kappa is looking at 
disagreements.  Weighting schemes have been published and are recommended 
over using individual schemes to allow comparisons to be made with other studies.  
However there are similarities between the weighted Kappa and the ICC and the 
overall the decision over which to use may come down to how easy each calculation 
is to perform and preference (de Vet et al. 2011). 
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2.3.2.2.3 Considering agreement  
Rankin and Stokes (1998) discuss limits of agreement and how they should be used 
with ICCs.  They suggest neither should be used alone as they present two different, 
but related, aspects of reliability (Rankin and Stokes 1998).   
 
There are several agreement parameters that can be calculated for an outcome 
measure, see table 2.5. 
 
Table 2.5   Description of agreement parameter indices (Streiner et al. 2014, Bland and Altman 1986) 
Agreement  
Parameter Indices 
Description 
Standard Error of 
Measurement (SEM) 
Represents the variance between subjects.  Depending on the 
method of calculation will take in to account systematic error. 
Limits of Agreement 
(LoA) 
Presented in graphic form where outliers will be obvious   
Separates the effect of random error from the main effect of 
the measure. 
 
Reliability coefficients involve error variance, also known as standard error of 
measurement (SEM) and variance between subjects, often presented as standard 
deviation (SD).  By reworking the calculations, the SEM of a measure can be 
presented. Standard error of measurement is expressed in the unit of the outcome 
measure and allows a confidence interval to be drawn around a score (Stratford 
2004).  Whether this is the observed or “true” score, i.e. with systematic error 
accounted for, depends on the method of calculation. 
 
Bland and Altman (1986) present a method of examining agreement in an outcome 
measure that does not take account of the true variability of observations.  The 
Bland Altman method uses similar calculated values to those used in ICCs and this 
absolute measure of agreement separates the main effect of the measure from 
random error.  The graph or plot that is produced is integral to the reporting of the 
method. By plotting the mean difference of each participant’s data, against the 
difference in their scores on the same two occasions, any systematic differences or 
increase in error that may be related to the value of the measurement are seen 
graphically. Any obvious outliers can also be seen in the graph (Bland and Altman 
1986).  The limits of agreement (LoA) that are represented on the graph are also 
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approximately twice the measurement error values that are reported for the same 
population. 
 
Agreement is more a characteristic of the instrument itself and is preferable in all 
situations where the instrument will be used for evaluative purposes.  It is the 
degree to which scores or ratings are identical irrespective of who performs or 
scores the test.  However, if the question concerns a subject’s health status and 
measuring any changes in that, then agreement parameters should be presented, 
as the main concern is ensuring that the result is accurate. Arguably, both 
consistency and agreement should be presented to give full account of the 
measurement properties for the outcome measures and reflect both the consistency 
and accuracy of the instrument (de Vet et al. 2006, Kottner et al. 2011). 
 
2.3.2.2.4 Measurement error 
In a health care setting, we are often concerned with measuring change in health 
status.  Any systematic and random errors that are not attributed to true changes in 
the construct to be measured must be taken into account. The threshold of error is 
inherent to the population and condition being studied and for well-established tests 
this threshold is well known, e.g. weighing scales will be accurate to 1-2kg which is 
deemed acceptable for adults where daily weights may fluctuate to this extent, 
however this value would not be appropriate for infants or adults who were on 
dialysis.  The clinical interpretation of SEM can be expressed as the minimal 
detectable change (MDC) value or smallest detectable change (SDC) (Haley and 
Fragala-Pinkham 2006).   
 
Reliability and agreement parameters are population specific and to establish error 
values for new tests, multiple data points must be recorded for many patients of 
different ages who have demonstrated different levels of change and with different 
conditions if the test is to be used across populations, conditions and age ranges 
(Kottner et al. 2011).  
 
 
2.3.2.3 Validity  
In the past, validity was only seen as testing the psychometric properties of a given 
scale or measurement tool.  However, there is now a shift towards focusing on the 
28 
 
subjects who perform or complete the scales by considering both the population and 
the context of application when testing the properties (Streiner et al. 2014).  
Assumptions are made from the results about the people, and their attributes, who 
complete the outcome measures.  Therefore validity of an outcome measure is no 
longer seen as a simple dichotomous state of being valid or not, but more as a 
continual process of demonstrating validity in defined groups of people in different 
situations.  For example, after testing, an outcome measure may be shown to be 
valid in adults during early prosthetic rehabilitation following delivery of their primary 
(first) prosthesis.  This validation process looks to confirm three types of validity: 
content, criterion and, construct validity. These three aspects of validity are 
considered separately by the COSMIN group and it is advocated that they should be 
established independently of the other (Mokkink et al. 2010b, Mokkink et al. 2010a).   
 
2.3.2.3.1 Content Validity 
Content or face validity investigates the items or questions included in an instrument 
and evaluates whether it is actually looking at the construct or concept it is 
supposed to be when it is implemented.  The content is often agreed by a group of 
experts when developing a new outcome measure who should clearly identify the 
aim of the outcome measure, the target population and the reason for selecting 
each of the items included.  Scrutiny of the expert panel will, in part, uphold whether 
good content validity has been achieved. Whether individual items in a scale or sub-
scales inter-correlate and are measuring the same construct or concept can be 
investigated through factor analyses and calculation of Cronbach’s alpha, both of 
which give an indication of the internal consistency of a measure that is made up of 
more than one item / question. 
 
2.3.2.3.2 Construct validity 
Underlying factors that contribute to activities or behaviours that cannot be seen or 
easily measured may be referred to as hypothetical constructs.  It is these 
constructs, or theoretical relationships that are investigated in construct validity.  It is 
necessary to clearly list and explain the relationships that are expected, both in 
direction and magnitude in the form of hypotheses before performing the trial.  
Afterwards the results are compared to investigate if the hypotheses were proved or 
not. 
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Specificity and sensitivity are terms often used when representing the structural 
validity of an instrument.  Specificity considers how well an instrument can detect 
the construct being studied, i.e. if an outcome measure has been developed to look 
at standing balance, measuring the person’s ability or perceived ability walking up 
and down stairs may reflect standing balance as part of the results but the 
instrument may not be specific enough to measure specific aspects of standing 
balance ability alone.  With sensitivity the ability of the measure to detect differences 
between different groups of patients when measuring the same construct is 
considered, e.g. is a measure able to detect differences between people with TTAs 
and TFAs, or pwLLAs in different age groups when measuring standing balance. 
This may also be considered as discriminative validity i.e. looking at the ability of an 
outcome measure to show different results for different groups.  For example, the 
TUG times have been shown to be slower for patients aged 65 and older or for 
single TF amputees compared to single TT amputees, therefore the TUG has shown 
discriminative validity in this context (Bohannon 2006, Schoppen et al. 1999, 
Podsiadlo and Richardson 1991).  
 
Convergent validity will investigate how closely related a new scale is to other 
measures purporting to measure the same construct. Using hypothesis testing 
again, the objective will be to see how the results correlate.  A moderate correlation 
will infer that there is a relationship but not overly strong to indicate that the scales 
are measuring identical constructs.  It is also important to look at how dissimilar 
results are for scales that are measuring constructs that are not related.  
Discriminant or divergent validity will investigate this relationship using hypothesis 
testing, this time looking for low correlations for the areas where they are not 
related. 
 
2.3.2.3.3 Criterion validity 
Criterion validity is investigated by comparing the instrument to a “gold standard” 
instrument.  If one is not available, as is often the case in rehabilitation studies, then 
hypotheses can be proposed on what the results will show when compared to other 
similar measures. There are two main types of criterion validity; concurrent and 
predictive validity. Concurrent validity is investigated by giving the new measure at 
the same time as the “gold standard” or other comparator measure and correlations 
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are made.  Whereas when testing predictive validity the results from the comparator 
measure may not be known until later in the future when the predictive quality of the 
new measure will be tested, again using correlation techniques. 
 
2.3.2.4 Responsiveness 
Responsiveness is considered by some to be a component of validity.  However 
other authors believe that as there are several different elements to determining 
whether an instrument is sufficiently responsive it should be considered as a 
separate psychometric parameter. Stratford et al, (1996) asserted that 
responsiveness was a measure of longitudinal validity, i.e. it is a component of 
validity rather than a distinct entity (Stratford et al. 1996b).  While Kirschner & 
Guyatt, 1985, stated that an effective evaluative measure has three properties; firstly 
reliability, which characterises low intra-subject variability, secondly validity which 
outlines any change detected should be consistent with an external standard and 
finally responsiveness which should be able to detect any clinically important 
changes (Kirshner and Guyatt 1985).   
 
The terminology used is also the cause of some confusion as sensitivity to change is 
sometimes used instead of responsiveness.  However, one distinction suggested by 
Liang in 1995 was that sensitivity to changes describes the ability of an instrument 
to measure any change, while responsiveness assesses an instrument’s ability to 
detect clinically important change, i.e. with some context to the changes (Liang 
1995).  In 2000, Husted et al, attempted to bring some order to the confusion over 
the different terminology.  In their article they highlighted the distinction between 
“internal” and “external” responsiveness.  They also tried to clarify both the 
properties and interpretation of the frequently used responsiveness statistics and in 
addition, recommended the use of regression models in external responsiveness 
(Husted et al. 2000).   
 
Internal responsiveness characterises the ability of a measure to change over a time 
frame.  It is the ability of the instrument itself and how it is constructed to detect 
changes and is represented using statistical methods of analysis, e.g. effect size 
(ES), standardised response mean (SRM), paired t-test, Guyatt’s responsiveness 
index (GRI), all of which present statistical significant results, and are also known as 
“distribution-based” methods of calculating responsiveness. 
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There are several different indices which measure the magnitude of change, most of 
which are based on ES, see Table 2.6.  There is little to choose between them and 
the choice is likely to depend on the study design, i.e. whether there is a treatment 
group or not, together with a personal preference for one over the other.  Cohen’s 
effect size is considered the original and is calculated by dividing the average 
change by the standard deviation of the baseline scores. Guyatt’s measure is used 
in a two group design with a pre and post treatment test.  In this case it is the ratio of 
the average change in the treatment group to the standard deviation in the control 
group.  The SRM is different again and is the ratio of the average change of a single 
group to the standard deviation of the change scores.   
 
It should be noted that while it has been shown statistically that an outcome 
measure can detect a change, i.e. that the change did not occur by chance or was a 
measurement error, a statistically significant change may occur without the change 
being a clinically significant one (Husted et al. 2000).  The level of “clinical 
significance” must take into account the patient’s condition, the chronicity/stage of 
disease, environment etc. (Guyatt et al. 1989) and is usually defined by the clinician 
or expert group of clinicians, though it has been defined by the patient in some 
instances (Haley and Fragala-Pinkham 2006).  This relates to the external 
responsiveness described by Husted et al (2000), as the ability of the instrument to 
respond to the changes in the concept it is measuring in a particular population.  
This can be confirmed for an outcome measure by reporting on what constitutes a 
change in clinical condition by either comparing results with a “gold-standard” 
outcome measure or by gathering data from clinicians or patients.  Using another 
outcome measure is known as “criterion-based”.  Whereas gathering data from 
clinicians or patients is referred to as an “anchor-based” method of measuring 
external responsiveness and is presented using MCID, MID or MCDC, all of which 
present clinically important results.   
 
Calculating the MCID is one approach to investigating how much change is enough 
change in an outcome measure to detect a change in the clinical condition.  It was 
demonstrated, in a review of 29 studies that calculated 56 MCIDs, that the mean 
MCID was almost exactly equal to Cohen’s effect size of 0.5 (moderate) (Norman et 
al. 2003).  When considering the MCID for groups, an ES of 0.5 would be a 
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reasonable approximation of the threshold of important change.  Three criteria were 
outlined for evaluating the threshold for individuals: i) the individual baseline score 
should be within the range found for “dysfunctional groups”, ii) the score at the end 
of the treatment should fall within the “normal” range, and iii) the amount of change 
is more than would be expected by the measurement error i.e. MDC value 
(Jakobsson and Westergren 2005). 
 
Any instrument is more sensitive to large treatments than small ones and therefore it 
is hard to distinguish the characteristics of the measure from the characteristics of 
the treatment.  Whichever of the methods are chosen sensitivity to change to a 
treatment is seen as a characteristic of both the treatment and the variance of the 
population being tested.  Therefore the responsiveness of an outcome measure is 
distinct for each different clinical population unless proved otherwise. 
 
Researchers often reported several indices of responsiveness as there is no Gold 
Standard or consensus on how responsiveness should be quantified or reported. 
Some examples are listed below in Table 2.6.  The definitions in the table were 
taken from the following sources: (Stratford et al 1996b, Husted et al 2000, Haley 
and Fragala-Pinkham 2006 and Iyer et al 2003). 
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Table 2.6   Description of “responsiveness” indices 
Responsiveness Term Description Measuring 
Effect size 
 
(ES) 
A standardised measure of change obtained by dividing the average change 
between baseline and follow-up measurements by the SD of the baseline, 
Direction and 
magnitude of change 
Standardised Response Mean (SRM)
 
The SRM is calculated by dividing the average change between initial and 
follow-up measurements by the SD of the change score. 
Direction and 
magnitude of change 
Paired t test 
 
Wilcoxon Rank Paired test 
The paired t value for the difference between initial and follow-up scores is 
closely related to SRM.  It is calculated by multiplying the SRM by the √ (n) 
Wilcoxon rank paired test is the non-parametric equivalent, using ranking of the 
pairs to calculate significance. 
Significance and 
direction of change 
(but not magnitude) 
Repeated Measures ANOVA 
Friedman’s ANOVA 
Similar to paired t test but used to estimate differences between several scores. 
Friedman’s ANOVA is the non-parametric equivalent. 
Significance and 
direction of change 
(but not magnitude) 
Guyatt Responsiveness Index 
 
(GRI) 
This index represents the ratio of observed change in a group of patients 
expected to undergo a change to the variability in a group of stable patients.  It is 
calculated by dividing the change in the group expected to change by the 
variability in the stable patients. 
Direction and 
magnitude of change 
Minimal Clinically Important Difference 
(MCID) 
The smallest change that would change the patient's management or be 
considered worthwhile or important by the clinician, caregiver, or patient 
Direction, magnitude 
and clinical importance 
of change 
Minimal Important Difference (MID) 
Minimally Clinical Detectable Change 
(MCDC) 
Synonymous with MCID  
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2.3.2.5 Interpretability of results 
How an outcome measure is administrated, whether self-reported or observed will 
have an effect on the results.  Consideration of self-efficacy and self-confidence 
should be taken into account as outcome measures pertaining only to the physical 
aspects of participation and activity also have to consider psychosocial factors that 
may be an influence especially in those outcome measures that rely on the 
individual to score themselves in self-reported outcome measures.  Therefore, 
consideration of the population under study, knowledge of the choice of statistical 
analysis method used to investigate it’s psychometric properties and how it was 
administered are critical to understanding whether the outcome measure is an 
appropriate choice or not.  
 
Most research and clinical studies collect data in groups and understanding whether 
the results obtained can be interpreted at the individual level is also key.  When 
results are presented following repeated measurements of groups of participants / 
patients they are presented as reaching an acceptable standard and consequently 
the results can then be interpreted for other similar groups, or at the group level.     
However, closer inspection of how the results were calculated or more stringent 
standards may be required if the results are to be interpreted for individual patients, 
or at the individual level.  The identification of whether results can be interpreted at 
an individual level is not always presented explicitly and may be inferred or assumed 
by the reader or clinician.  For example ICC values should be at least 0.90, and 
preferably higher than 0.95, for the results to be acceptable at the individual level, 
whereas an ICC or 0.7 is acceptable if the outcome measure is used   when 
measuring a group of patients (Shrout and Fleiss 1979, Landis and Koch 1977, 
Cicchetti 1994).  Further discussion on this aspect will be presented throughout the 
following chapters.   
 
2.3.3 International Classification of Functioning Disability and Health  
The ICF framework was developed by the World Health Organisation (WHO).  It is a 
framework that sets out to define components of health and well-being (USTUN et 
al. 2003).  The framework uses a common language and the intention is to facilitate 
communication across the world through the various health professional disciplines 
about health status and health care.  Use of these common terms when articulating 
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the constructs being measured by different outcome measures will assist when 
comparing or combining results of outcome measures that measure the same 
constructs. 
 
The components of the framework address the main areas of Functioning and 
Disability with other contextual factors also being taken into account.  There are two 
component areas which are further sub-divided: a) Body and, Functions and 
Structure, where body functions are defined as the physiological (including the 
psychological) functions, and body structures are defined as the anatomical parts; b) 
Activities and Participation, where any task or action performed by an individual as 
part of their everyday life is considered an activity and limitations are considered any 
difficulties the individual may have undertaking these activities.  The contextual 
factors which are considered are: environmental i.e. factors external to the individual 
but may have an influence and; personal factors e.g. gender, age, lifestyle habits 
etc., all of which are not classified in ICF but are collected.  The relationships can be 
seen in Figure 2.1 
 
The difference between performance and capacity is subtle but important within this 
classification.  Within the ICF framework, if an individual has a problem executing a 
task or action they are classified as having a limitation at the person level.   
 
 
Figure 2-1   ICF framework (WHO, 2002) 
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It is important to consider what an individual is able to do within their current 
environment, including the use of assistive devices or support if required as this is 
measured as their “performance”.  However, if, for example, an amputee is 
assessed without their prosthesis and walking aids (if required), their capability or 
“capacity” in this “standardised environment”, is likely to be reduced.  If information 
is known about both the “capacity” and “performance” it will be clear if the person's 
current environment has enabled him/her to perform better than their “capacity” 
would predict.  This will also help understand whether some aspect of the 
environment is a barrier to their performance.  This difference between 
“performance” and “capacity” is an important aspect of the ICF classification but it is 
one that is rarely captured by the use of outcome measures that only consider 
performance of pwLLAs.   Self-reported outcome measures may capture some of 
this subtlety but it is not known what influence self-efficacy and self-confidence has 
on the results.  This has not been considered and is outside the scope of this thesis, 
however is worthy of consideration in future work.   
 
Rehabilitation impacts on activity for an individual however, as seen from the bio-
psychosocial model of disability that is the basis for ICF, activity at an individual 
level is interlinked with impairments at the body level and also limitations at a 
societal level. An individual is considered to have limitations at a societal level if they 
are unable to perform a task to participate or be involved in personal, social or work 
activities.  For a pwLLA the use of either a wheelchair or a prosthesis, as well as any 
underlying issues with their body function, will influence their activity patterns.  
These will then have an impact on the level they interact in society on personal, 
social and economic terms. 
 
An instrument called the “Rehabilitation Problem-Solving Form” (RPS-Form) has 
been developed which allows health care professionals to assess patient problems, 
particularly from the patients’ perspective, from within the ICF framework (Steiner et 
al. 2002).     Outcome measures that are based on the ICF have the potential to 
improve the recording, monitoring and communication of a patients’ rehabilitation 
and also their limitations. Numerous ICF Core Sets have been published for a 
number of conditions (Steiner et al. 2002, Cieza et al. 2004).  A recent study by 
Kohler et al, (2011) has looked at the feasibility of using a condition-specific Core 
Set for pwLLAs as the basis for an outcome measures.  Initial findings show the 
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Core Set has content validity and sensitivity as a measure of change in patients 
following an amputation (Kohler et al. 2009, Kohler et al. 2011).  However, further 
work is required to demonstrate its psychometric properties, as well as promote its 
use in clinical practice.  
 
In an effort to evaluate which outcome measures, currently used with pwLLAs, have 
been classified within the ICF, two systematic reviews were carried out.  One 
explored the ICF category of activity and participation and identified a number of 
outcome measures that had the potential for use during the rehabilitation period 
following amputation (Deathe et al. 2009).  The other review looked at outcome 
measures in the category of body function or structure, but identified only a few 
measures that had been well validated (Hebert et al. 2009).   The authors of both 
reviews agreed that responsiveness of any of the outcome measures used to detect 
changes in the amputee’s performance or condition had not been well established.  
They recommended that this be the focus of future studies, along with the continued 
establishment of validity and reliability.  Authors of a previous review had concluded 
that while some outcome measures were valid, the studies included in the review 
were complex using “inconsistent” and “confusing terminology” which clinicians 
would not find helpful when choosing an outcome measure (Condie et al. 2006).   
 
Two more reviews looking at outcome measures used with pwLLAs have been 
published recently (Hawkins et al. 2014, Heinemann et al. 2014).  Hawkins et al 
(2014) did conclude that there were a number of “high quality” validated instruments.  
However, the quality rating criteria used (based on Johnston and Graves 2008) 
described the level of evidence for these “high” quality outcome measures as 
“adequately/reasonably valid for the main defined purpose” and “OK to use in 
studies, although checking of assumptions or small improvements may be desirable 
to further improve the measure (e.g. classical measures would benefit from item-
response theory or Rasch analysis)”.  The narrative review presented by Heinneman 
et al (2014) did not contain any quality assessment of the studies reviewed, but the 
authors did note that they were encouraged that responsiveness of measures is 
often reported.  However, only SEM or MDC values were presented as evidence of 
responsiveness or sensitivity within the summary table, with no other indices of 
responsiveness provided to support the claims.  The last of their key points was that   
“emerging information about responsiveness of outcome measures improves their 
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clinical utility”, but there is clearly still more work required to provide this in a form 
that is understandable for clinicians in the field of prosthetic rehabilitation. 
 
There is a wide variety of outcome measures purporting to measure aspects of 
physical function, and a full understanding of their psychometric properties will help 
clinicians and researchers choose the most appropriate.  However, the apparent 
lack of evidence available on these psychometric properties, has led to the second, 
third and fourth research questions in this thesis: 
 
Research Q2 
Which outcome measures, used to measure physical function during prosthetic 
rehabilitation, have been investigated and published in peer-reviewed journals; and 
what are the characteristics (i.e. psychometric properties) that have been 
presented?    
 
Research Q3 
What is the methodological quality of the published studies presenting results for 
psychometric measurement properties of the outcome measures used to measure 
physical function during prosthetic rehabilitation?  
 
Research Q4  
What are the levels of evidence presented in these studies? 
 
These questions will be addressed in Chapter 4. 
 
 
Providing more data on the psychometric properties of outcome measures 
commonly used by AHPs in prosthetic rehabilitation is likely to be of value to both 
clinicians and researchers in this field.  Having an understanding of the reliability, 
measurement error and responsiveness is especially important when using outcome 
measures to evaluate changes following an intervention.  However, a lack of such 
information on outcome measures used with pwLLAs has been commented upon in 
several systematic reviews (Kannenberg et al. 2014, Fortington et al. 2012, Deathe 
et al. 2009, Hebert et al. 2009, Orendurff 2012, Shultz and Olszewski 2013).   
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This need for more data on reliability, measurement error and responsiveness of 
outcome measures has prompted the final two questions in this thesis: 
 
Research Q5  
What are the reliability and measurement error parameters of outcome measures 
most regularly used by AHPs for the assessment of physical function during 
prosthetic rehabilitation?  
 
This question will be addressed in Chapter 5 
 
 
Research Q6  
What is the responsiveness of Physical Function outcome measures regularly used 
with lower limb amputees when assessing change during the rehabilitation period 
immediately following limb fitting?   
 
This question will be addressed in Chapter 6 
 
 
 
2.4 Measuring the quality of studies presenting psychometric 
data  
Standardised checklists are available that check the methodological quality of 
studies that investigate the impact of treatments and interventions on patients. 
However, the quality of any outcome measure used within these studies is 
considered only with a yes/no check, on whether the measure(s) used were 
“reliable” and/or “valid” and/or “responsive”.  Studies presenting data on the 
psychometric measurement properties of outcome measures that measure physical 
function of pwLLA’s have been investigated in several reviews (Rommers et al. 
2001, Condie et al. 2006, Deathe et al. 2009, Hebert et al. 2009, Hawkins et al. 
2014).  The most commonly used criteria used to measure the quality of the studies 
in these reviews were published by Johnston & Graves in 2008 (Johnston and 
Graves 2008).  These criteria outline aspects of reliability and validity that should be 
presented when developing or testing a measure in a new population. An overall 
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quality rating is given taking into account the absence or presence of evidence of 
reliability and/or validity.  However, the level of the evidence presented per 
measurement property for each outcome measure is not considered.  
 
In 2007, Terwee et al published criteria that could be used when measuring the 
quality of studies by individually rating the validity, reliability and responsiveness, as 
well as the interpretability of results (Terwee et al. 2007). This was part of the early 
work by the COSMIN group as they worked to bring together a consensus of opinion 
on how measurement property parameters should be defined, studied and reported.  
The primary aim stated on their website is: “improve the selection of health 
measurement instruments”.  As part of this initiative, the COSMIN group developed 
a critical appraisal tool or checklist that contains standards for evaluating the 
methodological quality of studies on the properties of health measurement 
instruments (Mokkink et al. 2010a, Mokkink et al. 2010c). It was developed as part 
of an international Delphi study as a multidisciplinary, international collaboration 
(Mokkink et al. 2006). While the focus is on HR-PROs, the checklist can also be 
used for evaluating studies on other kinds of health measurement instruments, such 
as performance-based instruments or clinical rating scales.  It has been updated 
since the first release and now rates the items within each measurement property on 
a 4-level scale.  It has been used in many systematic reviews since it has been 
published (e.g. Dobson et al. 2012, Pin 2014, Green et al. 2014, Ammann-Reiffer et 
al. 2014, Larsen et al. 2014, Proud et al. 2015). 
 
 
2.5 Rationale for the overall aim(s) of the thesis 
The issues of the variability and errors associated with measurement have been 
introduced in this background chapter to highlight the importance of establishing the 
“robustness” and “appropriateness” of any outcome measure in use.  This is 
specifically important for pwLLA where provision of correct prosthetic component 
has a positive impact on their limb-wearing function. There is little consensus on 
prosthetic provision guidelines, beyond the initial price of the component and 
classification of activity in the early stages of rehabilitation.  This is potentially 
limiting for amputees, particularly for those with lower activity ability as they often 
receive little beyond the basic componentry.  The need to test more technologically-
advanced components for effectiveness in this population is critical.  However, there 
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is still little agreement on which outcome measurement tools to use. More 
importantly, the evidence of their psychometric qualities is lacking so the choice for 
clinicians about which are appropriate and robust enough to effectively measure the 
effect of interventions is not clear. 
 
This background chapter has outlined the need for improved understanding of which 
outcome measures are regularly being used with pwLLAs, (research question1) 
because of the continued lack of a consensus of practice, with regard to the 
collection of outcome measurement data in this population.   A survey conducted 
with clinical staff will attempt to provide some information in this area (chapter 3). 
 
It has also been demonstrated that there are still gaps in the evidence to support the 
use of specific physical outcome measures during prosthetic rehabilitation.  
Therefore the need to have a clearer understanding of what the current quality of 
evidence of the psychometric properties of the outcome measures used with lower 
limb amputees, (research questions 2, 3 and 4) will be addressed by a systematic 
review of the literature (chapter 4).   
 
The evidence for reliability, measurement error and responsiveness of these 
outcome measures is particularly lacking.  Therefore, there is a need to add to this 
evidence by providing a clearer understanding of the reliability, measurement error 
and responsiveness of the outcome measures currently used in clinical practice 
(research questions 5 and 6).  Both the test re-test study (study III in chapter 5) and 
the longitudinal cohort study (study IV in chapter 6) will address these gaps.   
 
This thesis will therefore attempt to answer each of the research questions to help 
provide a better overall understanding of the psychometric properties of outcome 
measures used to measure changes in physical function in pwLLAs during 
prosthetic rehabilitation.  An overview of the thesis, visually presenting the 
relationship between the research questions and the gap in the current evidence is 
presented in Figure 2.2. 
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Figure 2-2   Thesis overview 
Conceptual questions about the effectiveness of outcome measures of 
physical function in adult unilateral lower limb amputees during prosthetic 
rehabilitation: their use in clinical practice and their psychometric properties 
Which outcome measures are currently being used in 
clinical practice? 
What is the evidence for their psychometric properties? 
Survey (chapter 3) 
Systematic Review (chapter 4) 
RESEARCH QUESTIONS 
Provide new and/or supplementary psychometric evidence to support 
clinicians’ and researchers’ choices of outcome measures  
Current practice & evidence base EVIDENCE GAP 
What is the measurement error for the most 
commonly used outcome measures? 
What is the responsiveness of the most commonly 
used outcome measures? 
Repeatability Study 
(chapter 5) 
Longitudinal Cohort 
Study (chapter 6) 
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3 Chapter 3 Survey (study I) 
3.1 Purpose of chapter 
The purpose of this chapter is to describe the methodology, and present and 
discuss the results of a survey carried out with Allied Health Professionals (AHP’s) 
who work in prosthetic rehabilitation across the UK.  The survey was carried out to 
answer Research Question 1. 
 
Research Q1 
What outcome measures are used regularly in clinical practice during prosthetic 
rehabilitation?   
 
A supplemental question was also considered when designing the survey:  Which 
factors are considered influential in contributing to a successful prosthetic outcome 
for a pwLLA from both the AHP and pwLLA’s perspective? 
 
3.2 Background 
3.2.1 Outcome measurement with lower limb amputees 
The large choice of outcome measures that can be used with pwLLAs has been 
highlighted in several reviews of the literature (Rommers et al. 2001, Condie et al. 
2006, Deathe et al. 2009, Hebert et al. 2009, Hawkins et al. 2014, Heinemann et al. 
2014, Sinha and Wim J. 2011). However, the number of outcome measures 
identified in these reviews, suggests that there is a lack of consensus about which 
outcome measure(s) should be used, under which circumstances, and with which 
patients. 
 
Turner-Stokes & Turner-Stokes surveyed members of the British Society of 
Rehabilitation Medicine (BSRM) Consultants in 1997, regarding their use of 
outcome measures in all areas of rehabilitation medicine. Only the Harold Wood 
score (now known as the SIGAM) was listed, by respondents to the survey, as an 
outcome measure designed specifically for use with pwLLAs (Turner-Stokes and 
Turner-Stokes 1997).  When Skinner and Turner-Stokes repeated the survey in 
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2005, no other amputee-specific outcome measures were included, but a growing 
usage of the SIGAM was noted (Skinner and Turner-Stokes 2006). This increased 
use of the SIGAM may have been in response to the publication of a study by Ryall 
et al in 2003, reporting on its reliability, validity and responsiveness. The results from 
the 2005 survey by Skinner and Turner-Stokes (2006) were used to update the 
BSRM “Basket” of Measures recommended for their members, and consequently 
the SIGAM was included.   
 
Increased pressure to use valid and reliable outcome measures in clinical practice 
from Professional Bodies in the late 1990’s and early 2000’s (Skinner and Turner-
Stokes 2006, Hammond 2000, Moseley et al. 2002), appears to have prompted the 
release of some documents.  In addition to the BSRM recommendations, the British 
Association of Chartered Physiotherapists in Amputee Rehabilitation (BACPAR) 
produced an Outcome Measures Toolbox to assist clinicians with the choice of 
which outcome measure to use during prosthetic rehabilitation.  To be included in 
the Toolbox, outcome measures were required to have evidence of their validity, 
reliability and responsiveness, as well as being practical to use. The BACPAR 
Toolbox is intended to be a guide for clinicians and is not mandatory; the decision 
regarding when to use the outcome measure, i.e. which patient group, and at which 
time point during the rehabilitation period, is left to the clinician.  The Toolbox was 
updated in 2014 and the currently recommended outcome measures are: the 
Activities-specific Balance Confidence (ABC) Scale-UK, Amputee Mobility Predictor 
(AMP), Houghton Scale, Locomotor Capabilities Index (LCI)-5, Trinity Amputation 
and Prosthesis Experience Scales (TAPES), Timed Up and Go (TUG), L-Test, 2min 
and 6 min timed walk tests and the Berg Balance Scale (BBS) (Cole et al. 2014).   
 
More recently the British Association of Prosthetists and Orthotists (BAPO) released 
a document, containing advice for their members on the use of outcome measures 
(Young et al. 2015).  It included the recommendation to use outcome measures, 
where appropriate, routinely in their clinical practice and includes: the Numeric 
Rating Scale (NSR-11) for pain; the TUG and 10 metre walk test, to be used for 
lower limb patients, as well as the Socket Comfort Score (SCS) exclusively for use 
with amputees. 
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Although lists of recommended outcome measures are available, it is not known 
which, if any, are regularly used in clinical practice.  Nor is it known whether there is 
a difference in the outcome measures being used with pwLLAs of different activity 
levels.  Therefore, the primary aim of the survey was to establish which outcome 
measures are being regularly used by AHP’s, i.e. physiotherapists, occupational 
therapists and prosthetists during prosthetic rehabilitation.   
 
3.2.2 Factors influencing prosthetic outcome 
There are several physical factors, such as balance, pain, and muscle strength, 
which play a role during prosthetic rehabilitation and have an influence on the final 
outcome.  The final outcome is unique to each amputee, but a prosthetic outcome 
may be considered successful when the amputee is mobilising maximally with their 
prosthesis.   Psychosocial factors also have an impact on the prosthetic outcome.  
Sansam et al (2009) reviewed the literature to investigate which factors predicted 
walking with a prosthesis (Sansam et al. 2009).  They concluded that comparisons 
were difficult across the identified studies and there were some conflicting 
conclusions with regard to positive predictive factors (Sansam et al. 2009).  In order 
to identify which factors were considered by pwLLAs to be most impaired, Demet et 
al (2003) carried out a study with Part I of the Nottingham Health Profile (NHP). The 
NHP is used to measure perceived distress associated with a variety of health 
conditions and Part I assesses the level of distress in 6 areas: energy levels; pain; 
emotional reactions; sleep; social isolation; and physical disability.  Respondents 
perceived that energy levels, pain and physical disability were the areas that were 
impaired the most (Demet et al. 2003). However, it was not clear if these were 
perceived to be most important to the pwLLAs, in terms of their rehabilitation.   
 
A secondary aim of these surveys therefore, was to find out which factors both 
AHP’s and pwLLAs, considered most influential in contributing to a successful 
prosthetic outcome.     
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3.3 Methodology 
3.3.1 Survey questionnaire design 
Two survey questionnaires were designed specifically for use in this study, one for 
AHP’s and one for pwLLAs, (see appendices 1 & 2).  Although the surveys were 
answered anonymously, both included questions to obtain basic demographic 
variables. In the AHP survey, the respondents were asked to state: their profession; 
the length of time they had been qualified; the length of time they had worked with 
amputees; and the amount of time per week they worked in prosthetic rehabilitation.  
The survey for pwLLAs asked for their age-range, sex, level of amputation and 
number of years of prosthetic use.  Both surveys were piloted within a multi-
disciplinary prosthetic team.  The team also asked patients currently undergoing 
rehabilitation to feedback on the patient survey.   Minimal comments on the 
readability and appropriateness of the questions were received and only minor 
changes were made. 
 
3.3.1.1 Inclusion criteria for pwLLA respondents 
The pwLLA had to meet the following inclusion criteria:  established limb wearers of 
at least one year duration; and attending a prosthetic clinic.  Established limb 
wearers were those who had been wearing their prosthesis for at least one year, 
were wearing it for at least eight hours per day and could walk at least one kilometre 
outdoors, with or without a walking aid.  These criteria approximately equate to level 
K3 and above on the Medicare K-Level classification system (see Table 3.1).   
 
Table 3.1    K-Level classification (K3 & K4 - Adapted from AAO&P website)    
K-Level Description 
K3 The patient has the ability or potential for ambulation with variable cadence with 
the ability to traverse most environmental barriers and may have vocational, 
therapeutic, or exercise activity that demands prosthetic use beyond simple 
locomotion 
K4 The patient has the ability or potential for prosthetic ambulation that exceeds 
basic ambulation skills, exhibiting high impact, stress, or energy levels  
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Suitable patients were introduced to the survey by their prosthetist and all surveys 
were completed and returned anonymously to the researcher in stamped addressed 
envelopes.   
 
3.3.1.2 List of Outcome Measures in AHP survey 
The AHP survey included a list of 30 outcome measures which are validated for use 
with pwLLAs (see table 3.2).  The list included both patient-reported outcome 
measures (PROMs) where a respondent either completes a questionnaire 
themselves or has his/her answers recorded, and observed measures, where an 
observer (clinician or researcher) records the activity of an amputee, either using a 
criterion-based rating scale or direct performance scores, i.e. distance or time.  
There were also outcome measures that used a combination of data collection 
methods included. 
 
Table 3.2   Outcome measures included in AHP Survey 
Outcome Measure Type Main Constructs being 
Measured 
Activities-specific Balance Confidence 
(ABC) Scale-UK 
PROM Balance, Functional Mobility 
Amputation Related Body Image Scale PROM Body Image 
Amputee Activity Score PROM Functional Activities 
Amputee Mobility Predictor with 
Prosthesis 
Observed Functional Activities 
Attitude to Artificial Limb Questionnaire PROM Satisfaction with prosthesis 
Barthel Index Mixed Activities of Daily Living (ADL) 
Body Image Questionnaire PROM Body Image 
Canadian Occupational Performance 
Measure (COPM) 
Mixed Functional Activities 
Frenchay Activities Index (FAI) PROM Functional Mobility, ADL, 
Occupational performance 
Functional Measure for Amputees 
(FMA) 
PROM Functional Activities 
Functional Independence Measure 
(FIM) 
Observed Functional Activities 
Houghton Scale PROM Prosthetic Use 
Locomotor Capabilities Index (LCI)  or 
Modified LCI-5 
PROM Functional Mobility 
Orthotics and Prosthetics National Mixed Health-related Quality of Life  
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Outcomes Tool (OPOT) (HR-QoL), Functional Mobility 
Patient Generated Index PROM ADL, General Health, Motor 
Activities 
Perceived Social Stigma Scale PROM NR-QoL 
Prosthesis Evaluation Questionnaire 
(PEQ) 
PROM Prosthetic-related Quality of Life 
(PR-QoL) 
Prosthetic Profile of the Amputee 
(PPA) 
PROM PR-QoL, Functional Activities 
Prosthetic Observational Gait Score 
(POGS) 
Observed Gait 
Rivermead Mobility Index (RMI) Mixed Functional Mobility, Balance 
Russek's Code Observed Functional Ability 
Short Form 12 or 36 Health Survey 
(SF-12 or 36) 
PROM HR-QoL 
Sickness Impact Profile (SIP) PROM HR-QoL, ADL 
Special Interest Group in Amputee 
Medicine (SIGAM) Mobility Grades 
PROM Functional Mobility 
Socket Comfort Score (SCS) PROM Pain / Discomfort 
Timed “Up and Go” Test (TUG) Observed Mobility and Balance 
Timed Walk Test (TWT) - 2min 
(2MWT) or 6min (6MWT) 
Observed Mobility Endurance 
Trinity Amputation and Prosthesis 
Experience Scales (TAPES) 
PROM HR-QoL 
 
 
The AHP respondents were asked to indicate which, if any, of the outcome 
measures listed, they used regularly with low, medium and high level activity 
amputees.  The amputee’s activity level was defined by their K-Level, see Table 2.1 
in  chapter 2 for full list of K-level criteria.  In addition, AHP’s were asked to indicate 
whether they use the outcome measures with primary and/or established limb-users.  
Primary limb-users are considered to be those who have just received their primary 
or first limb, while established limb-users are those who are considered, by their 
AHP, to be established on their primary limb, or be at least one year post primary 
limb delivery.  Information was also gathered about whether the respondents had 
stopped using any of the outcome measures, and if so why.  Finally, they were also 
asked to name any outcome measures they used regularly but which were not in the 
included in the original list of 30. 
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3.3.1.3 Factors influencing the outcome of prosthetic rehabilitation  
Both surveys included a list of ten factors that could potentially influence a 
successful outcome following prosthetic rehabilitation.  The AHP respondents were 
asked to consider the factors with respect to outcomes according to each K-level 
(see Table 2.1). Amputee respondents were asked to consider the factors with 
respect to their own prosthetic outcome.  According to the selection criteria, this was 
equivalent to at least a K3 level, i.e. that of a typical community limb-user whose 
activities extend beyond simple ambulation (see Table 3.1).  The factor list was 
compiled and adapted using clinical experience. The findings from the Demet study 
(Demet et al. 2003), where respondents perceived energy levels, pain and physical 
disability were used as a starting point for a draft list. Some level descriptors and 
dimensions from the International Classification of Functioning, Disability, and 
Health (World Health Organisation September 2003) were also used to add to the 
draft list.  For example: from Body Functions – “b110 Consciousness functions 
(state of awareness and alertness)” is associated with motivation; from Activities and 
Participations – “d410 & d415 Changing & maintaining body position” relate to 
balance and coordination; and in Environment -  “e3 Support and relationships” 
includes family and friends.  The draft list became the final list, see (Table 3.3) after 
it was  piloted with a group of pwLLAs and AHPs and no additional factors were 
suggested.   
 
Table 3.3   Factors influencing a positive prosthetic outcome. 
Factor Example ICF codes and descriptors 
Balance & Coordination 
 
d410 & d415 Changing & maintaining body 
positions 
Energy, Drive & Motivation 
 
b110 Consciousness functions (state of 
awareness and alertness) 
General Muscle strength  
 
b730 Muscles power functions 
General Range of Movement 
 
b710 Mobility of joint functions 
Manual Dexterity 
 
b710 & b730 Specifically of the hand and fingers 
Memory 
 
b144 Memory functions 
Pain Control  
 
b280 Sensation of pain 
Self Confidence  
 
b1266 Confidence  
Socket fit & comfort 
 
b280 Sensation of pain 
Support of family & friends 
 
e3 Support and relationships 
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All respondents were asked to rank, in order of importance from 1 to 10, with ‘1’ 
being the most important, the factors they considered the most important to 
achieving successful prosthetic rehabilitation.  They also had the opportunity to list 
any additional factors they felt were important.  
 
3.3.2 Survey distribution 
The AHP survey was distributed during May, June and July 2013.   
 
Surveys were sent via professional networks and sub-groups where possible. For 
example: surveys were sent to physiotherapists, by e-mail, to all BACPAR members 
(n=137) as well as to all members of the Scottish Physiotherapists in Amputee 
Rehabilitation Group (SPARG) (n=27).  This was done through the network 
secretaries who sent an e-mail to all members.    
 
The survey was also distributed to occupational therapy colleagues through their 
Special Interest Groups both in England and Scotland, but it was through one of the 
members and not the network secretary and therefore the sample size was 
unknown.   
 
Distribution amongst prosthetists was initially less widespread, as the survey was 
only e-mailed to the Lead Prosthetists at the three largest centres in Scotland 
(Dundee, Edinburgh and Glasgow) asking them to distribute throughout their teams. 
Onward distribution by physiotherapists to colleagues within prosthetic multi-
disciplinary teams to both prosthetists and occupational therapists helped to 
encourage as wide a reach as possible, within the limited contacts of the researcher.  
 
The multi-disciplinary nature of prosthetic rehabilitation with a relatively small 
number of specialist centres (n=43 across the UK) meant that some clinicians may 
have received the survey several times.   All surveys were completed anonymously 
and returned to the researcher using either stamped addressed envelopes or by e-
mail.  If any surveys were returned by e-mail, they were saved and the e-mails 
deleted prior to the data being collated, to protect the anonymity of the respondents.   
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3.3.3 Statistical analysis 
Descriptive analysis was undertaken detailing the characteristics of the respondents, 
and summarising the ranking of the factors in order of importance and the use of 
outcome measures commonly used by AHP’s.    
 
The rankings of factors listed were averaged for each of the two groups of 
respondents, i.e. the AHP’s and the pwLLAs, to establish an overall ranking for each 
group. In addition, the responses from AHP’s for K3 and K4 were averaged to match 
the activity levels of the pwLLA respondents. 
 
 
3.3.4 Ethical opinion 
Prior to conducting the surveys, the Scientific Officer for the South East Scotland 
Research Ethics Service was contacted.  They advised that an ethical review was 
not required under the terms of the Governance Arrangements for Research Ethics 
Committee in the UK.  The project was considered an opinion survey seeking the 
anonymous views of NHS staff and patients on aspects of service delivery.  
 
 
 
3.4 Results 
3.4.1 Allied Health Professional respondent characteristics (or descriptors)  
By the end of the three month recruitment period, 23 physiotherapists, seventeen 
prosthetists and five occupational therapists had responded (see Table 3.4).   These 
45 AHP’s represented a convenience sample following a pragmatic decision to close 
the survey at the end of three months. No more responses were received after this 
period.  The majority (34/45) of respondents had been qualified for over 10 years 
and the same percentage (76%) had been working with amputees for at least 5 
years.  Almost three quarters (33/45) of the respondents worked with amputees for 
at least two-thirds of their working week. 
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Table 3.4   Characteristics of AHP respondents 
Professional 
Group 
Years qualified Years  working 
with amputees 
% of work connected with 
amputee rehabilitation 
< 5 5-10  >10 < 5 5-10  >10 0 - 30 31 - 60 61 – 100 
Physiotherapists 
n= 23 
1 2 20 5 5 13 4 
 
5 
 
14 
 
Prosthetists 
n=17 
3 
 
2 
 
12 
 
2 
 
3 
 
12 
 
2 
 
0 
 
15 
 
Occupational 
Therapists 
n=5 
1 
 
2 
 
2 
 
2 
 
2 
 
1 
 
1 
 
0 
 
4 
 
Total 
n=45 5 6 34 9 10 26 7 5 33 
 
3.4.1.1 Response Rates 
Assuming all physiotherapists were members of BACPAR (n=137, at time of survey) 
this represents a 17% (23/137) return rate.  To protect the anonymity of 
respondents, information on their place of work was not collected.  However, 14 of 
the physiotherapists declared that at least two-thirds of their time was connected to 
amputee rehabilitation. Prosthetic centres across the UK, each employ a multi-
disciplinary team (MDT) to assess and deliver the specialist prosthetic rehabilitation. 
Assuming that each of the physiotherapist respondents represented a prosthetic 
centre, of which there are 43, the return rate rises to 32% (14/43).  The rate was 
44% (19/43) with the inclusion of physiotherapists who worked for more than a third 
of their time in amputee rehabilitation.  
 
It is difficult to estimate a return rate for prosthetists on the same basis.  They are 
dual trained in both Prosthetics and Orthotics, and their professional body, BAPO, 
includes a large number of practising orthotists who do not see pwLLAs.   
 
3.4.2 Lower limb amputee respondent characteristics (or descriptors)  
Twelve pwLLAs had responded by the end of July 2013 (see Table 3.5 for details).  
Four were aged between 26 and 50 years with the remaining eight over 51.  Eight 
were unilateral amputees, with only one at trans-femoral level. Two were bilateral at 
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the trans-tibial level and two had other level amputations.  The majority (eight) had 
their amputation over 10 years ago. 
 
Table 3.5   Characteristics of pwLLA respondents 
Age range Gender Level 
(Bilateral) 
Years had a 
prosthesis 
18-
25 
26-
50 
51-
65 
 
>65 
 
M 
 
F TTA TKA TFA Other 1-5  5-10  >10  
0 4 4 4 8 4 7 
(2) 
0 
(0) 
1 
(0) 
2 3 
 
1 
 
8 
 
 
 
3.4.3 Outcome measures commonly used in clinical practice 
Thirty two of the 45 AHP respondents (71%) indicated they used outcome measures 
regularly, i.e. at least once a week.  Breakdown by professional group was:  100% of 
physiotherapists (23/23), 41% of prosthetists (7/17) and 60% of occupational 
therapists (3/5). 
 
Physiotherapists indicated that they used a total of 14 different outcome measures 
from the list.  The prosthetists used 8 different outcome measures, though only the 
SIGAM and SCS most regularly.  The occupational therapists used only three.  
Table 3.6 illustrates the numbers of all AHP respondents who regularly used the 
outcome measures listed in the survey and at what level. The choices of the 
physiotherapists, prosthetists and occupational therapists respondents are detailed 
in tables included in the Appendix 3. 
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Table 3.6   Total number of AHP respondents who regularly used the listed outcome measures 
 Activity Level K0 – K2 
Non-limb wearer, 
indoor or limited outdoor ambulator 
Activity Level K3 
Wearing limb daily and fully 
ambulant outdoors 
Activity Level K4 
Undertakes athletic activities 
in addition to daily tasks 
TOTALS 
 
Primary Established Primary Established Primary Established  
Activities-specific Balance 
Confidence (ABC) Scale-UK 
3 1 3 2 1 2 12 
Amputee Activity Score 
 
3 3 3 3 2 3 17 
Amputee Mobility Predictor with 
Prosthesis 
4 2 4 2 2 1 15 
Attitude to Artificial Limb 
Questionnaire 
1 0 1 0 0 0 2 
Barthel Index 
 
3 0 2 0 2 0 7 
Canadian Occupational 
Performance Measure (COPM) 
2 1 2 0 0 0 5 
Functional Independence Measure 
(FIM) 
2 0 2 0 1 0 5 
Houghton Scale  
 
5 4 5 4 1 1 20 
Locomotor Capabilities Index or  
LCI-5 
11 8 13 9 7 6 54 
Prosthesis Evaluation Questionnaire 
 
1 1 1 2 0 2 7 
Short Form 12 or 36 Health Survey 
(SF-12 or 36) 
1 0 0 4 0 0 5 
Special Interest Group in Amputee 
Medicine (SIGAM) Mobility Grades 
16 14 16 13 9 10 78 
Socket Comfort Score (SCS) 
 
9 10 9 10 6 7 51 
Timed “Up and Go” Test (TUG) 
 
14 12 13 11 7 6 63 
Timed Walk Test - 2min or 6min 
(TWT) 
10 11 12 12 6 6 57 
Trinity Amputation and Prosthesis 
Experience Scales 
2 2 3 6 2 2 17 
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The totals in the last column exceeds the total number of respondents because they 
could select each outcome measure for more than one activity level with both 
primary and established amputees. 
 
The five outcome measures used more often than any others were: SIGAM Grades 
(78 out of maximum possible 270 [6 options x 45 respondents]), TUG (63), TWT 
(57), LCI / LCI-5 (54) and SCS (51). Two of these are observed performance 
measures; the TUG which measures mobility and balance (Podsiadlo and 
Richardson 1991) and the TWTs which measures mobility and endurance (Butland 
et al. 1982). The other three are PROMs; the SIGAM (Ryall et al. 2003b) and LCI / 
LCI-5 (Gauthier-Gagnon et al. 1998, Franchignoni et al. 2007b) both measure 
functional mobility, and the SCS (Hanspal et al. 2003) measures the patient’s 
perceived comfort of his/her socket.   Respondents also identified that the use of 
several outcome measures had been discontinued (see Table 3.7).   Various  
reasons were given and in no particular order:  lack of time to collect data; no 
relevance to clinical practice; lack of sensitivity i.e. ceiling and/or floor-effect 
observed, took too long to administer, not user or therapist-friendly or a license was 
required. 
 
Table 3.7   Outcome measures discontinued and/or not selected by AHP respondents 
Outcome Measure Type Main Construct being 
Measured 
Discontinued (D)  
 and / or  
Not Selected (NS) 
Activities-specific Balance 
Confidence Scale-UK 
PROM Balance, Functional 
Mobility 
NS 
Barthel Index Mixed Activities of Daily Living 
(ADL) 
D 
Body Image Questionnaire PROM Body Image NS 
Frenchay Activities Index (FAI) PROM Functional Mobility, ADL, 
Occupational performance 
NS 
Functional Independence 
Measure (FIM) 
Observed Functional Activities D 
Functional Measure for 
Amputees (FMA) 
PROM Functional Activities D and NS  
Houghton Scale PROM Prosthetic Use D 
Locomotor Capabilities Index 
(LCI)  or Modified LCI-5 
PROM Functional Mobility D 
Orthotics and Prosthetics Mixed Health-related Quality of NS 
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National Outcomes Tool 
(OPOT) 
Life (HR-QoL), Functional 
Mobility 
Patient Generated Index PROM ADL, General Health, 
Motor Activities 
NS 
Perceived Social Stigma Scale PROM NR-QoL NS 
Prosthesis Evaluation 
Questionnaire 
PROM Prosthetic-related Quality 
of Life (PR-QoL) 
D 
Prosthetic Profile of the 
Amputee (PPA) 
PROM PR-QoL, Functional 
Activities 
D and NS 
Prosthetic Observational Gait 
Score (POGS) 
Observed Gait NS 
Rivermead Mobility Index (RMI) Mixed Functional Mobility, 
Balance 
NS 
Russek's Code Observed Functional Ability D and NS 
Sickness Impact Profile (SIP) PROM HR-QoL, ADL NS 
Special Interest Group in 
Amputee Medicine (SIGAM) 
Mobility Grades 
PROM Functional Mobility D 
Trinity Amputation and 
Prosthesis Experience Scales 
(TAPES) 
PROM HR-QoL D 
 
While thirteen of the outcomes measures were not selected, fourteen additional 
outcome measures were named when the respondents were asked to list any other 
they used regularly, see Table 3.8.  One respondent also reported using their own 
questionnaire, though no further details were given. 
 
Table 3.8   Additional outcome measures listed by AHPs  
Outcome Measure Type Main Construct being Measured 
Clinical Test of Sensory Integration and 
Balance (CTSIB) 
Observed Balance 
EQ-5D-5L
TM
  PROM Global Health 
Functional Goal Setting PROM Functional Activities 
Goal Attainment Scale (GAS) PROM ADL, General Health, Motor Activities 
Hospital Anxiety and Depression Score 
(HAD) 
PROM Anxiety and Depression 
L-test Observed Mobility and Balance 
Reintegration into Normal Living Index 
(RNLI) 
PROM ADL, Social Relationships 
Satisfaction with Prosthesis Score PROM Satisfaction with Prosthesis 
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(SATPRO) 
Step Test Observed Mobility and Balance 
4-step Square Test Observed Mobility and Balance 
T-test Observed Mobility and Balance 
Trans-femoral Predictor Tool Observed Functional Activities 
Visual Analogue Scale PROM Any – depends on the question asked 
Walking Ability Questionnaire (WAQ) PROM Functional Mobility 
 
3.4.4 Important factors  
The ranking of factors influencing a successful rehabilitation chosen by AHP’s is 
split by activity level and whether the patient is a primary or established amputee.  
However, not all AHP respondents indicated a ranking for each activity level 
possibly indicating a lack of experience with amputees at this activity level, or they 
don’t use OM for that activity level.  Slightly fewer responses in the “established” 
columns may reflect a similar lack of experience, but also a lack of contact with 
AHP’s beyond the “primary” rehabilitation stage.  Details of all responses are shown 
in Table 3.9.   
 
 There was only one additional factor added by any of the respondents and that was 
considered to have any influence: “the relationship between the amputee and the 
AHP”. 
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Table 3.9   Average ranking of factors influencing a successful rehabilitation by AHP’s 
 
 
Factor 
Activity Level K0 – K2 
Non-limb wearer, 
indoor or limited outdoor ambulator 
Activity Level K3 
Wearing limb daily and fully 
ambulant outdoors 
Activity Level K4 
Undertakes some athletic activities 
in addition to daily tasks 
No of AHP Respondents  No of AHP Respondents No of AHP Respondents 
41 35 40 34 38 32 
Primary Established Primary Established Primary Established 
Balance & 
Coordination 
2 2 2 2 3 3 
Energy, Drive & 
Motivation 
3 3 4 4 4 2 
General Muscle 
strength  
4 4 3 3 2 4 
General Range 
of Movement 
7 7 6 6 6 5 
Manual  
Dexterity 
10 10 10 9 9 9 
Memory 
 
6 8 8 8 8 8 
Pain Control  
 
5 5 5 6 5 7 
Self Confidence  
 
9 9 7 5 7 6 
Socket fit & 
comfort 
1 1 1 1 1 1 
Support of 
family & friends 
8 6 9 10 10 9 
1 is the most important and 10 is the least important 
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The sample of pwLLAs also considered the same factors and their average rankings 
are listed in table 3.10.  The numbers again are represented when 1 is considered 
the most important factor and 10 the least important. 
 
 
Table 3.10   Average ranking of importance by pwLLA respondents 
Factor Rank 
Balance & Coordination 
 
2 
Energy, Drive & Motivation 
 
3 
General Muscle strength  
 
8 
General Range of Movement 
 
5 
Manual Dexterity 
 
9 
Memory 
 
10 
Pain Control  
 
6 
Self Confidence  
 
4 
Socket fit & comfort 
 
1 
Support of family & friends 
 
7 
 
 
The activity levels of the amputee respondents were considered K3 and above and 
so it was possible to compare their responses with those of the AHP’s by K level.  
 
The average rankings for all the AHP’s responses are broadly similar compared to 
those of the pwLLAs, except for General Muscle Strength and Self Confidence as 
illustrated in figure 3.1 below.  This similarity is also seen when looking at the 
responses from AHP’s for K3 and K4 only, also seen in the scatter plot 
 
 
 
 
 
 
 
60 
 
 
 
 
 
Figure 3-1   Average ranking of factors by AHP’s and pwLLA respondents  
 
 
3.5 Discussion  
3.5.1 Respondents and response rates 
The survey respondents included a high number of physiotherapists in comparison 
to the prosthetists and occupational therapists.  Regarding the experience and ratio 
of time all respondents spent working with amputees, most of the responses 
appeared to have come from a group of AHP specialists.  There are 43 Prosthetic 
Centres across the UK, each employing a MDT to assess and deliver specialist 
prosthetic rehabilitation. Assuming that each of the physiotherapy respondents 
represented a prosthetic centre, then this finding may be sufficient to make 
assumptions for physiotherapists who work with pwLLAs regarding the use of 
outcome measures.  However, there is a need to be cautious when considering the 
generalisability of these finding for both prosthetists and occupational therapists.  
The method of distribution to the occupational therapists did not involve any 
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specialist professional networks and there were much smaller numbers of 
respondents from them and the prosthetists.   
 
The use of standardised outcome measures is recommended widely (Skinner and 
Turner-Stokes 2006, Hammond 2000, Jette et al. 2009, Corr and Siddons 2005, 
Abrams et al. 2006); and potential respondents were asked to return the survey, 
even if they did not use any outcome measures.  However, it could be ventured that 
those AHP’s who do not regularly use outcome measures in their clinical practice, 
did not wish to complete the survey, even though it was anonymous.   
  
The lack of response by prosthetists and occupational therapists may also be due to 
the method of distribution, which was through personal contacts.  The physiotherapy 
BACPAR and SPARG members were asked to forward copies to their AHP 
colleagues in their MDT.   It is not always the case that there is an occupational 
therapist in every prosthetic MDT, therefore the low response rate from them may 
be due to their scarcity.  In contrast, there is a dedicated prosthetist in every 
prosthetic MDT, so it could be suggested that the lack of response from this 
profession may indicate that outcome measures are not used regularly in clinical 
practice.  However, only two respondents (both prosthetists) stated that they did not 
use any, indicating that 82% of prosthetists who completed the survey did use 
outcome measures regularly.  This is in contrast to the findings of a recent survey 
distributed by BAPO, where it was reported that only 24% of respondents (both 
prosthetists and orthotists) regularly use outcome measures, with the main barriers 
being time and insufficient training in the use of outcome measures (Young et al. 
2015).  The survey response rate for those working in lower limb prosthetics was 
only 21%.   The use of outcome measures among prosthetists in the United States 
also appears limited and confidence in administering them is low (Gaunaurd et al. 
2014).   
 
The use of outcome measures by occupational therapists within the field of lower 
limb prosthetic rehabilitation has not been recorded, according to the author’s 
knowledge.   
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3.5.2 Outcome measures  
The findings from this survey show that there is a wide range of outcome measures 
being used by AHP’s, during lower limb prosthetic rehabilitation in the UK.  The top 
five outcome measures selected most often were: the SIGAM, LCI / LCI-5, TUG, 
TWT and the SCS. The original LCI and modified version, LCI-5, were considered 
together in the current survey.  All five were used both by physiotherapists and 
prosthetists, except the LCI / LCI-5 which was not used by the prosthetists.  None of 
these top five outcome measures were used by the occupational therapists who 
took part in the survey.  
 
While it is recognized that rehabilitation following amputation should consider both 
physical and psycho-social factors, all of the top five outcome measures, most 
regularly used by physiotherapists and prosthetists, measure constructs of physical 
function or are closely connected, i.e. the interface between residuum and the 
prosthesis or socket fit in the SCS.  Outcome measures concerned with measuring 
psycho-social factors, such as quality of life or body image, were selected less often 
by the respondents of this survey.   
 
The LCI / LCI-5, TUG and TWT feature in the BACPAR Toolbox (Cole et al. 2014), 
the SIGAM Mobility Grades is recommended for use by the BSRM (Skinner and 
Turner-Stokes 2006), and BAPO recommend the SCS as well as the TUG (Young et 
al. 2015).  It is interesting to note that some respondents reported that they 
discontinued using the SIGAM and LCI / LCI-5. Reasons cited were: a lack of 
relevance to clinical practice, an apparent lack of sensitivity to the amputee’s 
changing condition, and a possible ceiling effect when used with higher functioning 
pwLLAs.  Franchignoni et al (2007) reported on the development of the LCI-5, which 
extended the response categories for each question from four to five, to distinguish 
whether the amputee used walking aids or not when they scored themselves able to 
complete a task alone (Franchignoni et al. 2007b).  This increased the measure’s 
ability to discriminate between patients and reduced the ceiling effects seen with the 
original version, especially when it was used with high-functioning amputees.  It is 
possible that some respondents to the survey were commenting on the use of the 
original version (LCI) with patients at K level 3 or 4, and therefore seeing the ceiling 
effect described by Franchignoni et al (2007).  In contrast to some comments seen 
in the survey, the SIGAM was reported to be easy to use and not time-consuming by 
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Rommers et al (2008), who reported on its translation into Dutch (Rommers et al. 
2008).     
 
In addition to stating that a lack of time restricted the use of outcome measures, 
respondents also specifically stated, that if an outcome measure took too long to 
administer then they would stop using it.  For a busy clinician, it is vital that time 
spent collecting data provides results from outcome measures with proven 
psychometric properties to ensure correct interpretation. 
 
There is published evidence for the validity and reliability for each of the top five 
OMs in the survey; TUG (Schoppen et al. 1999, Deathe and Miller 2005, Resnik and 
Borgia 2011), TWT, both the two minute (2MWT (Resnik and Borgia 2011, Brooks et 
al. 2001, Brooks et al. 2002)) and six minute (6MWT (Resnik and Borgia 2011, Lin 
and Bose 2008)), LCI / LCI-5 (Gauthier-Gagnon et al. 1998, Franchignoni et al. 
2007b, Miller et al. 2001, Franchignoni et al. 2004), SCS (Hanspal et al. 2003) and 
SIGAM Mobility Grades (Ryall et al. 2003b).   The psychometric properties of LCI / 
LCI-5 have been assessed most often, with internal consistency reported in four 
different studies and construct validity reported in three.  While reliability has been 
reported for all the top five, measurement error values have only been published for 
the TUG, 2MWT and 6MWT.   
 
The one study that reported the reliability and criterion-validity for the SCS, provided 
data on its responsiveness to socket changes as well as.  Responsiveness is also 
reported for the SIGAM but it is from the same study that reported on its reliability 
and validity (Ryall et al. 2003).  Chapter 4 presents results from the systematic 
review of the literature that investigates the psychometric measurement properties 
of outcome measures of physical function used with adults with a lower limb 
amputation and these studies will be discussed in detail there.  Later chapters will 
also present details and further discussion on the reliability and measurement error 
(chapter 5) and responsiveness (chapter 6) values for all the top 5 outcome 
measures.    
 
3.5.3 Factors influencing prosthetic outcome 
The pwLLA respondents reflected on their own prosthetic outcome, which was at 
least at the level of K3 i.e. a “community ambulatory”, when considering the most 
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influential factors.  The AHP respondents considered different outcomes according 
to the activities level in each K-level.  Results showed that the amputee respondents 
identified “Socket Fit & Comfort”, “Balance & Coordination” and “Energy Drive & 
Enthusiasm” as the three most important factors that influenced the outcome of their 
prosthetic rehabilitation.  While, the same three factors were reported by the AHPs 
in most of the patient groups, they also considered “General Muscle Strength” 
important for primary amputees at the two highest functioning levels (K level 3 and 
4).   
 
Three of the top factors identified were similar to two themes of interest to pwLLAs, 
reported by Legro et al (1999) (Legro et al. 1999).  The comparable themes were: 
“socket fit” which relates to the factor “Socket Fit and Comfort” in this survey; and 
“other non-mechanical issues” which relates to “Balance and Coordination” and 
“General Muscle Strength”.  The other two themes mentioned by Legro et al (1999) 
were: “adaptation to life and the support of others“ which could relate to the factor 
“Support of Family and Friends”, however, this was ranked quite low with all 
respondents; and  “mechanical aspect of the prosthesis” which does not relate to 
any of the ten factors in this survey.  Mechanical aspects of the prosthesis, beyond 
the fit of the socket, were not included as understanding the external influence of 
different prosthetic components could form a single topic for another survey.  
Although support of family and friends were not highly rated in this survey, a meta-
analysis of qualitative literature, conducted sometime after the completion of this 
survey, did recommend that this group of patients make greater use of patients’ 
social support networks, peer support from other pwLLAs, as well as professional 
psychotherapy support (Murray and Forshaw 2013).  The aim of the meta-analysis 
was to provide a more detailed understanding of some of the “common and 
recurring” areas of importance to adults who had undergone a lower limb 
amputation and were aiming for successful prosthesis.   
 
Energy levels have previously been shown to relate to quality of life (Demet et al. 
2003).  It was therefore not surprising that “Energy, Drive and Motivation” was 
chosen by both the pwLLAs and AHPs as one of their top three factors here.  
Motivation was also considered one of the most important predictors in the 
rehabilitation process following a Delphi Study which involved prosthetic users and 
health professionals (Schaffalitzky et al. 2012).  
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AHP respondents ranked “General Muscle Strength” of high importance (ranked 
two) for the more active amputees, though the pwLLA respondents ranked this 
factor, on average, the eighth most important.  It may be that they took this factor for 
granted, as it is likely that their muscle strength would have improved over the 
course of their therapy which is planned by the AHP’s.  For the pwLLAs, “Self-
confidence” was much more important and was listed at number four in their 
ranking, whereas AHP’s did not rank it higher than five, and mostly much lower.  
Self-confidence or self-efficacy is known to affect performance (Bandura 2010, Ryan 
and Deci 2000), so it is important to take note of the influence that self-confidence 
and self-efficacy can have on physical performance. 
 
3.5.3.1 Do the most widely used outcome measures measure constructs that 
align to the most influential factors? 
It is easy to see why “Socket Fit and Comfort” is critical to successful prosthetic 
rehabilitation and the SCS is used to quantify how good or bad the fit is, as 
perceived by the comfort of the socket.   If the interface between the amputee and 
prosthesis does not fit and is uncomfortable, all activities using the prosthesis will be 
compromised.     
 
The remaining top four outcome measures all measure aspects of mobility, 
quantifying how well the prosthetic outcome has been achieved in terms of distance, 
time and level of independence.  However, none of the top five outcome measures 
assessed the factors: balance and coordination, energy, drive and enthusiasm, or 
general muscle strength directly.  
 
There is a high correlation between the Activities-specific Balance Confidence 
(ABC) Scale-UK, the 2MWT and the TUG (Miller et al. 2003) and therefore 
improvements in balance are likely to show improvements in the times (TUG) and 
distances (2MWT) recorded and vice versa.  However, if good balance and 
coordination are considered important in achieving a successful prosthetic outcome 
by the AHP’s, it can be argued that measures focused on balance, e.g. the ABC and 
BBS will be more successful in establishing the amputee’s balance capability.  
Results from these specific balance scales can help focus therapy programmes, to 
facilitate better balance and subsequently better prosthetic use for the pwLLA.  
While there were some AHP’s who reported using the ABC Scale-UK, many more 
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reported using a TWT and / or the TUG.  This may have been because they are 
easier to implement, i.e. quicker to use, simple to understand and require less 
equipment, or it could be because the AHP’s are just more familiar with a TWT and 
the TUG.  The BBS is a familiar outcome measure to many physiotherapists working 
with the elderly, but it was not included in the survey.  This was because, at the time 
of designing the survey, there was no published evidence of its validity and reliability 
with pwLLAs.   A study by Major et al (2013) has since shown the BBS to have high 
inter-rater reliability and good internal consistency in pwLLAs (Major et al. 2013, 
Wong 2013, Wong et al. 2013).  Wong et al (2013) also reports good construct 
validity for the BBS, but there was a suggestion of a ceiling effect with some high 
functioning amputees scoring at the top of the scale (Wong 2013).  Interestingly, 
none of the respondents of this survey reported using the BBS with pwLLAs. 
 
Energy, drive and enthusiasm are difficult concepts to measure as they are largely 
subjective, but hugely important.  With the link between emotional well-being and 
physical activity well documented (Bherer and Liu-Ambrose 2013), it could be 
argued that if a pwLLA has more energy their physical performance overall is likely 
to improve.  Determination to walk and motivation were considered important 
predictors in the rehabilitation process by prosthetic users and health professionals 
(Schaffalitzky et al. 2012).  Patient-reported outcome measures, designed to capture 
the patient’s experiences and perspective, and especially those that measure 
Quality of Life may be more suited to interpreting how much drive and enthusiasm 
the person has.  However, these types of outcome measure were not favoured by 
the AHP’s in this survey.  It is not known why, though one possible explanation may 
be that physiotherapists, the largest number of respondents, use outcome measures 
primarily to assess physical function.  Physical function is the primary aim of 
physiotherapeutic interventions, and although the impact of psychosocial factors on 
the amputee’s physical performance is understood, they may not feel it necessary to 
overtly measure these factors.  This could also be true for prosthetists, but is likely 
to be less so for occupational therapists as they often aim to address psychosocial 
factors in their assessments and treatments.  
 
Respondents acknowledged the importance of both physical and psycho-social 
factors in a successful prosthetic outcome.   Therefore the significance of measuring 
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both the amputee’s physical and psychosocial state following any intervention 
should be emphasised.    
 
3.6 Limitations 
With the relatively small number of respondents in this survey, (45 of which 23 were 
physiotherapists) the generalisability of the results to AHP’s working with pwLLA 
clinical practice in the UK is limited.   
 
While the response rate was low, it was encouraging to see the experience of the 
respondents with amputee rehabilitation.  The aim of this survey was to gain 
information from those AHP’s who were working with amputees during prosthetic 
rehabilitation.  This aim was achieved with the majority of respondents having 
worked with amputees for at least 5 years and also working with this population for 
most of their working week.  Circulating the survey through Professional Special 
Interest Groups working with amputees helped achieved this.   
 
The method of distribution especially for the prosthetist and occupational therapist 
group could have been improved by following up initial e-mails to secretarial staff of 
the networks.   
 
The limited number of pwLLA respondents was disappointing and therefore further 
exploration of the factors considered important to them following prosthetic 
rehabilitation is required to further confirm or refute the findings of this small sample 
group.  
 
The choice of factors was limited to ten.  With only one additional factor added by 
any of the respondents it could be considered a comprehensive choice.  However, 
with the small sample size, this is another aspect that could be explored further to 
confirm the inclusiveness of the list. 
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3.7 Conclusions 
AHP’s use a wide variety of outcome measures during prosthetic rehabilitation in the 
UK, though not all professions use them regularly.  This variety of outcome 
measures used indicates there is still a lack of consensus on which outcome 
measures to use.  The group of outcome measures most commonly used, all 
measure constructs in the physical domain. 
 
The ranking of the most important factors influencing a successful prosthetic 
outcome was found to be similar in the pwLLAs and AHP respondents, with socket 
fit and comfort rated the most important by both groups. The factors considered 
important by both groups are not necessarily reflected in the choice of outcome 
measures that had been used regularly by the AHPs, except for the SCS.  However 
the outcome measures did provide a measure of the quality of the prosthetic 
outcome. 
 
Although the sample size was small, the specialist nature of the AHP respondents 
gives authenticity to the results within the context of prosthetic rehabilitation.   
 
The results from this very small sample of pwLLAs must be considered with caution 
and it is recommended that further work is carried out to confirm the findings from 
this group. 
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4 Chapter 4 Systematic Review (study II) 
4.1 Purpose of chapter 
The purpose of this chapter is to describe the methodology, and to present and 
discuss the results, of a systematic review of the literature that investigated the 
psychometric measurement properties of outcome measures of physical function 
used within populations of pwLLAs (adults only). Results for the assessment of the 
methodological quality and strength of evidence presented in the studies will be 
reported, and implications for clinical practice and future research will be discussed.   
 
The systematic review was undertaken to answer the following research questions: 
Research question 2 
Which outcome measures, used to measure physical function during prosthetic 
rehabilitation, have been investigated and published in peer-reviewed journals; and 
what are the characteristics (i.e. psychometric properties) that have been 
presented?    
 
Research question 3 
What is the methodological quality of the published studies presenting results for 
psychometric measurement properties of the outcome measures used to measure 
physical function during prosthetic rehabilitation?  
 
Research question 4  
What are the levels of evidence presented in these studies? 
 
The extent of the amputees’ capacity for physical function (and other related aspects 
of capability) that might have been assessed by outcome measures during 
prosthetic rehabilitation will not be considered in this chapter.  Rather, the quality 
and how strong the evidence is for judgement on that question will be the focus for 
this systematic review. 
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4.2 Background 
Financial accountability within the area of prosthetic rehabilitation, has led to a 
renewed interest in the ability of outcome measures to measure the efficacy of many 
interventions along the amputees’ care-pathway.  For example: “What is the effect of 
new surgical procedures” (Sullivan et al. 2003, Frossard et al. 2010); “which 
prosthetic componentry provides the most benefit” (Kannenberg et al. 2014, Gailey 
et al. 2012); and, “what is the long-term functional performance of our patients after 
discharge from rehabilitation” (van Twillert et al. 2013).   
 
Research has shown that the proper selection of appropriate outcome measures is 
crucial for clinical effectiveness (Johnston and Dijkers 2012).  The correct choice of 
outcome measure is critical to understanding the status of, or demonstrating change 
in, any patient’s condition, but correct interpretation of the results is also essential.  
A full understanding of the psychometric measurement properties of all outcome 
measure will permit the selection of the most appropriate one(s), in the right context, 
ensuring that the results are interpreted appropriately.     
 
Of the many constructs that may influence the outcome of prosthetic rehabilitation, 
consideration of physical function following lower limb amputation surgery, is a basic 
requirement (van Velzen et al. 2006).   Many studies have reported the 
development, and subsequent use, of outcome measures that measure constructs 
related to physical function of the pwLLA.  These studies have been performed in a 
variety of settings; before, during and after limb-fitting.  As highlighted in chapter 2 
previous reviews have reported on the measurement properties of such outcome 
measures, though to varying degrees.  Rommers et al detailed 35 different outcome 
measures that measured mobility in a review published in 2001.  There was little 
discussion of the psychometric properties of the measures, beyond commenting that 
test re-test reliability and validity were carried out.  Reliability was considered in 
three categories (test retest, inter-rater and internal consistency), with validity 
considered in four categories (face, content, construct and criterion) for the outcome 
measures reviewed by Condie et al in 2006.  However, only the presence or 
absence of appropriate values in each category were recorded for each study, using 
a checklist similar to that published by Jerosch-Herald in 2005 (Jerosch-Herold 
2005).  The authors also admitted that time did not allow them to undertake a 
comprehensive methodological quality review of the studies (Condie et al. 2006). 
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Three reviews (Deathe et al. 2009, Hebert et al. 2009, Hawkins et al. 2014) used 
guidelines published by Johnston & Graves (2008).  These criteria outline aspects of 
reliability and validity that should be presented when developing or testing a 
measure in a new population, with sensitivity to change considered within validity. 
The absence, or presence, of these different aspects of reliability and validity are 
recorded, and an overall quality rating is given.  The authors acknowledged that a 
multilevel grading of components of measurement quality would allow a grading to 
be given for each measurement property and “deserves investigation” (Johnston 
and Graves 2008).   
 
The psychometric measurement properties of outcome measures that measure 
physical function of pwLLAs have been previously presented.  However, the level of 
the evidence has not been presented per measurement property for each outcome 
measure, taking into account the methodological quality rating for the individual 
studies presenting the evidence.  
 
The aims of this systematic review are therefore, to: examine the published literature 
investigating outcome measures used to measure physical function of pwLLAs; 
provide a methodological quality-rating for each psychometric measurement-
property presented; and report the level of evidence obtained for each outcome 
measure.  A synthesis of the methodological quality and level of the evidence will be 
provided for each outcome measure to enhance the understanding of their utility.  
This will allow both the clinician and researcher to make a more informed choice 
about which outcome measure(s) to use from the many available.  
 
4.3 Methods 
4.3.1 Study Selection and Data Collection Process 
4.3.1.1 Literature Search Strategy 
 
The Cinahl, Medline, PsycInfo, SCOPUS and Pubmed databases were searched in 
December 2013 using the following search terms:   
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[lower limb amp* OR lower-limb amp* OR LLA OR transtibial OR trans-tibial OR 
transfemoral OR trans-femoral]  
AND [outcome measure* OR test OR score OR scale OR assessment OR 
questionnaire OR instrument OR index OR tool]  
AND [clinimetric properties  OR validity OR reliability OR responsiveness OR 
repeatability OR sensitivity OR internal consistency] 
 
As wide variety of search terms can be used when referring to psychometric 
measurement properties it was decided to incorporate a specific search strategy that 
had been developed, to check that no titles had been missed.  Two search filters for 
finding studies on measurement properties in Pubmed was published in 2009, 
(Terwee et al. 2009).  One search filter is highly sensitive for finding studies on 
measurement properties with a sensitivity of 97.4% and a precision of 4.4%.  While 
the other is a more precise search filter which needs less abstracts to be screened, 
but is at a higher risk of missing relevant studies. This filter has a sensitivity of 
93.1% and a precision of 9.4%.  Both filters are designed to be used in conjunction 
with specific construct and population searches, as required.  
 
The sensitive search filter described by Terwee et al (2009), was used together with 
the population search terms described above to search Pubmed. Versions of the 
filters are now available for other databases on the COSMIN website, but were not 
at the time of the initial search. See Appendix 4 for full details of the search terms.  
 
Filters were set in all databases to include adult participants and English text only.  
Dissertations, conference proceedings, editorials, opinion pieces, review studies, 
letters, single case studies and case series of four or fewer patients were excluded. 
 
Studies were also excluded if they: investigated outcome measures used to predict 
future outcome e.g. length of hospital stay or prosthetic usage; reported outcome 
measures used exclusively for measuring quality of life; examined the performance 
of either prosthetic componentry or instrumentation rather than that of the pwLLA; or 
were validation studies of translated versions of any outcome. 
 
Titles resulting from the searches were initially reviewed by one reviewer (PhD 
student, JS) to exclude any duplications and obviously irrelevant studies. The same 
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reviewer then categorized all studies as “include”, “exclude” or “possible” with 
reference to the following PICO criteria:  
 
Population:   Lower limb amputees, unilateral or bilateral at any level 
Intervention: Assessing measurement properties of outcome measures of 
physical functional  
Condition:    Any stage of prosthetic rehabilitation 
Outcome:   Reporting psychometric measurement properties 
 
Reference lists of included studies were also scrutinised and any relevant studies 
were added.  A second reviewer (PhD Director of Studies, MvdL) then checked the 
titles against the inclusion and exclusion criteria.  If there was any doubt or 
disagreement over relevance and / or adherence to the criteria, abstracts were read 
by both reviewers.  If there was any disagreement or doubt about including the 
paper at this stage it was submitted for full text review by both reviewers.    The 
reasons for all exclusions following abstract and full study review were logged and 
discussion notes between the two reviewers were logged throughout the process to 
compile “Reviewers’ notes“- see Appendix 5.  This helped to ensure consistency 
between the reviewers. 
 
4.3.2 Methodological quality analysis 
The methodological quality of studies selected for inclusion in the review was 
independently assessed by the same two reviewers.  This was undertaken using the 
COSMIN checklist (Terwee et al. 2012).  The COSMIN checklist was chosen as the 
quality review tool because of the multilevel grading of each measurement property 
within a standardised rating system and the extensive guidelines that accompany 
the checklist (Mokkink et al. 2012).  Standardisation of the reporting of systematic 
reviews is recommended by many (Moher et al. 2007, Moher et al. 2009, Gianola et 
al. 2013, Shamseer et al. 2015, van Tulder et al. 2003) and COSMIN provides 
detailed standards specifically for the preferred design characteristics and statistical 
methods of studies assessing measurement properties (Terwee et al. 2012).  The 
COSMIN standards are similar, but distinct, from those recommended for assessing 
studies measuring the effects of healthcare interventions (Furlan et al. 2015).  They 
expand on the requirements for individual measurement properties within previous 
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checklists (Johnston and Dijkers 2012) and the COSMIN checklist gives a grading 
for each measurement property, not the outcome measure as whole.  
 
The COSMIN checklist and the accompanying four-point scoring system of 
excellent, good, fair and poor (see Appendix 6) provides an overall score for the 
methodological quality of a study for each category of measurement property being 
examined.  Taxonomy of terms and their definitions, also provided by the COSMIN 
group (Mokkink et al. 2010b), facilitates agreement between reviewers when 
different terminology is presented across studies. There are nine categories outlined 
in the COSMIN checklist, each with a different number of items to be considered 
(Mokkink et al. 2010c).  These include: sample size; management of missing data; 
choice of statistical analysis; choice of gold standard or comparator instrument; and 
conduct of the study in terms of implementation and administration of the data.  In 
the Internal consistency category, there are 11 items, for Reliability (14 items), 
Measurement error (11 items), Content validity (5 items) Structural validity (7 items), 
Hypotheses testing (10 items) Cross-cultural validity (15 items), Criterion validity (7 
items), Responsiveness (18 items) and Interpretability (9 items).   All but one 
(Cross-cultural validity) of these categories were considered in this systematic 
review.  Comments on the generalisability of the results with regard to the 
population under study and the setting, were also to be included, but this section is 
not scored in the COSMIN checklist.   
 
An Excel™ spreadsheet was used to collect data in each of the relevant categories 
against the COSMIN 4-point scale of excellent, good, fair and poor.  The overall 
rating of each category was given as the lowest level response to any item within 
that category, as per the COSMIN guidelines.   
 
Where applicable, the rating for sample size within the methodology review was: 
excellent for n>100, good n=50-99, fair n=30-49 and poor n<30.  However, sample 
size was not considered during the methodological quality review.  This was to avoid 
penalising studies with small sample sizes twice.   
Though not explicitly stated in the guidelines, an overall quality rating of each study 
was also calculated using the same “worst score counts” principle, across all the 
measurement properties presented in the study.   
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4.3.3 Levels of evidence analysis  
The strength of the results provided within each study was also examined using  
published criteria (Terwee et al. 2007) (see Table 4.1).   The three possible levels of 
evidence are given in this checklist.  They are positive “+”, indeterminate “?”, and 
negative “-“.  Where no information is available a “0” rating is given.  
 
Table 4.1   Levels of evidence  - taken from (Terwee et al. 2007) 
 
For studies with a sample size of < 50 participants, an indeterminate “?” rating is 
given in several categories as the authors of the criteria determined this to be the 
number adequate for the statistical analyses (Terwee et al. 2007). In this review, 
sample size was considered when reporting the levels of the evidence and not when 
reporting on the methodological quality.  This procedure had also been adopted in 
 
 
+ ? - 
Internal 
consistency 
 
 
Factor analyses 
performed on adequate 
sample size (7 x # items 
and ≥100) 
AND Cronbach’s 
alpha(s) calculated per 
dimension  
AND Cronbach’s 
alpha(s) 
between 0.70 and 0.95 
No factor analysis 
OR doubtful design 
or method 
Cronbach’s alpha(s) 
<70 or >0.95, despite 
adequate design and 
method. 
Reliability 
 ICC or weighted Kappa   
≥0.70 
Doubtful design or 
method (e.g., time 
interval not 
mentioned) 
ICC or weighted 
Kappa <0.70, despite 
adequate design and 
method 
Measurement 
error 
 
 
Minimal Important 
Change (MIC) < SDC 
OR MIC outside the LoA 
OR convincing 
arguments that 
agreement 
is acceptable 
Doubtful design or 
method OR (MIC not 
defined AND no 
convincing 
arguments that 
agreement is 
acceptable) 
MIC ≥ SDC OR MIC 
equals or inside LoA, 
despite adequate 
design and method 
Construct 
Validity 
 
 
Specific hypotheses 
were formulated AND at 
least 75% of the results 
are in accordance with 
these hypotheses 
Doubtful design or 
method (e.g., no 
hypotheses) 
Less than 75% of 
hypotheses were 
confirmed, despite 
adequate design and 
methods 
Responsiveness 
 
 
SDC or SDC < MIC 
OR MIC outside the LoA 
OR RR >1.96 
OR 
AUC ≥ 0.70 
Doubtful design or 
method 
SDC or SDC ≥ MIC 
OR MIC equal or 
inside LoA 
OR RR ≤1.96 
OR AUC >0.70, 
despite adequate 
design and methods 
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many previous rehabilitation systematic reviews involving, for example: osteoarthritic 
hip and knee populations (Dobson et al. 2012), gait related outcomes in children 
with cerebral palsy (Ammann-Reiffer et al. 2014) testing 6MWT in children (Bartels 
et al. 2013) and testing 2MWT in adults (Pin 2014). 
 
4.3.4 Best evidence’ synthesis  
Methodological quality ratings for the measurement properties of each outcome 
measure were presented alongside the level of evidence in each study.  This 
allowed inferences to be made on the relative robustness of evidence for each 
outcome measure.   
A third reviewer was available, though not used, to resolve any disagreements 
between the reviewers over the level of ratings or methodological quality, or during 
the examination of the results and levels of evidence.  
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4.4 Results 
4.4.1 Search results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-1   Search strategy results 
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A total of 449 applicable titles were retrieved from all databases using the basic 
search terms: 222 from Cinahl, Medline, and PsycInfo, 219 from Pubmed and 8 from 
SCOPUS.  Additional sources, including reference lists of related studies, were also 
scrutinized to identify studies not found through the electronic searches and this 
produced a total of 15 additional titles.  The relatively high number of additional titles 
did raise some concerns about the sensitivity of the search terms.  This will be 
discussed later in the limitations section of the chapter.  When duplicates were 
removed a total of 261 studies remained see Figure 4.1.    
 
After reviewing the titles and abstracts against the inclusion / exclusion criteria, 73 
were retrieved for full text scrutiny.  No additional titles were added following the 
search using the published search filter terms, by Terwee et al (2009).  Inspection of 
the full text, and a further examination of the inclusion/exclusion criteria, resulted in 
the reviewers agreeing that 36 studies were to be quality assessed against the 
COSMIN scoring system.  Table 4.2 shows a breakdown of the reasons why studies 
were rejected firstly on the basis of the title and then on the basis of the abstract or 
full text review. 
 
Table 4.2   Reasons for excluding studies 
Reason for rejection Number rejected on 
basis of title 
Number rejected after 
reading full text 
Not relevant to main aim 197 3 
Main focus was  translation 7 2 
Main focus was Quality of Life  2 5 
Review papers i.e. no new data 2 2 
Sample size too small or a  
paediatric population 
0 2 
Main focus was measurement of 
instrumentation not performance of 
subjects 
0 11 
No psychometric data presented 0 9 
Main focus was  predictor tools 0 3 
TOTAL 208 37 
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4.4.2 Descriptive results 
The final 36 studies in the review investigated evidence from a total of 2,688 adult 
pwLLAs.  Sample sizes ranged from 8 to 448 and measurement properties were 
reported for 37 outcome measures.  Findings for two outcome measures were 
excluded from the results because they did not fit the inclusion criteria; the Amputee 
Mobility Predictor is used predominantly for predicting outcomes and the SF-36 is a 
measure of quality of life.  However, the study reporting on these two outcome 
measures was included in the review because it presented data on the 
measurement properties of six other outcome measures (Resnik et al 2011).   
Table 4.3 presents the number of studies included in the review and which 
measurement properties that were reported on.  See Chapter 2 for a discussion 
about the variety of terms used to describe similar properties and their full 
definitions.  The number of outcome measures on which results were presented on 
is also presented.  
 
Table 4.3   Number of studies with number of outcome measures presented per measurement property 
reported 
 
 
While the 36 studies provided sufficient data to populate all measurement-property 
categories, not all outcome measures received full psychometric scrutiny. Overall, a 
total of 27 studies reported reliability parameters for 29 outcome measures.  Some 
studies presented a single aspect e.g. inter-, intra-rater or test re-test reliability, 
while others studies presented more than one.  Content validity was not formally 
reported by any of the studies, though some comment was made where factor 
analysis had been performed.   It is agreed that “gold-standard” criteria are not yet 
established for this population, and thus were unavailable for use by any of the 
studies.  Nevertheless, construct validity of outcome measures was reported in 
Measurement Property Studies Outcome Measures 
Internal Consistency 16 9 
Reliability 27 29 
Measurement Error 15 18 
Validity 22 20 
Responsiveness 8 11 
Total 36 35 
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some of the studies by testing hypotheses stated before analysis of the data (a 
priori).  
 
Details of the aetiology and levels of amputation that the participants had undergone 
are given in Table 4.4.  This table also outlines the range of study designs and 
methodologies that were used.  Most studies included all aetiologies in their 
samples, though some studies did recruit only vascular participants (Schoppen et al. 
1999, Panesar et al. 2001) or only non-vascular participants (Hagberg et al. 2011). 
The study participants presented with a variety of amputation levels but the majority 
were trans-tibial and / or trans-femoral.   
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Table 4.4   Demographic and study-design details for all included studies 
Author(s) 
Date 
OMs studied 
 
Population Study Aim Study Design Sample size 
Amp Level(s) Aetiology 
Brooks et al 
2001 
 
2MWT Mixed levels 
of 
amputation, 
both uni and 
bilateral 
Mixed Determine construct 
validity and responsiveness 
of 2MWT  
 
Data was extracted from a rehabilitation 
database. 
The 2MWT times and SF-46 scores were 
obtained twice during admission: following 
initial fitting and 48hrs prior to discharge, and 
at 3mths post-discharge.  Houghton Scale 
scores only obtained at discharge.  
 
Convenience sample  
n=290 
Construct Validity  
n=56 (Houghton) to 
142 (SF-36)  
Responsiveness  
n=197 
Brooks  
et al  
2002 
2MWT Unilateral 
TTAs 
Mixed Determine inter and intra-
reliability of the 2MWT 
Participants, both in-patients and out-patients, 
completed two successive walks measured by 
two different raters on two consecutive days.  
The order of the raters was reversed on the 
second day.   
n=33 
Callaghan  
et al 
2002 
 
The Functional 
Measure for 
Amputees 
(FMA) 
Unilateral 
TTA, 
Mixed Describe development of a 
new outcome measure to 
collect long-term functional 
data, and determine its 
test-retest reliability. 
 
The FMA was developed from the Prosthetic 
Profile of the Amputee (PPA). Two FMA 
questionnaires were posted to participants 4 
weeks apart to assess reliability.   
n=133 
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de Laat  
et al 
2010 
Climbing stair 
Questionnaire 
 
Mixed levels 
of 
amputation, 
both uni and 
bilateral 
Mixed Determine construct 
validity and test-tetest 
reliability of the Climbing 
stair Questionnaire  
Participants were recruited during a 10 year 
period completed the questionnaire via a 
postal survey. Those repeating the survey 3 
weeks later were asked to confirm their status 
was stable before completing the 2
nd
 
questionnaire.  
Construct Validity 
n=172 
 
Reliability n=24 
 
de Laat  
et al 
2011  
Rising and 
sitting down 
Questionnaire 
As for De 
Laat et al 
2010 
Mixed Determine construct 
validity and test-retest 
reliability of the Rising and 
sitting down  Questionnaire 
As for De Laat et al 2010 Construct Validity 
n=171 
 
Reliability n=22 
 
de Laat  
et al 
2012  
Walking 
Questionnaire 
As for De 
Laat et al 
2010 
Mixed Determine the construct 
validity and test-retest 
reliability of the Walking 
Questionnaire. 
As for De Laat et al 2010  Construct Validity n= 
172 
 
Reliability n=22 
Deathe  
et al 
2005  
L-test Unilateral 
TTAs & TFAs 
Mixed Assess the concurrent 
validity and intra and inter-
reliability of the L-test 
A consecutive sample of participants were 
asked to complete a series of walk tests and a 
series of self-report questionnaires. A second 
rater conducted a second series of tests later 
in the same visit to assess inter-rater 
reliability.   Re-testing of all walking tests and 
questionnaires was undertaken 2 weeks later. 
Concurrent Validity 
n=93 
 
Reliability n=27 
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Devlin  
et al 
2004  
Houghton Scale Mixed levels 
of 
amputation, 
both uni and 
bilateral 
Mixed Evaluate responsiveness 
and ceiling and floor effects 
of the Houghton Scale. 
Confirm previous test-
retest reliability and 
convergent validity  
Two convenience sample groups were 
recruited.   
Sample 1 - Scores were collected, first by 
telephone interview and then again a week 
later. 
Sample 2 -  Data were collected at two time 
points, three months apart  
Test-retest reliability 
n=49 
 
Responsiveness, & 
validity n=76 
Franchignoni 
et al 
2003  
Rivermead 
Mobility Index 
(RMI) 
TTA and TFA  Mixed  Examine internal 
consistency, validity, 
responsiveness and 
scalability of the Rivermead 
Mobility Index 
A convenience sample of patients were 
recruited and data was collected at admission 
and discharge.  In addition the 10m walk test 
was performed as soon as the patient 
progressed out of the parallel bars.   
 
Internal consistency 
& responsiveness 
n=140 
Construct validity 
n=70 
Franchignoni 
et al 
2004  
Locomotor 
Capability Index 
(LCI) and 
revised  LCI-5  
Unilateral 
lower limb 
amputation 
Mixed  Assess reliability, validity 
and responsiveness of both 
versions of LCI 
Data was collected from consecutive patients 
undergoing prosthetic training, on admission 
and at discharge.     
IC, construct validity 
& responsiveness  
n= 50 
Test-retest n=37 
Franchignoni 
et al  
2007a 
 
 
Prosthesis 
Evaluation 
Questionnaire 
(PEQ Mobility 
Section (ms)) 
Mixed levels 
of 
amputation, 
both uni & 
bilateral 
Mixed Perform a Rasch analysis of 
the PEQ (MS) and confirm 
validity and reliability  
Consecutive sample who had completed a 
prosthetic rehab programme were sent a 
questionnaire pack.  
n=123 
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Franchignoni 
et al 
2007b 
LCI-5 Mixed levels 
of 
amputation, 
both uni and 
bilateral 
Mixed Perform a Rasch analysis of 
the LCI-5 and confirm 
validity and reliability  
Consecutive sample who had completed a 
prosthetic rehabilitation programme were sent 
a questionnaire pack.   
n=123 
Gardiner et al 
2002  
 
 
 
Harold Wood -
Stanmore 
Mobility Scale, 
Handicap 
Mobility Scale, 
Handicap 
Physical 
Independence 
Scale. 
No demographic detail 
was available for the 
patients included in the 
study. 
Assess inter-rater reliability 
for three 
disability/handicap scales.  
Four assessors completed admission and 
discharge scores on pwLLAs during in-patent 
prosthetic rehabilitation.   
n=14 
Gauthier-
Gagnon et al  
1994 
Prosthetic 
Profile of the 
Amputee 
Questionnaire 
(PPA) 
Unilateral 
TTAs and 
TFAs 
Mixed Assess test-retest reliability 
and construct validity of 
the PPA. 
The PPA was sent on two occasions to pwLLAs 
after they had been discharged from hospital.  
 
n=60 
(sample that 
completed 
questionnaires on 
both occasions) 
Gauthier-
Gagnon et al 
1998 
LCI Mixed levels Mixed Internal consistency and 
report on content validity 
of LCI 
PPA questionnaire (which contains the LCI was 
sent to 89 adult pwLLAs who had completed 
their prosthetic rehabilitation. 
Response rate 81%  
n=70 
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Hagberg et al 
2010  
Physiological 
Cost Index (PCI) 
Unilateral 
mixed levels 
Non-
vascular 
only 
Evaluate reliability of the 
PCI 
pwLLAs with at least three months prosthetic 
usage underwent within-day test-retesting, of 
continuous walking at comfortable walking 
speed, by the same rater. HR was logged at 
each minute and perceived excertion was 
recorded using the BORG scale.   
n=28 
Highsmith  
et al 
2013 
Hill Assessment 
Index (HAI) 
Unilateral 
TFAs 
Mixed Evaluate the inter-rater 
reliability of the HAI 
Ssubjects were asked to walk down a 0.9m 
wide and 4.9m long ramp at an angle of 5
o
, 
both before and 90 days after  switching from 
a non-microprocessor knee to a C-leg. The trial 
was timed, video-taped and independently 
scored by two raters.   
 
n=21 
Hillman et al  
2010  
Prosthetic 
Observation 
Gait Score 
(POGS) 
Unilateral 
mixed 
Mixed  Evaluate the repeatability 
of the POGS. 
All participants were videoed walking at self-
selected walking speed over a flat surface.  Six 
observers scored these videos on two 
occasions two weeks apart using POGS. 
 
n=10 
Kohler et al 
2011   
 
 
ICF checklist Mixed Mixed Feasibility, of using ICF 
checklist as an outcome 
measure Validity & 
responsiveness  
Checklist used at 4 time-points: pre-adm (self-
report recall), 1 week post-amputation 
(observed), at discharge (observed) and 3mths 
post-amp (phone call)  
n=20 
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Kristensen  
et al  
2014  
One leg stand 
test (OLST)  
Mixed  Non-
traumatic 
amputees 
Explore how many one leg 
standing tests (OLST) is 
need to provide a stable 
result, and investigate of 
proposed protocol.   
 
Participants were recruited early in the rehab 
period (ave 16 days post-amp).  Two tests 
were carried out on the same day. 
  
Protocol setting n=36 
 
Reliability n=30 
Lin & Bose 
2008  
Six minute walk 
test (6MWT) 
TTAs Mixed Investigate test-retest 
reliability and construct 
validity of the 6MWT. 
Three trials of 6MWT were conducted in one 
day and two weeks later the subjects carried 
out timed up and go (TUG) and one leg 
balance tests  
 
n=13 
Major et al 
2013   
Berg Balance 
Scale (BBS) 
Mixed  Mixed  Evaluate validity and 
reliability of the BBS 
The BBS was conducted twice in one day by 
two independent raters with 20mins rest 
between each test.   
 
n=30 
Miller et al  
2004  
Frenchay 
Activities Index 
(FAI) 
Unilateral 
TFA & TTA 
Mixed Establish reliability and 
validity of the FAI   
Subjects who had had their prosthesis at least 
6 months were recruited if considered stable.  
They completed the PROMS and walking tests 
at a clinic appointment.  Two weeks later 
participants either completed the FAI again at 
the clinic (n=29) or they completed it a home 
on receipt of a postal copy (n=55). 
n=84 
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Miller et al  
2001  
 
The Houghton 
Scale 
PPA-LCI, PEQ-
ms 
 
Unilateral 
mixed levels 
Mixed 
 
Establish reliability and 
validity of the Houghton 
scale and replicate 
reliability and validity for 
the PPA-LCI and the PEQ -
ms 
 Sample 1 (n=60) were recruited from an OP 
database of pwLLAs who were stable and 
walking tests and questionnaires were 
completed while attending an OP clinic.  A 
second set of questionnaires were sent in the 
post 4 weeks later to complete.   
Sample 2 (n=329) were recruited from the 
same facility but subjects had been discharged 
for at least 1 year.  They received a set of 
questionnaires in the post on one occasion. 
 
Internal consistency 
and reliability n=60 
 
Validity n=329  
Miller et al  
2003  
 
 
 
 
Activities-
Specific Balance 
Confidence 
(ABC) Scale  
Unilateral TT 
and TTAs 
Mixed Establish the internal 
consistency, reliability and 
validity of the ABC Scale 
Sample 1 (n=50) were recruited from an OP 
database of pwLLAs who were stable.  Walking 
tests and questionnaires were completed 
while attending an OP clinic.  A second set of 
questionnaires were sent in the post 4 weeks 
later to complete.   
Sample 2 (n=329) were recruited from the 
same facility but subjects had been discharged 
from at least 1 year.  They received a set of 
questionnaires in the post on one occasion. 
 
Internal consistency 
& reliability n=50 
 
Validity n=329  
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Monteiro  
et al  
2013  
 
 
 
DSF-84 
Checklist 
16-52 adult 
male 
amputees.  
No details 
given on 
levels 
No details 
given 
Develop a new instrument 
devised to assess the 
functional and social 
performance. Also to 
establish reliability. 
138 subjects participated in finalizing the items 
included in the checklist and 30 were filmed 
answering the checklist then four assessors 
viewed the footage twice to give their scores.   
Reliability 
n=30 
 
 
 
 
Panesar et al  
2001  
 
 
 
Office of 
Population 
Censuses and 
Surveys (OPCS)  
Functional 
Independence 
Measure (FIM)  
Amputee 
Activity Score 
(AAS) 
Mixed levels Vascular 
disease 
Assess validity and 
responsiveness of three 
established outcome 
measures used to measure 
levels of disability in early 
pwLLA rehab. 
Scores were collected on admission, discharge 
and at 8 weeks following discharge from 
rehabilitation. 
 
n=34 
Resnik et al  
2011  
 
 
 
 
PEQ, 2MWT, 
6MWT, TUG, 
OPUS and PSFS,  
Mixed levels Veteran 
population 
only 
Item analysis of modified 
PEQ and estimate the 
reliability and 
measurement error for all 
outcome measures. 
Subjects completed all outcome measures on 
two occasions 1 week apart.  The same rater 
carried out the testing procedures.  
n=44` 
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Rushton et al  
2002  
Goal 
Attainment 
Scaling (GAS) 
Unilateral 
mixed levels 
Mixed Establish inter-rater 
reliability, validity and 
responsiveness of the GAS  
with pwLLAs 
A GAS assessment was completed within the 
first week of a rehabilitation programme by 
one of two raters with a second assessment 
taking place 48 hours later.  A final GAS 
assessment took place at discharge.    
 
n=10 
Ryall et al  
2003b 
 
 
 
 
 
Special Interest 
Group in 
Amputee 
Medicine 
(SIGAM) 
mobility grade 
Mixed  Mixed  Develop a protocol and 
establish reliability, validity 
and responsiveness for the 
SIGAM mobility grade 
Subjects recruited following completion of 
their prosthetic rehabilitation. 
Study 1 (part A) Subjects completed the SIGAM 
and a timed walk test  on two occasions, 2-4 
weeks apart  - repeatability.  (part B) SIGAM is 
a single-item scale so another measure was 
conducted at the same time, their results  
were combined in a "matrix of mobility" and a 
Rasch analysis was conducted 
Study 2 investigated the responsiveness of the 
scale by completing the SIGAM at least twice 
throughout the rehabilitation period. 
Reliability n=62 
 
Validity n=200 
 
Responsiveness n=33 
Ryall et al  
2003a 
 
 
Rivermead 
Mobility Index 
(RMI) 
Mixed Mixed Establish reliability and 
validity for RMI in pwLLAs. 
 
Subjects were following completion of their 
prosthetic rehabilitation. 
Part A: the RMI was independently completed 
twice on the same patient by two raters on the 
Reliability n=62 
 
Validity n=200 
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same day.  One rater also completed a second 
assessment two - four weeks later on the same 
group of patients.  
Part B: through stratified sampling more 
pwLLAs were recruited at the first time point 
to achieve a more representative sample for 
this part which involved a Rasch analysis to 
investigate the construct validity of the RMI. 
Sakakibari  
et al  
2011 
 
Activities-
Specific Balance 
Confidence 
(ABC) Scale 
Mixed Mixed Evaluate reliability of the 
ABC scale  
Survey and chart review data from three 
previous studies.  The data collected 
previously was grouped into each of the 
response formats and then entered into the 
two models chosen (Partial Credit Model and 
Rating Scale Model).    
 
n= 448 
Schoppen  
et al 
1999  
TUG Unilateral 
TTA or TFAs 
aged 60 + 
Vascular 
disease 
only 
Establish inter and intra-
rater reliability  and validity 
of the Timed Up and Go 
(TUG) in a population of 
pwLLAs 
Subjects who were deemed stable were 
recruited and studied in their homes using 
standardized equipment. 
Two different raters assessed the subjects 
twice on the same day. The same rater then 
assessed the same subject two weeks later. 
 
n=32 
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Theeven et al 
2010  
 
 
Assessment of 
Daily Activity 
Performance in 
Transfemoral 
amputees 
(ADAPT) 
Unilateral 
TFAs.   
Majority 
trauma 
Determine the feasibility  
and test-re-test reliability 
of a new assessment of 
activity performance  
measured by ADAPT 
Subjects completed a circuit of 9 activity 
stations and after one hour resting period they 
repeated the circuit.   
 
 
n=20 
Wong et al  
2013  
Berg Balance 
Scale (BBS) 
Mixed  Mixed  Assess the internal 
consistency of the BBS and 
determine its validity with 
pwLLAs who live in the 
community.   
BBS data was collected on one occasion.  Four 
physical therapists and four physical therapy 
students were trained in the use of the BBS 
following a standardized protocol. 
 
n=40 
Wong et al  
2013  
 
 
BBS Unilateral; 
TTA (3), TFA 
(1) and one 
ankle dis-
articulation 
Mixed Investigate the inter-rater 
reliability of the BBS when 
used with pwLLAs and the 
impact of using raters with 
various levels of clinical 
experience (registered 
clinicians and students).   
 
Subjects were video-recorded undertaking the 
BBS.  Two clinicians independently rated the 
pwLLAs at the time of recording.  Four-six 
weeks later 14 other raters, of varying clinical 
experience, viewed the videos and 
independently scored the patients using the 
BBS scoring system.  The original two raters 
also rated the patients again by viewing the 
videos to try to establish the intra-rater 
reliablity.   
n=5 
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The studies report on a selection of measurement properties, with few presenting 
results on all the psychometric properties of the outcome measures being 
investigated, i.e. reliability, measurement error, validity and responsiveness, with 
internal consistency when the measure contains multiple questions or items. 
Whether the results represented a complete picture of the psychometric evaluation 
of the outcome measure will be discussed later.  Measurement properties of the 
Locomotor Capability Index (LCI) and the modified version LCI-5, were reported by 
the most number of studies (n=5) (Gauthier-Gagnon et al 1998, Miller et al 2001, 
Rushton et al 2001, Franchignoni et al 2004 and Franchignoni et al 2007) with 
results available for all psychometric categories.  The 2MWT was reported by three 
studies (Brooks et al 2001, Brooks et al 2002 and Resnik et al 2011) and again 
results were available for all appropriate psychometric categories (internal 
consistency is not required for interval scales such as the 2MWT).  However, whilst 
the Prosthetic Evaluation Questionnaire mobility section (PEQ (ms)), Timed up and 
Go (TUG) and the derived L-test were also reported in 3 studies, there were no 
published results on the responsiveness of these outcome measures.      
 
The Houghton Scale, the Rivermead Mobility Index (RMI), 6 minute walk test 
(6MWT) and the Activities-specific Balance Confidence (ABC) scale were reported 
by two studies each.  The performance of the Houghton Scale and the RMI had 
been considered in all appropriate psychometric categories; with two studies 
presenting results for their reliability and validity, but only one for their 
responsiveness.  The 6MWT and the ABC scale had no results presented for 
responsiveness.  The remaining 24, of the 35, outcome measures had only one 
study publish results on any of their measurement properties. 
 
4.4.3 Methodological quality results 
There was 97% agreement between the two reviewers on the individual COSMIN 
items reviewed.  There was no disagreement for the final ratings of methodological 
quality and therefore the third reviewer was not required.   
 
While an overall quality rating for a study is not necessarily helpful when reviewing 
the utility of an outcome measure on individual measurement properties.  This gives 
the impression that all the measurement properties have equal importance, when 
this may not necessarily be the case depending on what the outcome measure is to 
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be used for.  However, an overall rating will give an indication of the methodological 
quality of the studies presented.  The number of studies and the overall quality 
ratings for each study is seen in Table 4.5.   Where a study presented data on one 
or more outcome measure or for more than one measurement property, the overall 
quality rating of the study was calculated using the “worst score counts”.  For 
example, Miller et al (2001) reported on reliability and measurement error for the 
Houghton Scale which received a fair rating, and on internal consistency which 
received a poor rating.  Therefore, the overall methodological rating for the study 
was poor. 
 
Table 4.5   Overall methodological quality rating of each study 
Quality rating Number of studies 
Excellent 0 
Good 9 
Fair 22 
Poor 5 
TOTAL 36 
 
 
A detailed breakdown of all the methodological quality ratings for each 
measurement property is given in  Table 4.6.   The total number of studies at the 
bottom of each column does not add up to the number of ratings in the 
measurement property category, as some studies presented data for more than one 
outcome measure.  However, no studies were rated as having excellent 
methodological quality, with the majority only rated as being fair. 
 
Table 4.6   Methodological quality ratings per measurement property  
Quality 
Rating 
Internal 
Consistency 
Reliability 
Measurement 
Error 
Construct 
validity 
Responsiveness 
Excellent 2 0 0 0 0 
Good 1 12 9 7 0 
Fair 8 21 13 17 9 
Poor 7 0 0 0 0 
TOTAL 
number of 
studies  
 
16 
 
27 
 
15 
 
21 
 
8 
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The methodological quality ratings and results for each measurement property from 
each study are presented by outcome measure in the following tables.  Table 4.7 
presents results for the measurement properties of internal consistency, reliability 
and measurement error, and Table 4.8 presents findings for validity, responsiveness 
and interpretability. 
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Table 4.7   Results per outcome measure:  Internal consistency, reliability and measurement error 
Author, year 
main outcome measure (s)  
Internal consistency Reliability  Measurement Error 
Locomotor Capability Index (LCI) / LCI-5 & PPA (LCI section) 
Gauthier Gagnon et al 
1998 
 
LCI 
 
 
Cronbachs alpha = 0.95 for original scale and 0.92 
when 4 redundent items were removed. Only 1 was 
removed in final version. 
Factor analysis identified two underlying factors: 
relating to basic and advanced locomotor activities . 
Quality:  Good 
% of missing items not given 
 
  
Franchignoni 
et al 2004 
 
Original LCI and revised 
version 
 
At discharge Cronbachs alpha = 0.95 
Item to total correlation coefficients: 0.5 – 0.87 
 
Quality:  Excellent 
Test-retest  
Reliability 
ICC =0.984  
for both LCI & LCI-5. 
Quality:  Fair 
Conducted during rehab phase. 
 
Bland Altman plot revealed no 
systematic variations for either 
version 
Quality:  Fair 
Conducted during rehab phase. 
 
Franchignoni  
et al 2007 
 
LCI-5 and modified version 
LCI-10-4 
Rasch analysis highlighted redundancy of 4 items and 
suggested combining lowest two levels   
Item separation reliability = 0.98 
Person– separation reliability  = 0.94  for LCI-10-4 
Item separation index = 7.39 
Person  separation index =  3.90 
 
Quality:  Fair 
Details of how missing data handled not given. 
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Miller et al  2001 
 
The Houghton Scale 
 
PPA-(LCI) 
 
Prosthetic Evaluation 
Questionnaire – mobility 
subscale (PEQ-ms) 
 
Cronbach’s alpha: 
 
Houghton= 0.68 
PPA-LCI = 0.89 
PEQ-ms = 0.95 
 
Quality:  Poor 
No factor analysis described 
 
Test retest reliability  
 
ICC: 
Houghton= 0.85 
PPA-LCI = 0.88 
PEQ-ms = 0.77 
 
Quality:  Fair 
Details of how missing data handled 
not given 
 
Standard error of measurement 
(SEM): 
 
Houghton= 0.93 
PPA-LCI = 2.7 
PEQ-ms = 1.1 
 
Quality:  Fair 
Details of how missing data 
handled not given 
 
Two minute walk test (2MWT) 
Brooks et al 2002 
 
2MWT 
 
 
 
 Inter and intra-rater reliability  
ICC > 0.98 
 
ANOVA showed significant difference 
for days (p<0.001) but no sig for 
raters (p=0.259) 
 
Quality: Fair 
Details of how missing data handled 
not given. 
 
 
Resnik et al 2011 
 
PEQ (modified version),  
Orthotics and Prosthetics 
Users' Survey (OPUS),  
Patient-Specific Functional 
Scale (PSFS),  
2MWT, 6MWT, TUG,  
 
 
 Test re=test reliability 
ICC: 
2MWT = 0.83 
 
Quality:  Good 
Administrations assumed to be 
independent, not confirmed 
 
Minimum Detectable Change 
(MDC): 
 
2MWT = 34.3m 
 
Quality: Good 
Administrations assumed to be 
independent, not confirmed 
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Berg Balance Scale (BBS) 
Major et al  
2013 
 
BBS 
 
Cronbachs alpha = 0.827 
 
Quality: Poor 
No factor analysis performed 
 
Inter-rater reliability ICC=0.945 
 
Quality:  Fair  
Details of how missing data handled 
not given. 
 
Wong et al  
2013 
 
BBS 
 
Rasch Analysis indicated a single dimension as 70.4% 
was explained by the model.  Person Specification 
Index =2.72  
Item Specification Index =  4.7   
 
Quality:  Fair 
Details of how missing data handled not given 
  
Wong et al 
2014 
 
BBS 
 
 
 Inter-rater reliability ICC =0 .99  
Intra-rater reliablity ICC = 0.99 (but 
only 2 raters).   
 
Quality: Fair 
Details of how missing data handled 
not given 
 
Prosthesis Evaluation Questionnaire (PEQ)  
Franchignoni  
et al 2007 
 
Original PEQ (ms) section 
and revised version 
 
 
Cronbachs alpha = 0.96 for both versions 
 
Item -  separation reliability & Person  separation 
reliability  > 0.95 for both versions 
Item separation index – both versions  > 7.48 
Person  separation index  both versions > 4.15 
  
Rasch analysis of both versions showed all items fit the 
model except “shower / bathe”  
 
Quality:  Fair 
Details of how missing data handled not given. 
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Miller et al  
2001 
 
The Houghton Scale, 
PPA-(LCI) 
Prosthetic Evaluation 
Questionnaire – mobility 
subscale (PEQ-ms) 
 
Cronbach’s alpha: 
Houghton= 0.68 
PPA-LCI = 0.89 
PEQ-ms = 0.95 
 
Quality:  Poor 
No factor analysis described 
 
Test retest reliability ICC: 
Houghton= 0.85 
PPA-LCI = 0.88 
PEQ-ms = 0.77 
 
Quality: Fair 
Details of how missing data handled 
not given 
 
SEM: 
Houghton= 0.93 
PPA-LCI = 2.7 
PEQ-ms = 1.1 
 
Quality:  Fair 
Details of how missing data 
handled not given 
 
Resnik et al  
2011 
 
PEQ (modified version),  
OPUS, PSFS,  
2MWT, 6MWT, TUG,  
 
PEQ overall alpha score = 0.922 
 
Item to total scores range*: 0.69-0.79,  
Item to rest scores range*: 0.61-0.74  
 
*except Shower & bathe safely 
 
Quality:  Excellent 
 
Test re=test reliability 
ICC: 2MWT = 0.83 
 
Quality:  Good 
Administrations assumed to be 
independent, not confirmed 
MDC:  
2MWT = 34.3m 
 
Quality:  Good 
Administrations assumed to be 
independent, not confirmed 
 
Timed Up and Go (TUG) & L-test 
Resnik et al 2011 
 
PEQ (modified version),  
OPUS, PSFS,  
2MWT, 6MWT, TUG,  
 Test re=test reliability  
ICC: TUG = 0.88 
 
Quality:  Good 
Administrations assumed to be 
independent, not confirmed 
 
MDC:   
TUG = 3.6s 
 
Quality:  Good 
Administrations assumed to be 
independent, not confirmed 
 
Schoppen et al  
1999 
 
TUG 
 
 
 Spearman correlation coefficient 
Inter-rater reliability = 0.96 
Intra-rater reliability = 0.93 
 
Quality:  Fair 
Spearman cc only presented no ICC 
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Deathe et al 
2005 
 
L-test 
 
 
 Inter-rater ICC =  0.96,  
Intra-rater ICC = 0.97. 
 
Quality:  Fair 
Details of how missing data handled 
not given.  
Bland Altman plot suggested a 
ceiling effect  & SEM = 3s  
 
Quality: Fair 
Details of how missing data 
handled not given. 
Six minute walk test (6MWT) 
Lin & Bose 
2008 
 
6MWT 
 
 Test re-test reliability 
ICC: 6MWT = 0.94 
 
Quality:  Fair 
Details of how missing data handled 
not given. 
Bland Altman plot showed no 
systematic variation 
 
Quality:  Fair 
Details of how missing data 
handled not given. 
Resnik et al  
2011 
 
PEQ (modified version),  
OPUS, PSFS,  
2MWT, 6MWT, TUG,  
 Test re=test reliability 
ICC: 6MWT = 0.97 
 
Quality:  Good 
Administrations assumed to be 
independent, not confirmed 
MDC:6MWT = 45m 
 
Quality:  Good 
Administrations assumed to be 
independent, not confirmed 
 
Activities-Specific Balance Confidence (ABC) Scale 
Miller et al 
2003 
 
ABC Scale 
 
Cronbach’s alpha = 0.93 
Stepwise deletion of each item did not affect overall 
alpha 
 
Quality:  Poor 
No factor analysis described 
 
Test retest reliability  
ICC = 0.91 
 
Quality:  Fair 
Details of how missing data handled 
not given 
 
Bland Altman plot - better 
repeatability for higher scores 
SEM = 6.3 
 
Quality:  Fair 
Details of how missing data 
handled not given 
Sakakibari et al  
2011 
 
ABC Scale 
 
 
Item person map showed good coverage of all levels. 
Cronbachs alpha range across the threshold levels  = 
0.75-0.94 
 
Quality:  Fair 
Details of how missing data handled not given 
 SEM range across the threshold 
levels  = 0.27 – 0.4 
 
Quality:  Fair 
Details of how missing data 
handled not given 
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Houghton Scale 
Devlin et al 2004 
 
Houghton Scale 
 
 
 
 
 
Cronbachs alpha = 0.71 
at discharge and 0.70 at follow up 
 
Quality: Poor 
No factor analysis applied and Cronbachs alpha 
applied to total score only 
Test re-test reliability ICC = 0.96 
Kendall r-b = 0.743 (item 1), 0.688 
(item 2), 1 (item 3)  
Cohen’s k = 0.712 (item 4a), 0.824 
(item 4b), 0.453 (item 4c) 
 
Quality: Fair 
Details of how missing data handled 
not given 
 
Miller et al  
2001 
 
The Houghton Scale 
PPA-LCI, PEQ (ms) 
Cronbach’s alpha: 
Houghton= 0.68 
PPA-LCI = 0.89 
PEQ-ms = 0.95 
 
Quality:  Poor 
No factor analysis described 
 
Test retest reliability 
ICC: 
Houghton= 0.85 
PPA-LCI = 0.88 
PEQ-ms = 0.77 
 
Quality: Fair 
Details of how missing data handled 
not given 
SEM: 
Houghton= 0.93 
PPA-LCI = 2.7 
PEQ-ms = 1.1 
 
Quality:  Fair 
Details of how missing data 
handled not given 
Rivermead Mobility Index (RMI) 
Franchignoni 
 et al 2003 
 
RMI 
 
At admission Cronbachs alpha = 0.85 
Item to total correlation coefficients: 0.33-0.74 
 
Quality:  Fair 
Details of how missing data handled not given 
 
  
Ryall et al 2003 
 
RMI 
Timed 10m walk (from 
standing) 
 
 
Rasch analysis: 
Person separation =1.66 
Item Separation 7.99 
 
Quality:  Fair 
Details of how missing data handled not given 
Intra-rater reliability: ICC= 0.99 
Inter-rater: 
Kappa coefficient ranged 0.78 - 1 
 
Quality:  Fair 
Details of how missing data handled 
not given. 
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Assessment of Daily Activity Performance in Transfemoral amputees  (ADAPT) 
Theeven et al 
2010 
 
ADAPT 
 Test re-test reliability 
Pearson’s correlation r>0.8  
except for 1 station (strip 
bedclothes) 
 
Quality:  Fair 
Details of how missing data handled 
not given 
Bland Altman plot shows high 
levels of agreement with no 
specific trends or biases 
 
Quality:  Fair 
Details of how missing data 
handled not given 
 
Climbing Stair Questionnaire 
de Laat et al 2010 
 
Climbing stair 
Questionnaire 
 
 Test re-test reliability 
ICC 0.79; 95% CI, (0.57–0.90). 
 
Quality:  Good 
Postal  -  test conditions assumed 
identical.  
Bland Altman plot: Overall 
acceptable agreement, but large 
differences for two subjects in 
mid-range 
 
Quality:  Good 
Postal  - test conditions assumed 
identical. 
DSF-84 
Monteiro et al 
2013 
 
DSF-84 
 
Cronbachs alpha range across 5 domains = 0.52-0.89 
 
Quality:  Poor 
No factor analysis applied 
Inter-rater ICC > 0.99 all domains 
 
Quality: Fair 
Details of how missing data handled 
not given 
 
 
Frenchay Activities Index (FAI) 
Miller et al  
2004 
 
FAI 
 
 
 
Cronbachs alpha = 0.81 
Factor analysis confirmed 3 factors 
 
Quality:  Fair 
Details of how missing data handled not given 
Test-retest reliability ICC=0.79 
 
Quality: Fair 
Details of how missing data handled 
not given 
Bland Altman plot large variations 
> 2SDs 
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Functional Measure for Amputees (FMA) 
Callaghan et al 2002 
 
FMA 
 
 
 
 
 Test-test reliability 
ICC: continuous -  0.64 – 0.96 
categorical data  20 - 70%  
 
Quality:  Good 
Postal  -  test conditions assumed 
identical and patients stable. 
 
Goal Attainment Scaling (GAS) & Barthel Index 
Rushton et al  
2002 
 
GAS 
 
 
 Inter-rater reliability ICC = 0.67 
 
Quality:  Fair 
Details of how missing data handled 
not given & early rehab so subjects 
may have changed  
 
Harold Wood-Stanmore Mobility Scale, Handicap Mobility Scale, Handicap Physical Independence Scale. 
Gardiner et al 2002 
 
Harold Wood -Stanmore 
Mobility Scale,  
Handicap Mobility Scale,  
Handicap Physical 
Independence Scale. 
 
 
 Inter-rater  reliability  ICC: 
HW-S adm =  1, d/c  = 0.83 
Handi (mob) adm = 0.49, d/c = 0.83 
Handi (phys) adm = 0.15, d/c = 0.69 
 
Quality: Fair 
Details of how missing data handled 
not given. 
 
 
Hill Assessment Index (HAI) 
Highsmith et al 2013 
 
HAI 
 
 
 
 
 Inter-rater reliability  ICC: 
test 1= 0.97  
test 2 = 0.99 
 
Quality:  Good 
Spearman’s Rho used to calculate 
ICC 
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One leg stand test  (OLST) 
Kristensen et al 
2014 
 
OLST 
 
 
 
 
 
 
 Inter-rater reliability 
ICC=0.87 
 
Quality:  Fair 
Details of how missing data handled 
not given. 
 
SEM and single patient Smallest 
Real Difference (SRD): 
OLST 10s:    
SEM=2.92     SRD=8.09 
OLST 20s:     
SEM= 5.84    SRD= 16.18 
OLST 40s:     
SEM 11.68   SRD= 32-36 
 
Quality:  Fair 
Details of how missing data 
handled not given. 
 
Orthotics and Prosthetics Users' Survey (OPUS), Patient-Specific Functional Scale (PSFS) 
Resnik et al  
2011 
 
PEQ (modified version),  
OPUS, PSFS,  
2MWT, 6MWT, TUG,  
 
 
 Test re=test reliability 
ICC: 
OPUS = 0.67 
PSFS = 0.83 
 
Quality:  Good 
Administrations assumed to be 
independent, not confirmed 
 
MDC: 
OPUS = 10.3pt 
PSFS = 11.2pt 
 
Quality:  Good 
Administrations assumed to be 
independent, not confirmed 
 
Physiological Cost Index (PCI) 
Hagberg et al 
2010 
 
PCI 
 
 
 
 Intra-rater reliability 
ICC = 0.966 
 
Quality:  Good 
no model of ICC described 
Bland Altman plot showed 
acceptable agreement 
 
SDC = 0.116, coeffiecient of 
variation = 20% 
 
Quality:  Good 
no model of ICC described 
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Prosthetic Observational Gait Score (POGS) 
Hillman et al 2010 
 
POGS 
 
 
 
 Intra-rater reliability  
coefficient of repeatability (CoR) 
range 1.5-4.6 
Inter-rater CoR range 6-5.9 
 
 % agreement of each item of the 
score range 50-87. 
 
Kappa statistics range -0.03-0.6 
 
Quality:  Fair 
Details of how missing data handled 
not given 
 
. 
 
Prosthetic Profile of the Amputee (PPA) 
Gauthier-Gagnon et al 
1994 
 
PPA 
 
 
 Test-retest reliability 
 
Continuous data: ICC 0.8 – 0.92 
Categorical data: k=0.46 – 0.86 
 
Quality:  Good  
Postal  -  test conditions assumed 
identical 
 
Rising and sitting down Questionnaire 
de Laat et al 2011 
 
Rising and sitting down 
Questionnaire 
 
 Test re-test reliability 
ICC 0.83, 95% CI (0.65 - 0.93) 
 
Quality:  Good 
Postal  -  test conditions assumed 
identical.  
Bland Altman plot, acceptable 
overall but large differences for 
two subjects in mid-range 
SDC = 18.6% 
 
Quality:   Good 
Postal  - test conditions assumed 
identical 
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Special Interest Group in Amputee Medicine (SIGAM)  mobility grade 
Ryall et al  
2003 
 
SIGAM 
Rasch analysis: 
Person separation = 2.6 
Item Separation 7.99 
Quality:  Fair 
Details of how missing data handled not given 
Test re-test ICC = 0.79 
Kappa coefficient = 0.86 
 
Quality:  Fair 
Details of how missing data handled 
not given 
 
Timed 10m walk test (from standing) 
Ryall et al  
2003 
 
RMI 
Timed 10m walk (from 
standing) 
 
 Intra-rater reliability ICC= 0.99 
Inter-rater 
Kappa coefficient ranged 0.78 - 1 
 
Quality:  Fair: 
Details of how missing data handled 
not given 
Bland Altman plot indicated high 
level of agreement at the two 
time pts 
 
Quality:  Fair: 
Details of how missing data 
Walking Questionnaire 
de Laat et al 2012 
 
Walking Questionnaire 
 
 
 
 Test re-test reliability 
ICC 0.73, 95% CI (0.43 - 0.88) 
 
Quality:  Good  
Postal  -  test conditions assumed 
identical. 
Bland Altman plot, acceptable 
overall but large differences for 
one subject in mid-range 
 
Quality:  Good  
Postal  - test conditions assumed 
identical. 
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Sixteen studies looked at the internal consistency of 9 outcome measures.  The 
majority of the studies reported Cronbachs alpha (10/16), while factor analysis was 
performed in 11 out of the 16 studies to investigate the dimensionality of the 
measure.  This demonstrates that both the Classical Test Theory approach and the 
Item Test Theory had been used by the authors.   
 
Twelve studies looked at inter-rater reliability in thirteen different outcome 
measures.  Two studies used video footage of the same patient, with the remaining 
studies testing the same patient on two different occasions with time intervals 
varying between 2 hours and 6 weeks.   
 
Twenty studies looked at the intra-rater reliability reporting results on 21 outcome 
measures.  Most studies utilised the test-retest study-design with the same patient 
and time intervals ranged between the same day and up to 2 weeks.  This extended 
to 6 weeks when video footage of the patient was employed (Hillman et al 2010).   
 
Where intra-class correlations (ICCs) had been presented, the particular model was 
mentioned in 13 out of the 27 studies.   Where the model was reported the reason 
for choosing a particular model was often not stated.  Within the COSMIN checklist, 
this lack of clarity over the ICC model used, results in a lower quality rating.    
 
When testing reliability, it is essential to consider any day to day variation in the 
health (clinical) status of a participant that may impact on test conditions and 
increase the random measurement variation, and this was detailed in five studies.  
Stability of the participant’s clinical condition was assumed in the remainder where 
no details had been given.  A “good” rating was given in these cases, unless the 
phase of rehabilitation and time interval caused concern that a change in the 
patient’s clinical condition may have occurred.   
 
The same scrutiny was applied when judging the item “test conditions”.  Any 
variation in how the measure was implemented e.g. in clinic and a subsequent 
postal delivery for the first and second administration of a self-reported measure, 
was considered “not similar” and the quality rating was reduced.  In many cases, the 
“test conditions” were only assumed to be identical, i.e. no details had been given, 
and therefore only a  ”good” rating could be given. 
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Means and standard deviations (SD) were offered in most studies reporting on 
reliability.  However, measurement error or agreement parameters, e.g. standard 
error of measurement (SEM), limit of agreement (LoA), minimal detectable change 
(MDC) or equivalent, were not presented in 13 out of the 27 studies that reported 
reliability results.  
 
Of the 14 studies that had reported measurement error parameters, five presented 
SEM results for six different outcome measures: L-test; one leg stand test; 
Houghton Scale; PEQ (ms); PPA (LCI); and ABC scale.  In addition, six studies 
described LoA for: PCI; Frenchay Activities Index; ABC scale; 10m timed walk (from 
standing); and ADAPT.  Values for MDC, or equivalent using synonymous terms, 
were presented for outcome measures in four studies (see chapter 2 for a full 
definition of the variety of terms used to describe similar properties).  Minimal 
detectable change values were calculated for the PEQ (ms), OPUS, PSFS, 2 & 6 
MWT and TUG by Resnik (2011); the smallest detectable difference (SDD) was 
calculated for the Rising and Standing Questionnaire by de Laat et al (2011); the 
smallest detectable change (SDC) was calculated for the PCI by Hagberg et al 
(2011); and the smallest real difference (SRD) was calculated for the one leg stand 
test (Kristensen et al 2014).    All the authors used the SEM to calculate these 
values except Hagberg et al (2011) who had used the intra-individual standard 
deviation (IISD).  All parameters had been reported using 95% CI, with the 
exception of those in the study by Resnik et al (2011), where 90% CI had been 
reported.  There was one study that presented SEM values without presenting any 
reliability data (Sakakibara et al 2011).   
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Table 4.8   Methodological quality ratings and results (level of evidence) for validity / responsiveness / interpretability per outcome measure. 
Author, year 
Main outcome measure (s)  
Construct Validity Responsiveness Interpretability 
Locomotor Capability Index (LCI) / LCI-5 & PPA (LCI section) 
Franchignoni 
et al 2004 
 
Original LCI and revised 
version 
 
Spearmans p values 
2MWT = 0.667 (LCI), 0.708 (LCI-5),  
 
RMI = 0.752 (LCI), 0.757(LCI-5), 
 
FIM = 0.617(LCI), 
 0.622 (LCI-5) 
 
Quality:  Good 
Only two aprori hypotheses presented. 
 
Wilcoxon signed rank showed significant 
differences for both LCI and LCI-5 during 
rehabilitation period (mean 36 days) 
Effect size = 1.09 (LCI) & 1.40 (LCI-5) 
 
Quality:  Fair 
Effect size  
The percentage of participant who 
had the highest possible scores 
reflected a change in the ceiling 
effect reported for the original 
version compared to the LCI-5 
Franchignoni  
et al 2007 
 
LCI-5 and modified version 
LCI-10-4 
Spearmans rs  = 0.77 showed strong correlation 
with the PEQ(MS) 
 
Quality:  Fair 
Details of how missing data handled not given. 
 
 Study population relatively young: 
mean age = 54 
 
High prevalence of traumatic 
amputees (56%) 
Miller et al  
2001 
 
The Houghton Scale 
 
PPA-(LCI) 
 
Prosthetic Evaluation 
Questionnaire – mobility 
subscale (PEQ-ms) 
All hypothesized relationships confirmed by 
Pearson’s r: 
Houghton/PPA-LCI= 0.59 
Houghton/PEQ-ms= 
0.55 
PPA-LCI/PEQ-ms=  
0.83 
 
Quality:  Fair 
Details of how missing data handled not given 
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Rushton et al  
2002 
 
Goal Attainment Scaling 
(GAS) 
 
Comparator results LCI 
 
 
 
 
 Effect size  
LCI = 3.7 
 
Relative efficiencies  
Houghton vs LCI = 4.7 
 
Quality:  Fair 
Details of how missing data handled not 
given. 
Interim period not described. 
Effect size  
 
Two minute walk test (2MWT) 
Brooks  
et al 2001 
 
2MWT 
 
 
 
 
 
 
Pearsons correlation r=0.22 between distance 
walked and SF-36 prior to d/c 
r=0.48 at follow up 
r=0.49 between Houghton total score and 
distance walked at d/c 
 
 
Quality:   Fair 
Details of how missing data handled not given.  
Houghton and SF-36 used in the absence of a 
gold standard measure of physical function for 
pwLLAs.  SF-36 not validated in pwLLAs. 
Houghton scale measures prosthetic use, not 
mobility. 
The distances walked indicated a change 
during rehabilitation. 
 ANOVA , p<0.001  
 
 
Quality:    Fair 
Details of how missing data handled not 
given.   
The interim period was not described. 
ANOVA calculated on mean differences. 
 
Retrospective study. 
Distances walked did indicate a 
change but no SDC or MIC was 
calculated. 
Berg Balance Scale (BBS) 
Major et al  
2013 
 
 
BBS 
Spearman’s rank correlation with: 
ABC scale=0.634, PEQ(ms) = 0.584, 
FAI = 0.607, 2MWT = 0.675, L-test = -0.802 
 
Quality:  Fair 
Details of how missing data handled not given 
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Prosthesis Evaluation Questionnaire (PEQ) 
Franchignoni  
et al 2007 
 
PEQ (ms) and revised 
version 
 
All hypothesized relationships confirmed by 
Spearmans r   
 
LCI= 0.78  
 
Quality:  Fair 
Details of how missing data handled not given. 
 
 Study population relatively young: 
mean age = 54 
 
High prevalence of traumatic 
amputees (56%) 
Miller et al  
2001 
 
The Houghton Scale 
 
PPA-(LCI) 
 
PEQ-(ms) 
All hypothesized relationships confirmed by 
Pearson’s r: 
 
Houghton/PPA-LCI = 0.59 
Houghton/PEQ-(ms) = 0.55 
PPA-LCI/PEQ-(ms) = 0.83 
 
Quality:  Fair 
Details of how missing data handled not given 
 
  
Timed Up and Go (TUG) & L-test 
Schoppen et al  
1999 
 
TUG 
 
 
 
 
 
 
 
All hypothesized relationships confirmed by 
Spearmans r: 
  
Sickness Impact Profile (SIP68)    
mobility control =0.46 
mobility range = 0.36 
 
Groningen Activity Restriction Scale (GARS) = 
0.39 
 
Quality:  Good 
Spearman only presented, no means or SD 
 
 Elderly vascular subjects only 
therefore results not generalisable. 
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Deathe et al 
2005 
 
L-test 
 
 
 
 
 
Pearsons correlations (r = 0.22 – 0.93) with 
other mobility measures recorded. 
 
 
Quality:  Fair 
Details of how missing data handled not given. 
 Bland Altman plot suggested a 
ceiling effect in the L-test however 
3 recorded ceiling effect for L-Test 
not TUG and 14 recorded ceiling 
effect for TUG not L-Test. 
McNemar Test showed 66 did not 
demonstrate ceiling effects.  
 
Six minute walk test (6MWT) 
Lin & Bose 
2008 
 
6MWT 
 
 
 
Pearson's correlation: 
 TUG r=0.76,  
One leg balance test (eyes open) r=0.00, (eyes 
closed) r=0.42 
 
Quality:  Fair 
Details of how missing data handled not given. 
  
Activities-Specific Balance Confidence (ABC) Scale ABC scale 
Miller et al 
2003 
 
ABC scale  
All hypothesized relationships confirmed by 
Pearson’s r: 
2MWT= 0.72 
TUG = -0.70 
 
Quality:  Fair 
Details of how missing data handled not given 
 ABC scale did not discriminate 
between groups according to 
amputation level. 
Houghton Scale 
Devlin et al 2004 
 
Houghton Scale 
 
 
 
All hypothesized relationships confirmed by 
Pearsons correlations (r = 0.24 - 0.65)  
 
Quality:  Fair 
Details of how missing data handled not given. 
And aprori hypotheses not presented. 
Wilcoxon signed rank showed significant 
differences for mean score changes from 
discharge to follow-up   
Effect size = 0.6 3mth period after d/c 
 
Quality:  Fair 
Effect size  
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Miller et al  
2001 
 
The Houghton Scale 
 
PPA-(LCI) 
 
PEQ-(ms) 
All hypothesized relationships confirmed by 
Pearson’s r: 
 
Houghton/PPA-LCI = 0.59 
Houghton/PEQ-(ms) = 0.55 
PPA-LCI/PEQ-(ms) = 0.83 
 
Quality: Fair 
Details of how missing data handled not given 
 
  
Rivermead Mobility Index (RMI) 
Franchignoni 
 et al 2003 
 
RMI 
 
Spearman rank correlations (rs = 0.69 – 0.7) 
with other measures recorded 
 
Quality:  Fair 
Details of how missing data handled not given 
 
Effect size = 1.35 calculated for 
prosthetic training period (time not 
defined) 
 
Quality:  Fair 
Effect size  
 
RMI appears more useful for 
epidemiological studies than at an 
individual level on the basis of this 
study. 
Ryall et al  
2003 
 
RMI 
Timed 10m walk (from 
standing) 
Spearman’s Rho 
TWT = -0.58 
 
Quality: Fair 
Details of how missing data handled not given.  
Apriori hypotheses not fully described.  
 
  
Assessment of Daily Activity Performance in Transfemoral amputees  (ADAPT) 
Theeven et al 
2010 
 
ADAPT 
Mann Whitney demonstrated significant 
differences in performance times for 6/9 (75%) 
of the test stations 
 
Quality:  Fair 
Details of how missing data handled not given 
 
 ADAPT appears to be able to 
differentiate between groups of 
users by their prosthetic 
componentry. 
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Climbing Stair Questionnaire 
de Laat et al 2010 
 
Climbing stair 
Questionnaire 
 
2/10 hypotheses rejected (> 75% confirmed) -  
validity considered good.  
 
 
Quality:  Good 
Magnitude of expected differences not stated a 
priori 
 
 Recommended for group 
comparisons but not individual 
Frenchay Activities Index (FAI) 
Miller et al  
2004 
 
FAI 
 
 
 
 
All hypothesized relationships confirmed by 
Pearson’s r  
 
2MWT  =0.526 
TUG = -0.486 
PEQ(ms) =0.385 
ABC =0.505 
 
 
Quality:  Fair 
Details of how missing data handled not given 
 
 Reliability is adequate to detect 
group but not individual level 
differences 
Goal Attainment Scaling (GAS)  
Rushton et al  
2002 
 
GAS 
 
Barthel Index (comparator 
only) 
 
 
 
All hypothesized relationships confirmed by 
Pearson’s r : 
Barthel Index = 0.44 
LCI = 0.35 
 
Quality:  Fair 
Details of how missing data handled not given 
Effect size = 6.5 
Relative efficiencies vs Barthel Index=3.1 
Vs LCI = 4.7 
 
Quality:  Fair 
Details of how missing data handled not 
given & interim period not described. 
Effect size  
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ICF Checklist 
Kohler et al  
2011 
 
ICF Checklist 
 
 
 
 Wilcoxon signed rank tests indicated a 
functional significant deterioration 
immediately after amputation with a 
gradual improvement over the next 3 
weeks. 
 
Quality:  Fair 
No apriori hypotheses formulated 
 
 
Office of Population Censuses and Surveys (OPCS) Scale, Functional Independence Measure (FIM), Amputee Activity Score (AAS) 
Panesar et al  
2001 
 
OPCS Scale, 
FIM,   
AAS 
Kendall’s coefficient of concordance X
2
  shown  
with each other at each time point, and with 
LCI confirming hypotheses: 
 
adm = 65.79 
d/c = 71.8 
follow-up = 72.81 
 
LCI = 57.28 
 
Quality:  Good 
Expected direction and magnitude of 
hypotheses not stated 
 
All scores showed statistically significant 
changes (p<0.00001) between adm & 
d/c 
 
Kendalls correlation coefficient z: 
OPCS = 6.25 
FIM = 5.37 
AAS = 5.39 
 
Quality:   Fair 
No description of interim period. 
 
Prosthetic Profile of the Amputee (PPA) 
Gauthier-Gagnon et al 
1994 
 
PPA 
 
 
Two hypotheses confirmed using Pearson’s 
product-moment correlation coefficients for all 
three constructs of PPA and RNL index: (0.30 – 
0.73) 
 
Quality:  Good  
Postal  -  test conditions assumed identical 
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Rising and sitting down Questionnaire 
de Laat et al 2011 
 
Rising and sitting down 
Questionnaire 
 
 
 
1/10 hypotheses rejected 
(> 75% confirmed)  
 
 
Quality: Good 
Magnitude of expected differences not stated a 
priori 
 Recommended for group 
comparisons and not individual. 
Special Interest Group in Amputee Medicine (SIGAM)  mobility grade 
Ryall et al  
2003 
 
SIGAM 
 
Significant differences between timed walk 
tests and non-adjacent grades were found. 
 
Quality:  Fair 
Details of how missing data handled not given. 
Apriori hypotheses not fully described.  
Effect size = 10.66 
 
Quality:  Fair 
Details of how missing data handled not 
given. Apriori hypotheses not fully 
described.  
Effect size  
 
 
Walking Questionnaire 
de Laat et al 2012 
 
Walking Questionnaire 
 
 
 
1/11 hypotheses rejected  
(> 75% confirmed)  
 
Quality:   Good 
Magnitude of expected differences not stated a 
priori 
 
 Recommended for group 
comparisons and not individual. 
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Gold standard measures are not well established within the field of rehabilitation and 
as a consequence criterion validity was not reported.  Hypothesis testing was used 
in all of the studies (n=21) aiming to report on construct validity, with none 
reporting criterion validity.  Where correlations with comparator outcome measures 
were presented, they were mostly either Pearson’s product-moment correlation (10 
studies) or Spearman’s rank correlations (9 studies).  In one study, Kendall’s k 
correlations were presented and one study used Rasch analysis to provide 
additional information on the structural validity of the outcome measure.   
The quality of the hypotheses that had been presented, were variable.  Most stated 
a priori hypotheses with expected relationships to comparator outcome measures 
that purported to be measuring the same construct(s).  Where explicit hypotheses 
had not been stated, the intention was often easy to interpret, but this still reduced 
the methodological quality level for that property to “fair”.   
 
Responsiveness, or the ability of the outcome measure to measure a change in the 
clinical condition, was reported in eight studies on 11 outcome measures: 2MWT; 
Houghton scale; Rivermead Mobility Index; LCI; ICF checklist; FIM; OPCS; Amputee 
Activity Score; Goal Attainment Scaling; Barthel Index; and SIGAM.  Analysis of 
variance (ANOVA), effect size, Wilcoxon signed rank test, Kendall’s correlation 
coefficient and Relative Efficiency results had been presented to demonstrate the 
responsiveness of the OM under study and to detect change in the clinical condition 
(in a variety of settings) using a longitudinal study design.  While these eight studies 
reported either statistical significance of the differences or the magnitude of change, 
or both, no authors reported the “clinical” responsiveness of the outcome measures 
under study, i.e. whether any detected changes in scores reflected a true clinical 
change in condition or function, using either a subjective or gold standard anchor.  
Minimally important clinical differences (MICD) were not reported by any of the 
studies included in this review. 
 
4.4.4 Levels of evidence of the results 
The level of evidence ratings was awarded by examining the results obtained in 
each study for each measurement-property against the standards described in 
Terwee et al (2007); see Table 4.1 for full details of the standards.  Results for 106 
measurement properties were reported for 35 outcome measures across the 36 
studies reviewed, and all except three were deemed to be positive ‘’+”.  The 
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Orthotics and Prosthetics Users' Survey (OPUS) presented in the study by Resnik et 
al (2011), the Goal Attainment Scaling (GAS) OM (Rushton et al 2002) and the 
continuous items in the PPA (Gauthier-Gagnon et al 1994), all presented results that 
were considered to have a negative rating for reliability, i.e. ICC or weighted Kappa 
<0.70. 
There were twenty studies where the evidence had been awarded a positive rating 
but the final rating was changed to indeterminate “?” due to small sample sizes, i.e. 
< 50 participants.  The remaining indeterminate ratings were due to: no factor 
analysis and/or no Cronbach’s alpha reported for internal consistency, both of which 
are required for a positive result; no comment made on the limits of agreement when 
reporting on measurement error which is required; or a poor choice of statistical 
analysis when reporting responsiveness, i.e. no ROC analysis or reference to any 
minimal importance change (MIC) values.  All the evidence ratings together with a 
the methodological quality ratings are presented in Table 4.9.   
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Table 4.9   Summary of quality ratings and levels of evidence 
 
Author, year 
Main outcome measure(s)  
Internal consistency Reliability  Measurement Error Construct Validity Responsiveness 
Locomotor Capability Index (LCI) / LCI-5 & PPA (LCI section) 
 
Gauthier Gagnon et al 
1998 
 
LCI 
 
Quality: Good 
(% of missing items not 
given) 
Evidence: + 
 
    
Franchignoni 
et al 2004 
 
Original LCI and revised 
version 
 
Quality: Excel  
Evidence: +  
 
 
 
Quality: Fair  
(Conducted during 
rehab phase) 
Evidence: ?  
(sample size) 
 
Quality:  Fair  
(Conducted during 
rehab phase) 
Evidence: ?  
(sample size) 
 
Quality: Good (Only two 
aprori hypotheses presented) 
Evidence: + 
 
 
Quality: Fair (Effect 
size) 
Evidence: ?  
(choice of analysis) 
  
Franchignoni  
et al 2007 
 
LCI-5 and modified 
version LCI-10-4 
Quality:  Fair 
(Details of how missing 
data handled not given) 
Evidence: +  
 
  Quality:  Fair 
Details of how missing data 
handled not given. 
Evidence: + 
 
 
Miller et al 2001 
 
PPA-(LCI) 
 
Quality: Poor 
(No factor analysis 
described) 
Evidence: ?  
(no factor analysis) 
 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
Evidence: + 
 
 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
Evidence: ?  
(no comment on LoA) 
Quality: Fair 
(Details of how missing data 
handled not given) 
Evidence: +  
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Rushton et al 2002 
 
Comparator results LCI 
 
     Quality: Fair 
(Details of how 
missing data handled 
not given & interim 
period not described 
& effect size) 
Evidence: ? 
(choice of analysis) 
  
Two minute walk test (2MWT) 
 
Brooks et al 2001 
 
2MWT 
 
   Quality:  Fair  
(Details of how missing data 
handled not given. Houghton 
and SF-36 were used in the 
absence of a gold standard 
measure of physical function 
for pwLLAs.   
SF-36 not validated in pwLLAs. 
Houghton Scale measures 
prosthetic use, not mobility) 
 
Evidence: + 
 
Quality:  Fair  
(Details of how 
missing data handled 
not given.  The 
interim period was 
not described. 
ANOVA calculated on 
mean differences) 
 
Evidence:  ?  
(choice of analysis) 
 
Brooks et al 2002 
 
2MWT 
 
 
 Quality:  Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ?  
(sample size) 
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Resnik et al 2011 
 
2MWT 
 Quality: Good 
(Administrations 
assumed to be 
independent, not 
confirmed) 
 
Evidence: ?  
(sample size) 
 
 
Quality: Good 
(Administrations 
assumed to be 
independent, not 
confirmed) 
 
Evidence: ? 
(no comment on LoA) 
 
  
Berg Balance Scale (BBS) 
Major et al 2013 
 
BBS 
Quality: Poor  
(No factor analysis 
performed) 
 
Evidence:?  
(no factor analysis) 
 
Quality: Fair.  
(Details of how missing 
data handled not 
given) 
 
Evidence: + 
 
 Quality: Fair 
(Details of how missing data 
handled not given) 
 
Evidence: + 
 
 
 
Wong et al 2013 
 
BBS 
 
Quality: Fair 
(Details of how missing 
data handled not given) 
 
Evidence: ? 
(no Cronbachs alpha) 
  
    
Wong et al 2014 
 
BBS 
 
 Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ?  
(sample size) 
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PEQ original and mobility scale 
Franchignoni et al 2007 
 
PEQ (ms) and revised 
version 
 
Quality: Fair 
(Details of how missing 
data handled not given) 
 
Evidence: +  
  
  Quality: Fair 
(Details of how missing data 
handled not given) 
 
Evidence+ 
 
 
Miller et al 2001 
 
PEQ-(ms) 
 
Quality: Poor 
(No factor analysis 
described) 
 
Evidence: ? 
(no factor analysis) 
 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: + 
 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ?  
(no comment on LoA) 
Quality: Fair 
(Details of how missing data 
handled not given) 
 
Evidence: + 
 
 
Resnik et al 2011 
PEQ (modified version),  
Quality: Excellent 
 
Evidence: ? 
(sample size)  
 
Quality: Good 
(Administrations 
assumed to be 
independent, not 
confirmed) 
 
Evidence: ? 
(sample size) 
 
Quality: Good 
(Administrations 
assumed to be 
independent, not 
confirmed) 
 
Evidence: ? 
(no comment on LoA) 
  
Timed Up and Go (TUG) & L-test 
Resnik et al 2011 
 
TUG  
 
 Quality: Good 
(Administrations 
assumed to be 
independent, not 
confirmed) 
 
Evidence: ?  
(sample size) 
 
Quality: Good 
(Administrations 
assumed to be 
independent, not 
confirmed) 
 
Evidence: ? 
 (no comment on LoA)  
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Schoppen et al 1999 
 
TUG 
 
 Quality: Fair 
(Spearman cc only 
presented no ICC) 
 
Evidence: ? 
(sample size) 
 
 Quality: Good 
(Spearman cc only presented 
no ICC) 
 
Evidence: ? 
(sample size) 
 
Deathe et al 2005 
 
L-test 
 
 Quality:  Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: inter +, intra 
? (sample size)  
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: + 
 
Quality: Fair  
(Details of how missing data 
handled not given) 
 
Evidence: + 
 
 
 
Six minute walk test (6MWT) 
 
Lin & Bose 2008 
 
6MWT 
 Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ?  
(sample size)  
 
Quality:  Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ? 
(sample size) 
Quality: Fair 
(Details of how missing data 
handled not given) 
 
Evidence: ?  
(sample size) 
 
 
Resnik et al 2011 
 
6MWT 
 
 Quality: Good 
(Administrations 
assumed to be 
independent, not 
confirmed) 
 
Evidence: ?  
(sample size) 
 
Quality: Good 
(Administrations 
assumed to be 
independent, not 
confirmed) 
 
Evidence: ? 
(no comment on LoA) 
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Activities-Specific Balance Confidence (ABC) Scale 
Miller et al 2003 
 
ABC scale 
Quality: Poor 
(No factor analysis 
described) 
 
Evidence: ? 
(no factor analysis) 
 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: + 
 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: + 
 
Quality: Fair 
(Details of how missing data 
handled not given) 
 
Evidence: + 
 
 
 
Sakakibari et al 2011 
 
ABC Scale 
 
Quality: Fair 
(Details of how missing 
data handled not given) 
 
Evidence: + 
 
 Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ?  
(no comment on LoA) 
 
  
Houghton Scale 
Devlin et al 2004 
 
Houghton Scale 
 
 
Quality: Poor 
(No factor analysis 
applied and Cronbachs 
alpha applied to total 
score only) 
 
Evidence: ? 
(no factor analysis) 
 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ?  
(sample size) 
  
 Quality: Fair 
(Details of how missing data 
handled not given. And aprori 
hypotheses not presented.) 
 
Evidence: ?  
(no hypotheses) 
 
Quality: Fair 
(Effect size) 
 
Evidence: ? 
(choice of analysis) 
 
Miller et al 2001 
 
The Houghton Scale 
 
Quality: Poor 
(No factor analysis 
described) 
 
Evidence:? 
(no factor analysis) 
 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: + 
 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ?  
(no comment on LoA) 
Quality: Fair 
(Details of how missing data 
handled not given) 
 
Evidence: + 
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Rivermead Mobility Index (RMI) 
Franchignoni  et al 2003 
 
RMI 
 
Quality: Fair 
(Details of how missing 
data handled not given) 
 
Evidence: +  
 
  Quality: Fair 
(Details of how missing data 
handled not given) 
 
Evidence: + 
 
Quality: Fair 
(Effect size) 
 
Evidence: ?  
(choice of analysis) 
 
Ryall et al 2003 
 
RMI 
 
Quality: Fair 
(Details of how missing 
data handled not given) 
 
Evidence: ?  
(no Cronbachs alpha) 
 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: + 
 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: + 
 
Quality: Fair  
(Details of how missing data 
handled not given. Apriori 
hypotheses not fully 
described.) 
 
Evidence: + 
 
 
Assessment of Daily Activity Performance in Transfemoral amputees (ADAPT) 
Theeven et al 2010 
 
ADAPT 
 
 Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ? 
(sample size) 
 
Quality:  Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ? 
(sample size) 
 
Quality:  Fair 
(Details of how missing data 
handled not given) 
 
Evidence: ? 
(sample size) 
 
 
Climbing Stair Questionnaire 
de Laat et al 2010 
 
Climbing stair 
Questionnaire 
 
 Quality:  Good  
(Postal - test 
conditions assumed 
identical) 
 
Evidence: ?  
(sample size) 
 
Quality:  Good 
(Postal - test 
conditions assumed 
identical) 
 
Evidence: ? 
(sample size)  
Quality:  Good 
(Magnitude of expected 
differences not stated a 
priori) 
 
Evidence: + 
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DSF-84 
Monteiro et al  2013 
 
DSF-84 
 
Quality:  Poor 
(No factor analysis 
described) 
 
Evidence: ?  
(no factor analysis)  
 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ? 
(sample size) 
   
Frenchay Activities Index (FAI) 
Miller et al 2004 
 
FAI 
 
Quality: Fair 
(Details of how missing 
data handled not given) 
 
Evidence: + 
 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: + 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: + 
Quality: Fair  
(Details of how missing data 
handled not given) 
 
 
Evidence: +  
 
Functional Measure for Amputees (FMA) 
Callaghan et al 2002 
 
FMA 
 
 Quality: Good  
(Postal - test 
conditions assumed 
identical and patients 
stable) 
 
Evidence: + 
   
Goal Attainment Scaling (GAS) 
Rushton et al 2002 
 
GAS 
 
 Quality: Fair 
(Details of how missing 
data handled not given 
& early rehab so 
subjects may have 
changed) 
 
Evidence: - 
 
 Quality: Fair  
(Details of how missing data 
handled not given) 
 
Evidence: ?  
(sample size)  
 
 
Quality: Fair  
(Details of how 
missing data handled 
not given & interim 
period not described. 
Effect size) 
 
Evidence: ?  
(choice of analysis) 
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Harold Wood -Stanmore Mobility Scale, Handicap Mobility Scale, Handicap Physical Independence Scale. 
Gardiner et al 2002 
Harold Wood -Stanmore 
Mobility Scale,  
Handicap Mobility Scale,  
Handicap Physical 
Independence Scale. 
 
 Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ? 
(sample size) 
 
   
Hill Assessment Index (HAI) 
Highsmith et al 2013 
 
HAI 
 
 Quality: Good 
(Spearman’s Rho used 
to calculate ICC) 
 
Evidence: ?  
(sample size)  
   
ICF Checklist 
Kohler et al 2011 
 
ICF Checklist 
 
    Quality: Fair 
(No apriori 
hypotheses 
formulated) 
 
Evidence: ?  
(choice of analysis)  
 
Office of Population Censuses and Surveys (OPCS) Scale, Functional Independence Measure (FIM), Amputee Activity Score (AAS) 
Panesar et al 2001 
 
OPCS Scale, 
FIM,  
AAS 
   Quality: Good 
(Expected direction and 
magnitude of hypotheses not 
stated) 
 
Evidence: ?  
(sample size)  
Quality:  Fair 
(No description of 
interim period.) 
 
Evidence: ? 
(choice of analysis) 
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One leg stand test  (OLST)  
Kristensen et al 2014 
 
OLST 
 
 Quality:  Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ? 
(sample size)  
 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ? 
(no comment on LoA) 
  
Orthotics and Prosthetics Users' Survey (OPUS), Patient-Specific Functional Scale (PSFS) 
Resnik et al 2011 
 
OPUS,  
PSFS  
 
 Quality:  Good 
(Administrations 
assumed to be 
independent, not 
confirmed) 
 
Evidence: -  
 
Quality: Good 
(Administrations 
assumed to be 
independent, not 
confirmed) 
 
Evidence: ?  
(no comment on LoA) 
  
Physiological Cost Index (PCI) 
Hagberg et al 2010 
 
PCI 
 Quality: Good  
(no model of ICC 
described) 
 
Evidence: ?  
(sample size)  
Quality: Good 
(no model of ICC 
described) 
 
Evidence: ?  
(sample size) 
  
Prosthetic Observational Gait Score (POGS) 
Hillman et al 2010 
 
POGS 
 
 Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ?  
(sample size)  
. 
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Prosthetic Profile of the Amputee (PPA) 
Gauthier-Gagnon et al 
1994 
 
PPA 
 Quality:  Good  
(Postal - test 
conditions assumed 
identical) 
Evidence: Cont +, Cat –  
 
 Quality:  Good  
(Postal - test conditions 
assumed identical) 
 
Evidence: + 
 
 
Rising and sitting down Questionnaire 
de Laat et al 2011 
 
Rising and sitting down 
Questionnaire 
 
 
 Quality:  Good 
(Postal - test 
conditions assumed 
identical) 
 
Evidence: ?  
(sample size)  
Quality: Good 
(Postal - test 
conditions assumed 
identical) 
 
Evidence: ?  
(sample size) 
Quality: Good 
(Magnitude of expected 
differences not stated a 
priori) 
 
Evidence: + 
 
 
Special Interest Group in Amputee Medicine (SIGAM)  mobility grade 
Ryall et al 2003 
 
SIGAM 
Quality: Fair 
(Details of how missing 
data handled not given) 
 
Evidence: ?  
(no Cronbachs alpha)  
 
 
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: ? 
(sample size) 
 
 
 
 Quality: Fair  
(Details of how missing data 
handled not given. Apriori 
hypotheses not fully 
described.) 
 
Evidence: ?  
(no hypotheses) 
 
 
Quality: Fair 
(Details of how 
missing data handled 
not given. Apriori 
hypotheses not fully 
described.  
Effect size) 
 
Evidence: ?  
(choice of analysis)  
Timed 10m walk test (from standing) 
Ryall et al 2003 
 
Timed 10m walk (from 
standing) 
 
 Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: +  
Quality: Fair 
(Details of how missing 
data handled not 
given) 
 
Evidence: +  
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Walking Questionnaire 
de Laat et al 2012 
 
Walking Questionnaire 
 
 Quality:  Good  
(Postal - test 
conditions assumed 
identical) 
 
Evidence: ? 
(sample size)  
 
Quality:  Good  
(Postal - test 
conditions assumed 
identical) 
 
Evidence: ? 
(sample size) 
Quality: Good  
(Magnitude of expected 
differences not stated a 
priori) 
 
Evidence: + 
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4.4.5 Best evidence synthesis  
Assessment of the strength of evidence was determined using the levels of 
evidence together with the methodological quality against criteria noted in table 
4.10.   
 
Table 4.10  Strength of evidence for the measurement properties (based on the Cochrane Back 
Review Group 2003 (van Tulder et al. 2003) adapted from Terwee et al 2007)  
Level Rating Criteria 
Strong +++ or --- 
Consistent findings in multiple studies of good 
methodological quality 
  
OR in one study of excellent methodological quality 
  
Moderate ++ or -- 
Consistent findings in multiple studies of fair 
methodological quality OR in one study of good 
methodological quality 
  
OR in one study of good methodological quality 
  
Limited + or - One study of fair methodological quality 
Conflicting ± Conflicting findings 
Unknown ? Only studies of poor methodological quality 
+ = positive results; ? =indeterminate results; - =negative results 
 
The full results of the best evidence synthesis are detailed in Table 4.11, with a 
summary of the strength of evidence presented for physical function outcome 
measures in pwLLAs presented in Table 4.12.  
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Table 4.11    Synthesis of best evidence 
 
Outcome Measure (number of studies) 
Measurement Parameter 
Strength of Evidence 
Internal 
Consistency 
Reliability Measurement 
Error 
Construct Validity Responsiveness 
LCI / LCI-5 / PPA-LCI section (5) Strong positive Limited positive Unknown Strong positive Unknown 
2MWT (3) N/A Unknown Unknown  Limited positive Unknown 
BBS (3) Unknown Limited positive  Unknown  
PEQ /PEQ (ms) (3) Limited positive Limited positive Unknown  Moderate positive  
TUG (3) 
L-Test (1) 
N/A Unknown Unknown Unknown  
N/A  Limited + & - Limited positive Limited positive  
6MWT (2) N/A Unknown Unknown Unknown  
ABC Scale (2) Limited positive Limited positive Limited positive Limited positive  
Houghton Scale (2) Unknown Limited positive Unknown Limited positive Unknown  
RMI (2) Limited positive Limited positive Limited positive Moderate positive Unknown 
ADAPT  (1)  Unknown Unknown   
Climbing Stair Questionnaire (1)  Unknown Unknown Moderate positive  
DSF-84 (1) Unknown Unknown    
FAI  (1) Limited positive Limited positive Limited positive Limited positive  
FMA (1)  Moderate positive    
GAS  (1)  Unknown  Unknown Unknown 
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Barthel Index (comparator only) (1)     Unknown 
Harold Wood/Stanmore Mobility Scale (1)  Unknown    
Handicap Mobility Scale (1)  Unknown    
Handicap Physical Scale (1)  Unknown    
Hill Assessment Index (1)  Unknown    
ICF Checklist (1)     Unknown 
OPCCS, (1)    Unknown Unknown 
FIM  (1)    Unknown Unknown 
AAS  (1)    Unknown Unknown 
One leg stand test  (1)  Unknown Unknown   
OPUS (1)  Unknown Unknown   
PSFS (1)  Unknown Unknown   
PCI (1)  Unknown Unknown   
POGS (1)  Unknown    
PPA (1)  Moderate  + & -  Moderate positive  
Rising and sitting down Questionnaire (1)  Unknown Unknown Moderate positive  
SIGAM (1) Unknown Unknown  Unknown Unknown 
Timed 10m walk test (1) N/A  Limited positive Moderate positive  
Walking Questionnaire (1)  Unknown Unknown   
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Table 4.12   Summary of evidence strength  
 
Strength of 
evidence 
Measurement Properties 
Internal 
Consistency 
Reliability Measurement 
Error 
Construct 
Validity 
Responsiveness 
Strong + 1     
Moderate +  2  7  
Moderate -  1    
Limited + 4 8 5 5  
Limited -  1    
Unknown 4 19 14 8 11 
Total 9 31* 18 20 11 
* strength of evidence results for PPA were different for categorical and ordinal data and for 
Ltest they were different for intra- and inter-rater reliability, therefore the number of outcome 
measures does not match the number studied (see table 4.2) 
 
With the exception of construct validity and internal consistency, the majority of 
evidence for reliability, measurement error and responsiveness is unknown. Eight 
outcome measures have strong or moderate positive evidence in one or more 
measurement properties: LCI/LCI-5, PEQ, RMI, Climbing Stair Questionnaire, FMA, 
PPA, Rising and Sitting Down Questionnaire and the Walking Questionnaire. Five 
outcome measures have limited evidence to support positive results for 
measurement error: L-Test, ABC scale, RMI, FAI and 10m walk test.  Evidence for 
responsiveness for any outcome measure in this population was either absent or 
unknown.   
 
 
4.5 Discussion  
The aims of this systematic review were to: a) examine the published literature 
investigating outcome measures used to measure physical function of lower limb 
amputees walking with a prosthesis; b) provide a methodological quality-rating for 
each psychometric measurement property presented; and c) report the level of 
evidence obtained for each outcome measure.   
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Synthesis of the results demonstrated a scarcity of high quality evidence.  The 
implications of this will be discussed below, taking into account the context of the 
population pwLLA and also the intended use of an outcome measure. 
 
4.5.1 Quantity and quality of evidence  
Evidence is either not present or unknown for at least one measurement property, 
for each of the many outcome measures reported in this review.   The lack of data 
presented to support the responsiveness of these outcome measures is especially 
noted.    Results from previous reviews involving pwLLAs have commented on the 
limited evidence of responsiveness (Sawers and Hafner 2013, Condie et al. 2006, 
Deathe et al. 2009, Hebert et al. 2009).  
 
The review carried out by Hawkins et al in 2014 did not make any comment on the 
evidence on responsiveness, but they did note that several OMs were rated +++, as 
per the Johnstone and Graves criteria (Johnston and Graves 2008). The definition of 
+++ is: 
 “Adequately/reasonably valid for the main defined purpose. (Widely used 
outside of population of interest, with formal studies/use in population of 
interest.). OK to use in studies, although checking of assumptions or small 
improvements may be desirable to further improve the measure (eg, 
classical measures would benefit from item-response theory or Rasch 
analysis) “   
 
This definition does leave some element of doubt over the completeness of the 
measures and while the authors comment in their discussion that “there are a 
number of validated instruments that are of high quality and are widely used”, the 
results of this current systematic review do not concur with the label of high quality.  
Within the Johnstone and Graves criteria, used in this review as well as the Deathe 
et al  (2009) and Hebert et al (2009) reviews, there is no requirement to qualify 
measures of “sensitivity to change” (assessed within validity), merely to report 
significant differences or medium to large effect size.  Responsiveness of the 
measures may therefore be under reported in these reviews.  Also “overall” quality is 
presented, not per measurement property as in COSMIN.   
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Heineman et al (2014) presented a narrative review of the outcome instruments for 
prosthetics.  In their abstract they stated “It is encouraging that responsiveness of 
measures is often reported, as this information is needed to improve clinical utility.” 
However with no quality assessment of the studies or grading of the level or strength 
of evidence presented, there appears to be no basis for this statement. 
 
Systematic reviews in other patient populations have also found a similar lack of 
evidence for responsiveness and measurement error in walking tests for stroke 
survivors (Scrivener et al. 2013); PROMs in hip and knee arthroplasty (Alviar et al. 
2011), and performance based measures in hip and knee osteoarthritis (Dobson et 
al. 2012). It is important to note that while the methodological quality of some of the 
studies were marked down according to the criteria (Terwee et al. 2007), this may 
have been due to an omission by the authors when reporting the study, rather than 
in the conduct of the study.  For example handling of missing data and the 
independent administration of tests may have been methodologically sound, but not 
reported in the literature. Improvements in standardised reporting of such studies 
was a key aim for the COSMIN group when implementing the checklist (Mokkink et 
al. 2010c). 
 
The original LCI was studied most often, and was the only outcome measure which 
showed strong evidence (as defined by Terwee et al 2007 based on van Tulder et al 
2003), for any of the measurement properties.  Four studies presented results, 
either on the LCI section of the PPA (Miller et al 2001) or on a stand-alone version, 
(Gauthier-Gagnon et al 1998, Rushton et al 2002 and Franchignoni et al 2004) 
which is identical to the PPA section.  Strong evidence was presented for its internal 
consistency and structural validity (Gauthier-Gagnon et al 1998, Miller et al 2001 
and Franchignoni et al 2004).  On this basis, clinicians and researchers have 
reasonable confidence for the validity of the LCI i.e. they know that is measuring the 
functional mobility of their patient.   There was positive evidence from one study 
(Miller et al 2001) of fair methodological quality but with no comment on the 
measurement error, there is limited evidence for the variability of the LCI.  A second 
study did present positive evidence of reliability and measurement error for the LCI, 
however the testing was done on consecutive days during a rehabilitation period; 
and due to a small sample size (n=37) the evidence was recorded as unknown 
(Franchignoni et al 2004).  Clinicians should therefore be less confident about the 
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reliability and what constitutes a real change in scores for the LCI.  The effect sizes 
reported by Franchignoni et al (2004) and Rushton et al (2002) were large, however 
with only effect size reported the evidence was deemed unknown and clinicians 
should use the LCI with caution, if they wish to measure the effectiveness of an 
intervention.  
 
Franchignoni et al presented results on modified versions of the LCI in 2004 (LCI-5) 
and 2007 (LCI-5 and LCI-10-4) which helped to reduce the ceiling effect noted in the 
original version by increasing the number of response levels from 3 to 4 in the LCI-5.  
Little effect was noted in the Rasch analysis when the authors removed four items in 
the LCI-10-4 (Franchignoni et al 2007).  These are the only studies, to date, that 
have presented psychometric results on these modified versions and it is interesting 
to note that while clinicians reported using the LCI-5, in addition to the original LCI, 
in the survey reported in Chapter 3, none reported using the LCI-10-4.  
 
When measuring the impact of an intervention on the physical function of an 
amputee, e.g. a therapy programme or prosthetic component, it is essential that 
information on both the reliability (measurement error) and responsiveness is 
known, on any outcome measure being used (Streiner et al. 2014).  Reliability, or 
consistency, of the results obtained from a test re-test design is expressed in 
correlations (ICC or Kappa).  In addition, errors (random or systematic) that occur 
during completion of the test(s) will also affect the consistency of the results and are 
quantified by the measurement error value.  The amount of measurement error will 
determine how reliable the outcome measure is considered to be.  As it is presented 
in the same units of the outcome measure, the measurement error provides a 
meaningful guide for assessing confidence in the measured result (Stratford 2004).  
Knowledge of the quantity of error inherent in an outcome measure is therefore 
critical when detecting changes in clinical conditions with it. 
 
While there were good quality studies that reported reliability results for many 
outcome measures in this systematic review, the evidence reported for 
measurement error on the same outcome measure was either not reported or 
unknown due to lack of comment regarding the clinical relevance of the level of 
agreement.  Positive measurement error results were reported for the ABC scale 
(Miller et al 2003 and Sakakibari et al 2011), the L-test (Deathe et al 2005), the FAI 
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(Miller et al 2004) and RMI (Ryall et al 2003) but the evidence for these measures 
was considered limited due to low (“fair”) methodological quality of the studies.   
 
All studies reporting on responsiveness for any outcome measure were of fair 
quality only, and the results presented were considered “indeterminate” because of 
the author’s choice of analysis. The magnitude of the change was most often 
reported using effect size.  However, while effect size is an appropriate analysis tool 
to detect and quantify changes in the health status of a person, it alone is not 
considered an appropriate method of reporting the responsiveness of an outcome 
measure (Mokkink et al. 2010c, Terwee et al. 2003, Revicki et al. 2008).   A 
triangulation of methods is recommended to establish the significance, magnitude 
and clinical relevance of any changes detected (Husted et al. 2000, Revicki et al. 
2008, Beaton 2001).   
 
The ongoing debate about responsiveness and how to measure it, leave  some 
authors uncomfortable that traditional methods of defining and measuring it, are 
being challenged (Angst 2011).  However, assuming that responsiveness is 
considered an aspect of (longitudinal) validity then it is reasonable to suggest that 
the outcome measure under study should be assessed by administering it at least 
twice during a longitudinal study.  This was the case for all studies reporting 
responsiveness.  A second outcome measure, preferably a gold standard, should 
also be administered at the same time to confirm that a change in the patient’s 
condition, in the construct of concern, has taken place.  A longitudinal study with a 
single outcome measure will not be able to determine both; the responsiveness of 
an instrument, as well as demonstrate the magnitude of the change in health status 
using the same instrument.  The choice of analysis, in all studies reporting 
responsiveness, reduced the methodological quality to fair.  The choice of analysis 
also affected the strength of the evidence and if it was considered inadequate, i.e. 
no comparator outcome measure or the use of effect size alone, it was assessed as 
unknown.  Consequently there is an absence of evidence on responsiveness for all 
of the outcome measures included in this review.  
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4.5.2 Comments on quality issues 
4.5.2.1 Demographics / aetiology   
There was a variety of amputation levels and aetiologies, together with small sample 
sizes in many of the studies.  This did not provide opportunity for comment or 
conclusion from authors, on convergent or divergent validity.  In some studies, the 
aetiology of the sample was restricted e.g. all vascular or non-vascular participants 
(Panesar et al 2001, Schoppen et al 1999 and Hagberg et al 2010), which reduced 
the generalisability of the results to the wider population or pwLLA.  The 
confounding effect of age on physical function in amputees (Sansam et al 2009) 
gives cause for concern with regard to the interpretability of some study results.  
Schoppen et al (1999) recruited only elderly subjects into their study.  In contrast, a 
relatively young mean age (54 years) combined with a high prevalence of traumatic 
amputees, also reduced the generalisability of the results in the study on the LCI-5 
and LCI-10-4 by Franchignoni et al (2007). 
 
4.5.2.2 Study design  
Many different study-designs were represented in this review.  Test-rest 
methodology was used most often to measure reliability. A lower methodological 
quality rating was given when there was an inadequate explanation of the time 
interval between repeated measures; or when it was unclear whether participants 
were deemed to be stable (Rushton et al 2001, Franchignoni et al 2004).  In 
contrast, data collected at various time-points through the amputee’s rehabilitation 
journey, detected expected changes and allowed responsiveness indices to be 
calculated.  However, when details of the interim period between tests were not 
given, a lower rating was awarded (Brooks et al 2001, Rushton et al 2002).   
 
It is unusual to present details of both reliability and responsiveness using the same 
population sample during the same time period, though Ryall et al (2003) did so 
when reporting on the SIGAM, without detailing if there were different study periods.  
A lack of detail on how the overall effect size was calculated for different follow-up 
periods, and a priori hypotheses that had not been fully described contributed to the 
“fair” methodological quality rating for this study. 
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4.5.2.3 Sample size 
A small sample size is considered a weakness when assessing both methodological 
quality and level of evidence.  The COSMIN methodological checklist was 
developed for the assessment of HR-PRO questionnaires, which are completed by 
many respondents, and the thresholds for poor, fair, good and excellent in the 
checklist do appear stringent, especially with regard to sample sizes.  It is more 
usual to find larger samples when testing HR-PRO questionnaires.  However, it is 
prudent to consider the effect of different statistical analyses and sample size when 
assessing the level of the evidence.  To avoid penalising studies with small sample 
sizes when assessing methodological quality and strength of evidence, sample size 
was considered only when the strength of evidence was being assessed.  However, 
for many studies positive (“+”) results for strength of the measurement property were 
reduced to indeterminate (“?”) due to sample sizes being less than 50, according to 
the criteria.  This was most noticeable in the reliability and measurement error 
categories where all studies had the strength of evidence level reduced because a 
sample size was < 50 (Table 4.4).   
 
The difficulty of recruiting large participant numbers has been reported in other 
rehabilitation studies (Dobson et al. 2012, Scrivener et al. 2013), however the 
incidence of pwLLAs is lower than people undergoing hip or knee arthroplasty or 
stroke survivors.  This low incidence results in a very challenging recruitment 
environment, especially considering that only 40% of amputees are fitted with a 
prosthesis (Scott et al. 2016). 
 
If study-design and methodology are comparable amongst studies, results from 
multiple studies may be combined, thus improving the sample size.  However, this 
was not possible in the current review as there were insufficient similarities between 
the studies. 
 
4.5.2.4 Missing data 
Two items, in each of the measurement property categories (except content validity) 
in the COSMIN checklist, refer to missing data.  They are: “Was the percentage of 
missing items given?” and, “Was there a description of how missing data was 
handled?”.  Discussions took place between the two reviewers to ensure agreement 
of what was considered a missing “item” in each study i.e. whether it was an item of 
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a questionnaire or data from a whole visit, or both.  It was further agreed that when a 
full data set was not presented, e.g. when only means and standard deviations or, 
only total scores for questionnaires were presented, it was not possible to deduce if 
all data had been presented for all participants.  In nearly two thirds (22/36) of all 
studies reviewed, percentages of missing data could not be deduced and, there 
were no explanations about how any missing data was handled.  This failure to 
address the two questions adequately resulted in a “fair” rating for methodological 
quality rating for all these studies.  
 
Imputation analysis to account for missing data (both assessments and 
questionnaire items), is now being advocated.  This is designed to remove 
unintended bias by leaving out any participants’ data (Schafer and Graham 2002).  
However, no studies included in this review, mentioned its use. 
 
4.5.3 Gaps in published evidence 
In the 1990’s and early 2000’s, there was a push by professional bodies and 
networks to recommend the use of outcome measures in clinical practice 
(Hammond 2000, Jette et al. 2009, Abrams et al. 2006, Enderby and Kew 1995).  
The importance of reliability and validity was stressed and many new outcome 
measures were developed around this time, with work commencing on the content 
and structural validity of the measures.  Studies then continued investigating both 
intra- and inter-rater reliability, with the outcome measures then being validated 
within different population groups and sub-groups.  With the tightening of health 
budgets across the world, and the requirement to know the “value for money” of 
these interventions, there has been a rise in the interest of the responsiveness of 
any outcome measures in use.   
 
The most recent studies investigating reliability of outcome measures of physical 
function used with pwLLAs were published in 2011 and 2013 in studies by Resnik et 
al (2011) and Wong et al (2013).  However, before this, there had been a gap of 
nearly ten years in which no such studies were published.   There had been a 
similar pattern of publication for validity studies with two studies published in 2013 
(Wong et al and Major et al), but before this, there had been a gap of at least six 
years back to a series of studies that were published for the PEQ and LCI by 
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Franchignoni et al.  At the time of searching for this review, only one responsiveness 
study had been published since 2004 (Kohler et al 2011).    
 
Little has been published on the “clinical” responsiveness, i.e. the ability of an 
outcome measure to detect changes that are considered important either to the 
patient or clinician. Since this review, there has only been one study published that 
has reported clinical responsiveness of an outcome measure used with pwLLAs.  
The minimal clinically important difference (MCID) value was reported for the L-test 
when used with pwLLAs (n=33) (Rushton et al. 2014).  The MCID was calculated 
using Receiver Operator Curve (ROC) analysis, which is deemed an adequate 
analysis by COSMIN.  The methodological quality of the study was considered only 
fair because a description of the intervening period was not available.  The level of 
evidence was negative because the ROC was < 0.7, however the final level of 
evidence was deemed “unknown”, as the sample size was less than 50. 
 
This increased interest in using outcome measures to measure the many aspects of 
prosthetic rehabilitation, has arisen from the increased financial accountability, not 
only within prosthetics but also in the wider healthcare field. It is therefore essential 
that clinicians and researchers fully engage with choosing and implementing the 
correct outcome measure, as well as the correct interpretation of their results. 
Demonstrating changes with individual patients is obviously important to the 
individual clinician and his/her patient, but demonstrating effectiveness and 
efficiency of whole services is also crucial.   
 
 
4.6 Limitations  
Several limitations have been highlighted throughout the production of this 
systematic review.  
 
With additional titles found while examining the reference lists of included titles, a 
concern was raised that the search terms were not broad enough to cover all the 
inclusion criteria.  It was not clear on examination of the additional titles, which 
criteria, i.e. population, intervention, condition or outcome, was compromised. 
However, the use of the published search strategy by Terwee et al (2009) to check 
for any missed psychometric measurement-property terms, did help to allay some 
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concerns.  Terms related to prosthetics had not been used in the original search 
because it was thought they may widen the search too broadly.  A repeat search 
with the addition of prosth* within the population search terms, confirmed that this 
did not provide a more focused population coverage with 3,582 titles returned.  
However there were four which were of interest to this review. Two presented on the 
Orthotics and Prosthetics Users’ Survey (OPUS).  The first detailed the development 
of the survey and presented internal consistency results following a Rasch Analysis 
(Heinemann et al. 2003).  Results demonstrated good reliability with Person 
Separation Index (0.94) and Item Separation Index (0.98) for the Lower Limb 
Functional Measure section of the OPUS on 37 lower limb prosthetic users. 
However no further analysis was presented and, only a fair methodological quality 
rating was achieved due to the lack of information on how missing data was 
handled.   A second study presenting validity evidence for a modified version of the 
OPUS also achieved a fair rating because of the missing data information (Jarl et al. 
2012).  A Rasch Analysis was again undertaken, following the addition of eight new 
items at the higher activity end of the scale, this time with only ten lower limb 
prosthetic users,.  The results again demonstrated good reliability, but there was a 
ceiling effect seen.  No further analysis was presented and, when the results from 
both studies are combined the evidence for this outcome measure would be rated 
unknown. 
 
Reliability of the 6MWT in trans-tibial amputees was also presented in a study from 
India (Lahiri and Ghosh-Das 2012).  However despite presenting good ICC values 
(0.79-0.88) for intra and inter-rater reliability no agreement data was presented and 
there were only 21 participants in the study, therefore this study does not alter the 
overall strength of evidence for the 6MWT presented earlier.   
 
A study presenting initial reliability and validity results for the Orthotics and 
Prosthetics National Office Outcomes Tool (OPOT) was also found, though this tool 
primarily focused on measuring health-related quality of life and patient satisfaction 
and would not have been included in the review.   
 
Many studies were excluded because their focus had been on evaluating the 
performance of either prosthetic componentry or instrumentation rather than that of 
the pwLLA, e.g. The AMPro and Transfemoral Predictor.  While it is accepted that 
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these outcome measures do assess physical function of a pwLLA, predicting an 
amputee’s “readiness” for ambulating with a prosthesis may not mean that the 
amputee completes the functional action. Validation studies of translated versions of 
outcome measures were also excluded as it was assumed that only one 
measurement property (cross-cultural validity) in the COSMIN checklist would be 
presented.  It is possible that other psychometric measurement properties may have 
been presented within these studies however, the results are not presented here. 
 
It is also recognised that there is a large psychosocial impact on the pwLLA 
following amputation.  However, the degree to which factors such as self-efficacy 
and self-confidence influence the results of the self-reported measures was 
considered outside the scope of this thesis.  In addition, studies investigating 
outcome measures used exclusively for measuring quality of life were excluded.  
 
Finally, it is recognised that since the time the review was conducted in December 
2013 there may have been some further studies published that would be of interest.   
Therefore a repeat search was done using the same basic search terms and only 
three studies were found that met the original criteria.  Rushton et al (2014) 
presented MCID results for the L-test in a pilot study. Reid et al (2015) compared 
the validity of the 2MWT with the 6MWT and Franchignoni et al (2015) presented 
internal consistency results on a new questionnaire (Prosthetic Mobility 
Questionnaire) that is based on the PEQ. 
 
 
4.7 Conclusions 
There is a lack of high quality studies reporting the psychometric properties of 
physical function outcome measures used with lower limb amputees.  The ratings of 
the methodological quality of some studies were reduced because of weak 
description within the manuscripts e.g. how missing data was handled.  Poor 
choices for statistical analysis, especially with regard to responsiveness, together 
with small sample sizes of < 50, reduced the strength of evidence presented.    
 
The LCI-5 has the strongest evidence to recommend its use for measuring 
functional mobility, however only for internal consistency and structural validity.  
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Nevertheless, there is a lack of corroborating data (i.e. more than one study) for 
many other outcome measures.    
 
The lack of studies reporting on responsiveness, in particular the absence of MCID 
values, limits the number of outcome measures that can be recommended to 
investigate the effectiveness of any intervention on this population. 
 
Confidence with which clinicians and researchers might make an evidence-informed 
selection of outcome measures for use with patients who have undergone a lower 
limb amputation is reduced, due to the limited availability of robust psychometric 
data that has been identified by this review. 
 
 
4.8 Future work 
Further evidence is required, especially in relation to the reporting of measurement 
error, responsiveness and MCID values, to improve the utility and clinical 
applicability of physical function outcome measures used with pwLLAs.   
 
Standardised reporting of studies investigating psychometric properties of any 
outcome measure would enhance their methodological quality and strengthen the 
evidence presented.  Collaborative work is also needed alongside standardised 
reporting to facilitate meta-analysis of data and reduce the impact of small sample 
sizes in this population.   
 
Clear guidance on the use of statistical analyses should be made widely available 
with agreed protocols for their use to improve the reporting of measurement 
properties. 
 
The impact of psychosocial factors following an amputation and their influence on 
the results of self-reported outcome measures should also be investigated. 
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5 Chapter 5 Repeatability Study (study III) 
5.1 Purpose of chapter 
The purpose of this chapter is to describe the methodology, and to present and 
discuss the results, of a study that was performed to establish reliability and 
agreement parameters of commonly used outcome measures in clinical practice that 
measure physical function during prosthetic rehabilitation. This study was carried out 
to answer Research Question 5. 
 
Research Q5 
What are the reliability and measurement error parameters of outcome measures 
most regularly used by AHPs for the assessment of physical function during 
prosthetic rehabilitation?   
 
 
5.2 Background 
A survey of AHPs, carried out in 2013 showed that the five most regularly used 
outcome measures in prosthetic rehabilitation for pwLLAs (adults) were: the SIGAM 
mobility grades; the LCI together with the modified version (LCI-5); a TWT of either 
two or six minutes duration; the TUG and SCS, see Table 5.1.  Full details of the 
survey and the results were presented in Chapter 3.    
 
Table 5.1   Outcome measures most regularly used in prosthetic rehabilitation 
Name  Type of Outcome Measure Main construct being 
measured 
SIGAM PROM Functional mobility 
LCI / LCI-5  Patient-reported outcome measure Functional mobility 
Timed Walk 
Test 
Observed Mobility endurance  
TUG Observed Mobility and balance 
SCS PROM Socket fit and comfort 
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The most regularly used outcome measures in prosthetic rehabilitation will be used 
within this study.  Four of the five outcome measures listed are all concerned with 
measuring aspects of physical function.  The SCS the final outcome measure listed 
in the top five is also a PROM.  Although not measuring physical function per se, the 
SCS records the patient’s perception of the fit and comfort of their socket which 
greatly influences their physical function (Gailey et al. 2008).   
 
It was decided to also include a measure of global health in the study.  The EuroQol 
standardised five dimension and five level instrument (EQ-5D-5LTM) is 
recommended for use by the Chartered Society of Physiotherapists (currently only 
with musculoskeletal patients). The EQ-5D-5L is a measure of the global health of 
the respondent that can be applied across a wide range of health conditions and 
treatments to provide a simple descriptive profile and a single index value for health 
status (Rabin and Charro 2001).  It is often used to describe the health of a 
population and the results can also be used to evaluate the clinical and economic 
status of health care, in particular the cost-effectiveness of certain interventions 
(Brazier et al. 1999).  Knowledge of its test re-test reliability in the population of 
pwLLAs is unknown and therefore, its inclusion in this study is considered to be of 
value, both to clinicians and researchers interested in prosthetic rehabilitation. 
 
Chapter 4 reported on a systematic review that investigated the published evidence 
on the psychometric properties for outcome measures measuring physical function 
of pwLLA prosthetic limb-wearers.  When considering reliability and measurement 
error parameters in particular, it was found that 27 studies had reported inter-rater 
and/or intra-rater reliability for 30 outcome measures.  However, only 13 out of these 
27 studies had reported both reliability and measurement error results.   Of the 15 
studies reporting measurement error values, several different methods and 
terminology were used.  Six studies had reported Bland and Altman plots and LoA; 
five presented SEM, while four presented MDC or equivalent (i.e. the smallest 
detectable difference (SDD), the smallest detectable change (SDC), the smallest 
real difference (SRD)) for a variety of outcome measures.     
 
While the SEM estimates the standard error in a set of repeated scores the MDC 
relates to the smallest score that is beyond the measurement error of an outcome 
measure and therefore likely to represent a person’s “true” score.  Both are 
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meaningful for clinical practice, as they are presented in the unit of the outcome 
measure and the MDC can be derived from the SEM (Stratford 2004), represented 
by the following formula: MDC = 1.96 * √ 2 * SEM, where the 1.96 derives from the 
95% confidence interval, and √ 2 is included because two measurements are 
involved in measuring change (Beckerman et al. 2001).  
 
Previously published results for reliability and measurement error parameters on all 
the outcome measures included in this present study are presented in Table 5.2.  
The quality ratings and levels of evidence were obtained from the systematic review 
carried out and reported in Chapter 4.  The reasons for the indeterminate level of 
evidence found in each study are given, in parenthesis, in the extreme right column 
of the table.  The methodological quality ratings for each study are also given in the 
latter column, together with reasons for the rating.  See Chapter 4 for full details of 
the quality review processes used to obtain these results. 
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Table 5.2   Published reliability and measurement parameters  
Outcome 
Measure 
Study  Reliability parameters 
presented 
Measurement error parameters 
presented 
Level  of Evidence / 
Methodological Quality (reason for 
ratings) 
SIGAM Ryall et al 
(2003b) 
Test re-test: ICC=0.79 
Inter-rater: 
Kappa coefficient range = 
0.86 
None presented Indeterminate ? (sample size) /  
Fair (details of how missing data was 
handled not given) 
LCI / LCI-5 / 
PPA (LCI 
section) 
Franchignoni et 
al (2004) 
Test re-test:  
ICC =0.984 for both LCI and 
LCI-5 
Bland Altman plot  - no systematic 
variations for either LCI or LCI-5 
version.  
LoA: -1.41-1.79 (LCI), -1.34-2.48 
(LCI-5) 
?  (sample size)  /  
Fair (conducted during rehab phase) 
Miller et al 
(2001) 
Test re-test: 
ICC=0.88 for PPA-LCI 
SEM = 2.7 for  PPA-LCI ? (no comment on Limits of 
Agreement) /  
Fair (details of how missing data was 
handled not given) 
TUG Resnik et al 
(2011) 
Test re-test: 
ICC= 0.88 
MDC = 3.6s ? (sample size) /  
Good (administrations assumed to be 
independent, not confirmed) 
Schoppen et al 
(1999) 
Spearman’st: 
Inter-rater=0.96 
Intra-rater=0.93 
None presented ? (sample size) /  
Fair (Spearman’s cc only presented, 
no ICC) 
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2MWT Brooks et al 
(2002) 
Inter and intra-rater: 
ICC>0.98 
None presented ? (sample size) /  
Fair (details of how missing data was 
handled not given) 
Resnik et al 
(2011) 
Test re-test: 
ICC=0.83 
MDC = 34.3m ? (sample size) /  
Good (test administrations assumed 
to be independent, not confirmed) 
6MWT Lin & Bose 
(2008) 
Test re-test  
ICC = 0.94 
 
Bland Altman plot  - no systematic 
variation.   
LoA: -44.6-63.5 and -25.8-57.8 for 
two time periods. 
? (sample size) /  
Fair (details of how missing data was 
handled not given) 
Resnik et al 
(2011) 
Test re-test  
ICC = 0.97 
 
MDC = 45m 
 
 
? (sample size) /  
Good (test administrations assumed 
to be independent, not confirmed) 
SCS Hanspal et al 
(2003) 
Inter-rater: 
Kendall’s tau=0.99 
None presented ? (sample size) /  
Fair (Kendall’s tau  only presented, 
no ICC) 
EQ-5D- 
Index or VAS 
None published in this population 
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The lack of published evidence for agreement and measurement error values for 
these outcome measures, justifies the aim of this study which is; to establish 
estimates of reliability and measurement error for outcome measures regularly used 
by AHPs across the UK during prosthetic rehabilitation.   
 
 
5.3 Methods 
5.3.1 Participants 
Adult (18 years or older) single lower limb amputees, at either TT or TF level, were 
eligible for inclusion in the study.  They had to have been using a prosthesis for at 
least one year and wear it for at least 8 hours per day. With regard to their functional 
abilities, they were asked to declare themselves as an active outdoor limb-user, i.e. 
confirm that they had the ability to walk outdoors over different surfaces. In addition, 
as participants considered themselves in a stable state they were asked to report 
any issues, medical or otherwise, that might impact on their functional status during 
the period of the study.   
 
Participants were excluded from participating in the study if they: had a history of 
any recent (within 3 months) prosthetic component changes or physiotherapy 
treatment; had any co-morbidities that prevented them undertaking the physical 
activities involved in the outcome measures or; if they had poor cognition or an 
insufficient comprehension of the English language that prevented them from 
understanding the written questionnaires.  These exclusions were discussed with 
participants or with their clinical team as appropriate depending on the entry route to 
their participation, with the researcher making the final decision on who was 
included. 
 
5.3.1.1 Demography and aetiology of study population 
This was a convenience sample of self-selected amputees and twelve patients were 
recruited into the study.  Table 5.3 presents the demographic and basic aetiological 
data for all participants. 
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Table 5.3   Demography and basic aetiology of participants 
Age - yrs. 
Mean  (SD) 
Range 
61 (15) 
40-83 
Median [IQR]  63 [49-73] 
Gender 
 n % 
Male 10 83 
Female 2 17 
Level 
Trans-tibial (TT) 9 75 
Trans-femoral (TF) 3 25 
Side 
Right 7 58 
Left 5 42 
Main Cause of 
amputation 
Peripheral Arterial Disease (PAD) 1 8  
Diabetes 2 17 
Trauma 5 41 
Other 4 34 
Number of  co-
morbidities 
≤ Three 11 91 
≥ Four 1 9 
 
 
The mean age was 61 years which is slightly younger than the mean reported for 
the amputee population in Scotland.  The SPARG report, which is published 
annually presents data on every lower limb amputation in Scotland.  The latest 
published report for the year 2013, reported a mean age of 67 years for adult lower 
limb amputees (Scott et al 2016).  The male to female ratio in this study was slightly 
higher than that reported in the SPARG report however the TT to TF amputation 
ratio presented in Table 5.3 was similar to the SPARG numbers of limb-fitted 
amputees for 2013.   The main cause of amputation was trauma with 41% or other 
(34%), with only 25% being peripheral arterial disease (PAD) or diabetes.   The 
participants in this study do not appear to have a typical aetiological distribution for a 
group of pwLLA, compared to the percentages of referrals to prosthetic centres 
across the UK in 2011-12, published in the limbless statistics report (UNIPOD 2013).  
This report showed referrals for dysvascular reasons and diabetes accounted for 
57% of the total, whereas referrals for amputation caused by trauma accounted for 
only 10%, and 33% of referrals were for other reasons.   
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5.3.2 Ethical opinion 
Favourable ethical opinions were gained from both Queen Margaret University 
Ethics Committee and the NHS Ethics Committee (South East Scotland 02 
committee) before commencing the study.  NHS Lothian management approval was 
also sought and gained prior to conducting the study on NHS Lothian premises. 
 
5.3.3 Recruitment process 
The amputees were prospectively recruited into the study.  A flow chart provided in 
Appendix 7 outlines the full recruitment process.  Prosthetists, working at the 
Prosthetic Centre in Edinburgh, identified amputees who fitted the inclusion criteria 
described above from the centre’s patient database.  An invitation letter was sent to 
suitable patients outlining the study, together with a Study Information Pack (SIP) 
containing a ‘Consent to Contact Form’, Patient information Sheet (PIS) and a 
stamped addressed envelope.  Participants were also recruited through an 
advertisement, see Appendix 8. The advertisements were placed in the fitting rooms 
of the prosthetic centre and uploaded to the website of the Edinburgh Limb Loss 
Association (ELLA) patient group.  The chairperson of ELLA also sent the 
advertisement to all members via e-mail.  Those amputees, who responded to the 
advertisement and approached their prosthetist, were also given the same SIP.  Any 
interested members who saw the advertisement through ELLA contacted the 
researcher directly and were sent a SIP and the ‘Consent to Contact Form’ for 
further information. 
 
The researcher made contact with any amputee who returned the Consent to 
Contact Form to answer any questions they had and, if they wished to take part, 
arrange a suitable date and time for the first test (TV1).  The amputee was enrolled 
as a participant into the study at TV1 when written consent was obtained.  At least 
24 hours had elapsed after the amputee first received the SIP, or spoke to the 
researcher, before the TV1 occurred.  This ensured that the amputee had adequate 
time to consider all the information given to them.   
 
5.3.4 Study protocol 
All study visits took place in the main Physiotherapy Department at Astley Ainslie 
Hospital, Edinburgh. 
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Baseline measurements for all outcome measures were taken at TV1, as well as 
basic demographic data recording age, cause of amputation, level of amputation 
and any relevant concomitant medical history. 
 
Test Visit 2 (TV2) was planned exactly 7 days after TV1, when the outcome 
measures were repeated.  See Appendix 9 for a full study schedule. 
 
Every effort was made to complete the outcome measures at the same time of day 
for each participant’s test visit. The order of the measurements was randomly 
assigned for each patient, at both visits, and Table 5.4 shows details of each of the 
study visits. 
 
Table 5.4   Study visit plan. 
Visit   What When 
Recruitment Visit / 
Telephone call (as 
required) 
Explanation of Study Protocol and 
provision of Information Sheet & 
Consent Form 
As soon as participant 
identified 
Test Visit 1 (TV1) Enrolment of participant i.e. consent 
taken and baseline outcome 
measures carried out 
Arranged to suit participant 
Test Visit 2 (TV2) Repeat outcome measures 7 days after TV1 
 
 
5.3.5 Outcome measures  
Two walking tests and four PROMs were used in this study.  A brief description of 
each is given below.  The TUG test was performed in the physiotherapy gym where 
3m was measured out on the floor and the same chair was used each time.  The 
2MWT was carried out in a straight corridor that was 35m long and free from 
obstacles and distractions.  Data collection sheets and a detailed explanation of the 
procedures followed for each outcome measure can be seen in Appendix 10. 
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5.3.5.1 Walking tests 
5.3.5.1.1 Timed Up and Go (TUG) 
The TUG is a test of the manoeuvres required for basic mobility (Podsiadlo and 
Richardson 1991) and involves standing up from a chair, walking 3m, turning around 
a cone and returning to the chair and sitting down.  The time taken to complete the 
circuit is recorded. In this study the following instructions were given: “Sit with your 
back against the chair and your arms on the armrest.  When I say GO please get up 
and using your walking aid, walk around the cone, then return to the chair and sit 
back down.  I am going to be timing, but this is not a race, please go at a pace that’s 
comfortable and safe for you.”  At both test visits participants undertook the TUG 
three times, with at least a minutes rest between each time.  The first occasion was 
to familiarise them with what was required, and the fastest of the second and third 
occasions was recorded as the test time. 
 
5.3.5.1.2 Timed Walk Test (2MWT) 
The 2MWT is a test used to measure functional walking capacity related to 
endurance capability (Butland et al. 1982).  Participants are instructed to walk 
around a pre-measured circuit, covering as much ground as possible in the allotted 
two minute time period.  Rests may be taken during the test and the total distance 
walked is recorded.  Average speed may also be calculated, if it is of interest.  Long 
straight corridors with few or shallow turns are recommended, but any circuit is 
acceptable as long as the repeat test is carried out on the same circuit.  In this study 
the circuit used was a quiet corridor 35 metres long with 180 degree turns at either 
end. The participants were asked to perform the 2MWT only once at each visit. 
 
5.3.5.2 Patient reported questionnaires 
5.3.5.2.1 Locomotor Capability Index modified version (LCI-5)  
The Locomotor Capability Index (LCI-5) is a self-administered scale specifically 
designed for use with pwLLAs (Franchignoni et al. 2007b).  There are 14 questions 
about locomotor activities with 5 levels (0-4) available to score each question.   The 
scores from each question are added together for a possible maximum score of 56 
and a minimum of 0, with a higher score demonstrating better capability. 
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5.3.5.2.2 Specialist Interest Group in Amputee Medicine (SIGAM) Mobility Grades 
The SIGAM Mobility Grades is a single-item mobility scale comprising of a self-
reported questionnaire which has 21 yes/no items.  When the answers to the 
questionnaire are applied to an algorithm a final grade of mobility is assigned from 
six clinical grades (A–F) (Ryall et al. 2003b).   There are four sub-divisions for the C 
grade and three subdivisions for D that denote increasing levels of independence. 
The defined purpose of the SIGAM grades is to describe functional levels of mobility 
and the six grades describe a progression of increasing independence and 
functional locomotor ability from; limb abandoned/cosmetic only (A), through 
transfers only (B), walking less than 50m on even ground (C), walking greater than 
50m on uneven ground (D), using an occasional walking aid (E) to normal or near 
normal walking (F).  However, the scoring system takes into account increasing 
levels of walking support from a frame (a), two crutches or sticks (b), 1 crutch or 
stick (c) to none (d) for grade C and from (a) to (c) for grade D.  The grades; A, B, 
Ca, Cb, Cc, Cd, Da, Db, Dc, E and F, were allocated numerical scores from 1-11 in 
this study. 
 
5.3.5.2.3 Socket Comfort Score (SCS) 
This score is a simple subjective measure of how comfortable the amputee feels the 
socket is at the time the score is taken (Hanspal et al. 2003).  Amputees are asked a 
standard question: “On a 1 – 10 scale, if 1 represents the most uncomfortable 
socket fit you can imagine, and 10 represents the most comfortable socket fit, how 
would you score the comfort of the socket fit of your artificial limb at the moment?” 
Their response on the 10 point scale is then recorded.  
 
5.3.5.2.4 EQ-5D-5L™  
The EQ-5D-5L™ (EuroQol-5 dimension 5-level) tool is a self-administered 
instrument that measures health outcomes (Rabin and Charro 2001).  It has five 
dimensions: mobility, self-care, usual activities, pain / discomfort and anxiety 
/depression.  The respondent is asked to indicate their health status, in each 
dimension, on one of five levels: no problems, slight problems, moderate problems, 
severe problems, extreme problems or unable to do.  A simple descriptive profile 
from the five dimensions is derived, which can be converted into a single index (EQ-
5D-index) for health status, ranging from 1.000 (no problems in any dimension) to 0 
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(equivalent to being dead).  The UK value set was used in the conversion calculator 
for this study.  Also administered at the same time is the EQ (EuroQol) visual 
analogue scale (VAS).  The EQ-VAS records the respondents self-rated health on a 
20cm vertical VAS with end points labelled at 100 “the best health you can imagine” 
and at 0 “the worst health you can imagine.   
 
5.3.6 Statistical analysis  
The choice of analyses used was dictated by the type of data collected.  Table 5.5 
outlines the parameters of reliability and measurement error appropriate for 
continuous and ordinal data (de Vet et al. 2011). 
  
Table 5.5   Choice of analysis methods  
Measurement Property Continuous data Ordinal data 
Reliability ICC            ICC 
or 
weighted kappa 
Measurement error / 
agreement 
SEM  
or  
LoA 
% agreement 
 
Time and distance are considered continuous data containing equal ratios between 
each unit interval.  With ordinal level data, the interval between each score or 
composite score may be variable because the total score is calculated from several 
individual items or is subjective to individual interpretation, e.g. VAS.  Therefore, the 
2MWT and TUG provide continuous (ratio) data; with data derived from the LCI-5, 
SIGAM, SCS and both the EQ-index score and EQ-VAS scale at the ordinal level.   
 
Data from some ordinal scales have been considered continuous in previous studies 
with parametric descriptives, i.e. means, SDs, SEM and MDC values being 
presented (Resnik and Borgia 2011, Miller et al. 2001).  Some authors (Jakobsson 
and Westergren 2005, Svensson 2001) have cautioned against this because of the 
uncertain and sometimes unknown ratio between data points.  However, others are 
satisfied if the outcome measure, scale or questionnaire has been validated using 
Item Test Theory (ITT) techniques, such as Rasch Analysis (Franchignoni et al. 
2007a, Franchignoni et al. 2007b, Gallagher et al. 2007, Gallagher et al. 2010) that 
157 
 
will confirm if the ratio between points on the scale is consistent throughout the 
scale (Andresen 2000, Tesio 2003, McPherson et al. 2015).   
 
Scales, similar to the LCI-5 and SIGAM, where multiple items scores add up to a 
composite total score, e.g. the Roland Morris Questionnaire, the Western Ontario 
and McMaster Universities Arthritis Index (WOMAC), and the Berg Balance Scale 
have been considered continuous by many authors following a Rasch Analysis 
(Stratford et al. 1996a, Angst et al. 2001, Donoghue and Stokes 2009).  
 
Franchignoni et al (2007) carried out a Rasch Analysis on the original LCI and the 
modified LCI-5 which confirmed excellent internal consistency and internal structural 
validity. Both the EQ-5D-index score and EQ-5D-VAS have also been regarded as 
continuous data and analysed as such (Walters and Brazier 2005).  The argument 
for considering data collected in this study from SIGAM and SCS as continuous is 
not so strong because of the relatively small range of scores available, 11 and 10 
respectively.  However, a modified Rasch Analysis was completed for the SIGAM, 
on the shorter 1-6 grading system, by Ryall et al (2003), but to date there is an 
absence of either Rasch modelling or ITT analysis for the SCS.  Therefore, data 
retrieved from the SIGAM, LCI-5, TUG, 2MWT and EQ-5D-5L in this study, was 
described and analysed as continuous data, while the SCS was considered as 
ordinal. 
 
5.3.6.1 Missing data 
When the data was inspected no data points were found to be missing in; individual 
items on questionnaires, total scores in the PROMs or, observed times and distance 
in the walking tests. 
 
5.3.6.2 Summary descriptive statistics 
Normal distribution of the data collected for 2MWT, TUG, LCI-5, EQ-5D-5L index 
score, EQ-VAS and SIGAM was assessed using Shapiro Wilks in order to determine 
whether the data was normally distributed.   
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Summary descriptive statistics were derived: means and standard deviations for 
parametric data; and medians and inter-quartiles for non-parametric and ordinal 
data. 
 
5.3.6.3 Consistency analysis 
Test re-test reliability was calculated for each outcome measure using ICC (model 
2,1) (Shrout and Fleiss 1979).  This two way ANOVA model was used because each 
of the participants was rated by a single rater and the results were to be generalised 
to other raters.  For the SCS, the Cohen Kappa statistic was calculated (Scholtes et 
al. 2011). 
 
5.3.6.4 Agreement analysis 
Although not an appropriate measure of agreement in itself, a paired T-test or 
Wilcoxon ranked pairs test was performed on the outcome measures to confirm that 
none of the differences between the two repeated measurements were statistically 
significant.   
 
Limits of agreement were calculated and visualised using a Bland Altman plot 
(Martin Bland and Altman 1986) for all outcome measures except SCS. Percentages 
of agreement and Kappa statistic were calculated for the SCS.  
 
5.3.6.5 Measurement Error  
Minimal detectable change values with a 95% confidence interval were calculated 
from the SEM.   The SEM estimates the standard error in a set of repeated scores 
using the following equation:  SEM = SD (baseline) X √ (1 - ICC). 
The MDC value is calculated using the equation: MDC = 1.96 X SEM x √2.  
 
The MDC% value was calculated by dividing the MDC by the average of the 
measurements (across both visits) and multiplying by 100. 
 
5.3.6.6 Statistical software 
All data was analysed using SPSS version 21.0.0.1, dated 2012, except percentage 
agreement which was performed in Excel ™ 
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5.4 Results 
Participants were assumed to be “stable” with no major issues with their prosthesis 
that required any prosthetic or therapy input at recruitment.  While, no participant 
detailed any issues at TV1, one participant (participant P02R) reported an increase 
in the severity of his co-existing low back pain (declared at recruitment) during the 
period of the study, but did not consider that it had changed between the two visits.  
A second participant (P04R) mentioned that they were not feeling as well as they 
had at TV1 with regard to their concurrent gastro-intestinal medical problems.  A 
third participant (P03R) reported having a slight head cold at TV2.  These issues 
may have accounted for the changes noted for these participants, but other 
changes, both perceived and actual, were seen in all participants as can be seen in 
Table 5.6.  Changes in perceived performances (recorded from the PROMS) and 
actual changes recorded from the observed outcome measures are noted here. 
 
 
Table 5.6   Changes noted at second Test Visit  
Participant 
Outcome Measures (units) 
SIGAM 
(grades 
1-11) 
LCI-5 
(points 
1-56) 
TUG 
(seconds 
secs) 
2MWT 
(metres 
m) 
SCS 
(points 
1-10) 
EQ-5D-
index 
(points 
0-1.00) 
EQ-5D-
VAS 
(points 
0-100) 
P01R -1.0 1.0 -0.9 1.8 1.0 0 0.0 
P02R 0.0 0.0 -0.9 10.9 0.0 0.408 0.0 
P03R 0.0 1.0 0.5 -7.7 0.0 0 0.0 
P04R 0.0 -3.0 -1.0 13.6 -4.0 -0.229 -35.0 
P05R 0.0 -3.0 0.6 -13.3 0.0 -0.025 0.0 
P06R 0.0 0.0 0.4 0.0 0.0 0 -10.0 
P07R 0.0 0.0 0.4 14.1 0.0 0 10.0 
P08R 0.0 -3.0 -1.6 0.4 1.0 0.017 0.0 
P09R 0.0 0.0 -0.6 -4.4 1.0 0 0.0 
P010R 0.0 0.0 0.6 -1.2 1.0 0 0.0 
P011R 0.0 2.0 -1.8 7.1 -2.0 0.111 0.0 
P012R 0.0 2.0 -0.6 16.0 0.0 0 -10.0 
 
(improvement), (deterioration) 
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5.4.1 Summary descriptive statistics 
Shapiro Wilks test showed that the data were normally distributed for both test visits 
of the 2MWT and SCS, and TV2 for the SIGAM.  All other data was not normally 
distributed (see Appendix 11). 
Summary descriptive statistics are presented in Table 5.7, with means and standard 
deviations (SD) presented for parametric data, and medians, inter-quartile (IQ) 
ranges for non-parametric and ordinal data.  Mean (SD) presented for 2MWT, 
Median [IR] presented for all other outcome measures. A full presentation of the 
data collected at both test visits can be found in Appendix 12. 
 
Table 5.7   Summary descriptive statistics  
Outcome Measure 
units (range) 
Test Visit 1 (TV1) Test Visit 2 (TV2) 
SIGAM 
Grades (1-11) 
10.0 [9.0 – 10.3] 10.0 [9.0 – 10.3] 
LCI-5 
Points (0-56) 
53.0 [48.8 – 55.3] 52.5 [47.0 – 55.3] 
TUG 
Time (secs) 
10.1 [9.4 – 10.8] 10.1 [8.9 – 10.6] 
2MWT 
Distance (m) 
121.0 (26.9) 124.2 (24.9) 
SCS 
Points (0-10) 
9.0 [7.8 – 9.0] 9.0 [7.8 – 9.0] 
EQ-5D Index 
Points (0-1.000) 
0.802 [0.699 – 1.000] 0.923 [0.753 – 1.000] 
EQ-5D VAS 
Points (0-100) 
87.5 [80 – 95] 90 [80 – 95] 
 
5.4.2 Inferential statistics 
5.4.2.1 Consistency analysis 
Table 5.8 presents ICC and kappa statistics on the test re-test values obtained at 
TV1 and TV2. Intra-class correlations of >0.9 were found for TUG, 2MWT, LCI-5 
and SIGAM.  Values of >0.75 presented for ICC, and other indices of reliability, 
indicate an excellent level of practical and clinical significance for test re-test 
reliability as summarised by Cichetti in 1994 from the work of Landis and Koch 
(1977), Shrout and Fleiss (1979), and Cichetti and Sparrow (1981) (Cicchetti 1994).  
Good reliability was found for both the EQ5D index scores and VAS with ICC values 
>0.60 and <0.74 (Cicchetti 1994).  A Kappa statistic of 0.314 was presented for the 
SCS which represents fair reliability (Landis and Koch 1977).   
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Table 5.8    ICC (2,1) for all outcome measures except SCS, Kappa statistic  
Outcome Measure Intraclass Correlation Coefficients (95% CI) 
SIGAM 0.968 (0.894 – 0.991) 
LCI-5 0.972 (0.906 – 0.992) 
TUG 0.991  (0.968 - 0.997) 
2MWT 0.936 (0.794 – 0.981) 
SCS 0.314 
EQ-5D Index 0.728 (0.294 – 0.913) 
EQ-5D VAS 0.704 (0.247 – 0.905) 
ICC≥0.75 =  excellent,  ≥0.6 and <0.75  = good, <0.6 = fair 
 
5.4.2.2 Agreement analysis 
Limits of agreement were calculated and visualised using a Bland Altman plot  
(Bland and Altman 1986) for all outcome measures except SCS.  The mean 
difference was calculated by subtracting the mean of TV2 from the mean of TV1 and 
the LoA were calculated as 1.96 x SD of the mean differences.  As can be seen by 
the mean differences presented in Table 5.9, there is a deviation away from zero for 
all the outcome measures. This demonstrates a slight bias towards the first visit with 
a worse score at the second visit for LCI-5, EQ5D-VAS and SIGAM outcome 
measures; and a slight bias towards the second visit for the TUG and 2MWT, and 
EQ5D-index measures.   
 
Table 5.9   Mean difference between (TV2-TV1) and Limits of Agreement  
Outcome Measure 
units (range) 
Mean difference (LoA) 
Range of LoA 
1.96 x SD diff 
SIGAM 
Grades (1-11) 
0.1 (-0.5 – 0.7) 1.2 
LCI-5 
Points (0-56) 
0.3 (-3.3 – 3.8) 7.1 
TUG 
Time (secs) 
0.4 (-1.3 – 2.1) 3.4 
2MWT 
Distance (m) 
-3.1 (-21.3 – 15.1) 36.4 
EQ-5D Index 
Points (0-1.000) 
0.024 (-0.304 – 0.256) 0.560 
EQ-5D VAS 
Points (0-100) 
4 (-18 – 26) 44 
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Examination of the Bland Altman plots below, presented in Figures 5.1 – 5.6, show 
the plotted mean differences in the context of the LoA.  This allows comment on the 
magnitude of these limits and also whether any data points are lying outwith them.  
 
 
 
 
 
Figure 5-1   SIGAM Bland Altman plot  
 
 
 
There was one participant who changed his / her SIGAM score by 1 grade between 
the first and second visit and this showed up as an outlier on the Bland Altman plot 
(Figure 5.1).   
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Figure 5-2   LCI-5 Bland Altman plot 
 
 
 
All data points for the LCI-5 were within the limits calculated, but those participants 
scoring closest to the maximum (56) appeared to have a higher agreement between 
the two measurements compared to those with lower scores (Figure 5.2).  The 
deviation from zero of the mean difference was minimal (0.25) and unlikely to be 
considered clinically significant as it represent a change of less than one score on 
the scale between the two visits.  However, LoA for the LCI-5 of 7 points may be 
considered wide when interpreting variability in the clinical performance, but five 
participants had a difference of 2 or more points between the two visits.   
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Figure 5-3   TUG Bland Altman plot  
 
 
 
All data points are within the LoA for the TUG (Figure 5.3).  The two slowest 
participants were both quicker on the second visit and when their data were 
removed, the mean moved closer to zero, from 0.4 to 0.2s and the LoA reduced 
from 3.4secs to 2.7sec. When considering the clinical performance of a stable 
amputee, the width of the LoA of 3.4s (for all the participants) still represents a 
reasonable amount of variability for an individual pwLLA.  
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Figure 5-4   2MWT Bland Altman plot 
 
 
 
All data points were within the limits in the plot for the 2MWT, and there was no 
proportional bias noted.  The (negative) deviation from zero of the mean difference 
demonstrated a mean increase of 3m at the second visit, which is unlikely to be of 
clinical significance when taking in account the total distances recorded for this 
group of participants across each visit ranged between 74m and 160m.  However, 
the LoA is wide (-21.3–15.1, i.e. 36.4 m), when considering the clinical performance 
of a stable amputee. 
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Figure 5-5   EQ-5D-index Bland Altman plot 
 
 
 
There was one outlier outside the lower limit, lying close to the upper limit of 
agreement on the Bland Altman plot for the EQ-5D-index (Figure 5.5), and one that 
was just inside the upper limit.  All the other data points were lying close to the mean 
(-0.024).  With both outliers removed the mean moved closer to zero (-0.01) and the 
width of the LoA reduced from 0.559 to 0.146 
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Figure 5-6   EQ-5D- VAS Bland Altman plot 
 
 
There was one outlier outside the upper limit for the EQ-5D-VAS scores; whose 
mean score was 52.5 (see Figure 5.6).  The remaining data points were clustered to 
the right of the plot closer to zero, demonstrating a trend towards a higher level of 
agreement as the mean scores increased.   
 
The percentage agreement for SCS was reported as 50%.  This was higher than the 
percentage for LCI-5, which at 42% was the lowest, and SIGAM demonstrated the 
highest percentage agreement at 92%, (see Table 5.10).  The percentage 
agreement was not calculated for the continuous data collected for the TUG and 
2MWT. 
 
Table 5.10   Percentage agreement 
Outcome Measure Percentage Agreement between TV1 and TV2 
SIGAM 92% 
LCI-5 42% 
SCS 40% 
EQ-5D-index 58% 
EQ-5D-VAS 67% 
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5.4.2.3 Measurement error  
Table 5.11 presents the mean and SD for each visit together with the mean 
difference for each outcome measure.  The information below is basically the same 
as the Bland Altman plots with the MDC being half of the width of the LoA.   
 
Table 5.11   TV1 and TV2 means (SD), SEM, MDC and MDC%  
Outcome 
measure 
(units) 
TV1 
mean (SD) 
[range] 
TV2 
mean (SD) 
[range] 
(TV1-TV2) 
mean 
difference (SD) 
[range] 
SEM MDC 
MDC
% 
 
SIGAM 
(grades) 
 
9.8 (1.2) 
[7 – 11] 
9.7 (1.2) 
[7 – 11] 
0.1 (0.3) 
[0 – 1] 
0.2 0.6 6 
 
LCI-5 
(points) 
 
50.3 (7.8) 
[33.0 – 56.0] 
50.0 (8.0) 
[30.0 – 56.0] 
0.3 (1.8) 
[-2.0 – 3.0] 
1.3 3.5 7 
 
TUG 
(secs) 
 
11.9 (8.0) 
[7.4 - 32.1] 
11.5 (7.0) 
[7.9 - 30.2] 
0.4 (1.0) 
[-0.6 – 1.8] 
0.6 1.8 15 
 
2MWT 
(m) 
 
121.0 (28.1) 
[65.6 - 161.9] 
124.1 (25.9) 
[72.7 - 160.7] 
-3.1 (9.3) 
[-16.0 – 13.3] 
6.8 18.9 15 
 
SCS 
(points) 
 
8.5 (1.1) 
[7 – 10] 
8.3 (1.5) 
[5 – 10] 
0.2 (1.5) 
[-1 – 4] 
0.9 2.5 29 
 
EQ-5D- 
index 
(points) 
 
0.818 (0.186) 
[0.575 – 1] 
0.842 (0.218) 
[0.348 – 1] 
-0.020 (0.140) 
[-0.408 – 0.025]  
0.09 0.26 31 
 
EQ-5D-
VAS 
(points) 
 
87.5 (10.3) 
[70 – 100] 
83.8 (18.2) 
[35 – 100] 
3.8 (11.1) 
[-10 – 35] 
5.4 15.5 18 
 
The SEM and MDC values for the ordinal scale SCS were calculated using mean 
and SD values.  As previously stated, this is not recommended for ordinal data and 
therefore the results should be viewed with caution.  The MDC% values quantify the 
percentage change, with respect to the participant population mean values.  
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5.5 Discussion 
 
The focus for this study was on estimating reliability and measurement error for 
those outcome measures of physical function that are used regularly during the 
prosthetic rehabilitation of pwLLAs. Values for consistency, agreement and 
measurement error, were all calculated using a test re-test study design with an 
intervening period of 7 days between tests.  
This is the first study to present reliability indices for the EQ-5D-5L in a pwLLA 
population.  It is also the first time that both consistency and agreement parameters 
(including comments on LoA) have been presented for the SIGAM, LCI-5, TUG and 
2MWT in this population.  The MDC values stated for the SIGAM, LCI-5, and the 
EQ-5D-5L are also the first to be reported in relation to pwLLAs for these outcome 
measures. 
 
5.5.1 Consistency and agreement parameters 
Reliability is considered the extent to which scores are the same when tests are 
repeated under the same conditions i.e. how consistent the scores are, and how 
close in agreement they are, when the tests are repeated. Consistency within 
repeated measurements is often reported by means of ICCs, as in this study, using 
repeated ANOVA statistics.  However, correlations do not consider any systematic 
bias that may be present and the level of agreement between two test scores must 
also be taken into account, when commenting on the overall reliability of an outcome 
measure.   
 
Intra-class Correlation Coefficients of >0.9 were calculated for the TUG, 2MWT and 
LCI-5, representing excellent consistency (Cicchetti 1994).  This confirmed previous 
results seen for these measures: Schoppen et al (1999) reported Spearman’s 
coefficients of 0.96 (inter-rater) and 0.93 (intra-rater) reliability of the TUG in 1999; 
ICC of 0.88 was reported for the 2MWT by Brooks et al (2002) and Franchignoni et 
al reported 0.98 (ICC) for the LCI-5 in 2004. Resnik et al (2011) reported good 
reliability (>0.7 and <0.9) for the TUG with ICCs of 0.88 and 0.83 for the 2MWT.   
The ICC value for the SIGAM, was also better in this current study (>0.9) than in the 
only other previous study (n= 62), which reported good reliability (ICC = 0.79) (Ryall 
et al 2003).    
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With ICC (95% CI) values all >0.70, the TUG, 2MWT, LCI-5 and SIGAM could all be 
considered reliable enough to be used clinically on the basis of their consistency 
results.  A value of 0.70 is the minimum recommended level at which a test can be 
used with individuals, as opposed to groups in research (Streiner et al. 2014). 
 
In addition to excellent consistency, the TUG and SIGAM also showed good levels 
of agreement with low bias and narrow LoA in the Bland Altman plots.  Thus both 
outcome measures have shown good overall reliability for when used with pwLLAs.  
Previous Kappa coefficients, varying between 0.87 and 0.93, reported for the 
SIGAM in a previous study (Ryall et al 2003) confirmed good agreement of the scale 
when scored by patients and clinicians.  However, no comments on LoA were 
recorded by Ryall et al (2003).  With excellent consistency and good agreement, the 
SIGAM would appear to be of use to clinicians when evaluating functional mobility 
change in pwLLAs.  There have been no reported comments on agreement 
parameters for the TUG in any previous studies with pwLLAs known to date; 
therefore this study presents the first of this kind.  From these results the TUG would 
appear to be of use to clinicians and researchers when evaluating balance and 
mobility with pwLLAs. 
 
The wide LoA seen for the 2MWT (36.4m) may have compromised the level of 
agreement, as this distance constitutes nearly one third of the mean distances 
recorded during each of the two test visits.   Wide LoA for the 2MWT have been 
seen previously.  A study presented normative values for the 2MWT from a sample 
of 1137 (age range 18-83), and the authors stated that the Bland Altman plot, 
calculated from the sample, did not reveal any systematic error (Bohannan et al 
2015).  While this was probably correct, it is debateable whether the wide LoA 
(84.9m) presented, represents an acceptable level of agreement in a stable sample.  
The authors did comment that the multiple centres in the trial were a possible source 
of random error, but this is not likely to impact on LoA.  The wide age range of their 
participants was also cited as being partly responsible for the extensive variability 
reported.  This may have been because slower walking speeds, which are 
associated with increasing age and increasing disability levels, have been shown to 
increase within-day variation (Feys et al. 2014). It is known that TF amputees walk 
slower than those amputated at the TT level (Genin et al. 2008).  However, the 
Bland Altman plot for the 2MWT in this current study, did not show a trend towards 
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the slower walking speeds (as represented by the smaller total distances), despite 
the age range of 40 to 83.  On the evidence from this study, it is would appear that 
the 2MWT is suitable for interpretation at the group level only with pwLLAs.  The 
reporting of such wide LoA would suggest that the 2MWT may not be reliable for 
individual use in this population. 
 
Seven points may be considered wide LoA for the LCI-5 (-3.3–3.8) when interpreting 
variability in the clinical performance of a pwLLA.  The functional performance of a 
stable amputee is unlikely to decrease or even increase to the extent that there 
would be a change in score of more than 2 points on the LCI-5 in the space of one 
week, unless they started or stopped using a walking aid for some reason.  Neither 
the researcher, nor the participant, had access to the previous week’s results and 
therefore any change in scores had not been discussed or compared to their 
previous answers.  On closer inspection of the answers given by the five participants 
who registered a change of more than 2 points between the two visits found that 
they stated that; they either required a walking aid when previously they had not, or 
vice versa.  Though the reasons for this apparent change in dependence on a 
walking aid were not collected, it is assumed that there had been a change in 
confidence levels that may have affected their perceived locomotor abilities.  
Interestingly, two out of the three participants whose scores dropped by 3 points, 
indicating an increased dependence on walking aids or stand-by assistance, walked 
quicker in the TUG and further during the 2MWT.  One of these participants also 
registered a 4 point improvement in the comfort of their socket on the SCS.  
Kendall’s tau correlations between the change scores registered by the LCI-5 and 
the other outcome measures did not reveal any close relationships.  None were 
higher than 0.313 (LCI-5 and EQ-5D-index).  The relationship between perceived 
and observed outcome measures will be explored further in the overall thesis 
discussion in Chapter 7. 
 
Limits of Agreement for the LCI-5 have been presented in only one previous study 
(Franchignoni et al 2004) and were narrower (-1.3-2.5) than those presented here.  
Despite the authors of that previous study stating that the LoA demonstrated “good 
reproducibility” for the LCI-5, it can be argued that those limits are still wider than 
may be expected when repeat measures are only one day apart as was the case in 
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that study.   From the agreement evidence presented in the current study, it is 
therefore recommended that the LCI-5 be used for group level analysis only. 
 
The EQ-5D-5L is concerned with general health overall with respect to five individual 
domains, and while not all five are directly related to physical function, the areas 
covering pain and discomfort, and anxiety and depression, will have an impact.  
How much this is on a day to day basis is not known in pwLLAs, but pain and 
anxiety were the health problems that the English public deemed as most important 
to them, as measured by the EQ-5D-5L (Devlin et al. 2016).   It is difficult to 
comment whether the agreement limits reported are representative of reasonable 
variability in the clinical performance of the participants, as this is the first 
presentation of reliability for the EQ-5D-5L in a population of pwLLA.  However, both 
the EQ-5D-index score and VAS registered good ICCs of between >0.60 and <0.74.  
It is therefore recommended that the EQ-5D-5L should be used at the group-level 
only with pwLLAs until further data is collected. 
 
This is also the first study reporting agreement for the SCS.  However with an ICC of 
0.336, a Kappa statistic of 0.314 and only 50% agreement in the repeat scores, the 
SCS demonstrated poor overall reliability and may be limited for either group or 
individual use. 
 
5.5.2 Measurement error  
Measurement error may be reduced by performing repeated measurements and 
calculating average scores (de Vet et al. 2011 pg 107).  This principle of reducing 
measurement error is also applied when outcome measures are investigated for 
research purposes, in groups of patients and repeat measures are undertaken.  
Higher ICC values are required to recommend its use with individual patients (de 
Vet et al. 2011 pg 142).  The implication being that when results are obtained from a 
group in a research study, they are reduced by a factor dictated by the sample size.  
Consequently, any decisions in clinical practice taken for individual patients, should 
consider a MDC higher than that calculated from the group and greater changes 
must be detected to be sure their patient has made a true change (beyond random 
error) (de Vet et al. 2011 pg 244).  
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For the SIGAM, the MDC95 was calculated to be 0.56 and therefore a difference of 
at least 1 grade (when using the eleven grades) would be required to see a real 
difference in the level of an amputee’s functional mobility.   
 
With a MDC95 value of 3.5 for the LCI-5, this means that a difference of at least 4 
points is required, to detect a real change in the functional mobility level of an 
amputee, on the 56 point scale.   These are the first MDC values to be presented for 
the LCI-5 and SIGAM, in a population of pwLLA.  With no previous measurement 
error results presented for either the LCI-5 or SIGAM comparisons with other studies 
are not possible.  Miller et al (2001) did present SEM value for the original LCI, 
however the scoring system changed from a three level in the original scale to a 
five-level system in the LCI-5, so the values will not be comparable to this study. 
 
The MDC95 value for the TUG was calculated to be 1.8secs for the 12 participants in 
this study, but clinicians should look for time changes greater than this to be sure 
that a change has occurred in their patient’s condition with regard to their walking 
and balance abilities. This value represents 15% of the mean values over the two 
visits.  Results from the current study showed that the MDC95 was 18.9m for the 
2MWT, which also represents 15% of the mean distances covered by the group 
across the two visits.  Both these MDC95 values and percentages are considerably 
smaller than those recorded in a similar population by Resnik et al (2011).  They 
reported MDC90 values of 3.6s for the TUG (28%) and 34.3m (29%) for the 2MWT in 
a population of pwLLAs (Resnik et al 2011). There were two raters in the Resnik 
study with only one in this study, which may have reduced the random error and 
consequently contributed to the increased reliability recorded here.  The higher 
proportion of TF amputees in the Resnik study sample, compared to the current 
study, may also have contributed to the increased variability seen in their results.  
As previously stated; TF amputees walk slower than those amputated at TT level 
(Genin et al. 2008) and slower walking speeds may increase day to day variability.  
The normative study by Bohannan et al (2015) calculated a value of 42.5m (MDC95) 
from a subset of 157 participants (Bohannon et al. 2015), which although higher 
than the MDC reported by Resnik et al (2011), represented a lower percentage 
(25%) of the mean of the distances measured.    
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The MDC values observed, in this current study are; lower for the TUG and, within 
the ranges for the 2MWT, presented for other patient populations.  Values for the 
TUG range from 2.9s in a chronic stroke population (Flansbjer et al. 2005) to 11s in 
long standing Parkinsons Disease (Steffen and Seney 2008); and for the 2MWT 
13.4m in stroke survivors (Hiengkaew et al. 2012) to 22.9m in subjects with 
poliomyelitis (Stolwijk-Swuste et al. 2008). The MDC values presented in this study 
will add to the evidence for clinicians to use as reference values for their patients; 
and for researchers planning intervention studies. 
 
A change score of at least 0.258 (MDC95) on the EQ-5D index score and 15.5 on the 
EQ-5D VAS would be required to see a real difference in the global health of a 
pwLLA.  While measurement error values have not been presented in a similar 
population, SEM values have been presented in a study of cancer sufferers. The 
SEM value for the EQ-5D-index scores was 0.11 for the whole group (n=534) and 
0.12 for the smaller sub-set of lung cancer (n=50), both of which are similar to the 
SEM values recorded for this group of pwLLAs (0.10). As these are the first 
measurement error values presented for the EQ-5D-5L in a population of LLAs, they 
will provide reference values for researchers planning future studies. 
 
Minimal detectable change values were not calculated for the SCS.  This was 
because the SCS is an ordinal scale and, as such it was not considered appropriate 
to calculate SEM values using means and SDs.   
 
 
5.6 Limitations 
This study has the following limitations: 
 
As this was a single researcher PhD study inter-rater reliability was not investigated.  
 
The sample size was small and as such, the methodological quality of the study 
would be considered poor if assessed using the COSMIN quality criteria, and the 
quality of evidence would be deemed indeterminate.  However, it could be argued 
that having a higher sample size may have resulted in lower agreement with the 
increased possibility of higher variances in the participants.  There was reduced 
variability demonstrated in this study compared to other similar studies for the TUG 
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and 2MWT (Resnik et al 2011) and the SIGAM (Ryall et al 2003) that had higher 
sample sizes. 
 
Any generalisation to the wider population of pwLLA must be made with caution, 
especially to vascular amputees with diabetes. The proportion of participants with an  
amputation due to a vascular or diabetic cause was smaller in this study, compared 
to published figures for all amputations (Scott et al. 2016), though they were closer 
to those published for amputees referred for limb-fitting (United National Institute for 
Prosthetics,& Orthotics Development 2013). 
 
The MDC values have been estimated using a study group who have been walking 
on their prostheses for at least a year and generalisation of these values to those 
who may be in the early stages of their rehabilitation should be done with caution.  
However, it is still valuable to provide a guide to the error measurement for these 
outcome measures when used with pwLLAs.  
 
In clinical practice, a change score is based on the difference between pre-treatment 
and post-treatment scores, and the treatment period may extend to several weeks 
for an amputee.  When assessing test re-test reliability in a stable population, this 
would ideally be over the same time-period, however in practical terms this is not 
always possible.  Shorter test re-test periods, such as one week in this study, are 
often used and the assumption is made that the measurement error detected during 
this shorter period will be applicable to the longer periods seen in longitudinal 
intervention studies and rehabilitation programmes. 
 
 
5.7 Conclusions  
 
From the results of this repeatability study carried out on a small group of 
established stable pwLLAs the following conclusions have been drawn: 
 
Of all the outcome measures studied, only the SIGAM and TUG demonstrated 
excellent reliability for both consistency and agreement over repeated measures, 
when used with an established stable population of pwLLA.  On this basis, they can 
both be recommended for use at the individual level.    
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A change of at least one grade is required on the SIGAM, when the eleven grades 
are used, to demonstrate a real change in the functional ability of a pwLLA. 
 
A change of at least 1.8secs on repeat TUG measures is required to demonstrate a 
real change in the balance and mobility of a pwLLA. 
 
Both the 2MWT and LCI-5 demonstrated excellent consistency but the limits of 
agreement were questionable and therefore cannot be recommended for use at the 
individual level.   However, they may be considered reliable at the group level in this 
population.  It is recommended that more data is collected on the 2MWT and the 
LCI-5, and further agreement analysis is performed, before reliability can be 
confirmed at the individual level for these measures when used with pwLLAs. 
 
A change of at least 18.9m on repeat 2MWT measures is required to demonstrate a 
real change in the mobility and endurance of a pwLLA. 
 
A change of at least 4 points is required on the LCI-5 to demonstrate a real change 
in the functional abilities of a pwLLA. 
 
Good consistency was seen in both the EQ-5D index scores and VAS within 
repeated measures, but agreement was difficult to comment on.  It is recommended 
that more data is collected on pwLLAs with the EQ-5D-5L, before its reliability can 
be confirmed in this population. 
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6 Chapter 6 Longitudinal Cohort Study (study IV) 
6.1 Purpose of chapter 
The purpose of this chapter is to describe the methodology, and to present and 
discuss the results of a study that was performed to establish the responsiveness of 
the most commonly used outcome measures in clinical practice measuring physical 
function during prosthetic rehabilitation. This study was carried out to answer 
Research Question 6. 
 
Research Q6  
What is the responsiveness of physical function outcome measures regularly used 
with lower limb amputees when assessing change during the rehabilitation period 
immediately following limb fitting?   
 
6.2 Background 
6.2.1 Study context 
The setting for this study is the early prosthetic rehabilitation period, i.e. the period 
following the amputation surgery, when a pwLLA is fitted with his or her first 
prosthesis.  During this time, initial gait training and therapy is provided.  This early 
period also includes the immediate post-hospital discharge phase, when the pwLLA 
begins to adjust to his or her home circumstances with a prosthetic leg.  As the 
patient recovers from major surgery, changes will be occurring in their clinical 
condition and capabilities.  It is anticipated that improvements will be taking place 
with regards to their mobility and there will be increased participation in all activities 
of daily living, as they become accustomed to using a prosthesis for the first time.  
Clinicians are interested in measuring such progress, which can additionally be used 
to motivate their patients during these early stages of their rehabilitation.  Any 
outcome measure used to evaluate the impact of an intervention, such as gait 
training, a muscle strengthening programme or provision of a prosthesis, must be 
sensitive to changes in the amputee’s condition and physical abilities in whatever 
construct it purports to measures.  The ability of an outcome measure to be 
sensitive to change is considered one of its psychometric properties, which is also 
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referred to as its responsiveness (Kirshner and Guyatt 1985, Guyatt et al. 1989, 
Husted et al. 2000).  
 
Assessing the responsiveness of an outcome measure to changes in a patient’s 
condition is not the same as measuring the response of a patient to an intervention.  
When studies report changes in the physical condition or abilities of a particular 
patient population, in a particular setting, the assumption is often that the outcome 
measures used in these studies are sensitive, or responsive to these changes 
(Beaton 2001).  Although the same statistical methods and indices may be used 
when assessing the responsiveness of an outcome measure or when investigating 
patient responses; different hypotheses need to be tested in each case.  In this 
study, it is assumed, based on clinical experience, that there will be changes in the 
physical function of the participants, as they recover from major surgery, undergo 
gait and strengthening training as well as being fitted with a prosthesis.  Therefore, 
the focus of the study will be on calculating the responsiveness of the outcome 
measures, rather than on measuring the magnitude of the response to any of the 
interventions.  
 
6.2.2 How is responsiveness of an outcome measure represented? 
Responsiveness has previously been recognised as an aspect of validity, but more 
recently it is being considered separately (Husted et al. 2000, Beaton 2001, Mokkink 
et al. 2010b).  The distinction between validity and responsiveness being that, 
validity refers to a single score whereas responsiveness considers a change score 
based on two measurements (Guyatt et al. 1987).   
 
The aim of a recent review of the literature was to investigate the responsiveness of 
commonly used outcome measures that are used to measure physical recovery in 
the lower leg, ankle and foot.  However, a lack of consistency in how 
responsiveness was defined and reported in the studies chosen, led the authors to 
call for further work, in order that a standard reporting measure for responsiveness 
could be recommended (Shultz and Olszewski 2013).   
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6.2.2.1 Distribution-based methods of calculating responsiveness 
As detailed in Chapter 2, it is known that there are many indices that can be used to 
report the statistical significance of change scores as well as their direction and 
magnitude.  Statistically significant differences in test scores can be calculated using 
repeated measures ANOVA, paired sample t-test or the Wilcoxon signed rank test 
and the magnitude of the change can be reported using the effect size or a SRM.  
All of these are considered distribution-based methods of analysis, providing a way 
of expressing the observed change in a standardised metric (Hays et al. 2005).  
However, there is no indication about the level of importance of the changes from 
these parameters.   
 
6.2.2.2 Anchor- or criterion-based methods of calculating responsiveness 
The MCID is an example of a parameter of responsiveness that relies on clinically-
observed changes and can be derived using the anchor or criterion-based method 
(Copay et al. 2007).   A level of importance will be attributed to the observed change 
by the anchor or criterion. The criterion-based method uses a gold-standard 
comparator outcome measure that has already been found to be sensitive to 
changes in the population of interest.  The anchor-based method collects 
information from either the patient or clinician, about whether they consider a 
change in the condition has occurred.  Responses from either the criterion measure 
or the anchor change questionnaire, using a 5, 7 (or more) response Likert scale, 
are correlated with change scores collected from the outcome measure(s) under 
investigation.  These change scores can be correlated with responses in the “better” 
and “worse” response categories in the anchor questionnaire, to establish what 
scores represent a “clinically” important change.  Receiver operating characteristic 
(ROC) curves (Streiner et al. 2014) can be used with the outcome measure in 
question and these change questionnaires to establish their MCID values relative to 
sensitivity and specificity values (Turner et al. 2009), in the population being studied.   
 
Quantifying the responsiveness of an outcome measure by establishing MCID 
values will assist in defining the ability of that outcome measure to detect a clinical 
meaningful change.  Anchor- and criterion-based methods using ROC curve 
analysis are increasingly being used to establish the responsiveness of outcome 
measures in different study populations (Stratford et al. 1998, Bohannon and 
Glenney 2014, Castien et al. 2012) including pwLLAs (Rushton et al. 2015).  As 
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there are no recognised gold-standard outcome measures in the measurement of 
physical function with pwLLAs, the anchor-based method was therefore chosen for 
this study.    
As also previously outlined in Chapter 2, when assessing validity of an outcome 
measure, an existing measure that is considered the gold standard or criterion, is 
often used. If a gold standard measure is not available then a construct approach to 
validation may be adopted (also referred to as “hypothesis testing”).  Similarly, the 
assessment of responsiveness may also rely on testing hypotheses in the absence 
of a gold standard. However, when assessing responsiveness, the hypotheses 
should be concerned with expected mean differences between changes in scores in 
groups, or with expected correlations between changes in scores on the outcome 
measure in question and the changes in scores on another instrument that is known 
to have adequate responsiveness in the same population (de Vet et al. 2011). 
Direction and magnitude of any observed changes or correlations are also stated in 
any hypotheses, in order that they can be proved or otherwise. 
 
While it is recognised that distribution-based methods can demonstrate the ability of 
an outcome measure to measure change, these alone do not provide sufficient 
information for meaningful interpretation of the results regarding the responsiveness 
of a particular outcome measure (Beaton 2001). A statistically significant change 
may occur without the change being a clinically significant one (Husted et al. 2000).   
However, anchor- or criterion-based methods of calculating the MCID may be 
considered appropriate to assess responsiveness, as these methods compare the 
changes in the outcome measure under investigation with either: the change 
captured in the anchor questionnaire from the patient’s or clinician’s perspective on 
the clinical condition or; the change in the criterion measure that has been proved 
responsive in the population and clinical condition under investigation. 
 
6.2.3 Current evidence for the responsiveness of physical function outcome 
measures used with pwLLAs 
There is limited evidence of responsiveness for the top five outcome measures 
regularly used by AHPs across the UK during prosthetic rehabilitation.  Results from 
the systematic review reported in Chapter 4 show that indices of responsiveness 
were reported for only 11 outcome measures used with pwLLAs, namely: 2MWT, 
Houghton scale, Rivermead Mobility Index, LCI / LCI-5, ICF checklist, FIM, OPCS, 
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Amputee Activity Score,  Goal Attainment Scaling, Barthel and SIGAM.  However, 
the strength of the evidence presented, in all studies reporting responsiveness, was 
considered “unknown”, because the statistical analyses used in the studies was 
considered inappropriate according to published criteria (Terwee et al. 2007). 
The same six outcome measures; the SIGAM, LCI-5, TUG, 2MWT, SCS, EQ-5D-
5D, that were investigated in the Reliability Study reported in Chapter 5 were also 
investigated in this study.   The published evidence on the responsiveness of these 
outcome measures used with pwLLAs is limited, see Table 6.1.    
 
Rushton et al (2014) reported the MCID of the L-test, a modified TUG, for individuals 
with lower limb amputation in a recent study (n=33).  However, clinically important 
differences have not been established for any of the outcome measures used 
regularly by AHPs involved in prosthetic rehabilitation in the UK (chapter 2).  
Therefore, the aim of this study was to establish the responsiveness of physical 
function outcome measures regularly used with lower limb amputees when 
assessing change during the rehabilitation period immediately following limb fitting.   
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Table 6.1   Responsiveness data for outcome measures used in this current study 
Outcome 
Measure 
Study  Responsiveness parameters presented Level  of Evidence / Methodological Quality 
SIGAM Ryall et al 
(2003a) 
Effect size = 10.66 ? (choice of analysis) /  
Fair (details of how missing data was handled not 
given, Apriori hypotheses not fully described, effect 
size only) 
LCI / LCI-5 / 
PPA (LCI 
section) 
Franchignoni 
et al (2004) 
Wilcoxon signed rank showed significant difference for both 
LCI and LCI-5 
Effect size: 
LCI = 1.09,   LCI-5 = 1.40 
? (choice of analysis) /  
Fair (effect size only) 
Rushton et al 
(2002) 
 
Effect size 
LCI = 3.7 
? (choice of analysis) /  
Fair (details of how missing data was handled not 
given, interim period not described & effect size only) 
TUG None reported in this population 
2MWT Brooks et al 
(2001) 
ANOVA (p<0.001) calculated for distances walked before 
and after rehabilitation 
? (choice of analysis) /  
Fair (details of how missing data was handled not 
given, interim period not described & ANOVA only) 
SCS Hanspal et al 
(2003) 
Wicoxon z analysis showed sensitivity to changes: 
1. after socket adjustment (n=22) z = -4.16 p<0.001 
2. after delivery of new socket (n=5) z = -2.06 p<0.05 
? (choice of analysis) /  
Fair (effect size only) 
EQ-5D-5L None reported in this population 
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6.3 Methods 
6.3.1 Participants 
Adult (18 years or older) unilateral lower limb amputees, at either TT or TF level, 
who were receiving their first prosthetic limb were eligible for inclusion in the study.   
 
Amputees were excluded if they were going to be receiving a prosthesis for transfer 
activities only.  Patients with co-morbidities that prevented them undertaking any of 
the physical activities involved in the outcome measures, or if they had poor 
cognition or an insufficient comprehension of the English language that prevented 
them from understanding the written questionnaires, were also excluded from 
participating in the study.  These exclusions were discussed with participants and 
their clinical team before the researcher made the final decision on who was 
included. 
 
6.3.2 Ethical opinion 
Favourable ethical opinions were also gained from both Queen Margaret University 
Ethics Committee and the NHS Ethics Committee (South East Scotland 02 
committee) before commencing this study.  In addition, NHS Lothian management 
approval was sought and gained prior to conducting the study on NHS Lothian 
premises. 
 
6.3.3 Recruitment process 
Amputees receiving prosthetic rehabilitation with their primary prosthesis at Astley 
Ainslie Hospital in Edinburgh, and fitting the inclusion criteria, were prospectively 
recruited into the study.   
 
After the decision to fit a prosthesis was made by the multi-disciplinary team (MDT), 
comprising; physiotherapists, occupational therapists, prosthetists, nurses and a 
Consultant in Rehabilitation Medicine, potential participants were identified by the 
physiotherapist, according to the above inclusion and exclusion criteria.   
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Any amputees who matched the study criteria were given a Study Information Pack 
(SIP).  The SIP included an invitation letter, a Participant Information Sheet (PIS) 
and a copy of the consent form they would be asked to sign.   
 
The researcher was available to visit the amputees on the hospital ward, to answer 
any questions and discuss the study further with them before they decided to 
participate.  If the amputee decided to take part, the physiotherapist arranged a 
suitable date and time with the researcher for the first study visit (SV1) when the 
amputee was enrolled as a participant into the study.  Written consent was obtained 
from the participant at this visit which was always at least 24 hours after the 
amputee first received the SIP. 
 
The flow chart (Figure 6.1) outlines the decision process that was followed during 
recruitment. 
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Figure 6-1   Recruitment flow chart 
Amputee is 
measured for 
prosthesis 
Invitation letter 
and PIS given to 
the patient by 
the treating 
Physiotherapist 
Does the patient wish to consider  
taking part  in the study? 
Recruitment Decision Process 
Researcher is contacted by the treating 
Physiotherapist  to arrange a recruitment visit 
to answer any remaining questions 
Is the prosthesis for transfers only? 
Not suitable 
for the study 
YES 
NO 
If all questions are answered 
written consent is taken at 
Study Visit 1 and the amputee 
is enrolled as a study 
participant 
Does the patient fit the study criteria? 
YES 
Not suitable 
for the study 
NO 
Does the MDT agree with the amputee’s 
potential inclusion into the study? NO 
Not suitable 
for the study 
YES 
YES 
NO 
Not in the 
study 
186 
 
6.3.4 Study protocol 
 
All study visits took place in the main gym and long corridor (walking tests) and a 
side room (PROMs) in the Physiotherapy Department at Astley Ainslie Hospital, 
Edinburgh.  The study visits were planned to align with the model-of-care delivered 
for pwLLAs at this rehabilitation facility. See figure 6.2 for the individual participant 
pathway and Table 6.2 for a breakdown of activities at each study visit. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-2   Individual participant pathway  
 
 
Time Interval 1 (TI1) represents the period after delivery of the primary prosthetic 
limb and initial gait training and therapy.   Time Interval 2 (TI2) represents the 
immediate post-hospital discharge period and Time Interval 3 (TI3) represents the 
early prosthetic rehabilitation for a pwLLA which was the focus for this study.   
 
 
 
 
Study Visit 1 
(SV1) 
Individual Participant Pathway  
 
Study Visit 2 
(SV2) 
 
Study Visit 3 
(SV3) 
Time Interval 1:  SV1                     SV2  (2 wks) 
Time Interval 2:    SV2        SV3  (6-8 wks) 
Time Interval 3:   SV1                                                      SV3  (variable) 
1 week after 
prosthesis delivered 
3 weeks after 
prosthesis delivered 
6 weeks after 
hospital discharge 
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Table 6.2   Study visit details 
Activity  Details When / Where Who 
Identification 
of Study 
Participants 
Identification of potential study 
participants 
Provision of Information Sheet 
Prosthetic decision 
taken at hospital or in 
clinic 
Health 
Professional 
(Physiotherapist) 
Recruitment 
Visit 
(optional) 
Explanation of Study Protocol 
and answer any questions  
During the week before 
delivery of prosthesis at 
hospital 
Researcher 
Study  
Visit 1 (SV1) 
Enrolment of participant  -
written consent obtained 
Basic Demographic details  
Baseline measurements for all 
outcome measures  
1 week after prosthesis 
fitted at hospital 
Researcher 
Study  
Visit 2 (SV2)  
Repeat outcome measures 
and 
Activity Change Questionnaire 
(ACQ)   
3 weeks after prosthesis 
fitted at hospital 
Researcher 
Interim Study  
Visit  (SVi) 
  
Repeat outcome measures  
(not done if discharge occurred 
within 1 week of SV2.)  
 
3-5 days prior to 
discharge from hospital 
 
Researcher 
Study  
Visit 3 (SV3)  
Repeat outcome measures 
and ACQ 
6 weeks post-discharge 
at clinic visit 
Researcher 
 
 
At the first Study Visit (SV1) written informed consent was obtained from the 
amputee by the researcher and the amputee was enrolled as a study participant.  
Baseline measurements for all the outcome measures (see below) were taken at 
this visit as well as basic demographic data recording: sex; age; date, cause and 
level of amputation; date of prosthetic fitting and, any relevant concomitant medical 
history.   
 
Study Visit 2 (SV2) occurred two weeks following SV1 and the outcome measures 
were repeated.  Every effort was made to complete the outcome measures at the 
same time of day for each of the participant’s study visits and the order of the 
measurements was randomly assigned at each visit. An Activity Change 
Questionnaire (ACQ) was given to the participant to record how they felt their 
physical ability to perform everyday tasks had changed compared to when they first 
got their prosthetic limb (see later section on outcome measures for details).   
 
The final visit, Study Visit 3 (SV3) coincided with the participant’s six-week post-
discharge MDT clinic appointment at the Southeast Mobility and Rehabilitation 
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Technology (SMART) Centre.  The SMART centre is adjacent to the Physiotherapy 
Department at Astley Ainslie Hospital and the study data was collected in the same 
location as the previous visits. The outcome measures were repeated at this visit 
and in addition two further ACQs were given to record how the participants felt their 
physical ability to perform everyday tasks had changed compared to: i) when they 
were discharged from hospital and; ii) when they first got their artificial limb.   
 
6.3.5 Outcome measures 
The same outcome measures that were used in study III (the repeatability study 
reported in Chapter 5) were used in this study: SIGAM, LCI-5, TUG, 2MWT, EQ-5D-
5L™.  Full details of the outcome measures were given in Chapter 5 (section 5.3.5).  
In addition, an Activity Change Questionnaire (ACQ) was given to the participants to 
record how they felt they had changed, with respect to their physical function, 
between study visits. Data collection sheets and a detailed explanation of the 
procedures followed for each outcome measure in this study are included in 
Appendix 10. 
 
6.3.5.1 Activity Change Questionnaire (ACQ) 
The change questionnaire used in this study, was devised by the Researcher based 
on the five level response scales used in the SF-36 questionnaire asking patients to 
rate their general health (Ware and Gandek 1998).  However, the leading question 
associated with the change questionnaire used in this study, was related to their 
physical abilities.  Activity Change Questionnaires were presented to participants at 
both SV2 and SV4.  By circling one of the statements: much worse, worse, the 
same, better, or much better; participants were asked to indicate “how you feel your 
current physical ability to perform everyday tasks is today compared to …..”.  At SV2 
participants were asked to compare their physical ability to when they first received 
their artificial leg.  At SV4 they were asked the same question.  In addition there 
were asked how they felt their current physical ability to perform everyday tasks 
compared to when they left hospital (SV2).   
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6.3.6 Statistical analysis  
The method section in Chapter 5 (section 5.3.6) described the choice for 
considering the data on the TUG, 2MWT, LCI-5 EQ-5D-5L index score, EQ-5D-VAS 
and SIGAM  as  continuous data, while the SCS data were considered as ordinal. 
 
6.3.6.1 Statistical power 
An a priori sample size calculated showed that a sample size of n=30 would be 
sufficient to detect a statistically significant difference (2 sided α=0.05, power = 
80%) between the outcome measures at SV1 and SV2 with an effect size of 0.56 or 
higher (Hedeker et al 1999). 
 
6.3.6.2 Missing data and imputation analysis 
The total time, distance or scores recorded for each outcome measure was 
considered a data point and an individual question in any questionnaire was 
considered a data item.  All collected data was inspected at the time of collection.  
The data was inspected for missing data points and percentages were reported 
using SPSS.   Multiple imputation methodology is recommended for longitudinal 
studies (Schafer and Graham 2002), to maintain sample size in the statistical 
analysis and to minimise the risk of bias.  There were no missing data items in any 
of the questionnaire data collected and therefore multiple imputation was not 
required at the item level (Eekhout et al. 2014).  There were missing data points at 
SV2 (3/30) and at SV3 (6/30), though not the same participants.  SPSS was unable 
to run simulations on the missing data relative to the data available using the 
multiple imputation (regression method) analysis because there were too few unique 
data points available, i.e. some patients achieved the same scores.    Therefore, no 
multiple imputation was performed and descriptive and inferential statistical 
analyses were performed on the original data set.   
 
6.3.6.3 Summary descriptive analysis 
The Shapiro Wilks test was used to determine whether the data were normally 
distributed and thus informing the type of inferential statistics to be performed.   
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Summary descriptive statistics were derived: means and standard deviations (SD) 
for parametric data; and medians and inter-quartiles for non-parametric and ordinal 
data (i.e. SCS). 
 
6.3.6.4 Inferential Analysis 
6.3.6.4.1 Significant differences across each time interval  
Repeated measures ANOVA / Friedmans ANOVA were used to determine whether 
scores were significantly different over the three assessments for each outcome 
measure.  Where significant differences were detected, post-hoc tests (Paired t-test 
with Bonferoni adjustment / Wilcoxon signed rank test) were carried out to determine 
between which assessments statistically significant differences existed.  A level of 
p<0.05 (adjusting for Bonferoni p=0.05/3 = 0.017) was considered statistically 
significant  
6.3.6.4.2 Effect size calculations across each time interval 
The magnitude of change for each outcome measure was calculated using Cohen’s 
d effect size across each time interval using the following formula: 
 
𝑑 =  
𝑀1 − 𝑀2
𝑆𝐷 𝑝𝑜𝑜𝑙𝑒𝑑
 
where M1 = group 1 mean,  M2 = group 2 mean, SD = standard deviation, and 
  𝑆𝐷 𝑝𝑜𝑜𝑙𝑒𝑑 = √[(𝑆𝐷1
2 + 𝑆𝐷2
2) /2] 
 
If d < 0.5 then the effect size is considered to be “small”, 0.5 ≤ d < 0.8 represents a 
“medium” effect and d ≥0.8 represents a “large” effect size (Cohen 1988).   
  
6.3.6.4.3 Amputee perception of change  
The anchor-based method of calculating the responsiveness of each of the outcome 
measures utilised the ACQ as the anchor.   The ACQ collected the subjective 
perception of change by the participants.  These scores were then compared to the 
change scores of the outcome measures tested, for each time interval i.e. T1, T2 
and T3.  How often each outcome measure correctly identified the participants who 
had and had not undergone an important change, according to the ACQ, was also 
quantified in each of the time intervals.   
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6.3.6.4.4 Validity of the ACQ  
In addition to the statistical analyses performed on each of the outcome measures, 
the following criteria were used to assess the validity of the ACQ. The criteria used 
to established validity were based on those used in previous studies (Turner et al. 
2009, Rushton et al. 2015). The ACQ was assessed to ensure that it is a valid tool 
to assess change in the constructs measured by each of the outcome measures.   
For the ACQ to be deemed an adequate tool the following criteria must be true:   
 the correlation of the ACQ with the difference between follow-up (SV2 and 
SV3) and baseline (SV1) outcome measure scores is more than 0.5 in 
absolute value, and;  
 there is a negative correlation between the ACQ and the baseline outcome 
measure scores (SV1) in each time period, and;  
 there is a positive correlation between the ACQ and the follow-up outcome 
measure scores (SV2 and SV3) in each time period, and;  
 the correlation of the ACQ with the difference between follow-up (SV2 and 
SV3) and baseline (SV1)  outcome measure scores, is at least 0.2 greater (in 
absolute terms) than the correlations with either the baseline or the follow-up 
score. 
 
6.3.6.4.5 Receiver Operating Characteristic (ROC) curve analysis 
To determine the accuracy of each outcome measure in detecting a clinically 
meaningful change (as defined by the ACQ) a ROC curve analysis was performed 
for each outcome measure at each time interval.  This analysis requires a 
dichotomous split in the results where a cut off point is identified; in this case the 
point where a clinically meaningful change had occurred with reference to the ACQ 
scores.  In this instance, the two groups the participants were split into in each time 
interval were: those who recorded a rating of 5 on the ACQ and all the remaining 
participants.  A rating of 5 (“much better”) on the ACQ was used to identify 
participants who were considered to have undergone an important (clinically 
meaningful) change during each study time interval.  The remainder, those who 
reported “better” (4), “same” (3), “worse” (2), or “much worse” (1) on the ACQ, were 
considered not to have made an important change.  Therefore a cut-off point 
between those who were in a “positive actual state” or the “much better” group and 
those in a “negative actual state” or the “others” group was identified.   
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A ROC curve is produced by plotting sensitivity on the y-axis against 1-specificity on 
the x-axis (Streiner et al. 2014).   In the context of this study, sensitivity refers to the 
number of participants correctly identified by the outcome measure as having 
undergone an important change, divided by all participants who perceived that they 
underwent an important change, according to the ACQ.  Specificity refers to the 
number of participants who were correctly identified by the outcome measure as not 
undergoing an important change divided by all participants who perceived that they 
did not undergo an important change, according to the ACQ. To quantify how 
accurate each outcome measure was in correctly identifying individuals who had 
and had not undergone an important change, an area under the curve (AUC) was 
calculated.   
 See Figure 6.3 for an example graph demonstrating high (AUC> 0.90), moderate 
(0.70 – 0.90) accuracy and no better than chance result (<0.50) (Fischer et al. 
2003). 
 
Figure 6-3   Example ROC curve graph 
 
6.3.6.4.6 Minimal Clinically Important Difference (MCID) 
The MCID was defined as the change score that best distinguished between those 
participants who had and had not reported that they were much improved on the 
ACQ. The MCID was identified using the coordinate closest to the upper left hand 
corner of the ROC curve and its corresponding sensitivity and specificity values 
(Turner et al. 2009). 
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6.3.6.4.7 Construct approach to measuring responsiveness 
In addition to the analysis that described both clinically and statistically significant 
change scores and the magnitude of those changes, a construct approach 
(“hypothesis testing”) to measuring responsiveness was also taken (de Vet book).  
Specific a priori hypotheses were therefore formulated.   
 
It was hypothesised that;  
1) participants who rated themselves as having undergone a greater 
improvement in their physical function (i,e, higher ACQ scores) will show a 
superior improvement in the six outcome measures over the same time 
interval; i.e. they will have greater change scores in the SIGAM, LCI-5, SCS 
and EQ-5D-index and EQ-5D-VAS, greater change times in the TUG and 
greater change distances in the 2MWT. 
2) the magnitude of the change in the six outcome measures  would be larger 
in those who perceived that their physical function was “much better” (ACQ 
score = 5) compared to who did not. (ACQ scores 1-4) and:  
3) the outcome measures would correctly identify individuals who had and who 
had not undergone an important change (i.e. ACQ of 5 vs ACQ 1-4)  80% of 
the time. 
 
To address hypothesis 1; it was expected that there would be a correlation of at 
least 0.6 between the change in the instrument scores and the patient perceived 
change in physical function, as measured using the ACQ, for each time interval (1, 2 
and 3). The expected sign of the correlation will be negative for the TUG, and 
positive for all other outcome measures, as a decrease in TUG times denotes an 
improvement.   
 
To address hypothesis 2; it was expected that there would be a difference in the 
effect size of at least one “level” (i.e. low to medium, or medium to high, as denoted 
by the criteria presented by Cohen (1988) during each time interval (1, 2 and 3) for 
those amputees who rated 5 on the ACQ  vs  those who rated 1-4.  It was also 
expected that the group mean of the “improved greatly” group will be larger than the 
group mean of the rest, for each outcome measure, in each time interval. 
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To address hypothesis 3; it was expected that the AUC on a ROC curve analysis 
performed for each outcome measure for each time interval would achieve at least 
moderate accuracy i.e. 0.8, as interpreted using the following criteria: AUC of >0.9 = 
high accuracy; 0.7–0.9 = moderate accuracy; 0.5–0.7 = low accuracy; and ≤ 0.5 = 
chance result (Fischer et al. 2003).  
 
6.3.6.5 Statistical Software  
All descriptive and inferential statistics were calculated using IBM SPSS version 
21.0.0.1 (2012).  
 
 
6.4 Results 
6.4.1 Participants 
6.4.1.1 Demography and aetiology of study population 
A total of 124 amputees were screened during a twenty-two month recruitment 
period, as they passed through the rehabilitation hospital following their amputation 
surgery.  Of these, 83 did not meet the inclusion criteria. Table 6.3 details the 
reasons why these patients were not suitable for inclusion.  A further six patients did 
not give consent and for five the researcher was not available, hence a final total of 
thirty patients were recruited into the study.  Table 6.4 presents the demographic 
and basic aetiological data for the thirty participants. 
 
Table 6.3   Reasons for non-inclusion 
Reasons  Number of amputees 
Not limb-fitted 29 
Bilateral  18 
Unfit physically 15 
Not a primary amputation 8 
Discharged less than a week following fitting 7 
Unfit cognitively 6 
Total not suitable for inclusion 83 
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Table 6.4   Demography and basic aetiology  
Age - yrs 
mean (SD) 61 (13.7) 
median 61 
Gender 
 n % 
Male 24 80 
Female 6 20 
Level 
Trans-tibial (TTA) 22 73 
Trans-femoral (TFA) 8 27 
Side 
Right 13 43 
Left 17 57 
Main Cause of 
amputation 
PAD 13 43 
Diabetes 8 27 
Trauma 2 7 
Other 7 23 
Number of  co-
morbidities 
≤ Three 27 90 
≥ Four 3 10 
 
 
The mean age of participants in this study (61 years) was similar to the population 
recruited in the Repeatability study reported in Chapter 5.  This is again slightly 
younger than the mean age of 67 years reported for the amputee population by the 
SPARG annual report for 2013 (Scott et al. 2016).  As previously observed in 
chapter 5, only 40% of those patients undergoing a lower limb amputation are limb-
fitted and SPARG does not report on the ages of those amputees who are limb-fitted 
separately, but who are likely to be younger.  The male to female ratio was slightly 
higher (4:1) in this study than that reported in the SPARG report, which was 67% 
male to 33% female.  The proportion of TT amputees to TF amputees in the current 
study (73% vs. 26%) shows a slightly higher percentage of TT amputees to the 
percentages reported by SPARG.   The 2013 report stated that 65% of all limb-fitted 
amputees were at the TT level, 23% were at the TF level with the remainder at other 
levels. 
 
The main cause of amputation in this study was either peripheral arterial disease or 
diabetes, which presents a typical profile of the population of amputees across 
Scotland. However, the total percentages reported for these causes in the SPARG 
report is slightly higher with a combined total of 85% of all amputations compared to 
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70% in the current study.  As stated previously in Chapter 5, it is conceivable that 
pwLLAs who had an amputation because of trauma or other causes may be higher 
in the limb-fitted group.  The aetiology breakdown of participants in this study is 
more similar to the pattern of lower limb referrals to prosthetic centres across the 
UK, as seen in the limbless statistics report for 2011-12 (UNIPOD 2013).  This 
report showed that referrals for all dysvascular reasons and diabetes accounted for 
57% of the total, and referrals for trauma and other reasons accounted for 10% and 
33%, respectively.     
 
6.4.1.2 Walking aids used 
Of the 27 participants on whom data was collected at SV2, 11 demonstrated they 
were less dependent on walking aids compared with SV1, e.g. they were using one 
stick or crutch rather than two, see Figure 6.4.  Twelve participants recorded a 
decrease in walking aid use between SV2 and SV3 and 18 across the whole study 
period, thus demonstrating that participants were improving between each visit. 
 
 
 
Figure 6-4   Walking aids used at each study visit  
 
6.4.2 Study time periods 
The time periods to key milestones and for each time interval are displayed in Table 
6.5.  The range of days from amputation to fitting included four participants for whom 
the period from amputation to fitting was greater than 100 days.  However, there did 
0
5
10
15
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25
30
35
SV1 (n=30) SV2 (n=27) SV3 (n=25)
no walking aid
1 stick / crutch
2 sticks
2 crutches
zimmer / frame
not walking
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not appear to be any relationship between this and the results from the outcome 
measures.   
 
Table 6.5   Time periods in days 
 Amputation 
to fitting 
Fitting 
to SV1 
Fitting to 
discharge 
SV1 to SV2 
Time 
Interval 1 
SV2 to SV3 
Time 
Interval 2  
SV1 to SV3 
Time 
Interval 3 
mean 70 9 24 12 74 84 
SD 65 3 19 4 37 37 
range 25-351 5-16 2-111 6-21 42-184 49-195 
median 47 8 22 12 63 74 
 
6.4.3 Data collection issues 
There were some issues at both SV2 and SV3, which affected data collection.  
One participant had a delayed hospital discharge due to housing problems and 
therefore all his / her study visits were undertaken while this participant remained in 
hospital. Study visit 3 was undertaken approximately 6 weeks after SV2.   
 
Due to ongoing medical issues, one participant was readmitted after SV2, however, 
the participant was seen by the multi-disciplinary team for their 6 week “post-
discharge” review appointment while in hospital at approximately 6 weeks after their 
SV2.  Study data was collected at this time point for SV3.  Full details of all the 
issues and their impact can be found in Tables 6.6. and 6.7  
 
Table 6.6   Issues at SV2 
Participant  Issue Impact on SV2 
P02 Patient feeling unwell SV2 not completed 
P03, P06 
P10 
Discharged home prior to SV2, planned 
attendance as an out-patient 
No impact – SV2 data 
collected approx. 2 weeks 
after SV1 
P13 
Discharged home prior to SV2, no capacity 
for attendance as an out-patient 
SV2 not completed 
P21 
Discharged home prior to SV2, planned 
attendance as an out-patient, injury to 
residuum and patient feeling unwell. 
SV2 not completed   
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Table 6.7   Issues at SV3 
Participant  Issue Impact on SV3 
P02 
Did not attend (DNA) 1st clinic visit and not 
wearing limb at 2nd clinic visit due to fit 
issues 
Unable to collect SCS, 
TUG or 2MWT data 
P07 
P30 
Readmitted for further amputation surgery.  
Now bilateral, withdrawn from study. 
SV3 not completed 
P09 
Readmitted to hospital at time of post-
discharge clinic  appointment 
No impact - SV3 data 
collected while in hospital 
P16 
1st visit DNA - rescheduled  but unable to 
attend as in acute hospital with further 
complications, therefore withdrawn from 
study 
SV3 not completed 
P18 
Transport turned up and patient left clinic 
before completing the walking tests 
Unable to collect TUG or 
2MWT data 
P26 
Remained an in-patient at time of the 6 week 
post therapy discharge 
No impact - SV3 data 
collected approx. 6 weeks 
after SV2 
P27 Researcher unable to attend clinic. SV3 not completed 
 
 
6.4.4 Missing data  
There were no missing data items in any of the questionnaire data collected.  
However, due to the issues at SV2 and SV3 described above, some data points 
were missing at both visits.  Percentages of missing data points for each outcome 
measure are listed in Table 6.8. 
 
Table 6.8   Results from missing data point analysis by outcome measure  
Variable Missing / Total  (% missing) 
Demographic data None missing 
Outcome Measures SV1 SV2 SV3 
SIGAM 
None missing 
3 / 30 (10) 4 / 30 (13) 
TUG 3 / 30 (10) 6 / 30 (20) 
2MWT 3 / 30 (10) 6 / 30 (20) 
LCI-5 3 / 30 (10) 4 / 30 (13) 
SCS 3 / 30 (10) 5 / 30 (17) 
EQ-5D index score 3 / 30 (10) 4 / 30 (13) 
EQ-5D VAS 3 / 30 (10) 4 / 30 (13) 
ACQ  3 / 30 (10) 8 / 60 (13) 
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6.4.5 Summary descriptive analysis results 
Data collected for SIGAM, LCI-5, TUG, 2MWT, and EQ-5D-5L was assessed using 
Shapiro Wilks in order to determine whether the data were normally distributed.  It 
was found that only the EQ-5D-index data was normally distributed at all three time 
points (see Appendix 13).  Summary statistics were derived, as appropriate, for all 
available data collected at each time point and are presented in the following table 
(Table 6.9). 
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Table 6.9   Summary descriptive statistics all study visits 
Outcome 
measure 
(units) 
Summary 
Statistics 
SV1 
n=30 
SV2 
n=27 
SV3 
n= 24
†
, 25
††
, 26 
SIGAM 
(grades) 
Median [IRQ] 4.0 [4.0 – 4.0] 8.0 [4.0 – 8.0] 8.0 [4.8 – 9.0] 
Range 2-8 3-9 1-10 
LCI-5 
(points) 
Median [IRQ] 35.5 [25.0-41.25] 38.5 [35.0-44.0] 43.5 [38.7-47.3] 
Range 6-45 19-52 18-54 
TUG  
(secs) 
Median [IRQ] 30.7 [22.4-46.9] 21.8 [16.3-41.9] 15.7 [10.4-26.0] 
Range 15.1-84.3 9.2-62.6 7.9-41.1 
2MWT  
(m) 
Median [IRQ] 52.1 [35.0-62.4] 68.8 [42.7-73.3] 83.7 [50.2-112.7] 
Range 20.9-86.2 25.6-137.3 32.8-172.9 
SCS 
(points) 
Median [IRQ] 7 [6-8] 8 [6-8] 8 [7-9] 
Range 3-10 3-10 3-10 
EQ-5D- index 
(points) 
Mean (SD) 0.654 (0.186) 0.755 (0.132) 0.679 (0.205) 
Range 0.221-1.000 0.401-1.000 0.057-1.000 
EQ-5D- VAS 
(points) 
Median [IRQ] 80 [70-90] 90 [90-90] 80 [80-90] 
Range 50-100 45-100 50-97 
† 
sample size for TUG & 2MWT at SV3, 
††
 sample size for SCS at SV3
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The group mean differences recorded across each time interval are presented in 
Table 6.10.  The different sample size at each study visit is reflected in different 
paired sample sizes in TI2 and TI3 for some outcome measures. 
 
Table 6.10   Group mean differences (SD) across each time interval 
Outcome Measure 
(units) 
Time Interval 1 
SV1-SV2 
n=27 
Time Interval 2 
SV2-SV3 
n=22
†
, 23 
Time Interval 3 
SV1-SV3 
n=24
‡
, 25
‡‡
, 26 
SIGAM (grades) 2.0 (2.22) 0.8 (2.5) 2.5 (2.3) 
LCI-5 (points) 6.3 (7.3) 4.1 (6.9) 10.9 (8.7) 
TUG
† ‡  
(secs) -8.3 (7.2) -6.3 (7.1) -12.9 (9.3) 
2MWT
† ‡ 
 (m) 16.3 (20.8) 15.7 (22.3) 34.7 (34.4) 
SCS
† ‡‡ 
(points) 0.22 (2.1) 0.61 (2.2) 0.81 (2.1) 
EQ-5D index (points) 0.091 (0.163) -0.026 (0.167) 0.052 (0.259) 
EQ-5D VAS (points) 3.6 (10.8) -3.7 (12.0) 0.7 (9.5) 
† 
sample size for TUG, 2MWT & SCS in TI2,  
‡ 
sample size for TUG & 2MWT at TI3,  
‡‡
 sample size for SCS at TI3 
 
 
6.4.6 Inferential analysis 
6.4.6.1 Significant differences across each time interval  
The group mean differences indicated improvements for all outcome measures over 
all time intervals except for the EQ-5D-index and EQ-5D–VAS scores during TI2 
(post-hospital discharge).    
 
There were statistically significant differences recorded for all outcome measures 
except the SCS, EQ-5D-index and EQ-5D-VAS, as determined by repeated 
measures ANOVA for parametric data and Friedman’s ANOVA for non-parametric 
data. These results and those of the post-hoc tests are presented in Table 6.11.  
Post-hoc tests were not done for SCS or EQ-5D-index scores, but for those done 
they revealed that there were statistically significant differences between all the 
study visits for LCI-5, TUG and 2MWT.  
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6.4.6.2 Effect size calculations across each time interval 
The magnitude of change for each outcome measure was estimated by calculating 
Cohen’s d effect size, using pooled SD, across each time interval.  If d < 0.5 this is 
considered a “small” effect, 0.5 ≥ d < 0.8 a “medium” effect and d ≥0.8 represents a 
“large” effect size (Cohen 1988).  Therefore, in the table below (Table 6.11) effect 
sizes <0.5 have been labelled as “small’,  ≥ 0.5 and <0.8 as “medium”and ≥0.8 as 
“large”. 
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Table 6.11   Repeated measures ANOVA / Friedman’s with post-hoc analysis and effect size per outcome measure for each time interval 
Outcome 
measures 
Friedman’s  
ANOVA  
except  
EQ-5D-index: 
Repeated 
Measures 
ANOVA  
Post-hoc tests  
Wilcoxon Signed Ranks  
Cohen’s d 
Time Interval 1 
SV1-SV2 
n=22
†
, 23 
Time Interval 2 
SV2-SV3 
n=22
†
, 23 
Time Interval 3 
SV1-SV3 
n=22
†
, 23 
Time Interval 1 
SV1-SV2 
n=27 
Time Interval 2 
SV2-SV3 
n=22
†
, 23 
Time Interval 3 
SV1-SV3 
n=24
‡
, 25
‡‡
, 26 
SIGAM 
X
2
(2)=24.356, 
p<0.001 
<0.017* 0.156 <0.017* 1.03 0.35 1.13 
LCI-5 X2(2)=30.615,  
p<0.001 
<0.017* <0.017* <0.017* 0.66 0.53 1.13 
TUG  X2 (2)=31.182,  
p<0.001 
<0.017* < 0.017* <0.017* -0.53 -0.54 -1.12 
2MWT  X2 (2)=21.402,  
p<0.001 
<0.017* <0.017* <0.017* 0.69 0.47 1.20 
SCS X2 (2)=4.831,  
p=0.089 
Not required p>0.05 0.13 0.36 0.49 
EQ-5D-
index 
F(2,44)=2.672,   
p= 0.08 
Not required p>0.05 0.61 -0.20 0.25 
EQ-5D-
VAS 
X
2
 (2)=12.585,  
p=0.002 
0.019 0.087 0.685 0.31 -0.34 0.06 
  
† 
sample size for TUG & 2MWT  
 
*=statistically significant at p<0.017 in post-hoc  tests, 
adjustments for multiple comparisons: Bonferoni 
† 
sample size for TUG, 2MWT & SCS in TI2,  
‡ 
sample size for TUG & 2MWT at TI3,   
‡‡
 sample size for SCS at TI3 
 
d<0.5 =  “small”, d≥0.5, <0.8  = “medium” and 
d ≥0.8= “large” effect size 
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Activity Change Questionnaire 
The individual participant’s perception of change scores collected at SV2 and SV3 
are shown in Figure 6.5.  
 
Figure 6-5   ACQ scores 
 
6.4.7 Validity of the ACQ  
The results for all the correlations of: i) the ACQ with the difference between follow-
up and baseline outcome measure scores and; ii) between the ACQ and the 
baseline outcome measure scores, and; iii) between the ACQ and the follow-up 
outcome measure scores, and; between the ACQ and the difference between iv) 
follow-up and v) baseline outcome measure scores are presented in the following 
tables (Table 6.12 - TI1, Table 6.13 - TI2 and Table 6.14 - TI3).  
 
All correlations are Kendall’s tau except for the EQ-5D-index which are Pearson’s 
product-moment, due to the parametric nature of the data. 
 
The correlation criteria are listed in the first column and if the correlation is met for 
any of the outcome measures the result or a tick is highlighted in red in the table.  
For the ACQ to be considered a valid tool to measure perceived change then all 
criteria must be met. However, the ACQ did not satisfy all the criteria for any of the 
outcome measures across any of the time intervals. 
0
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ACQ1 ACQ2 ACQ3
5 much better
4 better
3 same
2 worse
1 much worse
not completed
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Table 6.12   Time Interval 1 ACQ correlations  
Correlation 
requirements 
SIGAM LCI5 TUG 2MWT SCS 
EQ5D 
index 
EQ5D 
VAS 
n=27 
i) ACQvsdiff >0.5 .146 .324 -.213 -.053 -.253 .167 .013 
ii) ACQvsSV1 
-‘ve correlation 
-.416 -.282 .192 -.148 .475** .283 .179 
iii) ACQvsSV2 
+’ve correlation 
-.100 -.086 .106 -.156 .100 .201 .295 
iv) ACQvsdiff – 
ACQvsSV1 >0.2  
√  X X X √ X X 
iv) ACQvsdiff – 
ACQvsSV2 >0.2  
X √ X X X X √ 
*p<0.05, **p<0.001  X = criteria not met, √ = criteria met 
 
 
 
 
Table 6.13   Time Interval 2 ACQ correlations  
Correlation 
requirements 
SIGAM LCI5 TUG 2MWT SCS 
EQ5D 
index 
EQ5D 
VAS 
n=23 n=22 n=23 
i) ACQvsdiff >0.5 .261 .166 .253 .288 -.089 -.269 .202 
ii) ACQvsSV1 
-‘ve correlation 
.195 .121 -.270 .367* .143 .144 -.069 
iii) ACQvsSV2 
+’ve correlation 
.375 .264 -.183 .245 -.083 -.153 .121 
iv) ACQvsdiff – 
ACQvsSV1 >0.2  
X X X X X X X 
iv) ACQvsdiff – 
ACQvsSV2 >0.2  
X X X X X X X 
*p<0.05, **p<0.001  X = criteria not met, √ = criteria met 
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Table 6.14   Time Interval 3 ACQ correlations  
Correlation 
requirements 
SIGAM LCI5 TUG 2MWT SCS 
EQ5D 
index 
EQ5D 
VAS 
n=26 n=24 n=25 n=26 
i) ACQvsdiff >0.5 .107 .141 -.005 -.089 -.035 .034 .159 
ii) ACQvsSV1 
-‘ve correlation 
-.095 -.144 .005 -.016 .156 -.059 .161 
iii) ACQvsSV2 
+’ve correlation 
-.024 -.051 0.47 -.026 .079 -.010 .350* 
iv) ACQvsdiff – 
ACQvsSV1 >0.2  
X X X X X X X 
iv) ACQvsdiff – 
ACQvsSV2 >0.2  
X X X X X X X 
*p<0.05, **p<0.001  X = criteria not met, √ = criteria met 
 
 
6.4.8 Receiver Operating Characteristic (ROC) curve analysis 
A ROC curve was produced by plotting sensitivity on the y-axis against 1-specificity 
on the x-axis.  The sample sizes of the groups in each ROC analysis, taking into 
account any missing data, are detailed in Table 6.15.  The same groups were 
utilised when testing all hypotheses.   
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Table 6.15    Group sample sizes of positive and negative actual states 
 Group sample sizes 
 
Time Interval 1 
SV1-SV2 
Time Interval 2 
SV2-SV3 
Time Interval 3 
SV1-SV3 
Positive actual state = 
ACQ response 5 =  
“much better” group 
All outcome measures 
n=18 
SIGAM, LCI-5, 
EQ-5D-index & VAS 
n=20 All outcome measures 
n=17  
TUG, 2MWT & SCS 
n=19 
Negative actual state =  
ACQ response 1-4 = 
 “all others” group 
All outcome measures 
n=9 
All outcome measures 
n=3 
SIGAM, LCI-5, 
EQ-5D-index & VAS 
n=9 
SCS n=8 
TUG & 2MWT 
n=7 
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The ROC curve for LCI-5 at TI1 is presented in Figure 6.6.  The AUC for this curve 
was calculated at 0.676 representing a low accuracy for the LCI-5 in this time 
interval.  ROC curve graphs for all outcome measures across each time interval are 
presented in Appendix 14 and AUC results are presented in Table 6.16.   
 
 
 
 
 
Figure 6-6   LCI-5 ROC curve for TI1 (from SPSS) 
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Table 6.16   ROC analysis area under the curve 
Outcome Measure 
Time Interval 1 
SV1-SV2 
Time Interval 2 
SV2-SV3 
Time Interval 3 
SV1-SV3 
SIGAM 0.565 0.742 0.546 
LCI5 0.676  0.692 0.539 
TUG 0.346 0.754 0.504 
2MWT 0.466 0.789 0.445 
SCS 0.330 0.417 0.507 
EQ5D index 0.552 0.333 0.549 
EQ5D VAS 0.485 0.700 0.572 
Null hypothesis: true area = 0.5 or above 
AUC >0.9 = high accuracy; 0.7–0.9 = moderate accuracy; 0.5–0.7 = low accuracy; and 
 ≤0.5 = chance result (Fischer et al 2003) 
 
 
It can be seen that both the SIGAM and LCI-5 have “better than chance” accuracy, 
over all time intervals, in measuring an important change, using the participant’s 
perception of change of physical ability as an anchor.  The results obtained for the 
TUG and 2MWT indicated that the accuracy of these measures to detect  an 
important change was at best, “moderate” in TI2 but was low or by chance in TI1 
and TI3.  
 
It should be noted there was at least one tie of scores occurring in both the positive 
actual state group and the negative actual state group for the SIGAM, LCI5, SCS, 
EQ-5D index and EQ-5D VAS in all time intervals, and for the 2MWT in TI1, which 
may bias the results. 
 
6.4.9 Minimal Clinically Important Difference (MCID) 
The MCID was identified using the coordinate closest to the upper left hand corner 
of the ROC curve and its corresponding sensitivity and specificity values, i.e. the 
coordinate where the highest sensitivity and lowest specificity scores met on the 
curve.  (NB similar results regarding accuracy to those presented in Table 6.16) 
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Table 6.17    MCID values from the ROC analysis  
Outcome Measure 
(units) 
Time Interval 1 
SV1-SV2 
Time Interval 2 
SV2-SV3 
Time Interval 3 
SV1-SV3 
SIGAM (grades) 2.5 -1.0 4.5 
LCI5 (points) 8.5 -1.5 21 
TUG (secs) -0.3 -12.4 -5.5 
2MWT (m) 57.9 2.0 55.4 
SCS (points) 2.0 1.5 2.5 
EQ-5D index (points) 0.108 0.041 0.168 
EQ-5D VAS (points) 12.5 -9.0 7.5 
Null hypothesis: true area = 0.5 or above 
AUC >0.9 = high accuracy; 0.7–0.9 = moderate accuracy; 0.5–0.7 = low accuracy; and ≤0.5 = chance 
result (Fischer et al 2003) 
 
 
6.4.10 Construct approach (hypothesis testing) to assessing responsiveness 
The group numbers in Table 6.15 were used throughout all the hypotheses testing 
analyses.  
 
6.4.10.1 Hypothesis 1 
“Participants who rated themselves as having undergone a superior improvement in 
their physical function (i,e, higher ACQ scores) will show a greater improvement in 
the six outcome measures over the same time interval; i.e. they will have greater 
change scores in the SIGAM, LCI-5, SCS and EQ-5D-index and EQ-5D-VAS, 
greater change times in the TUG and greater change distances in the 2MWT”. 
 
Pearson’s correlation coefficients were calculated across the three time intervals, for 
the EQ-5D-index data which was normally distributed.  Kendall’s Tau correlation 
was used for the ordinal data obtained from the SCS and the non-parametric data 
obtained from the remaining outcome measures (see Table 6.18).  The same 
groups, representing the positive and negative actual states, used in the ROC 
analysis (see  Table 6.13) were used in the correlation calculations presented here. 
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Table 6.18    Correlations per outcome measure for each time interval  
 
No correlations that were statistically significant and above 0.6 were found and 
therefore the hypothesis was not confirmed for any of the six outcome measure.    
Graphs showing plots of the correlations for the outcome measures across all the 
time intervals are presented in Appendix 15 
 
6.4.10.2 Hypothesis 2 
“The magnitude of the change in the six outcome measures would be larger in those 
who perceived that their physical function was much better (ACQ= 5) compared to 
who did not (ACQ 1-4).” 
 
In TI1 a greater effect size was noted for the SIGAM, LCI-5, TUG and EQ-5D index, 
see Table 6.19, for those amputees who rated themselves as having improved 
greatly (“much better” response on the ACQ), than for the others who felt they only 
slightly improved (“slightly better”), didn’t improve (“the same”) or were worse (either 
“slightly or much worse”).  In TI2 only the LCI-5 and 2MWT demonstrated greater 
effect sizes in the group who perceived their physical function to be much improved, 
though there were only 3 participants in the “other” group.  In TI3, only the SIGAM 
and EQ-5D index that recorded the greater effect sizes in the improved group. 
 
 
 
Outcome 
Measure 
Time Interval 1 
SV1-SV2 
Time Interval 2 
SV2-SV3 
Time Interval 3 
SV1-SV3 
Pearson’s 
Kendall’s 
Tau 
Pearson’s 
Kendall’s 
Tau 
Pearson’s 
Kendall’s 
Tau 
SIGAM  .146  .261  .107 
LCI-5  .268  .189  .061 
TUG  -.213  .253  -.005 
2MWT  -.053  .288  -.089 
SCS  -.253  -.089  -.035 
EQ-5D index .167  .269  .034  
EQ-5D VAS  .013  .202  .159 
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Table 6.19   Effect size for each time interval per ACQ responses  
 
 
Results for the other outcome measures show the opposite from what might have 
been expected: i.e during TI1 the 2MWT, SCS and EQ-5D VAS, during TI2 the 
TUG, SCS and EQ-5D index; and the SCS in TI3, the effect sizes were larger in the 
“other” group and not the group who perceived an improvement on the ACQ. 
 
It was also expected that the group mean of the “much better” group will be larger 
than the group mean of the rest, for each outcome measure, in each time interval.  
As the difference in group means are highly related to the effect size (i.e. the same 
except they are divided by SD) they showed a similar pattern except for LCI-5 over 
TI3, where the group mean for the improved group was greater than the other group 
(see Table 6.20).  The results are shown in red in the table where this was not the 
case. 
 
 
Outcome 
Measure 
Time Interval 1 
SV1-SV2 
Time Interval 2 
SV2-SV3 
Time Interval 3 
SV1-SV3 
Group 
sample sizes 
Much better 
n=18 
All 
others 
n=9 
Much better 
n=20 
n=19
†
 
All 
others 
n=3 
Much 
better 
n=17 
All others 
n=9 
n=8
‡
 
n=7
‡‡
 
SIGAM 1.24 0.71 0.48 0.24 1.44 0.70 
LCI-5 0.80 0.36 0.54 0.19 1.12 1.10 
TUG
† ‡‡
 0.58 0.40 0.44 1.32 1.05 1.17 
2MWT
† ‡‡
 0.64 0.77 0.48 0.09 1.18 1.15 
SCS
‡
 0.22 0.70 0.30 0.51 0.44 0.57 
EQ-5D index 0.58 0.47 0.32 0.41 0.62 0.14 
EQ-5D VAS 0.28 0.43 0.25 1.39 0.12 0.05 
d<0.5 =  “small”, d≥0.5 and <0.8  = “medium” d ≥0.8= “large” effect size 
† 
sample size for “much better”  group for TUG & 2MWT in TI2,  
‡ 
sample size  for “much better”  group for SCS in TI3,  
 
‡‡
 sample size for “much better”  group for TUG & 2MWT in TI3 
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Table 6.20   Group means for each time interval by ACQ responses 
 
 
6.4.10.3 Hypothesis 3 
“The outcome measures would correctly identify individuals who had and who had 
not undergone an important change 80% of the time.” 
 
This hypothesis can be tested by reviewing the ROC curve analysis. As can be seen 
in Table 6.16 presented earlier, the AUC was not above 0.8 for any of the outcome 
measures.  The conclusion reached is that none of the outcome measures were 
able to correctly identify the participants who had and who had not undergone an 
important change 80% of the time.  Results of over 70%, representing moderate 
accuracy, were obtained by the SIGAM, TUG, 2MWT and EQ-5D-5L for the index 
score, in TI2.    
Outcome Measure 
(units) 
Time Interval 1 
SV1-SV2 
Time Interval 2 
SV2-SV3 
Time Interval 3 
SV1-SV3 
Group sample sizes 
Much 
better 
n=18 
All 
others 
n=9 
Much better 
n=20 
n=19
†
 
All 
others 
n=3 
Much 
better 
n=17 
All others 
n=9 
n=8
‡
 
n=7
‡‡
 
SIGAM (grades) 2.2 1.4 1.0 -0.7 2.8 1.9 
LCI-5 (points) 7.8 3.1 4.4 1.0 11.4 10.0 
TUG
†
 
‡‡
 (secs) -9.8 -5.4 -5.1 -12.0 -12.0 -15.0 
2MWT
†
 
‡‡
 (m) 13.7 21.5 17.1 1.4 34.63 37.7 
SCS
‡
 (points) -0.3 1.3 0.5 1.3 0.71 1.1 
EQ-5D index (points) 0.098 0.075 -0.047 0.084 0.099 -0.037 
EQ-5D VAS (points) 3.4 3.9 -3.3 -10.0 1.3 -0.6 
† 
sample size for “much better”  group for TUG & 2MWT in TI2,  
‡ 
sample size  for “much better”  group for SCS in TI3,  
‡‡
 sample size for “much better”  group for TUG & 2MWT in TI3 
 
*p<0.05, **p<0.001 
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6.5 Discussion 
6.5.1 Study focus and setting 
The focus for this study was estimating responsiveness parameters, for outcome 
measures of physical function that are used regularly during the prosthetic 
rehabilitation of pwLLAs.   The study was set during the early phase of prosthetic 
rehabilitation, when changes in the physical ability and function of these amputees 
are to be expected. It was therefore likely that changes would be seen in those 
outcome measures of the constructs under investigation.  The gait training, 
strengthening programme or prosthetic componentry prescribed to participants 
during this early rehabilitation period are not described as they are not the focus of 
this study and therefore will not be discussed in any detail.  Thirty unilateral adult 
pwLLAs were followed in this study, from approximately one week after they were 
fitted with their first prosthetic limb, until their MDT clinic appointment at six weeks 
after their hospital discharge. Distribution-based parameters of responsiveness 
(such as repeated measures ANOVA and effect size) were calculated for the 
SIGAM, LCI-5, TUG, 2MWT, SCS and the EQ-5D-5L.   In addition, anchor-based 
parameters of responsiveness (MCID) were also calculated using the amputee’s 
perceived change in their physical abilities.  
 
During the early prosthetic rehabilitation period immediately after the amputee takes 
delivery of their first prosthesis, the physical function of a pwLLA is likely to improve, 
especially with regard to their mobility.  By collecting data at three data time points 
during this period, it was possible to investigate if there were any more pronounced 
changes during the phase immediately after delivery of the prosthesis (TI1, duration 
approximately two weeks) compared to the phase following discharge from hospital 
(TI2, duration approximately six weeks).   While this was not an explicit research 
question, it was noted that there was a superior improvement noted in TI1 compared 
to TI2, for all outcome measures except the SCS and the EQ-5D-VAS scores when 
considering the effect sizes derived from the change scores over each time interval.  
Only the LCI-5, TUG and 2MWT test results showed significant differences in both 
time periods (TI1 and TI2). 
 
This, apparently rapid, improvement in mobility and functional activities is not 
unexpected soon after delivery of the prosthetic limb.  The amputee is likely to be 
receiving daily gait training and physiotherapy during this in-patient period of 
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rehabilitation which will improve their mobility and function. If there are no issues 
with wound healing around the residuum and pain is well controlled then mobilising 
on a prosthesis will proceed at a pace dictated by the amputee.   Demet et al (2003) 
postulated a link between energy levels and quality of life, in a study looking at the 
Nottingham Health Profile with pwLLAs.  However, others highlighted the need to 
investigate the psychological adjustment of an amputee in the immediate post-
surgery phase more (Horgan and MacLachlan 2004).  It is interesting to note, that 
the pwLLA respondents to the survey reported in Chapter 3, put “energy, drive and 
motivation” in their top three factors that influenced a positive prosthetic outcome.  
This concurred with “determination to walk” and “motivation” that were considered 
important predictors in the rehabilitation process by prosthetic users and health 
professionals (Schaffalitzky et al. 2012).  Pain levels were not collected in this study 
but it is expected that physical function and mobility will be adversely affected by 
increasing levels of pain and this would be reflected in the data obtained from the 
outcome measures. “Severity of pain” also emerged as an important predictor of 
prosthetic limb use by both prosthetic users and health professionals who 
participated in the Delphi Study carried out by Schaffalitzky (2012).   
 
Following discharge from hospital, the amputee will be required to be self-motivated 
to continue their programme of exercises and gait practice to achieve his /her 
functional goals.  However, it is possible that the rate of any improvement towards 
these goals may slow, or even level off, as potential everyday difficulties become a 
reality when the amputee goes home.  This realisation, coupled with the absence of 
a daily therapy routine with their fellow patients and the health professionals to 
oversee the therapy programme, may contribute to a slowing of any functional 
improvements or in some cases, a decline. Such variations in performance were 
seen in a study by van Twillert et al (2014) where the physical performance declined 
relative to baseline, in nine out of thirteen pwLLAs who were followed at three and 
six months post-hospital discharge (van Twillert et al. 2014).  The same level of 
deterioration was not seen in this current study.  However the participants were only 
followed up until six weeks post-discharge, so it is possible that the decline in 
performance noted by van Twillert was not captured. 
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6.5.2 Perceived vs observed change 
The additional data collected from participants via the ACQ at SV2 and SV3 
provided an anchor of improvement perceived by the patient and was considered an 
indicator of the importance of the change.  Construction of the anchor question is 
considered of fundamental importance to the design of a competent scale and 
should be constructed to align with the domain of interest (Kamper 2009), in this 
case, physical function.  A time scale must also be included.  By asking the specific 
question “how do you rate your current physical ability to perform everyday tasks is 
today, compared to when you first got your artificial leg” in the ACQ in this current 
study, it was anticipated that an indication would be gathered of how the pwLLA felt 
they had changed with specific reference to their physical ability to undertake 
everyday tasks.  Despite the careful choice of wording in the change question, it is 
recognised that with only one anchor question but data from six outcome measures, 
all dealing with physical function but with slightly different constructs, there may be 
some issues with the alignment of the ACQ question.  As the SCS and the EQ-5D-
5L measure socket comfort and QoL, respectively, the wording of the anchor 
question may not be optimal for them. There will be more discussion of the validity 
of the ACQ for each outcome measures when they are presented individually, later 
in the discussion.  
 
The majority of the pwLLAs in this study felt their “physical ability to undertake 
everyday tasks” was “much better” according to the ACQ scores.  However, this did 
not always correspond to an improvement recorded by the outcome measures as 
evidenced by the poor correlations between the ACQ scores and differences 
recorded in each time period, (see Table 6.16).   There was no relationship seen 
between the ACQ scores and either of the two observed measures (TUG and 
2MWT) in any of the time periods.  This lack of correlation between perceived and 
actual performance has also been seen in a review by Kannenberg et al (2014) 
when performance-based outcome measures such as the 2MWT and the Hill 
Assessment Index demonstrated improvements in patients using micro-processor 
knee joints but self-reported measure results showed a lack of improvement 
(Kannenberg et al. 2014).   
 
There is some suggestion of recall bias with this method of collecting patient-
perception of change (Kamper 2009, Norman et al. 1997).   The exact phrasing of 
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the anchor question would appear to be key to the determination of the relationship 
between responses to the anchor question and changes in outcome measures 
collected at the same time; and any errors of measurement in the change 
questionnaire and any outcome measure being collected at the same time, are 
assumed to be unrelated.  However, any influences on the patient in their current 
state will affect their recall of their previous state (Ross 1989).  This is likely when 
the current state is being reported by both the patient or measured by an observer.  
 
While there may be concerns about whether both PROMS and observed measures 
can effectively detect changes in performance, the use of PROMs is being heralded 
as having the potential to transform healthcare by some. Black (2013) postulates in 
his editorial analysis in the British Medical Journal, that PROMs, both disease 
specific, e,g, the Oxford Hip Score, and generic measures like EQ-5D, will not only 
“help patients and clinicians make better decisions, but they can also enable 
comparisons of [health care] providers’ performances to stimulate improvements in 
services” (Black 2013).  A discussion around reporting perceived versus actual 
performance and the use of both patient-report and observed outcome measures 
will be presented in more depth in the final discussion chapter (chapter 7). 
 
6.5.3 Distribution-based parameters of responsiveness 
Following repeated measures analysis of variance, statistically significant 
differences were noted across the full period of the study (median 74 days duration), 
for all outcome measures, except the SCS and EQ-5D-5L.  The SCS and EQ-5D-5L 
were developed to measure the comfort of the socket and global health, respectively 
and this early rehabilitation period with the prosthesis is aimed primarily at functional 
mobility.  So although there is an expectation that there will be some changes in 
both socket comfort and global health during this period, these changes may not be 
so pronounced.  Post-hoc analysis showed significant differences during the 
rehabilitation period, immediately after limb-fitting in TI1 (median 12 days) for 
SIGAM, LCI-5, TUG and 2MWT.  However statistically significant differences were 
only noted for the TUG and 2MWT in TI2, the post-hospital discharge period 
(median 64 days).  Further discussion on these results will be presented later as 
each outcome measure is examined separately. 
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6.5.4 Anchor-based parameters of responsiveness 
The detection of statistically significant changes in scores during a time when 
changes were expected, have led some authors to conclude that the outcome 
measure in question, is effective in detecting changes i.e. is responsive (Brooks et 
al. 2001, Panesar et al. 2001, Kohler et al. 2011).  In a similar way, others have 
declared an outcome measure is responsive to changes in the participant’s 
condition, by presenting effect sizes (Devlin et al. 2004, Franchignoni et al. 2004, 
Ryall et al. 2003).  However, it is now recommended by many (Copay et al. 2007, 
Haley and Fragala-Pinkham 2006, Revicki et al. 2008) that in order to establish that 
an outcome measure is responsive to “clinically important” changes, these 
distribution-based methods are used to support anchor- or criterion-based MCID 
estimates as a responsiveness parameter.  It is also recognised that before an 
outcome measure can be deemed responsive, for a given population and context, 
any changes detected must be relevant to that population and context (Copay et al. 
2007, Haley and Fragala-Pinkham 2006, Terwee et al. 2012).  The a priori 
hypotheses stated in this study, were formulated with respect to triangulation of 
results (statistical significance, magnitude and clinical relevance), and the sensitivity 
to detect change by each of the outcome measures have been assessed in relation 
to these.  The MCID values for each outcome measure presented are also 
considered in relation to the validity of the ACQ and its accuracy across each of the 
time intervals.   
 
In TI2, the improved group, who considered themselves “much better”, consisted of 
20 participants for the SIGAM, LCI-5, EQ-5D-index and EQ-5D-VAS, and 19 for the 
TUG, 2MWT and SCS.  This was compared to only three who considered 
themselves only slightly better.  Even for the other time intervals, the numbers for 
the “other” group are not large (i.e. 7, 8 and 9).  Using a five point Likert change 
scale may have contributed to this imbalance, as the participants were not able to 
qualify how much they felt they had improved beyond the two choices; “slightly 
better” or “much better”.  End-aversion bias, also known as central tendency bias, 
may also render a five level scale equivalent to a three-level scale, and some 
authors argue that if a five-level scale is required seven options should be provided 
(Streiner et al. 2014).  In a review of global rating scales, Kamper et al (2007) noted 
that scales with seven to eleven levels, balanced around zero, appeared to offer 
good patient acceptability with the ability to discriminate improvement or 
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deterioration adequately (Kamper 2009).  Given that an improvement was to be 
expected in the time frame of this study, the five level scale used may have had 
insufficient levels describing “better” and will have compromised the ROC analysis 
and calculation of the MCID values, especially in TI2.  Further discussion of this, and 
the impact of the ACQ validity testing results will be considered below and when the 
outcome measures are discussed individually. 
 
6.5.5 Validity of the change questionnaire  
Overall, the validity of the change questionnaire (ACQ) in this context was not 
confirmed.  The accuracy of all the outcome measures in correctly identifying 
individuals who had and who had not undergone an important change based on the 
responses of the ACQ used in this study was also not good.  Both the question 
asked and number of options available in the scale, may have been responsible for 
this. Improving the ACQ with more specific questioning about the different aspects 
of the constructs being measured in each individual outcome measure, and 
providing a higher number of response options may have improved its accuracy.  
However, calculation of MCID values remains difficult even when a gold standard 
anchor is used.  In a study with stroke survivors, MCID values were calculated for 
gait speed in stroke survivors during the first 60 days post-stroke (Tilson et al. 
2010).  A well-established global criterion measure was used, the modified Rankin 
Scale (mRS).  The mRS assesses changes across five levels and is considered a 
gold standard anchor to identify minimal clinically important changes in disability.  A 
score is assigned by an assessor after a standardised three to four hour 
assessment. However, the authors still found the precision of the mRS was less 
than 80%, and they concluded that the anchor did not correlate directly with gait 
speed.   The topic of how the accuracy of specific change questionnaires, for 
example the mRS versus global change questionnaires such as the GRC, impacts 
on ROC analysis and the calculation of MCID values, will be explored more fully in 
chapter 7 (final discussion). 
 
A lack of confirmation of the validity of the ACQ challenges its use in the calculation 
of MCID values for each of the outcome measures and associated estimates of 
responsiveness.  Evidence for the responsiveness of the outcome measures is 
available, from the results derived through the distribution-based methods, that 
some of the outcome measures are sensitive to changes in the pwLLA’s condition in 
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this early rehabilitation period.  However, without support from the anchor-based 
derived results the clinical importance of any changes cannot be confirmed.   
 
6.5.6 Specific outcome measures 
For all outcome measures, three sets of results will be discussed.  Firstly, 
responsiveness parameters derived from distribution-based methods, i.e. ANOVA 
and effect sizes. Secondly, results from an anchor based-method using the ACQ to 
derive MCID values will be presented.  The accuracy of using the ACQ to derive 
these values for each outcome measure will also be considered.  Finally the validity 
of using the ACQ to act as an appropriate anchor in this context will be discussed.   
All results will be discussed with reference to the relevant literature,  
 
6.5.6.1 Patient Reported Outcome Measures (PROMs) measuring functional 
mobility  
6.5.6.1.1 SIGAM  
The SIGAM grades are assigned by following an algorithm after a series of 
questions on functional mobility have been answered (Ryall et al 2003a).  The 
purpose of a SIGAM grade is therefore to describe functional levels of mobility and 
the ACQ question appears to be well suited to the construct being measured by the 
SIGAM.  
 
Main ANOVA and post-hoc analysis showed statistically significant group mean 
differences and large effect sizes across the whole study period (TI3) and the 
immediate limb-fitting period (TI1), demonstrating that the SIGAM was sensitive to 
changes within these time frames. However, the group mean differences between 
SV2 and SV3 (TI2) were not seen to be significant and the effect size was only small 
in this period after hospital discharge. 
 
Despite the moderate accuracy seen for the ACQ from the ROC analysis for TI2, the 
MCID values obtained for all the outcome measures during this time interval may 
have to be discounted because of the low numbers in the “negative actual state” 
group (n=3).   There was low accuracy for the ACQ in both the immediate limb-fitting 
period (TI1) and across the whole study period (TI3), but results obtained from the 
distribution-based methods did provide better support for the MCID values obtained 
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for the SIGAM.  They were 2.5 (which translates into 3 grades) and 4.5 (5), for both 
TI1 and TI3 respectively.   
 
The results from the hypothesis testing for this time period were mixed for both T1 
and TI3.  However, due to the limitations of the change questionnaire (described 
above) and the small sample numbers in each group, it is not possible to suggest 
that the hypotheses may be proven or confirmed, and so the results are discussed 
in terms of whether a hypothesis is likely to be proven or not.   The indications were 
that hypothesis 1 (participants with higher ACQ scores will show a greater 
improvement) was unlikely to be confirmed, as there was very low, or no correlation 
between the ACQ scores and differences in all time intervals.  The second 
hypothesis (the size of the change would be larger in those who perceived that their 
physical function was much better (ACQ=5) compared to those who did not) did 
show positive results for both TI1 and TI3..  Finally, hypothesis 3 (outcome 
measures would correctly identify individuals who had and who had not undergone 
an important change 80% of the time) was tested using the ROC curve.  In TI1 and 
TI3 there was only slightly better than chance results with just over 50% for both   
Although there was moderate accuracy (just over 70%) for TI2, though as discussed 
earlier this result is likely to be compromised due to the very small numbers in the 
“negative actual state” or “other” group. 
 
The validation results for the ACQ in TI3, across the whole study period 
demonstrated a poor performance in relation to the SIGAM, with only two out of the 
five criteria met: a positive correlation between the ACQ and SV1 (baseline) and a 
difference of >0.2 in correlations between SV1 and SV3.  This means that the MCID 
value of 5 grades (total 11), calculated across the whole study period should be 
treated with caution.  Similar validation results in TI1 (two out of the five validity 
criteria met) mean that the MCID value of 3, for the very early in-patient 
rehabilitation period, is also presented with some caution.  The MDC that was 
presented for the SIGAM in chapter 5 was 1 grade, so both MCID values presented 
here are outside the measurement error value for this outcome measure.  It should 
be noted that, although they were all pwLLAs, the samples on which the MDC and 
MCID values were calculated were not the same.  This means that the results 
should be treated with caution and considered in this context, but it is still likely that 
both the MCID values are realistic in this rehabilitation setting.   
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It should be noted that the original six grades presented in Ryall et al (2003a) 
describe a progression of increasing independence and functional locomotor ability 
from limb abandoned/cosmetic only (A), through to normal or near normal walking 
(F).  However, within the scoring system there are 11 levels of grading that take into 
account the increasing levels of walking support from for grades C and D.   These 
11 levels were assigned in this study and therefore the MCID values of 3 or 5 
grades should be considered in relation to the increased number of levels.  Using 
the 11 grade scale, a SIGAM score would change by one grade each time a walking 
aid was changed.  With a reduction in the dependence on the type of walking aids 
noted between every visit in this study, a change of 3 to 5 grades may be 
considered reasonable in the context of this early rehabilitation period.  Though it 
should also be noted, that moving from indoor to outdoor walking is equivalent to a 
change of 4 grades on this 11 grade scale.  Therefore, it is would be advisable to 
carry out a Rasch analysis on the 11 grade scale to confirm the true interval nature 
of the scale, before these MCID levels are recommended. 
 
A very large effect size of 10.6 has been presented for the SIGAM in a previous 
study also undertaken during rehabilitation following delivery of a first prosthesis 
(Ryall et al 2003a).  Twenty five patients completed the SIGAM on 38 occasions 
throughout their rehabilitation period, however the time between assessments varied 
between 3 weeks and six months post-delivery of their prosthesis.  The authors 
concluded that the effect size demonstrated that the SIGAM was sensitive to 
changes over time, though it was not clear how the effect size was calculated (Ryall 
et al 2003a).  A timed walk was undertaken at the same time as the assessment 
visits and the results were used to demonstrate the construct validity of the SIGAM 
in that study. However, correlations of changes in the results of the timed walks with 
those of the SIGAM grades to confirm improvement were not presented.  Nor were 
any other parameters of responsiveness and it was therefore, not possible to 
establish whether the SIGAM was a responsive outcome measure from that study.  
This evidence was rated unknown in the systematic review reported in Chapter 4.     
  
6.5.6.1.2 LCI-5  
A large effect size was demonstrated and significant differences were seen between 
the group means for the LCI-5 scores across the whole period of the study, 
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providing evidence for the responsiveness of the LIC-5 from distribution-based 
parameters.  There was a similar pattern, but with medium effect sizes in both TI1 
and TI2.   
 
The LCI-5 demonstrated moderate accuracy when used with the ACQ across all 
time intervals.  The MCID values obtained for both TI1 and TI2, 8.5 and -1.5 
respectively (translating into 9 points for TI and 2 points for T2), are supported by 
the distribution-based results.  These changes appear to be reasonable and might 
be expected as the pwLLA’s mobility improves and the dependence on stand-by 
support of another person and on their walking aids decreases.  The support 
required from other people by the participant was not assessed, but a reduction in 
the dependence on walking aids was noted between every visit.  It might therefore 
be reasonable to assume that there could be an average swing of 14 points on the 
LCI-5 scale if the amputee requires assistance with all the basic tasks at his/her first 
visit and considers himself/herself able to perform the same tasks independently 
with walking aids at the final visit.  Potential for greater change scores in patients 
who have a greater level of disability and consequently lower baseline scores has 
been reported previously (Stratford et al. 1998).  However, a change of 21 points on 
the LCI-5 (MCID = 21 at TI3), may be unlikely, in this early rehabilitation period.    
An MDC of 4 points was presented in chapter 5 for the LCI-5, and as all the MCID 
values calculated in this study for the LCI-5 are well outside that, they could all be 
calculated in this context. 
 
The ACQ, again, demonstrated only low accuracy in its ability to detect those 
participants who had improved on the LCI-5.  It was expected that the anchor 
question was most related to the constructs that the LCI-5, and the SIGAM, are 
measuring and therefore does question the appropriateness of the wording of 
change questionnaires.  However, it is possible that a change in LCI-5 scores may 
occur, before the pwLLA perceives an improvement in his/her physical abilities. i.e. 
while the amputee recognises that they do not need the help of others and his/her 
dependence on walking aids lessens consequently lowering the LCI-5 score, they 
do not consider this to be a large improvement in physical function.  
 
The greater effect sizes and group mean differences in the much improved group 
(ACQ 5) compared to the other group (ACQ 1-4) for all time intervals is suggestive 
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of a positive outcome for hypothesis 2.  , hypothesis 1 was not confirmed and 
hypothesis 3 demonstrated only slightly better than chance results.  The validation 
results for the ACQ in all time intervals demonstrated a very poor performance in 
relation to the LCI-5.  Only one out of the five criteria were met in TI1 and TI2 and 
only two out of five in across the whole study period in TI3.  This, in addition to the 
poor accuracy of the ACQ in detecting important change, means that all MCID 
values should be treated with caution.  
 
Franchignoni et al (2004) presented an effect size of 1.4 in 2004 for a sample of 50 
pwLLAs (median age 51) studied during prosthetic training.  The period over which 
the changes were measured averaged 36 days, which was slightly shorter than the 
post-hospital phase in this study. However, this effect size of 1.4 was comparable to 
those recorded for the whole period in this study (i.e.1.15). No other parameters of 
responsiveness were presented and no further comment was made about the 
responsiveness properties of the LCI-5 by the authors.  The evidence for this LCI-5 
study Franchignoni et al (2004) was rated unknown in the systematic review 
reported in Chapter 4.   
 
6.5.6.1.3 SCS  
With no significant differences and small effect sizes recorded across all the time 
periods, there is no evidence that the SCS is a responsive outcome measure when 
using distribution-based methods.    
 
There is also little support for the robustness of any of the MCID values as none of 
the experimental hypotheses were likely to be upheld.  In addition, the validity of the 
ACQ was poorly demonstrated in all time intervals.   There is also no evidence that 
the SCS is a responsive outcome measure in any of the time periods when using a 
patient-anchor to detect changes in the physical ability of pwLLAs to undertake 
everyday tasks.  This may be because of the poor relationship with the question in 
the change questionnaire.  It may also be argued that socket comfort, or discomfort, 
does not affect physical function as much as was thought,  or that the SCS is not 
sensitive enough to measure the subtle changes in physical ability of the pwLLA that 
are affected by changes in socket comfort.   It is relatively easy to see when socket 
discomfort reaches a level that stops an amputee from walking altogether, but when 
the discomfort impacts only on the quality, and not the quantity, of their walking then 
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more subtle measures may be required to pick up these changes.  However, given 
rapid changes can occur in the socket / residuum interface on an hourly, let alone 
daily or weekly basis, estimating MCID values may be too challenging for this 
outcome measure.  Hanspal et al (2003) did demonstrate statistically significant 
differences using Wilcoxon analysis in SCS after socket adjustments, though no 
other parameters of responsiveness have been presented since that date by any 
authors.   
6.5.6.1.4 EQ-5D-5L: Index score and VAS 
There is limited evidence that the EQ-5D-5l is responsive to perceived changes  in 
physical function in pwLLAs as shown by low effect sizes and lack of statistical 
significance when both the index scores and VAS are scrutinised.  No significant 
differences and small effect sizes were presented for the EQ-5D-VAS score in all of 
the time periods. It is a similar pattern for the index scores except a medium effect 
size was noted in TI1.  Although the majority of effect sizes for both the index scores 
and VAS are small, there appears to be an anecdotal trend (no significance 
calculated) indicating deterioration in the pwLLA’s perceived global health status 
following discharge from hospital. 
 
Despite the medium effect size seen in TI1 for the EQ-5D-index score, there is little 
support for the precision of an MCID value of 0.108 because of the low accuracy 
demonstrated with an AUC of 0.552.  In addition, the validity testing was weak in all 
time intervals and therefore, there is also poor evidence that the EQ-5D-index score 
is responsive in any of the time periods when using a patient-anchor to detect 
changes in the physical ability of pwLLAs to undertake everyday tasks.  
 
None of the hypotheses were likely to be confirmed for either the EQ-5D-index or 
VAS scores, though there was moderate accuracy for the ACQ was seen in TI2 for 
VAS scores.  Despite the moderate accuracy there is little support for any of the 
MCID values obtained for the VAS, with the validity also testing poorly in all time 
intervals.  
 
 The poor relationship between the ACQ question and the construct measured by 
the EQ-5D-5L (global health) may be the cause of these disappointing results. In a 
similar way to socket comfort, it could be argued that global health, does not affect 
physical function in pwLLAs, as much as was thought, or that the level of physical 
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function does not affect the global health of pwLLAs as much as we thought.  It may 
also be that any changes in the global health of the amputee is masked in the early 
rehabilitation period.  It is possible that the EQ-5D-5L is not sensitive enough to 
detect subtle changes in physical ability of the pwLLA, that are affected by changes 
in the global health outcomes it measures, though the index score did register an 
effect size of 0.62 in TI1.   In the review by Horgan and MacLachlan (2004), it is 
argued that the period following discharge from a regular rehabilitation centre has 
not been well documented with regard to psychosocial adjustment.  The amputee 
has not yet entered the “long term adaptation phase” where they must adapt to the 
reality of their new life.  The relative short time-frame of this study may therefore not 
capture this realisation. 
 
There are no previous responsiveness results for the EQ-5D reported for a pwLLA 
population, but a review of minimal important difference (MID) values, similar to 
MCID, have been reported with other populations.  In eight studies that looked at the 
use of EQ-5D (3-level) in patient groups with a range of health conditions, a mean 
MID value of 0.074 was reported (range -0.011 to 0.140) (Walters and Brazier 
2005).  The MID value in each study was calculated by taking the mean change on 
the EQ-5D score of those patients who were considered as having experienced a 
change, as measured by Question 2 in the SF-36 (5 level rating scale of change).   
The authors noted the difficulty of establishing responsiveness parameters for utility 
questionnaires, such as EQ-5D, because of their complex nature “reflecting both 
preferences as well as status on health dimension”.  They felt that more research 
was required to fully understand the psychometric properties of these complex 
measures in other patient groups and populations.  It was also interesting to note, 
that Walter and Brazier (2005) felt that unlike the EQ-5D, other (types of) outcome 
measures have been studied “extensively” with regard to distribution and anchor-
based methods of establishing responsiveness.  However, this “extensive” work has 
not been seen in outcome measures used with pwLLAs. 
 
6.5.6.2 Observed measures of mobility, balance and endurance 
6.5.6.2.1 TUG mobility / balance 
Statistically significant differences were seen between all the study visits and 
associated medium (TI1 and TI2) and large (TI3) effect sizes were also recorded; 
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thus, demonstrating the ability of the TUG to detect changes in the physical ability of 
pwLLAs during the early rehabilitation period. 
 
Despite these distribution-based results in TI1 and TI2 the MCID values calculated 
for these time periods are not well supported by the results from the ROC curve 
analysis.  In TI1, the MCID (0.3s) was less than the measurement error value of 
1.8s, for the TUG presented in chapter 5.  This together with the accuracy, that was 
no more than chance would mean that the MCID value should be disregarded.  As 
previously stated for the SIGAM, despite moderate accuracy seen for the ACQ from 
the ROC analysis for the TUG in TI2, the MCID values obtained may have to be 
discounted because of the low numbers in the “negative actual state” group (n=3).   
The MCID of 5.5s for TI3 is presented with some caution because of the very low 
accuracy (on the cusp of a chance result) seen from the ROC analysis. However, it 
is greater than the measurement error value of 1.8s and thus detectable.  It is also a 
reasonable amount of improvement that you may expect to see in the TUG during 
the early rehabilitation period, considering the 11 week period covering TI3  (mean 
84 days).   
 
There was little relationship demonstrated between the ACQ and the change scores 
in any of the time intervals.  Moderate accuracy for the ACQ was found for TI2, but it 
did not reach 80%.  Therefore the results suggest that there was little support for the 
any of the hypotheses.   Overall this means there is little support for any of the MCID 
values that were calculated using the ROC analysis.  In addition, the ACQ validity 
testing demonstrated only two out of the five criteria, at best, in any of the time 
intervals.    
 
There are several possibilities for the lack of accuracy and validity results: Firstly, 
the ACQ question may be too general to relate to the specific constructs of balance 
and mobility that the TUG is measuring.  While a large number of pwLLAs did 
perceive an improvement in how they were performing everyday tasks, it is possible 
they did not relate this to how they were performing in relation to balance and 
mobility as assessed in a timed test. As discussed previously, formulating a specific 
question for each outcome measure may have allowed the changes perceived, to be 
related more closely to the specific constructs measured by the TUG.  For example 
the question could have been “how is your ability to get out of a chair, walk a short 
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distance turn around and sit down again, today, compared to….”  However, it could 
be argued, that it is not relevant to focus on each single task, when there are so 
many activities of daily living (ADL) that an individual amputee will undertake.  
Secondly, as discussed above it is also possible the number of options given on the 
ACQ was too small. Finally; there is the possibility that the answer to the anchoring 
question was influenced by pwLLA’s current state or perception on his/her current 
state thus affecting their recall (Ross 1989). However, previous times were not 
shared with the participant or the assessor at the time of the current visit and the 
ACQ was always acquired first at the study visit to avoid any overlay of performance 
bias.   
 
There are no published results for the responsiveness of the TUG in pwLLAs but  
Rushton et al (2014) did report an MCID value for the L-test for pwLLAs in a pilot 
study (n=33) that had been completed in 2014.  The L-test is closely related to the 
TUG, with similar start and finish points, i.e. sitting in a chair, but the patient is asked 
to stand up, walk to a cone 3m away, turn left (or right) to a second cone, and then 
retrace his/her steps back to the chair.  Similar to the TUG, patients are timed doing 
these manoeuvres. Participants in the Rushton study completed the L-test at 
baseline and then after variable lengths of rehabilitation (1.5 to 11.5 months and not 
detailed).  A global rating change (GRC) scale was collected at the follow-up visit, 
which rated the participant’s perception of a change in their condition using a 7 point 
scale.  Participants were asked about their “…ability to get up and walk with your 
prosthesis …….” if it had improved they were asked to rate the improvement using a 
7-point Likert scale, from 0 = almost the same, to 6 = a very great deal better. If they 
had deteriorated there was a similar 7-point scale using a “worse” perspective.  
Thus they used a 13-point scale. Two a prori hypotheses were postulated in a 
similar way to those in this current study:  Hypothesis 1 - individuals who rated 
themselves as having greater GRC scores would have greater changes in L-test 
scores and; Hypothesis 2 - the L-test would correctly identify pwLLAs who have and 
have not undergone important changes in  >80% of cases.  Hypothesis 1 was 
confirmed, but hypothesis 2 was not supported.  The L-test did identify patients 
having a perceived an important change, (i.e. those who score ≥ 5 on the positive or 
improved side of the GRC), but the GRC scale did not score highly on accuracy.  
The authors speculated that this was possibly due to recall bias related to the length 
of the rehabilitation intervention as some participants were not retested until nearly a 
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year after their baseline visit.  As discussed previously, the current state may 
influence recall of a previous state (Ross 1989).  Validity of the GRC scale was also 
tested by the authors, Rushton et al (2014), and it was found not to be a valid tool to 
assess important change in “the ability of an individual with a pwLLA to get up and 
walk with a prosthesis”.  Despite this, the authors went on to quote an MCID value of 
4.5s that was calculated using the GRC scores in a ROC analysis (AUC 0.67).  They 
did say that their results must be interpreted with caution in light of these low 
accuracy results.   Therefore, despite attempting to use a specifically framed 
question for the L-test in their anchor questionnaire and using a 13 point scale, 
Rushton et al (2014), also found the predictive value was also less than 80%, 
though did comment that it was “better than chance alone”.   
 
The merits, or otherwise,  of using a 13 point scale, such as the one used in the 
Rushton et al (2014) study, versus the 5 point scale used in this current study, will 
be explored further in the final discussion chapter.  
 
6.5.6.2.2 2MWT mobility / endurance 
The results obtained for the 2MWT presented a similar scenario to the TUG with 
regard to the distribution-based results. Statistically significant differences between 
group means and medium (TI1 and TI2) and large (TI3) effect sizes were recorded 
across all the study time intervals, thus demonstrating the ability of the 2MWT to 
detect changes in the performance capabilities of pwLLAs.  However, despite these 
significant differences, and medium and large effect sizes recorded, the MCID 
values calculated for the 2MWT are not well supported by the results from the ROC 
curve analysis in any of the time periods.  The accuracy of the ACQ to detect 
changes was no more than chance, according to the ROC analysis, in either time 
interval.  Therefore despite the MCID values of 57.9m (TI1) and 55.4m (TI3) being 
well outside the MDC value (18.9m) presented in chapter 5, the results must be 
viewed with caution in view of these accuracy results. 
 
The greater significant differences in the “improved” group compared to the “not-
improved” group for both TI2 and TI3 were the only results that may indicate that 
one of the hypotheses (hypothesis 2) might be confirmed.  The accuracy of the ACQ 
to detect these changes did not reach 80%, and with only low accuracy recorded for 
TI2, and no better than chance for both TI1 and TI3, it was unlikely that hypothesis 3 
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would be proved. Taking into account the limitations described earlier, it appears 
that there is little evidence that the ACQ is a valid tool as a patient-anchor to detect 
changes in the 2MWT in any of the time periods.  This is because of the validity 
testing demonstrating only one out of the five criteria, at best, in any of the time 
intervals, and none of the hypotheses likely to be accepted.  
 
It may be argued, in the same way as for the TUG, that by changing the question on 
the ACQ, this time to “how do you feel your ability to walk continuously is today, 
compared to…….”, a more accurate picture of the responsiveness of the 2MWT in 
this population, would have been presented.  This would be a recommendation for 
any future study that aims to assess the responsiveness of the 2MWT in any 
population.  
 
Brooks et al (2001) demonstrated significant differences in distances walked by 
pwLLAs before and after rehabilitation, using repeated measures ANOVA.  No other 
responsiveness parameters have been presented for a  population of pwLLA.  
However, MCID values have been presented for the six minute walk test (6MWT) in 
COPD patients (Polkey et al. 2013).  Data from lung function test producing FEV1 (1 
minute forced expiratory volume) values and 6MWT times were collected (amongst 
other clinical data) from 1,847 COPD patients in a 3-year, multicentre, longitudinal, 
prospective study.  At 3 and 6 months, and every 6 months thereafter, health status 
was measured using the COPD-specific St. George’s Respiratory Questionnaire 
(SGRQ-C). The authors attempted to use this health status questionnaire in an 
anchor-based method to calculate MCID values for the 6MWT but the correlations 
were so poor between the SGRQ-C and change scores for the 6MWT that the 
method was abandoned.  Instead, the MCID values for 6MWT were calculated 
retrospectively using mortality as an index and FEV1 values as the indicator of 
deteriorating cut-off points, i.e. 6MWT distances can then be related to respiratory 
function to give an indication of any deterioration, rather than use perceived health 
status (Polkey et al. 2013). 
 
6.5.7 Grouped outcome measures: PROMs related to observed 
The results for the individual outcome measures have been considered separately.  
An analysis of the correlations between changes in observed outcome measures 
and those in PROMs, was not undertaken. Any advantages of collecting both 
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PROMs and observed outcome measures will be explored further in the final 
discussion chapter (Chapter 7).   
 
6.6 Limitations 
 
The study was of a longitudinal cohort design, and patients were recruited on a 
sequential basis as they fitted the criteria and consented to be included.  To ensure 
recruitment of the sample size required by the calculations in a reasonable 
timescale, a pragmatic decision was made to include both TT and TF levels of 
amputations.  It was recognised that recruitment of both TF and TT amputees was a 
potential source of variation.  However, as participants are asked to consider their 
own progress in the anchor questionnaire and are therefore their own control, within-
subject analyses were undertaken and not between-subjects.  It would have been 
advantageous to consider the results by age, aetiology or amputation level, but, the 
sample size was too small to do an in-depth analysis on sub-groups. Additionally, 
the sample size in this study would also render the evidence collected in this study 
to be rated as “unknown” according to the COSMIN checklist. 
 
It could also be argued that the sample size was also too small to be considered for 
ROC analysis as Hanczar et al (2010) recommend that ROC curves must be used 
with extreme caution unless one has a very large sample (>1000) (Hanczar et al. 
2010).  Though even with a large sample size, the differences between true and 
estimated error can be considerable and they recommend that unless the lower 95% 
confidence for the AUC is greater than 0.5 (i.e. greater than chance) no conclusions 
can be reached. 
 
As discussed above, only one “general physical function” question was asked in the 
ACQ, it may have been more appropriate if specific questions relating to different 
constructs of each outcome measure had  been included. 
 
The ACQ used a five-level response questionnaire which, it can be argued, may not 
detect the small incremental changes that a larger number of levels would. Larger 
numbers in each group i.e. ”better” “the same” or “worse”, would ensure more robust 
ROC curve analysis with less tied results as was seen in this study.  However, when 
calculating MCID values using instruments with these higher numbers of levels, 
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there is a risk of arbitrary decisions being made when deciding which groups to 
combine for the analysis (Copay et al. 2007).  One way round this could be to 
present multiple MCID values for the range of responses (Stratford et al. 1998), 
however larger sample sizes would be required.   
 
There are many other factors that will influence the change scores throughout the 
course of this study, including the type and duration of gait training and therapy that 
each participant receives.  Details of these were not recorded as it was the impact of 
“total package” of rehabilitation as required by each individual that was of interest, 
and not the impact of specific aspects of the rehabilitation process.  The reduction of 
the participants’ dependence on walking aids was however, noted throughout the 
study.  It is recognised that this will have had an influence, not only on the times and 
distances recorded for the TUG and 2MWT, but also on the SIGAM and LCI-5 
scores.  However, it is not known by how much.  The use (or not) of walking aids 
was not accounted for in the data analysis as a confounding factor because of the 
superficial nature of the data collection.  Consideration of such influences in any 
future study on the use of outcome measures, would be of value in interpreting the 
context of the recovery of the pwLLA.  Increasing independence has been shown to 
help improve the participant’s confidence and self-efficacy (Schaffalitzky et al. 
2011), but again it is not known by how much this will have influenced the times, 
distances and scores recorded in this study.   
 
 
6.7 Conclusions 
 
All outcome measures, except the SCS and EQ-5D-5L, were responsive to changes 
across the whole study period, as evidenced from the ANOVA and effect size 
results. 
 
The LCI-5 and 2MWT recorded larger effect sizes in the in-patient period when 
compared to the post-hospital discharge period.  The effect sizes were similar in 
both the in-patient and post-hospital discharge periods for the TUG.  
 
Validity testing for the ACQ was confirmed (by achieving more than 50% of the 
criteria) for only one outcome measure, the SIGAM in TI1.  
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Limitations of the validity of the change questionnaire used and the small sample 
numbers in each group, deemed it impossible to positively claim that the hypotheses 
were proven or confirmed.  However, the following may be likely outcomes, as 
suggested by the results obtained. 
 
Hypothesis 1. i.e. participants who rated themselves as having undergone a greater 
improvement in their physical function (i.e. higher ACQ scores) did not show a 
greater improvement in the six outcome measures over the same time interval and 
was therefore likely to be disproved for all the outcome measures..  
 
Hypothesis 2. i.e. the magnitude of the change in the six outcome measures would 
be larger in those who perceived that their physical function was much better (ACQ= 
5) compared to who did not (ACQ 1-4), was likely to be upheld for SIGAM, LCI-5 
and TUG in TI1, for LCI-5 and SCS in TI2 and for SIGAM, LCI-5, EQ-5D-index and 
EQ-5D-VAS in TI3. 
 
Hypothesis 3 was unlikely to be confirmed for any of the outcome measures, i.e.  
none of the outcome measures correctly identified individuals who had and who had 
not undergone an important change 80% of the time.  However, it was noted that 
SIGAM, TUG and EQ-5D-VAS achieved over 70% accuracy in TI2. 
 
MCID values were established for all outcome measures during all time intervals. 
However, results of the hypothesis testing did not support the accuracy of any of the 
outcome measures, when used with the ACQ as a measure of patient perception of 
change.  The lack of confirmation of the validity for the ACQ also weakened the 
support for the MCID values.  Therefore, the values that have been presented 
should be used with caution and may have limited clinical use.  
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7 Chapter 7 Final Discussion 
7.1 Purpose of chapter 
The purpose of this final chapter is to consider and synthesise the findings from the 
empirical studies, i.e. study III, the repeatability study (chapter 5) and study IV, the 
longitudinal cohort study (chapter 6).  This final discussion will take into account the 
context of: the current usage of outcome measures in prosthetic rehabilitation in the 
UK, obtained from the survey (chapter 3); and the current supporting evidence for 
their psychometric properties as established by the systematic review of the 
literature (chapter 4). Thus the original parts of the thesis will be summarised and 
presented, in order to develop the current knowledge and understanding of outcome 
measures of physical function as they are used with pwLLAs (adults) during 
prosthetic rehabilitation.  Recommendations for clinicians and researchers regarding 
the application of the most commonly used outcome measures to both, the 
individual and groups will also be presented, with the limitations of the studies taken 
into account.  
 
7.2 Introduction 
The research topic of this PhD was prompted by an in interest in measuring the 
impact of prosthetic componentry on the lives of pwLLAs.  With ever increasing 
healthcare costs it is vital that clinicians, and also researchers, involved in the field 
of prosthetic rehabilitation, understand how to measure the impact of prosthetic 
componentry on their patients.  Is one knee “better” than another?  What does 
“better” mean?  If, for example, this means, “better mobility” then how is mobility 
measured?    
 
To evaluate the effectiveness of any intervention, the outcome measure being used 
to assess the impact must possess robust psychometric properties.  Knowledge of 
an outcome measures’ psychometric properties is vital when assessing differences 
between one prosthetic component and another.   The cost difference between two 
prosthetic knees can be thousands of pounds.  However, information from 
appropriate outcome measures can objectively support the clinical decision of which 
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component to choose by detecting significant differences in, for example, the 
functional abilities of a pwLLA.   
 
The background chapter (chapter 2) outlined the need for improved understanding 
of which outcome measures are regularly being used with pwLLAs.   The survey 
(study I) conducted with clinical staff provided information in this area and helped 
chart the current practice in the UK.  The current supporting evidence for outcome 
measures developed for use with pwLLAs, was outlined in the systematic review 
(study II).  Thus, the central tenets of the repeatability study  (study III) and the 
longitudinal cohort study (study IV) were formed because of the lack of specific 
evidence for measurement error and responsiveness for the outcome measures 
most commonly used by clinicians working in prosthetic rehabilitation.   
 
An overview of the thesis, visually presenting the relationship between the research 
questions and how the gap in the current evidence was addressed, is presented in 
Figure 7.1. 
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Figure 7-1  Final  thesis overview
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7.3 Outcome measurement in prosthetic clinical practice 
7.3.1 Current practice 
The findings from the survey showed that a wide variety of outcome measures are 
being used during prosthetic rehabilitation in the UK.  Survey questionnaires were 
distributed via professional networks and sub-groups to AHPs working in prosthetic 
rehabilitation.  They were distributed by e-mail to encourage onward distribution to 
multi-disciplinary colleagues, while the patient survey questionnaire was distributed 
to suitable pwLLAs by their prosthetist in the Edinburgh Prosthetic Centre.  Forty-
five AHPs and 12 pwLLAs responded. Thirty two of the 45 AHP respondents (71%) 
indicated they used outcome measures regularly, i.e. at least once a week.  
Physiotherapists that indicated they used a total of 14 different outcome measures 
from the list.  Prosthetists indicated they used 8 different measures though they 
used two (the SIGAM and the SCS) most regularly.  The occupational therapists 
used three, namely; the Barthel Index, COPM and FIM. This variety still indicates 
that there is a lack of consensus on which outcome measures to use. The five 
outcome measures used more often than any others were: the SIGAM, TUG, Timed 
Walk Tests (TWT), LCI / LCI-5 and SCS. This group of outcome measures all 
measure constructs in the physical domain, which may not be surprising given that 
the majority of respondents were physiotherapists.  The breakdown of respondents, 
by professional group, was:  23 physiotherapists, 17 prosthetists and 5 occupational 
therapists.  
 
Despite this bias towards outcome measures of physical function, “energy, drive and 
enthusiasm” was considered one of the top three most important factors to have a 
positive influence on prosthetic outcome.  The other two factors also recognised by 
both the AHP and pwLLA respondents were “socket fit and comfort” and “balance 
and coordination”.  While these results are from a very small sample of pwLLAs, and 
should be considered with caution, they do concur with the some of the findings by 
Schaffalitzky et al (2012) from their focus group work. They identified psychosocial 
factors, such as support from the family and MDT, as well as returning to work in a 
supportive environment were among those factors that are recognised as being 
facilitators to a positive outcome for the patient.   
 
These psychosocial factors are not explicitly assessed in any of the five most 
commonly used outcome measures in current practice, though they may be 
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recorded in other ways in the patient’s medical notes.  It would be beneficial if 
outcome measures measuring different constructs were collected by a variety of 
health professionals in the MDT, as this could lead to a more comprehensive 
understanding of the progress (or lack of progress) of the patient during 
rehabilitation.  However, consensus on which outcome measures to collect must be 
gained by the MDT.  This approach, to bring together a comprehensive view of the 
patient’s condition, performance and capabilities in the context of different clinical 
settings, is advocated by the COMET Initiative (Williamson et al. 2011).  The 
initiative aims to bring together people interested in the development and application 
of agreed standardised sets of outcomes, known as “core outcome sets” (COS). The 
premise for this approach is that the COS should represent the minimum data that 
should be measured and reported in clinical trials of a specific condition (Macefield 
et al. 2014, Williamson et al. 2012).  If the same data is collected from clinical trials 
conducted at single centres then data may be combined in meta-analyses more 
easily. Combining data in this way is one solution to small sample sizes and the 
difficulty in recruiting large numbers into rehabilitation studies that has already been 
noted.  
 
Although the COS has an emphasis on clinical trials, they are also suitable for use in 
clinical audit and research, other than randomised controlled trials. Collecting COS 
data will make it easier for the results of trials to be compared, contrasted and 
combined as appropriate; but it is anticipated, by the COMET authors, that 
researchers could continue to explore other outcomes and not be confined to the 
COS alone.   An example of a clinical area where a lot of work has been done 
developing this approach is Rheumatology with their OMERACT (Outcome 
Measures in Rheumatology Clinical Trials) initiative (Boers et al. 2014, Tugwell et al. 
2007, Bautista-Molano et al. 2014), though many other clinical teams are working on 
developing and using COSs, (http://www.comet-initiative.org/studies/search/)  
 
The survey results in Chapter 3 showed that while some outcome measures were 
favoured, some respondents are discontinuing the use of these same outcome 
measures.  For example, the reason given for discontinuing two of the most 
commonly used outcome measures, the LCI-5 and SIGAM, were: “lack of time” and 
“no relevance to clinical practice”.  Clinicians are also still attempting to use their 
own “in-house” outcome measures.  Anecdotally, from comments received in the 
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survey and also talking to colleagues working in prosthetic rehabilitation, it would 
appear clinicians prefer to use the outcome measure that they are most familiar 
with.  This is usually the one that is easiest to implement (no costly equipment 
and/or doesn’t take too long) and is the most acceptable to their patients, again 
usually the one that doesn’t take too much time.  Thus familiarity and clinical utility 
appear to be the most important factors deciding which outcome measures are 
used.  Evidence from the literature does support this, with a lack of confidence in 
administering and analysing data from outcome measures, shown to be a barrier to 
their implementation (Jette et al. 2009, Gaunaurd et al. 2014).   
 
The ease with which an outcome measure can be implemented must not be the only 
criteria by which a clinician makes a judgement on whether to use an outcome 
measure or not.  Many guidelines and advice papers have been published for health 
professionals to assist them in their choice (Hammond 2000, Herbert et al. 2005, 
Corr and Siddons 2005, Cole et al. 2014, Young et al. 2015).  These guidelines 
cover topics such as: establishing the outcome or construct to be assessed; 
understanding the psychometric properties that an outcome measure should have 
and; how to present the results.  With ever increasing healthcare costs there is a 
continued emphasis on evaluating services and treatments to ensure value for 
money.  Choosing the correct outcome measure with which to demonstrate the 
effectiveness of interventions has never been so critical.  Therefore, choosing an 
outcome measure that has demonstrated validity, reliability and responsiveness in 
the population of interest, has to be as important for clinicians as its clinical utility 
because using an inappropriate outcome measure to demonstrate effectiveness will 
waste both their and their patients’ time. 
 
7.3.2 Current supporting evidence 
Clinicians and researchers should be looking for evidence from high quality studies 
to reassure them of the validity, reliability and responsiveness of the outcome 
measure(s) they wish to use.  However, chapter 4 showed that there is a lack of 
high quality studies reporting the psychometric properties of physical function 
outcome measures used with lower limb amputees.  Ratings of the methodological 
quality of many studies were reduced because of weak description within the 
manuscripts and poor choices for statistical analysis, especially with regard to 
responsiveness.  Consequently, there is limited evidence to inform the clinicians’ 
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and researchers’ choices.  The systematic review reported in Chapter 4 concluded 
that while the LCI-5 had the strongest evidence to recommend its use for measuring 
functional mobility, the evidence was strong only for internal consistency (one study 
of excellent and two studies of good methodological quality presenting positive 
evidence) and structural validity (three studies of good quality). The evidence 
remained unknown for measurement error and responsiveness.   
 
There is a lack of corroborating data (i.e. more than one study) for many of the 
outcome measures used in prosthetic rehabilitation, in spite of the many studies that 
have investigated and reported the measurement properties of these outcome 
measures.  The systematic review (reported in Chapter 4) also showed a lack of 
studies reporting on responsiveness, and in particular the MCID values. The number 
of outcome measures that could be recommended to investigate the effectiveness of 
any intervention, based on its psychometric properties in this population was zero.  
There are several reasons for this lack of evidence: low methodology quality of the 
studies; small sample size; poor choice of analysis method and lack of corroborating 
studies to confirm findings.  The limited choice of outcome measures, with robust 
psychometric properties, creates a problem when compiling credible evidence for 
the relative effectiveness of different prosthetic components (Kannenberg et al. 
2014, Sawers and Hafner 2013).  It also reduces the confidence with which 
clinicians and researchers can make an evidence-informed selection of outcome 
measures to assess progress (or lack of) of patients who have undergone a lower 
limb amputation.   
 
Concern about the quality of prosthetics research evidence prompted a recent 
review of the literature (Hafner and Sawers 2016).  The aim of the review was to 
identify if there were any common methodological quality issues that may be 
affecting the level of evidence reported, in this case specific to the evidence being 
provided on MCPKs.  Common issues identified across the studies included: 
variable comparison conditions within studies, lack of blinding, small sample sizes, 
limited evidence of measurement reliability, participant attrition, and limited 
descriptions of participant selection criteria. The authors acknowledge that although 
the methodological quality of studies is improving there still needs to be more 
improvement in how the evidence is gathered and reported.  They also felt that 
educating recipients of the research, i.e. clinicians and researchers, of the 
242 
 
importance of the characteristics that are inherent to prosthetic research was critical 
to improving the quality of the evidence required.  The output of this thesis may help 
with this education.   
 
Several standards are currently available to help with the reporting of research and 
clinical studies, including: Preferred Reporting Items for Systematic Reviews and 
Meta-analyses (PRISMA) (Moher et al. 2016, Moher et al. 2016, Moher et al. 2009), 
Consolidated Standards for Reporting Trials (CONSORT) (Schulz et al. 2010), 
Transparent Reporting of Evaluations with Nonrandomised Designs (TREND) (Des 
Jarlais et al. 2004), and Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) (von Elm et al. 2014).  More details on these and other 
guidelines can be found on the EQUATOR (Enhancing the QUAlity and 
Transparency Of health Research) website (http://www.equator-network.org/).  
While these standards and guidelines appear to have been responsible for 
improving the quality of the research evidence being published (Hopewell et al. 
2010), it was noted that an editorial calling for the mandatory use of reporting 
guidelines that was simultaneously published in all participating publications, did not 
include any prosthetic and orthotics journals (Chan et al. 2014).    
 
The standardised checklists presented above only examine the quality of studies 
that investigate the impact of treatments and interventions not those studies 
exploring the psychometric properties of outcome measures. Within these checklists 
the quality of any outcome measure used is only assessed with a cursory yes/no 
check, on whether the measure(s) used were “reliable” and/or “valid” and/or 
“responsive”.  Therefore, there still remains a question over the integrity of the 
measurement properties of some outcome measures used in intervention studies, 
even if the methodological quality of these studies is high.  The COSMIN checklist, 
as detailed in Chapter 4, is a specific checklist concerned with the quality of studies 
investigating the psychometric properties of outcome measures.  It incorporates a 
multi-level grading system for each measurement property, thus giving detailed 
information on the quality of outcome measures to help support (or not) their use.  A 
specific standardised checklist, such as COSMIN, investigating the psychometric 
properties of outcome measures, should be included in the list of those being 
recommended by journal editors.  This would help to strengthen the quality of, and 
confidence in, the outcome measures being used in clinical practice and research; 
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and consequently strengthen any evidence from interventional studies that use 
them.  
 
It was also seen in the systematic review, reported in chapter 4, that the 
methodological quality of studies was often compromised because of inappropriate 
statistical analysis.   It would therefore be a recommendation from this thesis that in 
addition to guidelines on methodological quality requirements for intervention 
studies, that clear and understandable advice on the use of appropriate statistical 
analyses should also be made widely available. For example, the COSMIN checklist 
could be used as guidance when designing, as well as reporting, studies evaluating 
the psychometric properties of outcome measures in prosthetic rehabilitation.  This 
will further improve the quality of the evidence, as will the type of collaborative work 
recommended by the COMET initiative (Williamson et al. 2012).  Further discussion 
on the appropriateness of particular statistical analyses and their interpretation in 
studies investigating the measurement properties of outcome measures, will be 
undertaken later in this chapter. 
 
7.3.3 Contribution to psychometric evidence 
Further studies investigating the psychometric properties of outcome measures 
used with pwLLAs are recommended (section 4.8 (future work) in chapter 4). These 
studies are required to provide evidence, especially in relation to the reporting of 
measurement error, responsiveness and MCID values, to improve the utility and 
clinical applicability of outcome measures used in prosthetic rehabilitation.  Although 
many studies in the systematic review reported on the reliability of outcome 
measures, the majority only reported indices of consistency but did not comment on 
agreement.  Further, there was limited evidence of the measurement error values 
and responsiveness for outcome measures of physical function used with pwLLAs.  
These measurement properties are especially pertinent when evaluating the 
effectiveness of a treatment programme or prosthetic component.  Therefore, the 
aims of studies III and IV, reported in chapters 5 and 6, were to establish estimates 
of reliability (including measurement error) and responsiveness for outcome 
measures regularly used by AHPs across the UK during prosthetic rehabilitation.  
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7.3.3.1 Consistency, agreement and measurement error 
In study III (the repeatability study reported in chapter 5), estimated values for 
consistency, agreement and measurement error were calculated using a test re-test 
study design with an intervening period of 7 days between tests.  The results were 
obtained from a sample of 12 pwLLAs who were established walkers and who were 
not attending therapy or undergone any prosthetic component changes in the 
previous three months.  The stable condition of the participants and the strict 
repetitive nature of the administration of the tests attempted to reduce any 
systematic errors to a minimum.  The MDC values for the outcome measures in 
study III were derived from the SEM for the study population and the results were 
presented to a confidence level of 95% (MDC95).  The key findings from this study 
are presented in Table 7.1.   
 
Table 7.1    Key findings from study III 
Research Questions 
(study/chapter) 
Key Findings 
Question 5:  
What are the reliability 
and measurement error 
parameters of outcome 
measures most regularly 
used by AHPs for the 
assessment of physical 
function during prosthetic 
rehabilitation?   
 
(Repeatability study  - 
study III / chapter 5) 
 
SIGAM: MDC=1 grade TUG: MDC=1.8s  
Both demonstrated excellent reliability (consistency ICC >0.9) and 
agreement with LoA of 1.2 grades and 3.4s (respectively) and can 
therefore be recommended for use at the individual level.    
 
2MWT: MDC=18.9m LCI-5: MDC=4 points 
Both demonstrated excellent consistency (ICC >0.9) but 
questionably wide LoA, (36.4m and 7.1 points respectively therefore 
cannot be recommended for use at the individual level.    
 
Due to ordinal nature of the SCS, measurement error values were 
unable to be calculated for this measure and Kappa statistic was 
0.314 
 
ICC was reported as 0.728 and 0.704 for the EQ-5D-index and VAS 
respectively, therefore more data is required to be collected on the 
EQ-5D-5L in pwLLAs, before its reliability can be confirmed in this 
population. 
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It is recognised that the MDC represents half the LoA calculated for the same 
population (Norman et al. 2003) and therefore the recommendations for 
measurement error are similar to those put forward for the agreement parameters 
above.   
 
The results obtained, identified that only the SIGAM and TUG demonstrated 
excellent reliability over repeated measures for both consistency and agreement 
with ICC (2,1) values > 0.9 and no issues identified from the Bland Altman plots with 
sufficiently narrow LoA (SIGAM: 1.2 grade and TUG: 3.4s).  A MDC value had not 
been presented for the SIGAM before, and with excellent consistency and 
agreement there is confidence that this MDC95 of one grade (out of 11 possible 
grades) can be applied to the individual.  Therefore a change of one grade on the 
SIGAM or more is sufficient to demonstrate a “real”, change (i.e. not due to inherent 
variability) in the functional ability of a pwLLA.  This result is presented to a 
confidence level of 95% which means that if the same population is sampled on 
numerous occasions this MDC value (of one) would be found in approximately 95% 
of the cases.   
 
On the basis of the excellent consistency and agreement results for the TUG, the 
MDC95 of 1.8s can also be recommended to clinicians as the minimum value 
required to demonstrate a real change (in the balance and mobility) in an individual 
pwLLA.  A MDC90 value of 3.6s (the equivalent MDC95 value would be higher) had 
previously been presented for the TUG by Resnik et al in 2011, but with no 
comment on the acceptability of the LoA in the results or discussion it was not clear 
whether this MDC value was acceptable to be applied to changes seen in a 
individual patient.  However, the authors did recommend that clinicians look for a 
change of at least 3.6s between repeated results in order to be sure that a “real”, i.e. 
beyond measurement error, change had occurred in their patient.  Therefore 
inferring that the outcome measure used can detect a meaningful difference at the 
individual level (Resnik and Borgia 2011).   If no comment is made on limits of 
agreement it is better to assume that a larger measurement error is required than 
the one calculated from the group; and that changes greater than this must be 
detected for the clinician to be sure their patient has made a true change i.e. beyond 
random error (de Vet et al. 2011).   
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Excellent consistency was demonstrated for the LCI-5 and 2MWT with ICC values 
also over 0.9.  However, the evidence for agreement was less convincing for both.  
No MDC values have been previously presented for the LCI-5 either, but while the 
LCI-5 demonstrated excellent consistency (ICC>0.9) the wide LoA of 7.1 (range -3.3 
- 3.8 points) questioned the appropriateness of this outcome measure to assess 
change at the individual level.  The 2MWT also demonstrated excellent consistency 
(ICC>0.9) but the appropriateness of this outcome measure to assess change at the 
individual level was also questioned due to the wide LoA (36.4m).  Therefore, the 
MDC95 of 4 on the LCI-5 and 18.9m for the 2MWT, cannot be recommended for use 
at the individual level, but may be used in group level analysis on the basis of the 
results from this study.    
 
Good consistency (ICC >0.7 and <0.9) was reported for both the EQ-5D index 
scores and VAS within repeated measures.  However, agreement was difficult to 
comment on as this was the first presentation of reliability for the EQ-5D-5L in a 
population of pwLLA and it was not clear whether the agreement limits reported 
were representative of reasonable variability in the clinical performance of this 
population.   A change score of at least 0.258 (MDC95) on the EQ-5D index score 
and at least 15.5 on the EQ-5D VAS was calculated to be change required to be 
confident that a real change, has occurred in the global health of a pwLLA.  
However, with agreement difficult to comment on as discussed above and despite 
the good consistency seen for both the index score and the VAS, the collection of 
more data in clinical practice or research is recommended so that the values of the 
agreement parameters for the EQ-5D-5L can be put in to context with this 
population.  As these are the first measurement error values presented for the EQ-
5D-5L in pwLLA, it is hoped that they will provide reference values for researchers 
planning future studies.  Confirmation of the clinical applicability of these values 
could be gathered by comparing them to values reported in other studies on this 
population.   
 
Finally, with only fair consistency recorded for the SCS and 50% agreement 
between the two visits, neither the consistency nor agreement of this outcome 
measure can be confirmed on the basis of these results. 
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A clinician or researcher should not use an outcome measure to evaluate the 
effectiveness of an intervention without knowledge of its reliability (including their 
measurement error values).  This is because they cannot know if the patient’s 
performance (as measured by that outcome measure) has truly changed, i.e. is 
“real” and beyond measurement error.  The new data provided from the repeatability 
study on the reliability and measurement error values for these outcome measures 
will provide useful for clinicians and researchers in their work going forward in the 
context of prosthetic rehabilitation. 
 
7.3.3.2 Responsiveness  
In study IV (the longitudinal cohort study reported in chapter 6), thirty unilateral 
pwLLAs (adults) were followed during the early phase of prosthetic rehabilitation, 
when changes in the physical ability and function of the participants were expected.  
Study visits occurred: approximately one week after they were fitted with their first 
prosthetic limb; two weeks later and; to coincide with their MDT clinic appointment, 
six weeks after hospital discharge. Repeated measures ANOVA and effect size 
were calculated for the SIGAM, LCI-5, TUG, 2MWT, SCS and the EQ-5D-5L.   In 
addition, an anchor-based method of calculating external responsiveness was 
employed.  The anchor used was a change questionnaire focused on the 
participants’ perceived ability of undertaking physical tasks and the changes in that 
ability between milestones, i.e. delivery of prosthesis, discharge from hospital and at 
the time of their 6-week post-discharge clinic appointment.  Minimal clinically 
important differences were calculated for each outcome measure as an index of 
responsiveness for each time interval.  The key findings from this study are 
presented in Table 7.2 below. 
 
Table 7.2   Key findings from Study IV  
Research 
Questions 
(study/chapter) 
Key Findings 
Question 6:  
What is the 
responsiveness of 
Physical Function 
outcome measures 
 
All outcome measures, except the SCS and EQ-5D-5L, were 
responsive to changes across the whole study period, as evidenced 
from the ANOVA and effect size results. 
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regularly used with 
lower limb 
amputees when 
assessing change 
during the 
rehabilitation 
period immediately 
following limb 
fitting?   
 
(Longitudinal 
cohort study - 
study IV / chapter 
6) 
 
In addition to recording significant differences in both time intervals, the 
LCI-5, and 2MWT recorded larger effect sizes in the in-patient period 
when compared to the post-hospital discharge period, 0.66 vs 0.53 and 
0.69 vs 0.47 respectively.  
The effect sizes were similar in both the in-patient and post-hospital 
discharge periods for the TUG.  
 
Validity testing for the ACQ was confirmed (by achieving more than 
50% of the criteria) for only one outcome measure, the SIGAM in TI1. 
The lack of confirmation of the validity for the ACQ also weakened the 
support for the MCID values.  Therefore, the values that have been 
presented should be used with caution and may have limited clinical 
use. 
 
MCID values were established for all outcome measures during all time 
intervals. However, results of the hypothesis testing did not support the 
accuracy of any of the outcome measures, when used with the ACQ as 
a measure of patient perception of change  
 
 
Using the “distribution-based” approach for estimating responsiveness, (i.e. ANOVA) 
all outcome measures were considered responsive to change across the whole 
study period (TI3, which = TI1 + TI2).  Post-hoc tests showed statistically significant 
differences between the first and last study visits for all outcome measures except 
the SCS and EQ-5D-index scores 
 
When examining the magnitude of the changes detected in the different time 
intervals which were statistically significant, the LCI-5 and 2MWT recorded larger 
effect sizes in the immediate post limb-fitting period (TI1) when compared to the 
post-hospital discharge period (TI2).  The TUG recorded virtually identical effect 
sizes in both.  The effect sizes in TI1 were medium for all (0.66 - LCI-5, 0.53 – TUG 
and 0.69 - 2MWT), and in TI2 were either medium (0.53 – LCI-5 and 0.54 - TUG) or 
small (0.47 – 2MWT). However, these results alone would earn the study a rating of 
“fair” for the responsiveness measurement property within the COSMIN 
methodological quality checklist for only presenting effect size or results of 
inferential statistical tests.   
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No MCID values have been previously presented for pwLLA for any of the outcome 
measures in study IV.  According to the COSMIN guidelines, any values for 
responsiveness derived for the outcome measures in study IV must be considered 
in the context of a comparator instrument.  In this study the patient reported ACQ or 
clinical ‘anchor’ was considered a “comparator instrument” which recorded the 
pwLLAs’ perception of change with respect to their physical ability to undertake 
everyday tasks.   For a comparator instrument to be considered acceptable and 
achieve an excellent rating for methodology, according to the COSMIN checklist, 
both the instrument and its measurement properties should be adequately 
described.  While the ACQ was adequately described within the methodology for 
study IV, its psychometric properties were not confirmed.  The results, detailed in 
chapter 6 (section 6.4.7) did not confirm validity of the ACQ when used with any of 
the outcome measures being studied.  Therefore it is likely that a rating of poor may 
apply, i.e. “some information on measurement properties of the comparator 
instrument(s) in any study population”, but not a good rating: because “adequate” 
measurement properties of the comparator instrument had not been confirmed but 
not sure if these apply to the study population” (see Appendix 4.3 for COSMIN 
checklist).  Further discussion of the use of change questionnaires in the analysis of 
responsiveness will continue in section 7.4.1.2 below. 
 
The accuracy of the outcome measures in correctly identifying individuals who had 
and who had not undergone an important change based on the responses of the 
ACQ (much better vs better, same, worse and much worse) was no better than  
moderate and this was only seen in TI2    The moderately accurate findings were 
presented in TI2 for the SIGAM, TUG, 2MWT and EQ-5D-VAS are likely to be 
compromised due to the very small numbers in the “other” group (n=3) compared to 
the “much better group” (n=20) in the ROC curve analysis.  The remainder of the 
ROC curve analysis results demonstrated only low accuracy or chance results.  For 
example the accuracy results across the whole study period (TI3) was slightly better 
than chance, i.e. low accuracy, except when used with the 2MWT and the SCS 
where it was seen as a chance result.  Therefore the MCID results presented for 
SIGAM (5 grades), LCI-5 (14 points), TUG (5.5s) and EQ-5D index (0.168) and VAS 
(7.5 points) for the whole study period (TI3) can only be confirmed and 
recommended with caution. 
 
250 
 
 
7.4 Recommendations for future studies 
Several challenges (or limitations), have been identified throughout this thesis, and 
are tabulated later in the chapter (see Table 7.3 in section 7.5) together with future 
recommendations.  However, some of these are worthy of further scrutiny and will 
be examined in more detail in the following sections.   
 
7.4.1 Choice of statistical analysis 
Inappropriate statistical analyses and incomplete reporting of results for the 
psychometric properties of an outcome measure may make it difficult to interpret the 
evidence presented.  Consequently, incorrect interpretation of the evidence may 
result in an inappropriate outcome measure being used, which in turn will have 
implications on the reported effect of an intervention.  For example, the effects of an 
intervention may be under or over estimated when ordinal scores are used 
inappropriately (Stucki et al. 1996).  Ordinal scales, such as Likert scales, of which 
the SCS is a numerical example, will only record an order of magnitude.  It is not 
known how much better one level is than the one below or above, as the difference 
between the levels may not be considered equal by everyone using the scale. 
Correct use of ordinal data is also highlighted in Rethinking Rehabilitation, Theory 
and Practice where clinicians are encouraged not to use ordinal scales to evaluate 
the effectiveness of an intervention or therapy unless the scale had undergone a 
Rasch analysis (McPherson et al. 2015).  The following sections will address issues 
with the analysis and reporting choices for reliability and responsiveness, which are 
the main focus of the two interventional studies (III and IV). 
 
7.4.1.1 Reliability: consistency vs agreement 
It has been recognised that both consistency and agreement parameters are 
presented, as neither alone provides sufficient information on the reliability of an 
outcome measure to recommend its utility in rehabilitation studies (Rankin and 
Stokes 1998).  Consistency parameters are highly dependent on the heterogeneity 
of the characteristics of the performance of the study sample, whereas agreement 
parameters are more dependent on the characteristic of the measurement 
instrument and are (directly) related to the measurement error (de Vet et al. 2006).  
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However, there appeared to be a tendency in the literature studied for the 
systematic review in this thesis, for consistency parameters to be presented without 
commenting on agreement (systematic review in chapter 4).  High ICC values were 
presented without reference to agreement, and authors declared that the outcome 
measure in question demonstrated excellent or good reliability e.g. Wong et al 2013 
for the BBS, Brooks et al (2002) for the 2MWT and Resnik et al 2011 for 2MWT, 
TUG and others.  Following the Guidelines for Reporting Reliability and Agreement 
Studies (GRRAS) (Kottner et al. 2011), the recommendations and conclusions from 
the results in chapter 5 made comment on both consistency and agreement 
parameters for all the outcome measures studied.  Therefore, allowing the clinician 
or researcher to make a fully informed choice from all the evidence for the reliability 
of these outcome measures.  
 
7.4.1.2 Responsiveness: distribution-vs anchor-based methods 
Throughout this thesis, responsiveness has been considered a separate 
measurement property, distinct from validity.  The definition of this separation, 
proposed by Guyatt et al 1987, states that validity refers to a single score and 
responsiveness considers a change score based on two measurements.  This 
definition underpinned the study design and methodology in study IV (the 
longitudinal cohort study) and is supported by others (Mokkink et al. 2010, Beaton 
2001, Husted et al. 2000).  In 2000 Husted et al (2000) spoke of a distinction 
between internal and external responsiveness; with “internal” responsiveness 
characterised as the ability of a measure to change over a particular pre-specified 
time frame and “external” responsiveness as the extent to which changes in a 
measure over a specified time frame related to corresponding changes in a 
reference measure of health status.   What Husted et al (2000) referred to as 
“internal responsiveness” of an outcome measure, is presented using statistical 
methods of analysis, e.g. ES, SRM, paired t-test, GRI. These methods are also 
known as “distribution-based” methods of calculating responsiveness.  It is possible 
to show that an outcome measure can detect change by demonstrating a 
statistically significant change in group mean change scores; and that the change 
did not occur by chance or was a measurement error.  This is why the COSMIN 
checklist requires the presence of an appropriate comparator measure (i.e. proof of 
external responsiveness) for an excellent rating in the responsiveness measurement 
property category.  
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Despite the continued debate about which of the above methods should be used to 
measure responsiveness, possibly fuelled by the continuing division of opinion on its 
definition and separation from validity, it is now recommended by many (Haley and 
Fragala-Pinkham 2006, Copay et al. 2007, Revicki et al. 2008) that results from 
distribution-based methods are used to support anchor- or criterion-based results.   
This is because distribution-based indices provide no direct information about level 
of clinical importance, they are simply a way of expressing an observed change in a 
standardised metric (Hays et al. 2005). However there continues to be a lack of 
evidence on the ability of outcome measures to detect these “clinically” important 
changes in many populations.  For example, Scrivener et al (2013) published a 
systematic review on the responsiveness of measurement tools in the stroke 
population (Scrivener et al. 2013).   This was after finding in previous reviews (Salter 
et al. 2005, Tyson 2009) that responsiveness had rarely been investigated.  
Scrivener et al (2013) concluded that the lower limb physical performance 
measures, included in the review, did demonstrate “generally large” responsiveness 
(using distribution-based methods); however no comment was made on whether 
clinically important changes were detected.  
 
It is also recognised that changes detected by an outcome measure must be 
relevant not only to the patient but also the context before it can be deemed 
responsive (for that population and in that context) (Haley and Fragala-Pinkham 
2006, Copay et al. 2007, Terwee et al. 2003).  Calculating the MCID values using 
the anchor-based method and ROC analysis is one approach to investigating how 
much change is enough (or clinically important), and was the approach chosen in 
this thesis.  However, it may not only be concerns about which methods to use 
(Angst 2011) that are creating this continuing gap in the evidence for 
responsiveness.  Difficulties of implementing anchor-based methods in the area of 
healthcare and rehabilitation have been noted.  Validity of the anchor used to 
calculate MCID values must be considered to legitimise the values that are 
calculated using it (Gatchel and Mayer 2010).  However, as was seen in study IV, 
validation of the anchor used was challenging.  The number of points on the scale 
and the specificity of the anchor question were identified as possible causes of the 
poor validity results.  While some authors have noted similar problems (Rushton et 
al. 2015), others have found good validity when using the Global Rating of Change 
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(GRC) (Kamper 2009).  Examination of different examples of GRC scales used 
discovered that there was a wide variation in the type of question asked, the number 
of points on the scale, and also the labels that were assigned to the scale points 
(Kamper 2009). Variations in study design e.g. the time interval over which the 
change is being assessed and the method in which it is collected, may also affect 
the validity of the scale being used as an anchor, because of recall bias.  Kamper et 
al (2009) provide some advice from a review of the literature on both the wording of 
the question used and the size of the scale.  Firstly, the question asked must direct 
the patient / participant / clinician towards the construct being measured by the 
outcome measure under investigation.  Secondly, a specific time interval must be 
given so that the respondent can “anchor” their response to a time point from which 
he / she can compare the current status.  And finally, if both improving and 
deteriorating changes are to be collected then the scale should be balanced around 
zero.  A seven level scale was found to offer the best sense of balance between 
acceptability by the respondent (i.e. not too long), adequate discrimination between 
levels of change and test re-test reliability (Kamper 2009).   
 
Both global and specific change questionnaires have been used when trying to 
establish MCID values using a patient anchor.  The GRC, discussed briefly in the 
previous section is an example of a global health change questionnaire used in 
responsiveness studies.  For example, the GRC was used trying to estimate how 
well the L Test identified LLAs who had or had not undergone a clinically important 
change in their ability to get up and walk with their prosthesis (Rushton et al. 2015). 
The AUC was 0.67 (representing low accuracy of the L Test when using the GRC), 
therefore the authors concluded that the MCID value that was presented should be 
interpreted with caution.   The mRS (modified Rankin Score) is an example of a 
specific health outcome which measures the level of disability in people after a 
stroke and other neurological conditions.  The mRS was used in the study by Tilson 
et al in 2010 estimating the MCID value for comfortable gait speed (CGS) (Tilson et 
al. 2010).  The AUC was 0.69 and therefore there only low accuracy was also 
recorded for CGS. The authors noted that the failure to identify a clinically important 
improvement in CGS when using the mRS was probably because the mRS was not 
a gait-specific measure of disability.    However, it is expected that either a global or 
specific health questionnaire could be used to good effect as an appropriate anchor 
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questionnaire as long as the specific advice provided by Kamper et al (2009) 
(outlined earlier in the previous paragraph) is followed.  
7.4.2 Patient reported vs objectively measured outcome measures 
How an outcome measure is administrated, i.e. whether self-reported or observed 
will have an effect on the results.  Psychosocial factors such as low self-efficacy and 
self-confidence may influence the results of self-reported outcome measures or 
PROMs.  Collecting both PROMs and observed outcome measures at the same 
time may shed light on any such influences. While, an analysis of such correlations 
between the changes recorded in the observed measures and those in the PROMs 
was not undertaken in this thesis, links between the two have been explored 
previously, especially in the area of chronic pain and mental health.  For example, 
Wittink et al (2003) found that the self-report measure SF-36 physical functioning 
(PF) scale and a treadmill test (a performance-based assessment) provided 
information about distinct, although related, domains of physical functioning in 
patients with chronic low back pain (Wittink et al. 2003).   The strongest relationship 
was found between disability status and mental health (as measured by the SF-36).  
They also determined poor mental health was associated with lower SF-36 (PF) 
scores but the treadmill data was not correspondingly low, thus demonstrating a 
discrepancy between the self-reported and performance data people with poor 
mental health.  A recognised factor in this relationship is depression.  Given that the 
prevalence of depression (and anxiety) is relatively high in pwLLAs during the first 
two year post-amputation (Horgan and MacLachlan 2004), there is the possibility 
that the same relationship may exist between mental and physical health in pwLLAs.  
In 2010 Parker et al, published a study on the relationship between capacity and 
performance measures with specific reference to ambulation of people with pwLLAs 
in a community setting (Parker et al. 2010). In addition to establishing a high 
correlation between the 2MWT and a step activity monitor, they also saw a negative 
relationship between depressive symptoms and performance.  However, depression 
was only related to decreased performance as measured by the Trinity Amputation 
and Prosthesis Experience Scale (TAPES) Activity Restriction subscales (a self-
report measure (Gallagher and MacLachlan 2004)) and not the observed measures 
of performance.  
 
Data from both PROMs and observed performance should be taken into account 
when considering the impact of a prosthetic component.  High correlation between 
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perceived and actual performance would lend credibility to any improvements 
observed or perceived.  The review by Kannenburg et al (2014) looked at the 
benefits of micro-processor-controlled knees joints in community walkers. However, 
improvements in perceived function and mobility as assessed by self-reported 
outcome measures for use of a MPCK lagged behind the performance-based 
improvements with only 22 percent of the self-reported outcome measures related to 
function, mobility, and satisfaction showing significant improvements as a result of 
MPK use.  The findings were somewhat surprising to the authors who expected the 
observed improvements in function to be reflected more clearly in the pwLLAs’ 
perceptions.  However, it appeared that lower performing pwLLAs (as classified by 
the Medicare K-levels), did not subjectively report the improvements that were seen 
in objective performance by MPK use.  Both self-report and performance based 
outcome measures were also used in a study to determine functional differences 
between four categories of prosthetic feet. While significant differences were found 
in some groups using the Amputee Mobility Predictor with a prosthesis (AMPPRO), 
a performance measure, neither of the self-report measures (PEQ-13 and LCI-5) 
used in the study were able to detect differences between prosthetic feet (Gailey et 
al. 2002).   However, this is unlikely to have been due to lower performing pwLLAs 
perceiving less improvement, as found in the review by Kannenburg et al (2014), but 
is probably due to the high scores recorded for the PEQ-13 and LCI-5 throughout 
the study.  The authors noted the “ceiling” effect of both these measures (Gailey et 
al. 2002). 
 
The evaluative evidence presented in these, and other similar studies, is equivocal 
about which prosthetic component may be “better” for different groups of pwLLAs.  
Whether a self-reported or objectively measured outcome measure is being used, 
the question must be asked: How robust are the results from these studies if there is 
no strong evidence for the “external” responsiveness for any of the outcome 
measures being used?  A second question may also be asked: Are the “correct” (i.e. 
appropriate) constructs being measured in order to show differences across such a 
heterogenic population?   Whatever type of outcome measure is being used, the 
constructs being investigated are dictated by the assessor.  Maybe the person being 
assessed should choose the construct of interest, i.e. the performance, task, attitude 
that he/she would like to see a change in?   This could be done by patient-centred 
outcome measures (PCOMs), which can be regarded as PROMs because they are 
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reported by the patient.  However, in PCOMs the constructs being measured are 
identified BY the patient and not restricted.  This makes them distinct from other 
PROMs, where the constructs being measured are decided FOR the patient and are 
restricted to what the outcome measure was developed to measure. Therefore 
PCOMs can address any aspects covered in the ICF including any psychosocial 
aspects, if considered important to the amputee.  This type of outcome measure is 
being promoted in many areas of rehabilitation where the patient may have complex 
needs, including the area of pain management (O'Connell et al. 2015).  This 
approach has been investigated with pwLLAs, and the psychometric properties of an 
outcome measure of this type, the Goal Attainment Scale (GAS), has been reported 
by Rushton et al (2002).  However, the GAS does not seem to be regularly reported 
in the research.  Goal Attainment Scales may provide an alternative way to 
measuring the effectiveness of a treatment or intervention that is specific to the 
individual patient and thereby avoiding the use of multiple outcome measures. There 
are practical guides to help implement GAS within clinical teams (Steenbeek et al. 
2008, Turner-Stokes 2009).  Some guidance has been published on the 
mathematical analysis when using GAS (Tennant 2007), and a literature-based 
update on the use of GAS in rehabilitation was published in 2013 (Krasny-Pacini et 
al. 2013).  This outlined the utility of GAS across many areas of rehabilitation for 
multiple roles.  However, the authors noted that despite these many reviews there is 
no robust evidence for the psychometric qualities in clinical practice or research 
(Krasny-Pacini et al. 2013).  This was due, in part, to the lack of information on the 
methodological quality of the studies (i.e. no standardised checklist such as 
COSMIN was used) and variations in methodologies which could impact on the 
validity of the GAS in different situations and also the interpretation of the results. 
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7.5 Limitations and recommendations for future work 
Table 7.3   Main limitations identified throughout thesis 
Limitations Recommendations 
The sample size in the survey (study I – chapter 3) was limited in 
some groups (prosthetists, occupational therapist and pwLLAs) and it 
was conducted just over three years prior to thesis submission.   
A repeat survey, with a robust distribution plan would be recommended to 
reach a wider audience to confirm and/or update the results.   
Studies investigating outcome measures used exclusively for 
measuring quality of life were excluded from the systematic review of 
the literature.  In addition, the degree to which psychosocial factors 
impacted on the pwLLA following his/her amputation was not 
considered during the conduct of the interventional studies.   
It is now recognised that these factors have the potential to influence results 
obtained from both observed and self-reported outcome measures.  Therefore 
psychosocial factors should be recorded in any future studies to establish any 
confounding influences on the results. 
 
While the COSMIN checklist was developed for use with HR-PRO 
questionnaires, it was used in study II (the systematic review - chapter 
4) with observed measures of performance as well as multi-item 
questionnaires.   
The theoretical framework underpinning the development of the COSMIN 
checklist was applicable for the assessment of the psychometric properties of 
observed measures of performance as well as HR-PRO questionnaires.  
This was a single researcher PhD and therefore inter-rater reliability 
was not addressed in either study III (chapter 5) or study IV (chapter 6) 
The use of two raters, randomly assigned to participants and visits will provide 
the opportunity for both inter and intra-rater reliability analysis. 
 
The sample sizes were such that in both study III and study IV, the 
methodological quality of the study would be considered “poor” and 
“fair”, respectively, if assessed using the COSMIN quality criteria, and 
the strength of evidence would be deemed indeterminate.   
Collaborative multi-centre studies will increase the recruitment pool and 
subsequent sample size. 
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The outcome measures investigated (either patient-reported or 
observed) were measures where constructs being measured were 
restricted to a single construct and dictated by what the outcome 
measure was developed to measure. 
The use of patient-centred outcome measures, in addition to uni-dimensional 
measures, will capture changes in constructs identified by the patient and 
multi-dimensional effects could be measured. 
Recruitment of both TF and TT amputees was a potential source of 
systematic variation in both study III and IV. 
As above, the use of collaborative multi-centre studies would increase the 
potential recruitment pool and a larger sample size would allow for greater 
numbers in any sub-group analyses. 
The ACQ used in study IV was a five-level response questionnaire 
which was considered too limited to distinguish what is an important 
change.  The limited (and uneven) numbers in each group for the ROC 
curve analysis reduced the ability to detect the accuracy of the 
outcome measures. 
The use of a questionnaire with more than 7 levels may detect smaller 
incremental changes.  This coupled with a larger sample will produce larger, 
and more even numbers in each group for the ROC curve analysis.   
The question associated with the ACQ was not specific to each 
outcome measure.  The validity of the ACQ may have been improved 
if specific questions relating to the different constructs of each 
outcome measure had been included. 
Specific questions for each construct being measured should be devised when 
using an anchor-based method to estimate the responsiveness of an outcome 
measure. 
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7.6 Conclusions 
 
There is still no consensus on which outcome measures to use with pwLLAs in 
prosthetic rehabilitation.  The most common outcome measures used in prosthetic 
rehabilitation in the UK measure constructs in the physical domain (chapter 3). 
 
The need to use outcome measures that have robust psychometric properties to 
evaluate the effectiveness of interventions such as therapy and gait training 
programmes as well as prosthetic componentry is well recognised.  However, very 
few outcome measures that measure physical function, being used with pwLLAs in 
prosthetic rehabilitation, have high quality evidence, especially with regard to 
knowledge of their measurement error and their responsiveness (chapter 4).   
 
The results from both the repeatability study (chapter 5) and the longitudinal cohort 
study (chapter 6) have added to the evidence base for the psychometric properties 
for the most commonly used outcome measures measuring physical function in 
early prosthetic rehabilitation.  Further work is still required to confirm or refute these 
findings, largely due to the small sample sizes reducing the strength of the evidence 
presented.   
 
Difficulties were highlighted when using a patient anchor to establish external 
responsiveness of the outcome measures.  It is recommended that appropriately 
worded anchor questions specific to the construct being measured are constructed 
for any future work using change questionnaires as the anchor. The provision of at 
least three levels of responses for improvement and deterioration should also be 
considered.   
 
Recommendations have been presented for both clinicians and researchers 
regarding the use of outcome measures, with individuals and for groups in prosthetic 
rehabilitation and research.  However, some outstanding questions still remain 
surrounding the evidence for the use of these outcome measures to evaluate the 
effectiveness of an intervention.  Fundamental to these recommendations is the use 
of standardised guidelines and checklists when developing outcome measures, as 
well as when designing and reporting on studies that investigate the psychometric 
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properties of an established outcome measure in a new population.  Thus the choice 
of any outcome measure will be underpinned by strong evidence 
 
Outstanding questions also remain about the types of outcome measures that 
should be used and whether patient-report, patient centred or observed measures 
can capture clinically important changes when evaluating the effectiveness of any 
intervention.  Whichever individual outcome measure, or combination of measures is 
used, the construct(s) being measured must be one(s) that is (are) of concern to the 
“investigator”.  It has been argued that the “investigator” may be a clinician, 
researcher or the patient.   
 
Fundamental to the choice of outcome measures, whoever the investigator is, is that 
the psychometric properties of the measure have been established for its use with 
the particular population of patients, and in the particular context it is about to be 
used.   
 
The following quote, often (wrongly) attributed to Einstein, may be useful to 
remember when planning future research in this field: 
 
“Not everything that counts can be counted and  
not everything that can be counted counts” 
 (Cameron 1963) 
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Appendix 1  
Allied health professionals survey questionnaire 
 
  
 
 
 
 
  
Health Professionals Survey V1 19.03.12 
 
 
1 of 4 
 
What are you measuring and what matters most? 
 
Please complete the following questions by ticking the most applicable box.  If you do not 
wish to complete a question then leave it blank and move onto the next one. 
 
Please remember to fill the survey in on your own to keep your answers anonymous. 
 
Question 1:  What is your Profession, please tick: 
Occupational Therapist   
Physiotherapist   
Prosthetist   
 
 
Question 2: How many years have you been qualified, please tick: 
Up to 5yrs  
5-10 yrs  
>10yrs  
 
 
Question 3: How many years have you working with amputees, please tick: 
Up to 5yrs  
5-10 yrs  
>10yrs  
 
 
Question 4: What % of your work is connected with amputee rehabilitation, please tick:  
0 - 30%  
31 - 60%  
61 – 100%  
 
 
Question 5: Which members of the Multi-disciplinary Team do you regularly work with, i.e. 
on a daily basis, please tick all that apply: 
 
Clinical Psychologist  
Doctor  
Nurse  
Prosthetist    
Physiotherapist  
Occupational Therapist  
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Question 6: Please tick the Outcome Measures you use regularly, i.e. at least once a  
week with the following amputee populations: 
 Activity Level K0 – K2 
 
Non-limb wearer,  
indoor or limited outdoor 
ambulator  
 
Activity Level K3 
 
Wearing limb daily and 
fully ambulant outdoors  
Activity Level K4 
 
Undertakes athletic 
activities in addition to 
daily tasks 
Primary Established Primary Established Primary Established 
Activities-specific Balance 
Confidence Scale-UK 
      
Amputation Related Body 
Image Scale 
      
Amputee Activity Score 
 
      
Amputee Mobility Predictor 
with Prosthesis 
      
Attitude to Artificial Limb 
Questionnaire 
      
Barthel Index 
 
      
Body Image Questionnaire 
 
      
COPM 
 
      
Frenchay Activities Index (FAI) 
 
      
Functional Measure for 
Amputees (FMA) 
      
Functional Independence 
Measure (FIM) 
      
Houghton Scale  
 
      
Locomotor Capabilities Index  
 
      
LCI-5 
 
      
Orthotics and Prosthetics 
National Outcomes Tool 
      
Patient Generated Index 
 
      
Perceived Social Stigma Scale 
 
      
Prosthesis Evaluation 
Questionnaire 
      
Prosthetic Profile of the 
Amputee 
      
Prosthetics National Outcomes 
Tool (OPOT) 
      
Prosthetic Observational Gait 
Score (POGS) 
      
Rivermead Mobility Index 
(RMI) 
      
Russek's Code 
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 Activity Level K0 – K2 
 
Non-limb wearer,  
indoor or limited outdoor 
ambulator  
 
Activity Level K3 
 
Wearing limb daily and 
fully ambulant outdoors  
Activity Level K4 
 
Undertakes athletic 
activities in addition to 
daily tasks 
Primary Established Primary Established Primary Established 
Short Form 12 or 36 Health 
Survey (SF-12 or 36) 
      
Sickness Impact Profile (SIP) 
 
      
SIGAM 
 
      
Socket Comfort Score 
 
      
Timed “Up and Go” Test 
(TUG) 
      
Timed Walk Test (2min or 
6min) 
      
Trinity Amputation and 
Prosthesis Experience Scales 
      
 
Please add any other outcome measure not listed that you use regularly (at least once a 
week) 
_________________________________________________________________________ 
 
_________________________________________________________________________ 
 
_________________________________________________________________________ 
 
_________________________________________________________________________ 
 
Question 7: Did you use, then stop using any of the Outcome Measures listed above? 
please delete as appropriate.  Yes /No 
 
If Yes, which one(s) ____________________________________________________ 
and what was the reason, please tick all that apply: 
Lack of time 
 
 
No relevance to clinical practice 
 
 
Lack of sensitivity, i.e. ceiling or floor effect observed 
 
 
Other, please state:  
 
 
 
Health Professionals Survey V1 19.03.12 
 
 
4 of 4 
 
 
Question 8: What areas, from the following list, would you consider are the most important 
to achieving a successful rehabilitation with a prosthesis when working with the following 
amputee populations. 
 
Please rank in order with 1=most important and 10=least important in each group. 
 Activity Level K0 – K2 
 
Non-limb wearer,  
indoor or limited outdoor 
ambulator  
 
Activity Level K3 
 
Wearing limb daily and 
fully ambulant outdoors  
Activity Level K4 
 
Undertakes some 
athletic activities in 
addition to daily tasks 
Primary Established Primary Established Primary Established 
Balance & Coordination 
 
      
Energy, Drive & 
Motivation 
      
General Muscle strength  
 
      
General Range of 
Movement 
      
Manual Dexterity 
 
      
Memory 
 
      
Pain Control  
 
      
Self Confidence  
 
      
Socket fit & comfort 
 
      
Support of family & 
friends 
      
 
Please add any other area not listed that you consider important, and for which group 
______________________________________________________________________ 
 
_________________________________________________________________________ 
 
_________________________________________________________________________ 
 
_________________________________________________________________________ 
 
 
THANK YOU 
 
  
Please send the completed survey back to me using the stamped addressed envelope. 
Appendix 2  
Lower limb amputee survey questionnaire 
 
  
    
2 of 2 
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1 of 2 
 
What matters most? 
 
Please complete the following questions by ticking the most applicable box.  If you do 
not wish to complete a question then leave it blank and move onto the next one. 
 
Please remember to fill the survey in on your own to keep your answers anonymous. 
 
 
Question 1:  What is your age range, please tick: 
18-25  
26-50  
51-65  
>65  
 
 
 
Question 2: Are you, please tick: 
Male  
Female  
 
 
 
 
Question 3: What is the level of your amputation(s), please tick all that are applicable: 
 One leg Both legs 
Below-knee    
Through-knee   
Above-knee   
Other, please state: 
 
  
 
 
 
 
Question 4: How many years have you had a prosthesis, please tick: 
 
1 to 5yrs  
5-10 yrs  
>10yrs  
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Question 5: What factors, from the following list, would you consider were the most 
important to your rehabilitation with your prosthetic limb(s)? 
 
Please rank in order with 1 = the most important and 10 = the least important. 
 
 
Balance & Coordination 
 
 
Energy, Drive & Motivation 
 
 
General Muscle strength  
 
 
General Range of Movement 
 
 
Manual Dexterity 
 
 
Memory 
 
 
Pain Control  
 
 
Self Confidence  
 
 
Socket fit & comfort 
 
 
Support of family & friends 
 
 
 
 
Please add any other factor that is not listed that you considered was important to your 
rehabilitation 
______________________________________________________________________ 
 
______________________________________________________________________ 
 
______________________________________________________________________ 
 
______________________________________________________________________ 
 
 
 
 
 
THANK YOU 
 
 
Please send the completed survey back to me using the stamped addressed envelope. 
Appendix  3  
Number of Allied Health Professional respondents who regularly used 
the listed outcome measures, by profession 
 
  
  
Physiotherapists’ responses (n=23) 
 Activity Level K0 – K2 
Non-limb wearer, 
indoor or limited outdoor ambulator 
Activity Level K3 
Wearing limb daily and fully 
ambulant outdoors 
Activity Level K4 
Undertakes athletic activities 
in addition to daily tasks 
TOTALS 
 
Primary Established Primary Established Primary Established  
Activities-specific Balance 
Confidence (ABC) Scale-UK 
3 1 3 2 1 2 12 
Amputee Activity Score 
 
1 1 1 1 1 1 6 
Amputee Mobility Predictor with 
Prosthesis 
4 2 4 2 2 1 15 
Attitude to Artificial Limb 
Questionnaire 
       
Barthel Index 
 
2  2  2  6 
Canadian Occupational 
Performance Measure (COPM) 
       
Functional Independence Measure 
(FIM) 
1  1  1  3 
Houghton Scale  
 
4 4 4 4 1 1 18 
Locomotor Capabilities Index 
(original) 
2 1 2 1 1 1 8 
LCI-5 
 
9 7 11 8 6 5 46 
Prosthesis Evaluation Questionnaire 
 
   1   1 
Short Form 12 or 36 Health Survey 
(SF-12 or 36) 
1   4   5 
Special Interest Group in Amputee 
Medicine (SIGAM) Mobility Grades 
11 9 11 8 5 5 49 
Socket Comfort Score (SCS) 
 
7 7 7 7 5 5 38 
Timed “Up and Go” Test (TUG) 
 
13 12 12 11 7 5 60 
Timed Walk Test - 2min or 6min 
(TWT) 
9 10 11 11 6 6 53 
Trinity Amputation and Prosthesis 
Experience Scales 
2 2 3 5 2 2 18 
 
  
Prosthetists’ responses (n=17) 
 Activity Level K0 – K2 
Non-limb wearer, 
indoor or limited outdoor ambulator 
Activity Level K3 
Wearing limb daily and fully 
ambulant outdoors 
Activity Level K4 
Undertakes athletic activities 
in addition to daily tasks 
TOTALS 
 
Primary Established Primary Established Primary Established  
Activities-specific Balance 
Confidence (ABC) Scale-UK 
       
Amputee Activity Score 
 
2 2 2 2 1 2 11 
Amputee Mobility Predictor with 
Prosthesis 
       
Attitude to Artificial Limb 
Questionnaire 
1  1    2 
Barthel Index 
 
       
Canadian Occupational 
Performance Measure (COPM) 
       
Functional Independence Measure 
(FIM) 
       
Houghton Scale  
 
1  1    2 
Locomotor Capabilities Index or  
LCI-5 
       
Prosthesis Evaluation Questionnaire 
 
1 1 1 1 1 1 6 
Short Form 12 or 36 Health Survey 
(SF-12 or 36) 
       
Special Interest Group in Amputee 
Medicine (SIGAM) Mobility Grades 
5 5 5 5 4 5 29 
Socket Comfort Score (SCS) 
 
2 3 2 3 2 3 15 
Timed “Up and Go” Test (TUG) 
 
1  1    2 
Timed Walk Test - 2min or 6min 
(TWT) 
1 1 1 1   4 
Trinity Amputation and Prosthesis 
Experience Scales 
       
 
  
Occupational Therapists’ responses (n=5) 
 Activity Level K0 – K2 
Non-limb wearer, 
indoor or limited outdoor ambulator 
Activity Level K3 
Wearing limb daily and fully 
ambulant outdoors 
Activity Level K4 
Undertakes athletic activities 
in addition to daily tasks 
TOTALS 
 
Primary Established Primary Established Primary Established  
Activities-specific Balance 
Confidence (ABC) Scale-UK 
       
Amputee Activity Score 
 
       
Amputee Mobility Predictor with 
Prosthesis 
       
Attitude to Artificial Limb 
Questionnaire 
       
Barthel Index 
 
1      1 
Canadian Occupational 
Performance Measure (COPM) 
2 1 2    5 
Functional Independence Measure 
(FIM) 
1  1    2 
Houghton Scale  
 
       
Locomotor Capabilities Index or  
LCI-5 
       
Prosthesis Evaluation Questionnaire 
 
       
Short Form 12 or 36 Health Survey 
(SF-12 or 36) 
       
Special Interest Group in Amputee 
Medicine (SIGAM) Mobility Grades 
       
Socket Comfort Score (SCS) 
 
       
Timed “Up and Go” Test (TUG) 
 
       
Timed Walk Test - 2min or 6min 
(TWT) 
       
Trinity Amputation and Prosthesis 
Experience Scales 
       
 
 
 
 
 
 
Appendix 4  
Filter search terms used 
 
  
 
 
 
 
  
 
 
 
 
The following search terms were taken from the paper by Terwee et al 2009: 
 
Terwee CB, Jansma EP, Riphagen II, De Vet HCW. Development of a methodological 
PubMed search filter for finding studies on measurement properties of measurement 
instruments. Quality of Life Research 2009;18:1115–23. doi:10.1007/s11136-009-9528-5. 
 
(instrumentation[sh] OR Validation Studies[pt] OR ‘‘reproducibility of results’’[MeSH Terms] 
OR reproducib*[tiab] OR ‘‘psychometrics’’[MeSH] OR psychometr*[tiab] OR clinimetr*[tiab] 
OR clinometr*[tiab] OR ‘‘observer variation’’[MeSH] OR observer variation[tiab] OR 
‘‘discriminant analysis’’[MeSH] OR reliab*[tiab] OR valid*[tiab] OR coefficient[tiab] OR 
‘‘internal consistency’’[tiab] OR (cronbach*[tiab] AND (alpha[tiab] OR alphas[tiab])) OR ‘‘item 
correlation’’[tiab] OR ‘‘item correlations’’[tiab] OR ‘‘item selection’’[tiab] OR ‘‘item 
selections’’[tiab] OR ‘‘item reduction’’[tiab] OR ‘‘item reductions’’[tiab] OR agreement[tw] OR 
precision[tw] OR imprecision[tw] OR ‘‘precise values’’[tw] OR test–retest [tiab] OR (test[tiab] 
AND retest[tiab]) OR (reliab*[tiab] AND (test[tiab] OR retest[tiab])) OR stability[tiab] OR 
interrater[tiab] OR inter-rater[tiab] OR intrarater[tiab] OR intra-rater[tiab] OR intertester[tiab] 
OR inter-tester[tiab] OR intratester[tiab] OR intra-tester[tiab] OR interobserver[tiab] OR inter-
observer[tiab] OR intraobserver[tiab] OR intra-observer[tiab] OR intertechnician[tiab] OR 
intertechnician[tiab] OR intratechnician[tiab] OR intra-technician[tiab] OR interexaminer[tiab] 
OR inter-examiner[tiab] OR intraexaminer[tiab] OR intra-examiner[tiab] OR interassay[tiab] 
OR inter-assay[tiab] OR intraassay[tiab] OR intra-assay[tiab] OR interindividual[tiab] OR 
inter-individual[tiab] OR intraindividual[tiab] OR intra-individual[tiab] OR interparticipant[tiab] 
OR inter-participant[tiab] OR intraparticipant[tiab] OR intra-participant[tiab] OR kappa[-tiab] 
OR kappa’s[tiab] OR kappas[tiab] OR ‘‘coefficient of 
variation’’[tiab] OR repeatab*[tw] OR ((replicab*[tw] OR repeated[tw]) AND (measure[tw] OR 
measures[tw] OR findings[tw] OR result[tw] OR results[tw] OR test[tw] OR tests[tw])) OR 
generaliza*[tiab] OR generalisa*[tiab] OR concordance[tiab] OR (intraclass[tiab] AND 
correlation*[tiab]) OR discriminative[tiab] OR ‘‘known group’’ [tiab] OR ‘‘factor analysis’’[tiab] 
OR ‘‘factor analyses’’[tiab] OR ‘‘factor structure’’[tiab] OR ‘‘factor structures’’[tiab] OR 
dimensionality[tiab] OR subscale*[tiab] OR ‘‘multitrait scaling analysis’’[tiab] OR ‘‘multitrait 
scaling analyses’’[ 
tiab] OR ‘‘item discriminant’’[tiab]OR ‘‘interscale correlation’’[tiab] OR ‘‘interscale 
correlations’’[tiab] OR ((error[tiab] OR errors[tiab]) AND (measure*[tiab] OR correlat*[tiab] 
OR evaluat*[tiab] OR accuracy[tiab] OR accurate[tiab] OR precision[tiab] OR mean[tiab])) 
OR ‘‘individual variability’’[tiab] OR ‘‘interval variability’’[tiab] OR ‘‘rate variability’’[tiab] OR 
‘‘variability analysis’’[tiab] OR (uncertainty[tiab] AND (measurement[tiab] OR 
measuring[tiab])) OR ‘‘standard error of measurement’’[tiab] OR sensitiv*[tiab] OR 
 
 
 
 
responsive*[tiab] OR (limit[tiab] AND detection[tiab]) OR ‘‘minimal detectable 
concentration’’[tiab]ORinterpretab*[tiab] OR (small*[tiab] AND (real[tiab] OR detectable[tiab]) 
AND (change[tiab] OR difference[tiab])) OR ‘‘meaningful change’’[tiab] OR ‘‘minimal 
important change’’[tiab] OR ‘‘minimal important difference’’[tiab] OR ‘‘minimally important 
change’’[tiab] OR ‘‘minimally important difference’’[tiab] OR ‘‘minimal detectable 
change’’[tiab] OR ‘‘minimal detectable difference’’[tiab] OR ‘‘minimally detectable 
change’’[tiab] OR ‘‘minimally detectable difference’’[tiab] OR ‘‘minimal real change’’[tiab] OR 
‘‘minimal real difference’’[tiab] OR ‘‘minimally real change’’[tiab] OR ‘‘minimally real 
difference’’[tiab] OR ‘‘ceiling effect’’[tiab] OR ‘‘floor effect’’ [tiab] OR ‘‘Item response 
model’’[tiab] OR IRT[tiab] OR Rasch[tiab] OR ‘‘Differential item functioning’’[tiab] OR 
DIF[tiab] OR ‘‘computer adaptive testing’’[tiab] OR ‘‘item bank’’[tiab] OR ‘‘cross-cultural 
equivalence’’[tiab]) 
 
 
 
 
 
 
Appendix 5  
Reviewers’ Notes 
 
 
  
 
 
 
 
  
 
 
 
 
Reminder of criteria 
Inclusion criteria 
• Study population: adult (over 18 years) lower limb amputees, 
unilateral or bilateral at any level.    
• Studies reporting on clinimetric or psychometric properties of 
OMs of physical function used during any stage of Prosthetic 
Rehabilitation.   
 
Exclusion criteria 
• Dissertations, conference proceedings, editorials, opinion 
pieces, review papers, letters, single case studies and sample 
size of five or fewer patients  
• Studies that validate translated versions of the outcome 
measures  
• Outcome measures developed or used exclusively (75% rule) 
for predicting outcomes. 
• Outcome measures developed or used exclusively (75% rule) 
for measuring Quality of Life 
• Studies that examine the performance of either prosthetic 
componentry e.g. different types of knees/feet rather than that 
of the participants  
• Studies that examine the performance of any electronic or 
digital instrumentation rather than that of the participant, e.g. 
step counters, accelerometers, gait analysis instrumentation 
etc.    
 
 
 
 
Discussion points between reviewers with agreed actions  
• Missing data:  
If no mention then assume % not described - GOOD. 
If not described then not clear how items were handled - FAIR. 
 
• Sample size:  
Given that the sample sizes can be small because of the relatively small 
numbers of lower limb amputees will consider reporting results with and without 
taking the sample size into account. 
 
• Time Interval:  (boxes B & C) 
Consider the population under study and the parameter being studied when 
considering whether appropriate or justified. 
 
• Patient’s stability: (boxes B & C)  
Evidence should be provided in the text to be graded EXCELLENT. 
 
• Independent administration: (boxes B & C)  
Evidence should be provided that steps were taken for  the tester or the subject 
to have no knowledge of previous results and/or there was appropriate time 
interval (see above) to be graded EXCELLENT. 
 
• ICC calculations: (boxes B & C) 
The model/formula should have been mentioned in the text to achieve an 
EXCELLENT grading. 
 
• Comparator Instrument: (boxes F & I – where no Gold Standard)  
o Description of the instrument in the study text must have references 
pertaining to the study population to achieve an EXCELLENT grading.  If 
the title of the reference does not make it clear re: study population then 
the grading should be GOOD.  If unsure then it should be FAIR or even 
POOR. NB some references may be included in the review and therefore 
even if the title is not clear the grading may be higher as a consequence.  
These instances will be noted. 
o Similar for evidence of the measurement properties of the comparator. 
 
 
 
 
Appendix 6  
COSMIN 4-point checklist  
The checklist included  in this appendix is available to download from the COSMIN website 
http://www.cosmin.nl/Publications.html and is described in detail in the following article: 
Terwee CB, Mokkink LB, Knol DL, Ostelo RWJG, Bouter LM, de Vet HCW. Rating the 
methodological quality in systematic reviews of studies on measurement properties: a 
scoring system for the COSMIN checklist. Quality of Life Research 2012;21:651-657 
 
 
 
 
 
 
COSMIN checklist with 4-point scale 
 
Contact 
CB Terwee, PhD 
VU University Medical Center 
Department of Epidemiology and Biostatistics 
EMGO Institute for Health and Care Research 
1081 BT Amsterdam 
The Netherlands 
Website: www.cosmin.nl, www.emgo.nl  
E-mail: cb.terwee@vumc.nl 
 
 
Instructions 
This version of the COSMIN checklist is recommended for use in systematic reviews of measurement properties. With this version it is possible to calculate 
overall methodological quality scores per study on a measurement property. A methodological quality score per box is obtained by taking the lowest rating of 
any item in a box (‘worse score counts’). For example, if for a reliability study one item in the box ‘Reliability’ is scored poor, the methodological quality of that 
reliability study is rated as poor. The Interpretability box and the Generalizability box are mainly used as data extraction forms. We recommend to use the 
Interpretability box to extract all information on the interpretability issues described in this box (e.g. norm scores, floor-ceiling effects, minimal important 
change) of the instruments under study from the included articles. Similar, we recommend to use the Generalizability box to extract data on the characteristics 
of the study population and sampling procedure. Therefore no scoring system was developed for these boxes. 
 
This scoring system is described in this paper: 
 
Terwee CB, Mokkink LB, Knol DL, Ostelo RWJG, Bouter LM, de Vet HCW. Rating the methodological quality in systematic reviews of studies on 
measurement properties: a scoring system for the COSMIN checklist. Quality of Life Research 2011, July 6 [epub ahead of print]. 
 
 
Step 1. Evaluated measurement properties in the article 
 
 Internal consistency Box A 
 Reliability Box B 
 Measurement error Box C 
 Content validity Box D 
 Structural validity Box E 
 Hypotheses testing Box F 
 Cross-cultural validity Box G 
 Criterion validity Box H 
 Responsiveness Box I 
 
 
 
Step 2. Determining if the statistical method used in the article are based on CTT or IRT 
 
Box General requirements for studies that applied Item Response Theory (IRT) models 
  excellent good fair poor 
      
1 Was the IRT model used adequately described? e.g. One Parameter Logistic Model 
(OPLM), Partial Credit Model (PCM), Graded Response Model (GRM) 
IRT model 
adequately 
described 
IRT model not 
adequately 
described 
 
  
      
2 Was the computer software package used adequately described? e.g. RUMM2020, 
WINSTEPS, OPLM, MULTILOG, PARSCALE, BILOG, NLMIXED 
Software package 
adequately 
described 
 
Software package 
not adequately 
described 
  
      
3 Was the method of estimation used adequately described? e.g. conditional 
maximum likelihood (CML), marginal maximum likelihood (MML)  
Method of 
estimation 
adequately 
described 
Method of 
estimation not 
adequately 
described 
  
      
4 Were the assumptions for estimating parameters of the IRT model checked? e.g. 
unidimensionality, local independence, and item fit (e.g. differential item functioning 
(DIF)) 
assumptions of 
the IRT model 
checked 
assumptions of 
the IRT model 
partly checked 
assumptions of 
the IRT model not 
checked or 
unknown 
 
 
 
To obtain a total score for the methodological quality of studies that use IRT methods, the ‘worse score counts’ algorithm should be applied to 
the IRT box in combination with the box of the measurement property that was evaluated in the IRT study. For example, if IRT methods are 
used to study internal consistency and item 4 in the IRT box is scored fair, while the items in the internal consistency box (box A) are all scored 
as good or excellent, the methodological quality score for internal consistency will be fair. However, if any of the items in box A is scored poor, 
the methodological quality score for internal consistency will be poor. 
 
Step 3. Determining if a study meets the standards for good methodological quality 
 
 
Box A. Internal consistency 
  excellent good fair poor 
1 Does the scale consist of effect indicators, i.e. is it based on a reflective model? 
 
    
Design requirements     
      
2 Was the percentage of missing items given? Percentage of 
missing items 
described 
Percentage of 
missing items 
NOT described 
 
  
3 Was there a description of how missing items were handled? Described how 
missing items 
were handled 
Not described but 
it can be deduced 
how missing items 
were handled 
 
Not clear how 
missing items 
were handled 
 
4 Was the sample size included in the internal consistency analysis adequate? Adequate sample 
size (≥100) 
Good sample size 
(50-99) 
 
Moderate sample 
size (30-49) 
Small sample 
size (<30) 
5 Was the unidimensionality of the scale checked? i.e. was factor analysis or IRT 
model applied? 
Factor analysis 
performed in the 
study population 
Authors refer to 
another study in 
which factor 
analysis was 
performed in a 
similar study 
population 
Authors refer to 
another study in 
which factor 
analysis was 
performed, but not 
in a similar study 
population 
Factor analysis 
NOT performed 
and no 
reference to 
another study 
      
6 Was the sample size included in the unidimensionality analysis adequate? 7* #items and 
≥100  
5* #items and 
≥100 OR 6-7* 
#items but <100 
 
5* #items but 
<100 
<5* #items 
7 Was an internal consistency statistic calculated for each (unidimensional) 
(sub)scale separately? 
Internal 
consistency 
statistic calculated 
for each subscale 
separately 
  Internal 
consistency 
statistic NOT 
calculated for 
each subscale 
separately 
 
8 Were there any important flaws in the design or methods of the study? 
 
No other important 
methodological 
flaws in the design 
or execution of the 
study 
 Other minor 
methodological 
flaws in the design 
or execution of the 
study 
Other important 
methodological 
flaws in the 
design or 
execution of the 
study 
Statistical methods     
      
9 for Classical Test Theory (CTT), continuous scores: Was Cronbach’s alpha 
calculated? 
Cronbach’s alpha 
calculated 
 Only item-total 
correlations 
calculated 
No Cronbach’s 
alpha and no 
item-total 
correlations 
calculated 
 
10 for CTT, dichotomous scores: Was Cronbach’s alpha or KR-20 calculated? Cronbach’s alpha 
or KR-20 
calculated 
 Only item-total 
correlations 
calculated 
No Cronbach’s 
alpha or KR-20 
and no item-
total correlations 
calculated 
 
11 for IRT: Was a goodness of fit statistic at a global level calculated? E.g. χ2, reliability 
coefficient of estimated latent trait value (index of (subject or item) separation)  
Goodness of fit 
statistic at a global 
level calculated 
  Goodness of fit 
statistic at a 
global level NOT 
calculated 
 
NB. Item 1 is used to determine whether internal consistency is relevant for the instrument under study. It is not used to rate the quality of the study. 
 
 
Box B. Reliability: relative measures (including test-retest reliability, inter-rater reliability and intra-rater reliability) 
  excellent good fair poor 
Design requirements     
1 Was the percentage of missing items given? Percentage of 
missing items 
described 
Percentage of 
missing items 
NOT described 
 
  
2 Was there a description of how missing items were handled? Described how 
missing items 
were handled 
Not described but 
it can be deduced 
how missing items 
were handled 
 
Not clear how 
missing items 
were handled 
 
3 Was the sample size included in the analysis adequate? Adequate sample 
size (≥100) 
 
Good sample size 
(50-99) 
Moderate sample 
size (30-49) 
Small sample 
size (<30) 
4 Were at least two measurements available? At least two 
measurements 
 
  Only one 
measurement 
5 Were the administrations independent? Independent 
measurements 
Assumable that 
the measurements 
were independent 
Doubtful whether 
the measurements 
were independent 
 
measurements 
NOT 
independent 
6 Was the time interval stated? Time interval 
stated 
 Time interval NOT 
stated 
 
 
7 Were patients stable in the interim period on the construct to be measured? Patients were 
stable (evidence 
provided) 
Assumable that 
patients were 
stable 
 
Unclear if patients 
were stable 
Patients were 
NOT stable 
8 Was the time interval appropriate? Time interval 
appropriate 
 Doubtful whether 
time interval was 
appropriate 
 
Time interval 
NOT 
appropriate 
9 Were the test conditions similar for both measurements? e.g. type of administration, 
environment, instructions 
Test conditions 
were similar 
(evidence 
provided) 
 
Assumable that 
test conditions 
were similar 
Unclear if test 
conditions were 
similar 
Test conditions 
were NOT 
similar 
10 Were there any important flaws in the design or methods of the study? No other important 
methodological 
flaws in the design 
or execution of the 
study 
 Other minor 
methodological 
flaws in the design 
or execution of the 
study 
Other important 
methodological 
flaws in the 
design or 
execution of the 
study 
Statistical methods     
11 for continuous scores: Was an intraclass correlation coefficient (ICC) calculated? ICC calculated 
and model or 
formula of the ICC 
is described 
ICC calculated but 
model or formula 
of the ICC not 
described or not 
optimal. 
Pearson or 
Spearman 
correlation 
coefficient 
calculated with 
evidence provided 
that no systematic 
change has 
occurred 
Pearson or 
Spearman 
correlation 
coefficient 
calculated 
WITHOUT 
evidence provided 
that no systematic 
change has 
occurred or WITH 
evidence that 
systematic change 
has occurred 
 
No ICC or 
Pearson or 
Spearman 
correlations 
calculated 
12 for dichotomous/nominal/ordinal scores: Was kappa calculated? Kappa calculated   Only percentage 
agreement 
calculated 
 
13 for ordinal scores: Was a weighted kappa calculated? Weighted Kappa 
calculated 
 Unweighted 
Kappa calculated 
Only percentage 
agreement 
calculated 
 
14 for ordinal scores: Was the weighting scheme described? e.g. linear, quadratic Weighting scheme 
described 
Weighting scheme 
NOT described 
  
 
 
 
Box C. Measurement error: absolute measures 
  excellent good fair poor 
Design requirements     
1 Was the percentage of missing items given? Percentage of 
missing items 
described 
Percentage of 
missing items 
NOT described 
 
  
2 Was there a description of how missing items were handled? Described how 
missing items 
were handled 
Not described but 
it can be deduced 
how missing items 
were handled 
 
Not clear how 
missing items 
were handled 
 
3 Was the sample size included in the analysis adequate? Adequate sample 
size (≥100) 
Good sample size 
(50-99) 
Moderate sample 
size (30-49) 
Small sample 
size (<30) 
 
4 Were at least two measurements available? At least two 
measurements 
 
  Only one 
measurement 
5 Were the administrations independent? Independent 
measurements 
Assumable that 
the measurements 
were independent 
Doubtful whether 
the measurements 
were independent 
 
measurements 
NOT 
independent 
6 Was the time interval stated? Time interval 
stated 
 Time interval NOT 
stated 
 
 
7 Were patients stable in the interim period on the construct to be measured? Patients were 
stable (evidence 
provided) 
Assumable that 
patients were 
stable 
 
Unclear if patients 
were stable 
Patients were 
NOT stable 
8 Was the time interval appropriate? Time interval 
appropriate 
 Doubtful whether 
time interval was 
appropriate 
 
Time interval 
NOT 
appropriate 
9 Were the test conditions similar for both measurements? e.g. type of administration, 
environment, instructions 
Test conditions 
were similar 
(evidence 
provided) 
 
Assumable that 
test conditions 
were similar 
Unclear if test 
conditions were 
similar 
Test conditions 
were NOT 
similar 
10 Were there any important flaws in the design or methods of the study? No other important 
methodological 
flaws in the design 
or execution of the 
study 
 Other minor 
methodological 
flaws in the design 
or execution of the 
study 
Other important 
methodological 
flaws in the 
design or 
execution of the 
study 
Statistical methods     
      
11 for CTT: Was the Standard Error of Measurement (SEM), Smallest Detectable 
Change (SDC) or Limits of Agreement (LoA) calculated? 
SEM, SDC, or 
LoA calculated 
Possible to 
calculate LoA from 
the data 
presented 
 SEM calculated 
based on 
Cronbach’s 
alpha, or on SD 
from another 
population 
 
 
 
 
Box D. Content validity (including face validity) 
  excellent good fair poor 
General requirements     
1 Was there an assessment of whether all items refer to relevant aspects of the 
construct to be measured? 
Assessed if all 
items refer to 
relevant aspects 
of the construct to 
be measured 
 Aspects of the 
construct to be 
measured poorly 
described AND 
this was not taken 
into consideration 
 
NOT assessed if 
all items refer to 
relevant aspects 
of the construct 
to be measured 
2 Was there an assessment of whether all items are relevant for the study 
population? (e.g. age, gender, disease characteristics, country, setting) 
Assessed if all 
items are relevant 
for the study 
population in 
adequate sample 
size (≥10) 
Assessed if all 
items are relevant 
for the study 
population in 
moderate sample 
size (5-9) 
Assessed if all 
items are relevant 
for the study 
population in small 
sample size (<5) 
NOT assessed if 
all items are 
relevant for the 
study population 
OR target 
population not 
involved 
 
3 Was there an assessment of whether all items are relevant for the purpose of the 
measurement instrument? (discriminative, evaluative, and/or predictive) 
Assessed if all 
items are relevant 
for the purpose of 
the application 
Purpose of the 
instrument was 
not described but 
assumed 
NOT assessed if 
all items are 
relevant for the 
purpose of the 
application 
 
 
4 Was there an assessment of whether all items together comprehensively reflect the 
construct to be measured? 
Assessed if all 
items together 
comprehensively 
reflect the 
construct to be 
measured 
 No theoretical 
foundation of the 
construct and this 
was not taken into 
consideration 
NOT assessed if 
all items 
together 
comprehen-
sively reflect the 
construct to be 
measured  
 
5 Were there any important flaws in the design or methods of the study? No other important 
methodological 
flaws in the design 
or execution of the 
study 
 Other minor 
methodological 
flaws in the design 
or execution of the 
study 
Other important 
methodological 
flaws in the 
design or 
execution of the 
study 
 
 
 
 
Box E. Structural validity 
  excellent good fair poor 
1 Does the scale consist of effect indicators, i.e. is it based on a reflective model? 
 
    
Design requirements     
      
2 Was the percentage of missing items given? Percentage of 
missing items 
described 
Percentage of 
missing items 
NOT described 
 
  
3 Was there a description of how missing items were handled? Described how 
missing items 
were handled 
Not described but 
it can be deduced 
how missing items 
were handled 
 
Not clear how 
missing items 
were handled 
 
4 Was the sample size included in the analysis adequate? 7* #items and 
≥100  
5* #items and 
≥100 OR 5-7* 
#items but <100 
 
5* #items but 
<100 
<5* #items 
5 Were there any important flaws in the design or methods of the study? No other important 
methodological 
flaws in the design 
or execution of the 
study 
 Other minor 
methodological 
flaws in the design 
or execution of the 
study (e.g. rotation 
method not 
described) 
Other important 
methodological 
flaws in the 
design or 
execution of the 
study (e.g. 
inappropriate 
rotation method) 
 
Statistical methods     
      
6 for CTT: Was exploratory or confirmatory factor analysis performed? Exploratory or 
confirmatory factor 
analysis 
performed and 
type of factor 
analysis 
appropriate in 
view of existing 
information 
 
Exploratory factor 
analysis 
performed while 
confirmatory 
would have been 
more appropriate 
 No exploratory 
or confirmatory 
factor analysis 
performed 
7 for IRT: Were IRT tests for determining the (uni-) dimensionality of the items 
performed? 
IRT test for 
determining 
(uni)dimension-
ality performed 
  IRT test for 
determining 
(uni)dimension-
ality NOT 
performed 
 
 
 
Box F. Hypotheses testing 
  excellent good fair Poor 
Design requirements     
1 Was the percentage of missing items given? Percentage of 
missing items 
described 
Percentage of 
missing items 
NOT described 
 
  
2 Was there a description of how missing items were handled? Described how 
missing items 
were handled 
Not described but 
it can be deduced 
how missing items 
were handled 
 
Not clear how 
missing items 
were handled 
 
3 Was the sample size included in the analysis adequate? Adequate sample 
size (≥100 per 
analysis) 
Good sample size 
(50-99 per 
analysis) 
Moderate sample 
size (30-49 per 
analysis) 
 
Small sample 
size (<30 per 
analysis) 
4 Were hypotheses regarding correlations or mean differences formulated a priori 
(i.e. before data collection)? 
Multiple 
hypotheses 
formulated a priori 
Minimal number of 
hypotheses 
formulate a priori 
Hypotheses vague 
or not formulated 
but possible to 
deduce what was 
expected 
Unclear what 
was expected 
     
5 Was the expected direction of correlations or mean differences included in the 
hypotheses? 
Expected direction 
of the correlations 
or differences 
stated 
Expected direction 
of the correlations 
or differences 
NOT stated 
 
  
6 Was the expected absolute or relative magnitude of correlations or mean 
differences included in the hypotheses? 
Expected 
magnitude of the 
correlations or 
differences stated 
Expected 
magnitude of the 
correlations or 
differences NOT 
stated 
 
  
7 for convergent validity: Was an adequate description provided of the comparator 
instrument(s)? 
Adequate 
description of the 
constructs 
measured by the 
comparator 
instrument(s) 
Adequate 
description of 
most of the 
constructs 
measured by the 
comparator 
instrument(s) 
 
Poor description 
of the constructs 
measured by the 
comparator 
instrument(s) 
NO description 
of the constructs 
measured by 
the comparator 
instrument(s) 
8 for convergent validity: Were the measurement properties of the comparator 
instrument(s) adequately described? 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) in a 
population similar 
to the study 
population 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) but 
not sure if these 
apply to the study 
population 
Some information 
on measurement 
properties (or a 
reference to a 
study on 
measurement 
properties) of the 
comparator 
instrument(s) in 
any study 
population 
 
No information 
on the 
measurement 
properties of the 
comparator 
instrument(s) 
9 Were there any important flaws in the design or methods of the study? No other important 
methodological 
flaws in the design 
or execution of the 
study 
 Other minor 
methodological 
flaws in the design 
or execution of the 
study (e.g. only 
data presented on 
a comparison with 
an instrument that 
measures another 
construct) 
Other important 
methodological 
flaws in the 
design or 
execution of the 
study 
Statistical methods     
      
10 Were design and statistical methods adequate for the hypotheses to be tested? Statistical 
methods applied 
appropriate 
Assumable that 
statistical methods 
were appropriate, 
e.g. Pearson 
correlations 
applied, but 
distribution of 
scores or mean 
(SD) not 
presented 
Statistical 
methods applied 
NOT optimal 
Statistical 
methods applied 
NOT 
appropriate 
 
 
 
 
Box G. Cross-cultural validity 
  excellent good fair poor 
Design requirements     
1 Was the percentage of missing items given? Percentage of 
missing items 
described 
Percentage of 
missing items 
NOT described 
 
  
2 Was there a description of how missing items were handled? Described how 
missing items 
were handled 
Not described but 
it can be deduced 
how missing items 
were handled 
 
Not clear how 
missing items 
were handled 
 
3 Was the sample size included in the analysis adequate? CTT: 7* #items 
and ≥100 
IRT: ≥200 per 
group  
CTT: 5* #items 
and ≥100 OR 5-7* 
#items but <100 
IRT: ≥200 in 1 
group and 100-
199 in 1 group 
CTT: 5* #items 
but <100 
IRT: 100-199 per 
group 
CTT: <5* #items 
IRT: (<100 in 1 
or both groups 
4 Were both the original language in which the HR-PRO instrument was developed, 
and the language in which the HR-PRO instrument was translated described? 
Both source 
language and 
target language 
described 
 
  Source 
language NOT 
known 
5 Was the expertise of the people involved in the translation process adequately 
described? e.g. expertise in the disease(s) involved, expertise in the construct to be 
measured, expertise in both languages 
Expertise of the 
translators 
described with 
respect to 
disease, 
construct, and 
language 
 
Expertise of the 
translators with 
respect to disease 
or construct poor 
or not described 
Expertise of the 
translators with 
respect to 
language not 
described 
 
6 Did the translators work independently from each other? Translators 
worked 
independent 
Assumable that 
the translators 
worked 
independent 
 
Unclear whether 
translators worked 
independent 
Translators 
worked NOT 
independent 
7 Were items translated forward and backward? Multiple forward 
and multiple 
backward 
translations 
 
Multiple forward 
translations but 
one backward 
translation 
 
One forward and 
one backward 
translation 
Only a forward 
translation 
8 Was there an adequate description of how differences between the original and 
translated versions were resolved? 
Adequate 
description of how 
differences 
between 
translators were 
resolved 
 
Poorly or NOT 
described how 
differences 
between 
translators were 
resolved 
  
9 Was the translation reviewed by a committee (e.g. original developers)? Translation 
reviewed by a 
committee 
(involving other 
people than the 
translators, e.g. 
the original 
developers) 
 
Translation NOT 
reviewed by 
(such) a 
committee 
  
10 Was the HR-PRO instrument pre-tested (e.g. cognitive interviews) to check 
interpretation, cultural relevance of the translation, and ease of comprehension? 
Translated 
instrument pre-
tested in the target 
population 
Translated 
instrument pre-
tested, but unclear 
if this was done in 
the target 
population 
 
Translated 
instrument pre-
tested, but NOT in 
the target 
population 
Translated 
instrument NOT 
pre-tested 
11 Was the sample used in the pre-test adequately described? Sample used in 
the pre-test 
adequately 
described 
 
 Sample used in 
the pre-test NOT 
(adequately) 
described 
 
12 Were the samples similar for all characteristics except language and/or cultural 
background? 
Shown that 
samples were 
similar for all 
characteristics 
except language 
/culture 
Stated (but not 
shown) that 
samples were 
similar for all 
characteristics 
except language 
/culture 
 
Unclear whether 
samples were 
similar for all 
characteristics 
except language 
/culture 
 
Samples were 
NOT similar for 
all 
characteristics 
except language 
/culture 
 
13 Were there any important flaws in the design or methods of the study? No other important 
methodological 
flaws in the design 
or execution of the 
study 
 Other minor 
methodological 
flaws in the design 
or execution of the 
study 
Other important 
methodological 
flaws in the 
design or 
execution of the 
study 
 
Statistical methods     
      
14 for CTT: Was confirmatory factor analysis performed? Multiple-group 
confirmatory factor 
analysis 
performed 
 
  Multiple-group 
confirmatory 
factor analysis 
NOT performed 
15 for IRT: Was differential item function (DIF) between language groups assessed? DIF between 
language groups 
assessed 
  DIF between 
language 
groups NOT 
assessed 
 
 
Box H. Criterion validity 
  excellent good fair poor 
Design requirements     
1 Was the percentage of missing items given? Percentage of 
missing items 
described 
Percentage of 
missing items 
NOT described 
 
  
2 Was there a description of how missing items were handled? Described how 
missing items 
were handled 
Not described but 
it can be deduced 
how missing items 
were handled 
 
Not clear how 
missing items 
were handled 
 
3 Was the sample size included in the analysis adequate? Adequate sample 
size (≥100) 
Good sample size 
(50-99) 
Moderate sample 
size (30-49) 
 
Small sample 
size (<30) 
4 Can the criterion used or employed be considered as a reasonable ‘gold standard’? Criterion used can 
be considered an 
adequate ‘gold 
standard’ 
(evidence 
provided) 
No evidence 
provided, but 
assumable that 
the criterion used 
can be considered 
an adequate ‘gold 
standard’ 
 
Unclear whether 
the criterion used 
can be considered 
an adequate ‘gold 
standard’ 
Criterion used 
can NOT be 
considered an 
adequate ‘gold 
standard’ 
5 Were there any important flaws in the design or methods of the study? No other important 
methodological 
flaws in the design 
or execution of the 
study 
 Other minor 
methodological 
flaws in the design 
or execution of the 
study 
Other important 
methodological 
flaws in the 
design or 
execution of the 
study 
Statistical methods     
      
6 for continuous scores: Were correlations, or the area under the receiver operating 
curve calculated? 
Correlations or 
AUC calculated 
  Correlations or 
AUC NOT 
calculated 
 
7 for dichotomous scores: Were sensitivity and specificity determined? Sensitivity and 
specificity 
calculated 
  Sensitivity and 
specificity NOT 
calculated 
 
 
Box I. Responsiveness 
  excellent good fair poor 
Design requirements     
1 Was the percentage of missing items given? Percentage of 
missing items 
described 
Percentage of 
missing items 
NOT described 
 
  
2 Was there a description of how missing items were handled? Described how 
missing items 
were handled 
Not described but 
it can be deduced 
how missing items 
were handled 
 
Not clear how 
missing items 
were handled 
 
3 Was the sample size included in the analysis adequate? Adequate sample 
size (≥100) 
Good sample size 
(50-99) 
Moderate sample 
size (30-49) 
Small sample 
size (<30) 
 
4 Was a longitudinal design with at least two measurement used? Longitudinal 
design used 
  No longitudinal 
design used 
 
5 Was the time interval stated? Time interval 
adequately 
described 
 
  Time interval 
NOT described 
6 If anything occurred in the interim period (e.g. intervention, other relevant events), 
was it adequately described? 
Anything that 
occurred during 
the interim period 
(e.g. treatment) 
adequately 
described 
 
Assumable what 
occurred during 
the interim period 
Unclear or NOT 
described what 
occurred during 
the interim period 
 
7 Was a proportion of the patients changed (i.e. improvement or deterioration)? Part of the 
patients were 
changed 
(evidence 
provided) 
 
NO evidence 
provided, but 
assumable that 
part of the patients 
were changed 
 
Unclear if part of 
the patients were 
changed 
 
Patients were 
NOT changed 
 
Design requirements for hypotheses testing     
      
 For constructs for which a gold standard was not available: 
 
    
8 Were hypotheses about changes in scores formulated a priori (i.e. before data 
collection)? 
Hypotheses 
formulated a priori 
 Hypotheses vague 
or not formulated 
but possible to 
deduce what was 
expected 
Unclear what 
was expected 
     
9 Was the expected direction of correlations or mean differences of the change 
scores of HR-PRO instruments included in these hypotheses? 
Expected direction 
of the correlations 
or differences 
stated 
Expected direction 
of the correlations 
or differences 
NOT stated 
 
  
10 Were the expected absolute or relative magnitude of correlations or mean 
differences of the change scores of HR-PRO instruments included in these 
hypotheses? 
Expected 
magnitude of the 
correlations or 
differences stated 
Expected 
magnitude of the 
correlations or 
differences NOT 
stated 
 
  
11 Was an adequate description provided of the comparator instrument(s)? Adequate 
description of the 
constructs 
measured by the 
comparator 
instrument(s) 
 
 Poor description 
of the constructs 
measured by the 
comparator 
instrument(s) 
NO description 
of the constructs 
measured by 
the comparator 
instrument(s) 
12 Were the measurement properties of the comparator instrument(s) adequately 
described? 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) in a 
population similar 
to the study 
population 
Adequate 
measurement 
properties of the 
comparator 
instrument(s) but 
not sure if these 
apply to the study 
population 
Some information 
on measurement 
properties (or a 
reference to a 
study on 
measurement 
properties) of the 
comparator 
instrument(s) in 
any study 
population 
 
NO information 
on the 
measurement 
properties of the 
comparator 
instrument(s) 
13 Were there any important flaws in the design or methods of the study? No other important 
methodological 
flaws in the design 
or execution of the 
study 
 Other minor 
methodological 
flaws in the design 
or execution of the 
study (e.g. only 
data presented on 
a comparison with 
an instrument that 
measures another 
construct) 
Other important 
methodological 
flaws in the 
design or 
execution of the 
study 
Statistical methods     
      
14 Were design and statistical methods adequate for the hypotheses to be tested? Statistical 
methods applied 
appropriate 
 Statistical 
methods applied 
NOT optimal 
Statistical 
methods applied 
NOT 
appropriate 
 
Design requirement for comparison to a gold standard     
      
 For constructs for which a gold standard was available: 
 
    
15 Can the criterion for change be considered as a reasonable gold standard? Criterion used can 
be considered an 
adequate ‘gold 
standard’ 
(evidence 
provided) 
 
No evidence 
provided, but 
assumable that 
the criterion used 
can be considered 
an adequate ‘gold 
standard’ 
 
Unclear whether 
the criterion used 
can be considered 
an adequate ‘gold 
standard’ 
Criterion used 
can NOT be 
considered an 
adequate ‘gold 
standard’ 
16 Were there any important flaws in the design or methods of the study? No other important 
methodological 
flaws in the design 
or execution of the 
study 
 Other minor 
methodological 
flaws in the design 
or execution of the 
study 
Other important 
methodological 
flaws in the 
design or 
execution of the 
study 
Statistical methods     
      
17 for continuous scores: Were correlations between change scores, or the area under 
the Receiver Operator Curve (ROC) curve calculated? 
Correlations or 
Area under the 
ROC Curve (AUC) 
calculated 
 
  Correlations or 
AUC NOT 
calculated 
 
18 for dichotomous scales: Were sensitivity and specificity (changed versus not 
changed) determined? 
Sensitivity and 
specificity 
calculated 
  Sensitivity and 
specificity NOT 
calculated 
 
 
 
Interpretability 
 
We recommend to use the Interpretability box to extract all information on the interpretability issues described in this box of the instruments under study from 
the included articles.  
 
 
Box  Interpretability 
  
Percentage of missing items   
Description of how missing items were handled  
Distribution of the (total) scores   
Percentage of the respondents who had the lowest possible (total) score  
Percentage of the respondents who had the highest possible (total) score  
Scores and change scores (i.e. means and SD) for relevant (sub) groups, e.g. for normative 
groups, subgroups of patients, or the general population 
 
Minimal Important Change (MIC) or Minimal Important Difference (MID)  
 
 
Generalizability 
 
We recommend to use the Generalizability box to extract data on the characteristics of the study populations and sampling procedures of the included studies. 
 
Box Generalisability  
  
Median or mean age (with standard deviation or range)  
Distribution of sex  
Important disease characteristics (e.g. severity, status, duration) and description of treatment  
Setting(s) in which the study was conducted (e.g. general population, primary care or 
hospital/rehabilitation care) 
 
Countries in which the study was conducted  
Language in which the HR-PRO instrument was evaluated  
Method used to select patients (e.g. convenience, consecutive, or random)  
Percentage of missing responses (response rate)  
 
 
Invitation letter 
and PIS given 
to the amputee 
with a Consent 
to Contact Form 
Does the patient wish to participate in the study? 
Recruitment Decision Process from Advert 
Researcher contacts amputee 
using details given on the 
Consent to contact Form 
Researcher answers any 
remaining questions and enrols 
the patient into the study 
Does the patient fit the study criteria? 
NO Not suitable for the study 
YES 
YES 
NO Not in the study 
Study Title:  Outcome Measures for Amputees - A Repeatability Study 
Invitation letter 
and PIS sent  to 
the amputee 
with a Consent 
to Contact Form 
Does the amputee wish to participate in the 
study? 
Recruitment Decision Process from Database Search 
Researcher contacts amputee using 
details given on the Consent to 
Contact Form 
Researcher answers any 
remaining questions and enrols 
the amputee into the study 
Does the amputee fit the study criteria? 
NO Not suitable for the study 
YES 
YES 
NO Not in the 
study 
Study Title:  Outcome Measures for Amputees - A Repeatability Study 
 Appendix 8  
Recruitment adverts – study III 
 
   
 Repeatability Study Advert  version 1 (16/06/13)  
Would you like to take part in a study 
looking into Activity Outcome Measures?   
 
 
If you have had your artificial leg for over a year,  
you wear it all day,  and 
you are active outdoors,  
 
you may be eligible to help with this study. 
 
 
 
The study involves visiting the 
Physiotherapy Department 
here at Astley Ainslie Hospital 
on 2 separate occasions, a 
week apart.   
 
 
At each visit you will be asked to: 
 complete 4 questionnaires  
about your activity levels and  
 participate in two walking tasks.   
 
 
The visits should take no longer than 1 hour of your time and you 
will receive a £20 voucher when you complete the second visit. 
 
If you are interested in hearing more please contact your  
Prosthetist for an Information Study Pack.   
 
THANK YOU  
Judy Scopes, PhD Student, Queen Margaret University, Edinburgh 
The study is part of a Physiotherapy PhD taking place at  
Queen Margaret University, Edinburgh. 
 Repeatability Study ELLA  Advert  version 1 (27/06/14)  
Would you like to take part in a study 
looking into Activity Outcome Measures?   
 
 
If you have had your artificial leg for over a year,  
you wear it all day,  and 
you are active outdoors,  
 
you may be eligible to help with this study. 
 
 
 
The study involves visiting the 
Physiotherapy Department 
here at Astley Ainslie Hospital 
on 2 separate occasions, a 
week apart.   
 
 
At each visit you will be asked to: 
 complete 4 questionnaires  
about your activity levels and  
 participate in two walking tasks.   
 
 
The visits should take no longer than 1 hour of your time and you 
will receive a £20 voucher when you complete the second visit. 
 
If you are interested in hearing more please contact  
the Researcher, Judy Scopes on JScopes@qmu.ac.uk for an 
Information Study Pack.   
 
THANK YOU  
Judy Scopes, PhD Student, Queen Margaret University, Edinburgh 
The study is part of a Physiotherapy PhD taking place at  
Queen Margaret University, Edinburgh.  
Test Visit 1 (TV1) 
Written Consent 
obtained 
Demographic Data 
Outcome Measures: 
SIGAM 
LCI-5 
TUAG 
2minTWT 
SCS 
EQ-5D 
Data Collected at 
TV1: 
Test Visit 2 (TV2) 
Within 7-10 days of visit 1 
Data Collected at 
TV2: 
Outcome Measures: 
SIGAM 
LCI-5 
TUAG 
2minTWT 
SCS 
EQ-5D 
Study Schedule 
Study Title:  Outcome Measures for Amputees - A Repeatability Study 
Individual Participant Study Schedule 
Study Title:  Outcome Measures for Amputees - A Repeatability Study 
Test Visit 1 
(SV1) 
Written 
Consent 
Demographic 
Data 
SIGAM 
Date: 
LCI-5 
TUAG 
2minTWT 
SCS 
EQ-5D 
Venue: 
Participant  
No: 
Test Visit 2 
(SV2) 
Date: 
SIGAM 
LCI-5 
TUAG 
2minTWT 
SCS 
EQ-5D 
Venue: 
 
 
 
Appendix 10  
Data collection sheets and instructions for outcome measures 
 
Study III - Repeatability Study 
 
Study IV – Longitudinal Cohort Study (Rehabilitation Study) 
 
 
 
 
 
 
 
Demographic Data Repeatability Study Version 1 (16/06/13) 
 
Study Title:  Outcome Measures for Amputees - A Repeatability Study 
Demographic Data 
 
Participant 
Number: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GP Name:  _____________________ 
 
GP Address: _____________________ 
 
   _____________________ 
 
   _____________________
Age 
 
  
Cause of Amputation 
 
PVD  
Diabetes  
Trauma  
Tumour  
Other  
Level of Amputation TTA  
TFA  
Prosthetic usage Time since delivery 
of first artificial leg 
 
Other relevant Medical 
History 
PVD  
Diabetes  
Heart Disease  
Vascular Disease  
Blood Pressure  
Neurological 
conditions 
 
Arthritis  
Liver disease  
  
 
 
 
Demographic Data Repeatability Study Version 1 (16/06/13) 
 
Study Title:  Outcome Measures for Amputees - A Repeatability Study 
SIGAM Mobility Grades 
 
 
Participant No:  Date:  Test Visit:  
 
 
 
SIGAM Mobility 
Grade Recorded 
 
 
 
 
 
SIGAM Algorithm 
Study Title:  Outcome Measures for Amputees - A Repeatabilty Study 
SIGAM mobility grades Algorithm 
 
Guidelines for the use of SIGAM Algorithm 
 
1. Start at the top of page at question 1.  The number beside each box 
corresponds to the same numbered question. 
2. Depending on the answer “YES” or “NO” follow the arrows to assign one 
of Grade A – E. 
3. Once you reach    then that is the grade to be assigned.  
You do not need to proceed, except for Grades C & D to assign a sub-
grade. 
4. Sub-grades (a) – (d) apply depending on what walking aid is used to 
assist walking.  If a patient ticks “Yes” to more than one aid then he/she is 
graded based upon that which provides most support: frame  > 2 
crutches/sticks >  1 crutch/stick > none 
 
 
Reproduced from:  RYALL, N.H., et al, 2003. The SIGAM Mobility Grades: A New Population-Specific Measure for Lower 
Limb Amputees. Disability and Rehabilitation, vol. 25, no. 15, pp. 833-844.  
 
Grade….. 
 
 
 
Study Title:  Outcome Measures for Amputees - A Repeatability Study 
LOCOMOTOR CAPABILITIES INDEX - 5  
 
Whether or not you wear your prosthesis, at the present time, would you say that 
you are “able” to do the following activities WITH YOUR PROSTHESIS ON?   
 
Please circle the number that best describes your capability. 
 
ITEM 
NO YES, if 
someone 
helps me 
YES, if 
someone is 
near me 
YES, alone, with 
ambulation aids 
YES, alone, 
without 
ambulation aids 
1.  Get up from a chair 
 
0 1 2 3 4 
2.  Walk in the house  
 
0 1 2 3 4 
3.  Walk outside on even ground 0 1 2 3 4 
4.  Go up the stairs with a 
handrail 
0 1 2 3 4 
5.  Go down the stairs with a 
handrail 
0 1 2 3 4 
6.  Step up a sidewalk curb 
 
0 1 2 3 4 
7.  Step down a sidewalk curb 0 1 2 3 4 
Basic Activities Score 
 
     
1.  Pick up an object from the 
floor (when you are standing up 
with your prosthesis) 
0 1 2 3 4 
2.  Get up from the floor (e.g. if 
you fall) 
0 1 2 3 4 
3.  Walk outside on uneven 
ground (e.g. grass, gravel, 
slope) 
0 1 2 3 4 
4.  Walk outside in inclement 
weather (e.g. snow, rain, ice) 
0 1 2 3 4 
5.  Go up a few steps (stairs) 
without a handrail 
0 1 2 3 4 
6. Go down a few steps (stairs) 
without a handrail 
0 1 2 3 4 
7.  Walk while carrying an 
object. 
0 1 2 3 4 
Advanced Activities 
Score 
     
Total Score 
 
     
 
Participant No:  Date:  Test Visit:  
 
 
 
 
 Study Title:  Outcome Measures for Amputees - A Repeatability Study 
Timed up and Go Test 
Test Protocol 
 
1. Test setup 
An upright armchair is positioned in the gym area with a cone placed on the 
floor 3m away directly in front of the chair. 
2. Subject  preparation 
The participant is asked to sit in the chair and position themselves with any 
walking aids ready.  The position of any prosthetic knee joints will be noted as 
either locked or unlocked prior to starting the test and the same position will 
be  taken on any subsequent test. 
3. Explanation of the test 
The following instructions will be given: “Sit with your back against the chair 
and your arms on the armrest.  When I say GO please get up and using your 
walking aid, walk around the cone, then return to the chair and sit back down.  
I am going to be timing, but this is not a race, please go at a pace that’s 
comfortable and safe for you.” 
4. Timing 
Timing will start on the word GO and will stop when the participant’s buttocks 
first touch the seat. 
5. Repetitions 
If the participant is able, the test is repeated 3 times, giving time to recover 
between attempts.  The first attempt is used for familiarisation and checking 
they have understood the instructions.  The second and third times will be 
recorded and the faster of the two will be the score.  Note if only one attempt 
is possible and this will be the score. 
 
Participant No:  Date:  Test Visit:  
 
Attempt No: Knee 
position 
Walking aid 
used 
Time (secs) 
1 
 
   
2 
 
   
3 
 
   
 
Recorded Score (secs)  
 
 
 
 
Study Title:  Outcome Measures for Amputees - A Repeatability Study 
 2min Timed Walk Test 
Test Protocol 
 
1. Test setup 
A hallway free of obstacles with pre-measured distances marked for easy 
calculation of the total distance covered. 
 
2. Subject  preparation 
The position and type of any prosthetic knee joints will be noted at every 
test.  The type of walking aid used will also be noted as applicable. 
 
3. Explanation of the test 
The following instructions will be given to the participant: “Cover as much 
ground as possible over 2 minutes. Walk continuously if possible, but do 
not be concerned if you need to slow down or stop to rest. The goal is to 
feel at the end of the test that more ground could not have been covered 
in the 2 minutes.” 
 
4. Timing 
Timing will start when the participant starts walking and the distance 
covered will be measured at the end of 2 minutes.. 
 
 
Participant No:  Date:  Test Visit:  
 
 
Knee position Walking aid used Time (secs) 
 
 
  
 
 
 
 
 
 
Demographic Data Rehabilitation Study  Version 1 (16/06/13) 
Study Title:  Outcome Measures for Amputees - A Repeatability Study 
Socket Comfort Score 
 
 
Participant No:  Date:  Test Visit:  
 
 
On a scale of 0 – 10,  
if 0 represents the most uncomfortable socket fit you can imagine, 
and 10 represents the most comfortable socket fit,  
how would you score the comfort of the socket fit of your artificial limb 
at the moment 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
 
 
 
 
Demographic Data Rehabilitation Study  Version 1 (16/06/13) 
  
Study Title:  Outcome Measures for Amputees - A Rehabilitation Study 
Demographic Data 
 
Participant 
Number: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GP Name:  _____________________ 
 
GP Address: _____________________ 
 
   _____________________ 
 
   _____________________
Age 
 
  
Cause of Amputation 
 
PVD  
Diabetes  
Trauma  
Tumour  
Other  
Level of Amputation TTA  
TFA  
Prosthetic usage Time since delivery 
of first artificial leg 
 
Other relevant Medical 
History 
PVD  
Diabetes  
Heart Disease  
Vascular Disease  
Blood Pressure  
Neurological 
conditions 
 
Arthritis  
Liver disease  
  
 
 
 
Demographic Data Rehabilitation Study  Version 1 (16/06/13) 
Study Title:  Outcome Measures for Amputees - A Rehabilitation Study 
Activity Change Questionnaire SV2 
 
 
Participant No:  Date:  Study Visit: 2 
 
 
Please indicate, by circling one of the statements below, how you feel your 
current physical ability to perform everyday tasks is today, compared to when 
you first got your artificial leg. 
 
 
Much 
worse 
Slightly 
worse 
The 
same 
Slightly 
better 
Much 
better 
 
 
 
 
 
 
Demographic Data Rehabilitation Study  Version 1 (16/06/13) 
Study Title:  Outcome Measures for Amputees - A Rehabilitation Study 
Activity Change Questionnaire SV4a 
 
 
Participant No:  Date:  Study Visit: 4 
 
 
Please indicate, by circling one of the statements below, how you feel your 
current physical ability to perform everyday tasks is today, compared to  when 
you first got your artificial leg 
 
 
Much 
worse 
Slightly 
worse 
The 
same 
Slightly 
better 
Much 
better 
 
 
 
 
 
 
Demographic Data Rehabilitation Study  Version 1 (16/06/13) 
Study Title:  Outcome Measures for Amputees - A Rehabilitation Study 
Activity Change Questionnaire SV4b 
 
 
Participant No:  Date:  Study Visit: 4 
 
 
Please indicate, by circling one of the statements below, how you feel your 
current physical ability to perform everyday tasks is today, compared to when 
you left hospital. 
 
 
Much 
worse 
Slightly 
worse 
The 
same 
Slightly 
better 
Much 
better 
 
 
 
 
 
 
Demographic Data Rehabilitation Study  Version 1 (16/06/13) 
Study Title:  Outcome Measures for Amputees - A Rehabilitation Study 
SIGAM Mobility Grades 
 
 
Participant No:  Date:  Test Visit:  
 
 
 
SIGAM Mobility 
Grade Recorded 
 
 
 
 
 
SIGAM Algorithm 
Study Title:  Outcome Measures for Amputees - A Rehabilitation Study 
SIGAM mobility grades Algorithm 
 
Guidelines for the use of SIGAM Algorithm 
 
5. Start at the top of page at question 1.  The number beside each box 
corresponds to the same numbered question. 
6. Depending on the answer “YES” or “NO” follow the arrows to assign one 
of Grade A – E. 
7. Once you reach    then that is the grade to be assigned.  
You do not need to proceed, except for Grades C & D to assign a sub-
grade. 
8. Sub-grades (a) – (d) apply depending on what walking aid is used to 
assist walking.  If a patient ticks “Yes” to more than one aid then he/she is 
graded based upon that which provides most support: frame  > 2 
crutches/sticks >  1 crutch/stick > none 
 
 
Reproduced from:  RYALL, N.H., et al, 2003. The SIGAM Mobility Grades: A New Population-Specific Measure for Lower 
Limb Amputees. Disability and Rehabilitation, vol. 25, no. 15, pp. 833-844.  
 
Grade….. 
 
 
 
Study Title:  Outcome Measures for Amputees - A Rehabilitation Study 
LOCOMOTOR CAPABILITIES INDEX - 5  
 
Whether or not you wear your prosthesis, at the present time, would you say that 
you are “able” to do the following activities WITH YOUR PROSTHESIS ON?   
 
Please circle the number that best describes your capability. 
 
ITEM 
NO YES, if 
someone 
helps me 
YES, if 
someone is 
near me 
YES, alone, with 
ambulation aids 
YES, alone, 
without 
ambulation aids 
1.  Get up from a chair 
 
0 1 2 3 4 
2.  Walk in the house  
 
0 1 2 3 4 
3.  Walk outside on even ground 0 1 2 3 4 
4.  Go up the stairs with a 
handrail 
0 1 2 3 4 
5.  Go down the stairs with a 
handrail 
0 1 2 3 4 
6.  Step up a sidewalk curb 
 
0 1 2 3 4 
7.  Step down a sidewalk curb 0 1 2 3 4 
Basic Activities Score 
 
     
1.  Pick up an object from the 
floor (when you are standing up 
with your prosthesis) 
0 1 2 3 4 
2.  Get up from the floor (e.g. if 
you fall) 
0 1 2 3 4 
3.  Walk outside on uneven 
ground (e.g. grass, gravel, 
slope) 
0 1 2 3 4 
4.  Walk outside in inclement 
weather (e.g. snow, rain, ice) 
0 1 2 3 4 
5.  Go up a few steps (stairs) 
without a handrail 
0 1 2 3 4 
6. Go down a few steps (stairs) 
without a handrail 
0 1 2 3 4 
7.  Walk while carrying an 
object. 
0 1 2 3 4 
Advanced Activities 
Score 
     
Total Score 
 
     
 
Participant No:  Date:  Test Visit:  
 
 
 
 
Study Title:  Outcome Measures for Amputees - A Rehabilitation Study 
Timed up and Go Test 
Test Protocol 
 
6. Test setup 
An upright armchair is positioned in the gym area with a cone placed on the 
floor 3m away directly in front of the chair. 
7. Subject  preparation 
The participant is asked to sit in the chair and position themselves with any 
walking aids ready.  The position of any prosthetic knee joints will be noted as 
either locked or unlocked prior to starting the test and the same position will 
be  taken on any subsequent test. 
8. Explanation of the test 
The following instructions will be given: “Sit with your back against the chair 
and your arms on the armrest.  When I say GO please get up and using your 
walking aid, walk around the cone, then return to the chair and sit back down.  
I am going to be timing, but this is not a race, please go at a pace that’s 
comfortable and safe for you.” 
9. Timing 
Timing will start on the word GO and will stop when the participant’s buttocks 
first touch the seat. 
10. Repetitions 
If the participant is able, the test is repeated 3 times, giving time to recover 
between attempts.  The first attempt is used for familiarisation and checking 
they have understood the instructions.  The second and third times will be 
recorded and the faster of the two will be the score.  Note if only one attempt 
is possible and this will be the score. 
 
Participant No:  Date:  Test Visit:  
 
Attempt No: Knee 
position 
Walking aid 
used 
Time (secs) 
1 
 
   
2 
 
   
3 
 
   
 
Recorded Score (secs)  
 
 
 
 
Study Title:  Outcome Measures for Amputees - A Rehabilitation Study 
 2min Timed Walk Test 
Test Protocol 
 
5. Test setup 
A hallway free of obstacles with pre-measured distances marked for easy 
calculation of the total distance covered. 
 
6. Subject  preparation 
The position and type of any prosthetic knee joints will be noted at every 
test.  The type of walking aid used will also be noted as applicable. 
 
7. Explanation of the test 
The following instructions will be given to the participant: “Cover as much 
ground as possible over 2 minutes. Walk continuously if possible, but do 
not be concerned if you need to slow down or stop to rest. The goal is to 
feel at the end of the test that more ground could not have been covered 
in the 2 minutes.” 
 
8. Timing 
Timing will start when the participant starts walking and the distance 
covered will be measured at the end of 2 minutes.. 
 
 
Participant No:  Date:  Test Visit:  
 
 
Knee position Walking aid used Time (secs) 
 
 
  
 
 
 
 
 
 
Study Title:  Outcome Measures for Amputees - A Rehabilitation Study 
Socket Comfort Score 
 
 
Participant No:  Date:  Test Visit:  
 
 
On a scale of 0 – 10,  
if 0 represents the most uncomfortable socket fit you can imagine, 
and 10 represents the most comfortable socket fit,  
how would you score the comfort of the socket fit of your artificial limb 
at the moment 
 
0 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
 
 
 UK (English) v.2 © 2009 EuroQol Group. EQ-5D™ is a trade mark of the EuroQol Group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Health Questionnaire 
 
 
English version for the UK 
 
 
 
 
 UK (English) v.2 © 2009 EuroQol Group. EQ-5D™ is a trade mark of the EuroQol Group 
 
Under each heading, please tick the ONE box that best describes your health TODAY  
 
MOBILITY 
I have no problems in walking about       
I have slight problems in walking about      
I have moderate problems in walking about      
I have severe problems in walking about      
I am unable to walk about        
 
SELF-CARE 
I have no problems washing or dressing myself     
I have slight problems washing or dressing myself     
I have moderate problems washing or dressing myself    
I have severe problems washing or dressing myself    
I am unable to wash or dress myself      
 
USUAL ACTIVITIES (e.g. work, study, housework,  
family or leisure activities) 
I have no problems doing my usual activities     
I have slight problems doing my usual activities     
I have moderate problems doing my usual activities    
I have severe problems doing my usual activities     
I am unable to do my usual activities      
 
PAIN / DISCOMFORT 
I have no pain or discomfort        
I have slight pain or discomfort       
I have moderate pain or discomfort       
I have severe pain or discomfort       
I have extreme pain or discomfort       
 
ANXIETY / DEPRESSION 
I am not anxious or depressed       
I am slightly anxious or depressed       
I am moderately anxious or depressed      
I am severely anxious or depressed       
  
UK (English) v.2 © 2009 EuroQol Group. EQ-5D™ is a trade mark of the EuroQol Group 
 
 
• We would like to know how good or bad your health is  
TODAY. 
• This scale is numbered from 0 to 100. 
• 100 means the best health you can imagine. 
0 means the worst health you can imagine. 
• Mark an X on the scale to indicate how your health is TODAY.  
• Now, please write the number you marked on the scale in the 
box below.  
                     
 
 
 
YOUR HEALTH TODAY  = 
 
 
 
 
 
 
 
 
 
 
 
 
10 
0 
20 
30 
40 
50 
60 
80 
70 
90 
100 
5 
15 
25 
35 
45 
55 
75 
65 
85 
95 
The best health        
 you can imagine 
 
The worst health        
 you can imagine 
 
 
 
 
Appendix 11  
Normality testing results from SPSS 
Study III – Repeatability Study 
 
  
 
 
 
 
 
  
 
 
 
 
 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
SIGAMtv1 .254 12 .032 .851 12 .038 
SIGAMtv2 .199 12 .200* .872 12 .068 
LCI5tv1 .259 12 .025 .782 12 .006 
LCI5tv2 .267 12 .018 .779 12 .005 
TUGtv1 .362 12 .000 .585 12 .000 
TUGtv2 .388 12 .000 .554 12 .000 
Walktesttv1 .199 12 .200* .949 12 .617 
Walktesttv2 .206 12 .172 .939 12 .480 
SCStv1 .261 12 .024 .869 12 .063 
SCStv2 .262 12 .022 .876 12 .077 
EQ5Dindextv1 .262 12 .022 .825 12 .018 
EQ5Dindextv2 .276 12 .012 .795 12 .008 
EQ5DVAStv1 .271 12 .015 .844 12 .031 
EQ5DVAStv2 .250 12 .038 .758 12 .003 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
 
 
 
 
 
 
Appendix 12 
Test visit data 
Study III – Repeatability Study 
 
 
 
  
 
 
 
 
 
 
 
 
 
Test Visit 1 
 
  Visit Date 
SIGAM 
Mobility 
Grade 
Assigned 
scores LCI-5 TUAG 2MTWT SCS 
EQ-5D 
index 
assigned 
score 
EQ-5D 
VAS 
P01R 23/10/2013 E 10 54 11.42 111.70 8 21121 0.767 95 
P02R 31/10/2013 E 10 55 10.17 118.75 9 22222 0.592 80 
P03R 28/11/2013 E 10 52 7.47 150.30 9 11111 1.000 95 
P04R 30/01/2014 Dc 9 50 8.84 122.1 9 22223 0.577 70 
P05R 05/03/2014 E 10 55 9.62 119.1 10 21221 0.735 100 
P06R 03/07/2014 F 11 56 10.1 140 10 11111 1.000 80 
P07R 09/07/2014 E 10 52 10.27 112.4 7 11121 0.837 80 
P08R 13/08/2014 Dc 9 33 15.16 88.6 7 23222 0.575 80 
P09R 27/08/2014 F 11 56 9.78 148.2 8 11111 1.000 80 
P10R 01/10/2014 F 11 56 7.36 161.9 7 11111 1.000 95 
P11R 14/10/2014 Da 7 39 32.05 65.6 9 21221 0.735 95 
P12R 21/10/2014 Dc 9 45 10.55 112.9 9 11111 1.000 100 
 
  
 
 
 
 
Test Visit 2 
  Visit Date 
SIGAM 
Mobility 
Grade 
Assigned 
scores LCI-5 TUAG 2MTWT SCS 
EQ-5D 
index 
assigned 
score 
EQ-5D 
VAS 
P01R 30/10/2013 Dc 9 55 10.55 113.45 9 21121 0.767 95 
P02R 07/11/2013 E 10 55 9.27 129.60 9 11111 1.000 80 
P03R 05/12/2013 E 10 53 7.95 142.65 9 11111 1.000 95 
P04R 06/02/2014 Dc 9 47 7.87 135.7 5 22342 0.348 35 
P05R 12/03/2014 E 10 52 10.23 105.8 10 21231 0.710 100 
P06R 10/07/2014 F 11 56 10.47 140 10 11111 1.000 70 
P07R 16/07/2014 E 10 52 10.64 126.5 7 11121 0.837 90 
P08R 20/08/2014 Dc 9 30 13.59 89 8 22222 0.592 80 
P09R 03/09/2014 F 11 56 9.16 143.8 9 11111 1.000 80 
P10R 08/10/2014 F 11 56 7.96 160.7 8 11111 1.000 95 
P11R 21/10/2014 Da 7 41 30.24 72.65 7 12111 0.846 95 
P12R 27/10/2014 Dc 9 47 9.91 128.9 9 11111 1.000 90 
 
 
 
 
 
Appendix 13  
Normality testing results from SPSS  
Study IV – Longitudinal Cohort Study 
  
 
 
 
 
 
  
 
 
 
 
 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
SIGAMsv1 .458 23 .000 .618 23 .000 
SIGAMsv2 .369 23 .000 .728 23 .000 
SIGAMsv3 .319 23 .000 .803 23 .000 
a. Lilliefors Significance Correction 
 
 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
LCIsv1 .169 23 .085 .894 23 .019 
LCIsv2 .159 23 .136 .919 23 .065 
LCIsv3 .140 23 .200* .904 23 .031 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
TUGsv1 .152 22 .200* .940 22 .197 
TUGsv2 .243 22 .002 .870 22 .008 
TUGsv3 .155 22 .186 .901 22 .032 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Walktestsv1 .144 22 .200* .940 22 .198 
Walktestsv2 .181 22 .059 .911 22 .049 
Walktestsv3 .121 22 .200* .940 22 .195 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
 
 
 
 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
SCSsv1 .259 23 .000 .906 23 .034 
SCSsv2 .270 23 .000 .865 23 .005 
SCSsv3 .250 23 .001 .892 23 .018 
a. Lilliefors Significance Correction 
 
 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
EQ5Dindexsv1 .112 23 .200* .978 23 .864 
EQ5Dindexsv2 .109 23 .200* .969 23 .670 
EQ5Dindexsv3 .139 23 .200* .925 23 .087 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
 
Tests of Normality 
 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
EQ5DVASsv1 .159 23 .135 .940 23 .184 
EQ5DVASsv2 .184 23 .043 .868 23 .006 
EQ5DVASsv3 .136 23 .200* .961 23 .490 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
 
 
 
 
 
 
 
 
 
Appendix 14  
ROC curve graphs from SPSS 
  
 
 
 
 
 
  
 
 
 
 
SIGAM TI1 
 
 
 
Coordinates of the Curve 
Test Result Variable(s):   SIGAMdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-5.0000 1.000 1.000 
-2.0000 1.000 .889 
.5000 .667 .556 
2.5000 .500 .444 
5.0000 .000 .000 
The test result variable(s): SIGAMdiff has at least one tie between the positive actual state group and the 
negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is the 
maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
  
Area Under the 
Curve 
.565 
 
 
 
 
 
SIGAM TI2 
 
 
 
Coordinates of the Curve 
Test Result Variable(s):   SIGAMdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-5.0000 1.000 1.000 
-3.5000 .950 1.000 
-2.5000 .900 1.000 
-1.0000 .850 .667 
.5000 .500 .000 
1.5000 .300 .000 
3.0000 .250 .000 
4.5000 .150 .000 
6.0000 .000 .000 
The test result variable(s): SIGAMdiff has at least one tie between the positive actual state group and the 
negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is 
the maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
 
  
Area Under the 
Curve 
.742 
 
 
 
 
SIGAM TI3 
 
 
 
Coordinates of the Curve 
Test Result Variable(s):   SIGAMdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-4.0000 1.000 1.000 
-2.5000 1.000 .889 
-1.0000 1.000 .778 
.5000 .882 .778 
1.5000 .647 .444 
3.0000 .529 .444 
4.5000 .176 .333 
6.0000 .000 .000 
The test result variable(s): SIGAMdiff has at least one tie between the positive actual state group and the 
negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is 
the maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
  
Area Under the 
Curve 
.546 
 
 
 
 
LCI-5 TI1 
 
 
Coordinates of the Curve 
Test Result Variable(s):   LCI5diff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-2.0000 1.000 1.000 
-.5000 1.000 .778 
.5000 .944 .667 
1.5000 .778 .556 
2.5000 .667 .444 
3.5000 .556 .444 
4.5000 .444 .333 
5.5000 .389 .333 
7.0000 .333 .222 
8.5000 .333 .111 
9.5000 .333 .000 
11.5000 .278 .000 
16.0000 .222 .000 
20.0000 .167 .000 
21.5000 .111 .000 
23.0000 .056 .000 
25.0000 .000 .000 
The test result variable(s): LCI5diff has at least one tie between the positive actual state group and the 
negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is the 
maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
  
Area Under the 
Curve 
.676 
 
 
 
 
LCI-5 TI2 
 
 
Coordinates of the Curve 
Test Result Variable(s):   LCI5diff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-8.0000 1.000 1.000 
-6.5000 1.000 .667 
-4.5000 .950 .667 
-2.5000 .900 .667 
-1.5000 .850 .333 
.0000 .700 .333 
1.5000 .600 .333 
2.5000 .500 .333 
3.5000 .450 .333 
4.5000 .400 .333 
6.5000 .300 .333 
9.0000 .250 .333 
11.0000 .200 .333 
12.5000 .200 .000 
13.5000 .150 .000 
14.5000 .100 .000 
17.0000 .050 .000 
20.0000 .000 .000 
The test result variable(s): LCI5diff has at least one tie between the positive actual state group and the 
negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is 
the maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
  
Area Under the 
Curve 
.692 
 
 
 
 
LCI-5 TI3 
 
 
 
Coordinates of the Curve 
Test Result Variable(s):   LCI5diff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
.0000 1.000 1.000 
1.5000 .824 1.000 
2.5000 .824 .889 
3.5000 .765 .889 
4.5000 .765 .667 
6.0000 .765 .444 
8.5000 .647 .444 
11.0000 .529 .444 
12.5000 .412 .333 
13.5000 .235 .222 
14.5000 .176 .222 
17.0000 .118 .222 
21.0000 .118 .111 
24.5000 .059 .111 
32.5000 .059 .000 
40.0000 .000 .000 
The test result variable(s): LCI5diff has at least one tie between the positive actual state group and the 
negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is 
the maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
  
Area Under the 
Curve 
.539 
 
 
 
 
TUG TI1 
 
 
Coordinates of the Curve 
Test Result Variable(s):   TUGdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-22.7000 1.000 1.000 
-20.1000 .944 1.000 
-17.6800 .889 1.000 
-16.5250 .833 1.000 
-15.7000 .778 1.000 
-14.6100 .778 .889 
-13.9200 .722 .889 
-13.1400 .667 .889 
-12.3100 .667 .778 
-12.0850 .611 .778 
-11.6650 .556 .778 
-10.7400 .500 .778 
-9.2950 .444 .778 
-8.4200 .389 .778 
-8.2300 .389 .667 
-7.2550 .389 .556 
-6.2000 .333 .556 
-5.6150 .333 .444 
-5.2750 .278 .444 
-5.0500 .278 .333 
-4.8000 .222 .333 
-4.2800 .167 .333 
Area Under the 
Curve 
.346 
 
 
 
 
-2.5650 .167 .222 
-1.2150 .111 .222 
-.3150 .111 .111 
1.2200 .056 .111 
6.8400 .000 .111 
12.7000 .000 .000 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is the 
maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
 
TUG TI2 
 
Coordinates of the Curve 
Test Result Variable(s):   TUGdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-20.1700 1.000 1.000 
-19.0850 .947 1.000 
-18.4850 .895 1.000 
-15.7000 .895 .667 
-12.3850 .895 .333 
-9.6450 .842 .333 
-7.9200 .789 .333 
-7.7400 .737 .333 
-7.2500 .684 .333 
-6.6100 .632 .333 
-6.1600 .579 .333 
-5.7200 .526 .333 
Area Under the 
Curve 
.754 
 
 
 
 
-4.9700 .474 .333 
-4.2300 .474 .000 
-3.4700 .421 .000 
-2.4850 .368 .000 
-1.6600 .316 .000 
-1.3050 .263 .000 
-.7700 .211 .000 
-.0450 .158 .000 
.4900 .105 .000 
6.2600 .053 .000 
12.7200 .000 .000 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is 
the maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
 
 
TUG TI3 
 
  
Coordinates of the Curve 
Test Result Variable(s):   TUGdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-36.8600 1.000 1.000 
-31.9900 1.000 .857 
-25.5400 1.000 .714 
-22.0900 .941 .714 
-20.2900 .882 .714 
-18.8500 .824 .714 
Area Under the 
Curve 
.504 
 
 
 
 
-18.3250 .765 .714 
-17.3500 .706 .714 
-15.7750 .647 .714 
-14.9350 .588 .714 
-14.3750 .529 .714 
-13.6250 .471 .714 
-13.1850 .471 .571 
-12.7950 .471 .429 
-12.2200 .412 .429 
-10.4700 .353 .429 
-8.1100 .294 .429 
-7.0500 .235 .429 
-6.4250 .235 .286 
-5.5050 .235 .143 
-3.7400 .176 .143 
-2.1200 .118 .143 
-1.4450 .118 .000 
2.6400 .059 .000 
7.4400 .000 .000 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is 
the maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
  
 
 
 
 
2MWT TI1 
  
 
 
Coordinates of the Curve 
Test Result Variable(s):   Walktestdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-20.1000 1.000 1.000 
-17.3000 .944 1.000 
-8.3500 .944 .889 
-.6000 .944 .778 
1.3750 .889 .667 
3.7250 .833 .667 
4.7500 .778 .667 
5.5250 .778 .556 
6.5000 .722 .556 
6.7750 .667 .556 
7.2500 .611 .556 
9.3000 .556 .556 
11.6750 .500 .556 
12.6500 .444 .556 
13.4500 .389 .556 
15.0750 .389 .444 
16.8500 .333 .444 
19.0500 .278 .444 
21.2750 .222 .444 
22.1250 .167 .444 
25.7500 .111 .444 
31.2000 .111 .333 
37.3750 .056 .333 
Area Under the 
Curve 
.466 
 
 
 
 
47.3750 .056 .222 
57.9000 .056 .111 
65.1500 .000 .111 
68.6000 .000 .000 
The test result variable(s): Walktestdiff has at least one tie between the positive actual state group and the 
negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is the 
maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
 
 
2MWT TI2 
 
 
Coordinates of the Curve 
Test Result Variable(s):   Walktestdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-39.0500 1.000 1.000 
-23.3500 .947 1.000 
-8.2000 .895 1.000 
-5.3750 .842 1.000 
-1.2500 .842 .667 
.8500 .789 .667 
1.9500 .789 .333 
4.4000 .737 .333 
8.2000 .737 .000 
10.8250 .684 .000 
11.4250 .632 .000 
14.3250 .579 .000 
Area Under the 
Curve 
.789 
 
 
 
 
18.1250 .526 .000 
19.7500 .474 .000 
20.7500 .421 .000 
22.6000 .368 .000 
25.8500 .316 .000 
29.2250 .263 .000 
31.9750 .211 .000 
41.1750 .105 .000 
58.5750 .053 .000 
68.9000 .000 .000 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is 
the maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
 
 
2MWT TI3 
 
 
 
Coordinates of the Curve 
Test Result Variable(s):   Walktestdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-32.3000 1.000 1.000 
-24.9000 .941 1.000 
-12.2000 .941 .857 
-.4500 .882 .857 
7.0500 .824 .857 
10.3000 .765 .857 
12.2000 .706 .857 
Area Under the 
Curve 
.445 
 
 
 
 
17.5750 .706 .714 
22.4000 .647 .714 
26.0750 .647 .571 
31.2250 .588 .571 
33.5750 .529 .571 
35.7500 .471 .571 
37.5500 .412 .571 
39.3500 .353 .571 
41.0500 .294 .571 
41.4750 .294 .429 
46.5000 .235 .429 
53.1500 .235 .286 
55.3750 .235 .143 
56.8500 .176 .143 
66.2250 .118 .143 
76.5500 .059 .143 
107.0250 .059 .000 
136.5000 .000 .000 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is the 
maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
 
  
 
 
 
 
SCS TI1 
 
 
Coordinates of the Curve 
Test Result Variable(s):   SCSdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-5.0000 1.000 1.000 
-3.5000 .889 1.000 
-2.5000 .833 1.000 
-1.5000 .778 1.000 
-.5000 .722 .778 
.5000 .333 .556 
2.0000 .056 .333 
3.5000 .000 .222 
4.5000 .000 .111 
6.0000 .000 .000 
The test result variable(s): SCSdiff has at least one tie between the positive actual state group and the 
negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is 
the maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
 
  
Area Under the 
Curve 
.330 
 
 
 
 
SCS TI2 
 
 
 
 
Coordinates of the Curve 
Test Result Variable(s):   SCSdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-4.0000 1.000 1.000 
-2.5000 .950 .667 
-1.5000 .900 .667 
-.5000 .750 .667 
.5000 .300 .667 
1.5000 .250 .333 
2.5000 .200 .333 
3.5000 .100 .333 
5.0000 .000 .333 
7.0000 .000 .000 
The test result variable(s): SCSdiff has at least one tie between the positive actual state group and the 
negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is 
the maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
  
Area Under the 
Curve 
.417 
 
 
 
 
SCS TI3 
 
 
 
Coordinates of the Curve 
Test Result Variable(s):   SCSdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-5.0000 1.000 1.000 
-3.5000 .941 1.000 
-2.0000 .824 1.000 
-.5000 .824 .750 
.5000 .588 .625 
1.5000 .471 .375 
2.5000 .176 .125 
3.5000 .059 .125 
4.5000 .000 .125 
6.0000 .000 .000 
The test result variable(s): SCSdiff has at least one tie between the positive actual state group and the 
negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is 
the maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
  
Area Under the 
Curve 
.507 
 
 
 
 
EQ-5D-index TI1 
  
 
 
 
Coordinates of the Curve 
Test Result Variable(s):   EQ5Dindexdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-1.2330 1.000 1.000 
-.1510 .944 1.000 
-.0625 .944 .889 
-.0480 .889 .889 
-.0350 .889 .778 
-.0150 .833 .778 
.0085 .667 .778 
.0245 .611 .778 
.0365 .611 .667 
.0440 .556 .556 
.0520 .500 .556 
.0635 .500 .444 
.0725 .500 .333 
.0780 .500 .222 
.0835 .444 .222 
.0890 .389 .222 
.0980 .333 .222 
.1080 .333 .111 
.1280 .278 .111 
.1970 .222 .111 
.2530 .167 .111 
.3310 .111 .111 
.4320 .111 .000 
Area Under the 
Curve 
.552 
 
 
 
 
.4815 .056 .000 
1.5050 .000 .000 
The test result variable(s): EQ5Dindexdiff has at least one tie between the positive actual state group and 
the negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is the 
maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
 
 
EQ-5D-index TI2 
 
 
 
Coordinates of the Curve 
Test Result Variable(s):   EQ5Dindexdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-1.4700 1.000 1.000 
-.4205 .950 1.000 
-.3590 .900 1.000 
-.2375 .850 1.000 
-.1185 .800 1.000 
-.0905 .750 1.000 
-.0695 .700 1.000 
-.0540 .650 1.000 
-.0215 .650 .667 
-.0010 .600 .667 
.0005 .500 .667 
.0070 .450 .667 
.0265 .400 .667 
Area Under the 
Curve 
.333 
 
 
 
 
.0410 .300 .333 
.0430 .250 .333 
.0690 .200 .333 
.0960 .150 .333 
.0990 .100 .333 
.1225 .050 .333 
.1985 .000 .333 
1.2520 .000 .000 
The test result variable(s): EQ5Dindexdiff has at least one tie between the positive actual state group and 
the negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is 
the maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
 
 
EQ-5D-index TI3 
 
 
  
Coordinates of the Curve 
Test Result Variable(s):   EQ5Dindexdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-1.7030 1.000 1.000 
-.5865 1.000 .889 
-.2990 1.000 .778 
-.1215 .882 .778 
-.0720 .824 .778 
-.0240 .765 .778 
-.0095 .706 .778 
Area Under the 
Curve 
.549 
 
 
 
 
.0095 .647 .556 
.0245 .588 .556 
.0315 .588 .444 
.0370 .529 .444 
.0450 .471 .444 
.0610 .412 .444 
.0915 .353 .444 
.1105 .353 .333 
.1130 .294 .333 
.1245 .294 .222 
.1680 .294 .111 
.2465 .235 .111 
.3120 .176 .111 
.3415 .118 .111 
.4000 .059 .111 
.5245 .059 .000 
1.5990 .000 .000 
The test result variable(s): EQ5Dindexdiff has at least one tie between the positive actual state group and 
the negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is 
the maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
  
 
 
 
 
EQ-5D-VAS TI1 
  
 
 
 
Coordinates of the Curve 
Test Result Variable(s):   EQ5DVASdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-36.0000 1.000 1.000 
-25.0000 .944 1.000 
-10.0000 .944 .889 
-2.5000 .833 .889 
1.0000 .611 .778 
2.5000 .611 .667 
3.5000 .611 .556 
4.5000 .556 .556 
6.5000 .333 .333 
9.0000 .278 .333 
12.5000 .167 .111 
17.5000 .111 .000 
21.0000 .000 .000 
The test result variable(s): EQ5DVASdiff has at least one tie between the positive actual state group and 
the negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is the 
maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
 
  
Area Under the 
Curve 
.485 
 
 
 
 
EQ-5D-VAS TI2 
 
 
 
Coordinates of the Curve 
Test Result Variable(s):   EQ5DVASdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-21.0000 1.000 1.000 
-17.5000 .900 1.000 
-12.5000 .800 .667 
-9.0000 .650 .333 
-6.5000 .600 .333 
-4.5000 .450 .000 
-2.5000 .400 .000 
-.5000 .350 .000 
2.5000 .250 .000 
6.5000 .150 .000 
11.5000 .100 .000 
22.5000 .050 .000 
31.0000 .000 .000 
The test result variable(s): EQ5DVASdiff has at least one tie between the positive actual state group and 
the negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is the 
maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
 
  
Area Under the 
Curve 
.700 
 
 
 
 
EQ-5D-VAS TI2 
 
 
 
 
Coordinates of the Curve 
Test Result Variable(s):   EQ5DVASdiff   
Positive if Greater Than or Equal Toa Sensitivity 1 - Specificity 
-21.0000 1.000 1.000 
-17.5000 .941 1.000 
-12.5000 .882 1.000 
-7.5000 .824 .889 
-2.5000 .647 .556 
1.0000 .471 .333 
3.5000 .412 .333 
7.5000 .353 .111 
17.5000 .059 .000 
26.0000 .000 .000 
The test result variable(s): EQ5DVASdiff has at least one tie between the positive actual state group and 
the negative actual state group. 
a. The smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is 
the maximum observed test value plus 1. All the other cutoff values are the averages of two consecutive 
ordered observed test values. 
 
 
Area Under the 
Curve 
.572 
Appendix 15  
Correlation Plots: ACQ vs differences 
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